Nuevas plataformas analíticas en metabolómica by Álvarez Sánchez, Beatriz

TÍTULO: Nuevas plataformas analíticas en metabolómica
AUTOR: Beatriz Álvarez Sánchez
© Edita: Servicio de Publicaciones de la Universidad de Córdoba. 2012
Campus de Rabanales
Ctra. Nacional IV, Km. 396 A
14071 Córdoba
www.uco.es/publicaciones
publicaciones@uco.es
  
  
  
 
 
 
UNIVERSIDAD DE CÓRDOBA 
 
 
 
FACULTAD DE CIENCIAS 
DEPARTAMENTO DE QUÍMICA ANALÍTICA 
 
 
NUEVAS PLATAFORMAS ANALÍTICAS EN METABOLÓMICA  
 
 
NEW ANALYTICAL PLATFORMS IN METABOLOMICS 
 
 
 
 
 
Beatriz Álvarez Sánchez 
Córdoba, enero de 2012 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                     
            
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
Mediante la defensa de esta Memoria se pretende optar a la mención de 
Doctora Europea, habida cuenta de que la doctoranda reúne los 
requisitos exigidos para tal mención, a saber: 
 
1. Informes favorables de dos doctores pertenecientes a 
Instituciones de Enseñanza Superior de otros países europeos: 
 Prof. Dr. Carlos Cordeiro, Departamento de Química e 
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 Prof. Dr. Walter Jäger, Department of Clinical Pharmacy and 
Diagnostics, University of Vienna, Austria. 
 
2. Uno de los miembros del tribunal que ha de evaluar la Tesis 
pertenece a un centro de Enseñanza Superior de otro país 
europeo: 
 Prof. Dr. Oleg Mayboroda, Leiden University Medical Center, 
Biomolecular Mass Spectrometry Unit, Leiden, The Nederlands. 
 
3. La defensa de parte de esta Memoria se realizará en la lengua 
oficial de otro país europeo: Inglés. 
 
4. Estancia de tres meses en un centro de investigación de otro país 
europeo: 
 Biomedical Proteomics Group (BPRG) dirigido por el Prof. Jean-
Charles Sánchez, Department of Structural Biology and 
Bioinformatics Faculty of Medicine, University of Geneva, 
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Objetivos 
   
Objetivos 
 
El crecimiento exponencial que ha experimentado la metabolómica 
en los últimos años es un hecho incuestionable, debido a su significativa 
aportación en áreas de dominio exclusivo de ómicas desarrolladas con 
anterioridad; lo que pone de manifiesto que se trata de una disciplina 
totalmente aceptada por la comunidad científica. 
De las estrategias típicas de la metabolómica (análisis orientado o 
“targeting analysis”, perfil metabolómico global o “global metabolomics 
profiling” y huella metabólica dactilar o “metabolomics fingerprinting”) cada 
una de ellas está orientada a la obtención de un tipo de información 
característico. Dado el interés de estas estrategias, el objetivo genérico 
planteado al inicio de la investigación que constituye la presente Tesis 
Doctoral fue realizar aportaciones utilizando cada una de estas estrategias 
para contribuir a eliminar las lagunas existentes en metabolómica, de forma 
que se incremente la posibilidad de resolución de problemas por ella misma 
o integrada con otras ómicas (biología de sistemas). 
Apoyada en el equipamiento analítico del grupo de investigación en 
el que se integra la doctoranda {sistemas miniaturizados de preparación de 
muestra (laboratorio en una válvula, lab-on-valve o LOV), estaciones 
automáticas de extracción en fase sólida (SPE) acopladas en línea con 
cromatografía líquida (LC) o microcromatografía líquida (μ-LC) con detector 
de fluorescencia inducida por láser (LIF), de masas de triple cuadrupolo 
(QqQ), o de tiempo de vuelo–masas (TOF/MS); cromatografía de gases con 
detector de captura electrónica (GC–ECD); o en colaboración con otros 
grupos cuando no se ha dispuesto del equipo adecuado (espectrometría de 
resonancia magnética nuclear —NMR, espectrometría de infrarrojo cercano, 
NIRS), así como en la búsqueda y estudio de la información bibliográfica 
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sobre metabolómica, se planificaron los siguientes objetivos concretos, que 
se fueron materializando y se recogen en los diferentes capítulos que 
componen esta Memoria:  
1. Revisar de forma exhaustiva y crítica las etapas previas —desde el 
muestreo hasta la introducción en el analizador— al análisis mediante 
cualquiera de las estrategias en metabolómica. La experiencia del grupo en 
el que se integra la doctoranda en la preparación de la muestra y su 
formación personal en este ámbito han dado como resultado las dos 
publicaciones que se recogen como Capítulos 1 y 2. 
Los objetivos concretos en investigación de laboratorio se dividieron 
en función de la estrategia utilizada. Así, en análisis orientado los objetivos 
fueron: 
2. Innovar en la preparación de muestras clínicas, tanto con el diseño 
de las etapas a escala micro (utilizando estaciones LOV), como en su 
aceleración mediante el uso de energías auxiliares, como ultrasonidos. Tras 
la adecuada preparación de la muestra, la etapa de análisis mediante LC–
QqQ permite la cuantificación de familias de analitos diana en muestras 
complejas, como orina, y la orientación a analitos de interés clínico, como 
hormonas femeninas de tipo esteroide, dando lugar a la investigación que 
constituye los Capítulos 3 y 4.  
3. Llevar a cabo la determinación sensible y selectiva de compuestos 
lipídicos apolares, como los precursores de esfingolípidos, en suero y orina, 
mediante la automatización completa de la preparación de muestra 
(incluyendo extracción y derivatización) previa a la separación 
individual/detección mediante μ-LC–LIF.  
4. Desarrollar automáticamente el análisis completo mediante un 
acoplamiento en línea de la etapa de SPE con la separación cromatográfica y 
la detección por QqQ fue otro de los objetivos cumplidos (Capítulo 6). 
Validar el método mediante su aplicación a diferentes fluidos biológicos 
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(orina, suero y leche materna) fue otro de los logros perseguido y 
conseguido en esta investigación. 
5. Innovar en la preparación de muestras vegetales para su análisis 
por CG mediante la reducción drástica —con auxilio de ultrasonidos— del 
tiempo requerido para esta etapa. Tras esta mejora drástica, los analitos 
(ácidos haloacéticos) se determinan mediante GC–ECD (Capítulo 7).  
6. Obtener información amplia y complementaria sobre las familias 
de compuestos típicas del tomate mediante análisis orientados múltiples fue 
el objetivo cuyo desarrollo se recoge en el Capítulo 8. Partir de muestras 
liofilizadas y utilizar ultrasonidos para acelerar–mejorar la preparación de 
un extracto en el que determinar carotenoides y fenoles mediante LC–QqQ y 
mono- y disacáridos mediante GC–MS/MS constituyó el grueso de la 
planificación. La información obtenida y los métodos para llevarla a cabo se 
consideran de gran interés en el área agrícola dentro de programas de 
mejora de cultivos.   
Los objetivos concretos de la investigación recogida en los Capítulos 
9–10 fueron la obtención de perfiles metabólicos globales en fluidos 
humanos, en su mayor parte poco estudiados, como es el caso de la leche y la 
saliva. Estos objetivos fueron los siguientes: 
7. Proporcionar un método óptimo para el análisis metabolómico de 
saliva teniendo en cuenta los estudios que señalan el interés clínico de este 
biofluido para la búsqueda de biomarcadores de ciertas enfermedades. La 
comparación de diferentes protocolos de preparación de muestra y la  
obtención de su perfil metabólico por LC–TOF/MS fueron los aspectos más 
destacados, tal como se recoge en el Capítulo 9. Conseguir un protocolo de 
preparación de muestra óptimo que permitiera determinar un número 
grande de compuestos identificados (azúcares, lípidos, aminoácidos, 
antioxidantes, etc.), de muchos de los cuales no se había encontrado 
información en la bibliografía, constituía el hito más destacado de este 
objetivo. 
                                          Nuevas plataformas analíticas en metabolómica                                                                                      
 6 
8. Desarrollar y comparar diferentes protocolos de preparación de la 
muestra de leche materna para conseguir, mediante LC–TOF/MS, un perfil 
metabolómico lo más completo posible (Capítulo 10), que permita la 
evaluación nutricional de este biofluido. La  separación de las fases polar y 
no polar y el estudio de cada una de ellas en los modos positivo y negativo  
para obtener un perfil amplio de esta muestra poco estudiada, y el análisis 
directo mediante RMN, menos resolutivo, pero complementario estuvo 
dentro de lo planificado en este caso. 
9. La investigación recogida en los Capítulos 11–13 completa los 
objetivos concretos perseguidos, ya que está dedicada al análisis de huellas 
dactilares metabolómicas. Esta estrategia constituye una herramienta 
idónea para llevar a cabo la comparación genérica de espectros de 
poblaciones amplias obtenidos con diferentes técnicas y que, tras un 
indispensable, generalmente amplio, tratamiento quimiométrico, 
proporciona información de enorme interés para detectar–identificar 
variaciones o diferencias entre los miembros de la población en estudio. 
La población seleccionada para esta investigación (compuesta por 
individuos obesos a los que se administraron de forma controlada 
desayunos  preparados con cuatro tipos de aceites sometidos a fritura con 
diferente tipo y concentración de antioxidantes) proporcionó muestras de 
orina que constituyeron la diana de esta investigación, dedicada a: 
10. Proporcionar diferentes niveles de información para la 
comparación del efecto de la ingesta de cada uno de los desayunos en el 
metabolismo de los individuos que formaban la población en estudio. Para 
ello se planificó la utilización de  3 tipos de técnicas analíticas que han dado 
lugar a cada uno de los capítulos que forman este bloque. Así, NIRS —una 
técnica que se caracteriza por la alta frecuencia de análisis, reducido coste 
de análisis y facilidad de uso— permite el desarrollo de modelos 
quimiométricos con capacidad de predicción de la ingesta de cada uno de los 
desayunos administrados (Capítulo 11). Por otra parte, NMR, permite 
generar huellas dactilares para la discriminación temporal entre muestras, 
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así como la identificación básica de familias de metabolitos significativos 
(Capítulo 12). Finalmente, LC–TOF/MS constituye una plataforma que 
proporciona el nivel de información más avanzado para la identificación de 
metabolitos con mayor significado estadístico, a la vez que posee una 
enorme capacidad de discriminación (Capítulo 13). 
11. La formación de la futura doctora, que constituye el objetivo 
último de toda tesis doctoral, ha incluido el máster en “Química Fina”, en el 
que la doctoranda ha cursado el número de créditos correspondientes. 
Paralelamente a la investigación recogida en la parte principal de la 
Memoria, se ha pretendido una formación más amplia de la doctoranda con 
la realización de otras actividades que se recogen como anexos, tales como: 
Capítulo de la “Encyclopedia of Analytical Chemistry” sobre 
plataformas analíticas en metabolómica, estrechamente relacionado con el 
tema de la Tesis. (Anexo I). 
Investigación simultánea con la de la tesis realizada en colaboración 
con otros grupos de la UCO. (Anexo II). 
Capítulo del libro “Advances in Flow Injection Analysis and Related 
Techniques”, sobre separaciones mediante filtración y extracción líquido–
líquido basadas en membranas. (Anexo III). 
Comunicaciones en conferencias nacionales e internacionales (Anexo 
IV). 
Cursos de formación especializada en técnicas de análisis (HPLC y 
NIR) y en técnicas quimiométricas para el diseño y optimización de 
experimentos (Anexo V). 
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Objectives 
 
The exponential growing of Metabolomics in the last years is an irrefutable 
fact that shows the significant and accepted contribution of this discipline to a broad 
variety of field of research, together with other older omics. 
Among the typical strategies in metabolomics (targeting analysis, global 
metabolomics profile and fingerprinting), each of them is focused on obtaining a 
characteristic type of information. Taking into acount the interest of these 
strategies, the general objective in planning the research to be developed was to use  
of them to contribute to fill the existing gaps in metabolomics, in order to increase 
the possibility to solve the existing problems, by metabolomics itself or integrated 
with other omics (systems biology). 
Supported by the analytical equipment of the research team where the PhD  
student is integrated {miniaturized systems for sample preparation (lab-on-valve or 
LOV), automatic stations for solid-phase extraction (SPE) on line coupled to liquid 
chromatography (LC), or liquid microchromatography (μ-LC) with laser-induced 
fluorescence detector (LIFD), triple-quad mass detector (QqQ), or time-of-flight–
mass detector (TOF/MS); gas chromatography with electron capture detector (GC–
ECD}; o in colaboration with other groups when suitable equipment was not 
available in the laboratory of the group of the PhD student (nuclear magnetic 
resonance, NMR, near-infrarred spectroscopy, NIRS); as well as the searching for 
and exhaustive study of the bibliographic information on metabolomics, the 
following specific objectives were planned; then, they were carried out and 
constitute the different chapters of this book: 
1. To review, in an exhaustive and critical manner, the previous steps —
from sampling to insertion into the analyzer— to analysis by the metabolomics 
strategies. The experience in sample preparation of the group where the PhD 
student is integrated and her personal formation in this field have yielded two 
publications, which constitute Chapters 1 and 2.  
The specific objectives in laboratory research were classified as a function 
of the given strategy. Thus, in targeting analysis, the objectives were as follows: 
                                          Nuevas plataformas analíticas en metabolómica   
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2. To innovate in sample preparation of clinical simples, both by the design 
of microscale steps (by using LOV stations) and by accelerating them with the 
assistance of auxiliary energies such as ultrasound. After sample preparation, the 
analysis by LC–QqQ allowed application of the resulting method to complex samples 
such as urine for the determination of femail hormones of steroid type, giving place 
to the research which constitutes Chapters 3 and 4.   
3. To determine, in a sensitive and selective manner, lipidic non-polar 
compounds, such as sphingolipid precursos, in serum and urine with the complete 
automatization of simple preparation (including extraction and derivatization) prior 
to individual separation and detection by μ-LC–LIF. 
 4. To develop the entire analysis in an automatic way by coupling on-line 
the SPE step with the chromatographic separation and detection by QqQ was other 
of the fulfilled objectives (Chapter 6). To validate the method by application to 
different biological fluids (urine, serum and breast milk) was another pursued 
achievement in this research.  
5. To innovate in sample preparation involving vegetal samples for 
subsequent introduction into GC was an objective achieved by a drastic reduction of 
the time required for this step with the help of ultrasound. After this drastic 
improvement, the analytes (haloacetic acids) are determined by GC–ECD (Chapter 
7).  
6. To obtain wide and complementary information on other families of 
typical compounds in tomato by multiple targeting analyses was the objective of the 
research in Chapter 8. An extract from lyophilized samples (also with the help of 
ultrasound) was used for determination of carotenoids and phenols by LC–QqQ, and 
mono- and disaccharides by GC–MS/MS. The information thus obtained, with no 
similar precedent in the literature, and the methods for its development are of great 
interest in the agriculture programs to improve this field.  
 
The concrete objetives of the research in Chapters 9 and 10 were to obtain 
global metabolomics profiles in human fluids, mainly those scarcely studied, as is 
the case of breast milk and saliva. Therefore, the objectives were: 
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7. To provide an optimum method for sample preparation of saliva, prior to 
obtaining its metabolomic profile by LC−TOF/MS, as shown in Chapter 9.  To 
identify a wide number of compounds, extending the previous knowledge about 
composition of this biofluid, was also a milestone of this research.  
8. To develop and compare different protocols for sample preparation of 
breast milk in order to achieve, by LC–TOF/MS, a metabolomics profile as complete 
as posible (Chapter10). Separation of polar and non-polar phases and the study of 
each in the positive and negative ionization modes would provide a wide profile of 
this poorly studied sample, which could be completed by direct analysis by NMR, 
less resolutive than LC–TOF/MS,. 
9. The research in Chapters 11–13 completes the concrete objectives, as it 
was devoted to the analysis of metabolomics fingerprintings. This strategy 
constitutes a suitable tool to carry out generic comparison of spectra from wide 
populations, which can be obtained by different techniques. After a thorough, 
mandatory chemometrics treatment, the comparisons provide suitable information 
to detect–identify changes and/or differences among the members of the population 
under study. 
The population selected to implement this research was integrated by 
obese individuals, who ingested, in a controlled design, breakfasts prepared with 
four frying oils with different type and concentration of antioxidants. The target 
individuals provided urine samples which were the target of this research, which 
had as main aim: 
 10. To provide different information levels to compare the intake effect of 
each breakfast in the metabolism of the individuals forming the population under 
study. With this aim, three types of analytical techniques was planned to be used, 
the research developed with each constituting one of the chapters which make this 
part of the book. Thus, NIRS, a technique characterized by a high frequency of 
analysis, small analysis costs and easy handling, allows the development of  
chemometric models capable for predicting the intake of each of the supplied 
breakfasts (Chapter 11). The second technique, NMR, allows generation of 
fingerprintings for temporary discrimination among samples, as well as basic 
identification of significant metabolite families (Chapter 12). Finally, LC–TOF/MS 
constitutes an instrumental platform capable of providing a higher information level 
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for identification of analytes with more statistical significance, together with an 
excellent capacity for discrimination (Chapter 13). 
11. Formation of the future doctor, which constitutes the final objective of a 
doctoral thesis, has also included a master on “Fine Chemistry”. Simultaneously to 
the research which constitutes the main part of this book, a wider formation of the 
PhD student was pursued by participation in other activities, included in the book as 
annexes, such as:  
Chapter of the “Encyclopedia of Analytical Chemistry” on analytical 
platforms in metabolomics, closely related to the thesis subject. (Annex I). 
Research simultaneous with that of  the thesis resulting from collaborations 
with other groups in UCO. (Annex II). 
Chapter of the book “Advances in Flow Injection Analysis and Related 
Techniques” on membrane-based separations by filtration and liquid–liquid 
extraction. (Annex III). 
Poster communications in national and international meetings and   
conferences (Annex IV).  
Attendance to specialized courses on analytical techniques (NIRS and 
HPLC) and on chemometrics techniques applied to experimental design and 
optimization (Annex V). 
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Introduction 
 
1.  Systems biology and development of “omics” 
disciplines 
 
 Since the 1990s, and particularly since the elucidation of the 
human and other genomes, there has been a revolution of techniques and 
approaches used in molecular biology [1]. Such changes have fuelled a 
renewed interest in applying the information obtained from biological 
systems to different areas of knowledge, such as clinics, agriculture and 
pharmacy. However, molecular biology has failed in obtaining practical 
information about the physical state of organisms, as a direct relationship 
between the genome and the phenotype cannot be clearly observed [2]. 
In fact, within a molecular biology framework, it is generally accepted 
that there is a linear downstream flux of information that goes from 
genes to transcripts, proteins and down to metabolites through the action 
of enzymes. However, this traditional scheme is insufficient for 
interpreting biological systems, where metabolic processes are 
intimately networked with interactions among these structural levels [3]. 
The construction, visualization and understanding of these networks 
certainly pose huge challenges for modern biology, as does a full 
understanding of the metabolic fluxes and their responses to genetic 
variations or external stimuli [4]. 
 In this scenario, a new system-level approach, in contrast to the 
classical molecular-level approach, has emerged as a result of the urgent 
need to bridge this genotype-to-phenotype gap. “Systems biology” [5] is a 
relatively recent term arisen from the development of the “omics” 
technologies such as genomics, proteomics or metabonomics/-
metabolomics. In these fields of study, large amounts of data are obtained 
at each level of biomolecular organization [6]. One of the expectations of 
systems biology is that, in some way, such data can be integrated to give a 
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holistic picture of the state of a biological system, ultimately enabling the 
understanding of biology at both individual and population levels.  
 Figure 1 shows this change of scheme from molecular to systems 
biology [7], the latter regarding the phenotype of the organism under 
study as the final goal of knowledge. As can be observed in the figure, this 
evolution is intimately related to a rapid development in available 
analysis instruments used at each level. 
 
 Provided that the state of a living system, be it a cell, organ or 
whole organism, is a combination of genotype, physiology (e.g,. age), 
diseases, nutritional and environmental state, among other influencing 
factors, the complexity faced by systems biology is clearly enormous and 
can obviously be accomplished only by highly sensitive and accurate 
analytical and computational tools as well as by complete databases 
compiled in continuous feedback by devoted research organizations. 
Figure 1. A. Traditional central dogma of molecular biology. B. General scheme 
of systems biology. 
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2.  Metabolomics within the systems biology context 
 
 Since the objective of systems biology is to obtain an integrative 
model of systems and their interactions, the experimental techniques that 
better suit systems biology are those that are system-wide and attempt to be 
as complete as possible. Therefore, genomics, transcriptomics, 
metabolomics, proteomics and the main high-throughput techniques are 
used to collect quantitative data for the construction and validation of 
models. Hence, the suffix “omics” comes from the Latin form “ome”, which 
means “massive”. This has been used in a wide range of scientific areas to 
highlight the huge number of data handled in all of them. Nowadays, there 
are nearly 200 different named “omics” [4], many of them related to systems 
biology sub-disciplines. This number is even expected to increase, as there is 
a tendency to dilute the knowledge from cellular components into different 
emergent sub-omics, so it is important to bear that there is an urgent need 
to integrate the knowledge from them. 
 Therefore, existing omics are capable to provide comprehensive 
descriptions of nearly all components and interactions within the cell. Omics 
data sets can be generally classified into three categories [8,9]: components, 
interactions and functional-states data. Thus, components refer to the 
molecular content of cells or systems, interactions describe links between 
molecular components, and functional-states provide an integrated readout 
of all omics data types by revealing the overall cellular phenotype.  
 To highlight some of the most relevant omics, DNA (genomics) is first 
transcribed to mRNA (transcriptomics) and translated into proteins 
(proteomics), which can catalyse reactions that act on and give rise to 
metabolites (metabolomics) such as oligosaccharides (glycomics) or lipids 
(lipidomics). Many of these components can be tagged and localized within 
the cell (localizomics). The processes responsible for generating and 
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modifying these cellular components are generally dictated by molecular 
interactions, for example by protein–DNA interactions in the case of 
transcription, and protein–protein interactions in translational processes as 
well as enzymatic reactions. Ultimately, the metabolic pathways comprise 
integrated networks, or flux maps (fluxomics), which dictate the cellular 
behaviour or phenotype (phenomics) [10]. 
  Among omics sciences, metabolomics is one of the youngest 
disciplines but its impact is clearly justified by a rapid increase in the 
number of publications. Figure 2 shows the evolution in the number of 
publications on metabolomics as compared to proteomics. It is clear that 
there has been a tendency to increase its impact at least at the same pace 
than proteomics, which leads to the conclusion that its impact on systems 
biology will expectedly increase. 
 
 
Figure 2. Evolution of proteomics and metabolomics in the last fifteen years 
by number of devoted articles. 
 
 To this point, metabolomics is mature enough to be granted the 
same status as other omics, supported by the existing technology and the 
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emerging of metabolite database in an attempt to compile the existing 
knowledge to be applied to different organisms from bacterial to 
mammals, including humans. 
 The usefulness of metabolomics is justified by the direct 
connection between metabolome and phenotype. Intuitively, metabolites 
are further down the line from gene to function and so more closely 
reflect the activities of the cell at the phenotypic (functional) level, as 
highlighted in Figure 1B. In fact, physiological changes resulting from 
gene deletion or overexpression are amplified through the hierarchy of 
the transcriptome and proteome with a final result in the metabolome 
[11]. The formalism of Metabolic Control Analysis (MCA) [12,13] 
indicates that little changes in the expression level of individual proteins 
have large effects on the concentrations of intermediary metabolites. As a 
result, the metabolome is more sensitive to overall perturbations than 
the transcriptome and the proteome, because the activities of metabolic 
pathways are reflected more directly in the concentrations of metabolites 
than in those of the relevant enzymes or, indeed, those of their encoding 
mRNAs.  
 As suggested by Kell [14], metabolomics is often deemed more 
discriminating than transcriptomics and proteomics for reasons such as 
the following:  
 The number of metabolites is smaller than the numbers of genes 
and proteins, which reduces processing complexity. As an 
example, the human genome contains 31,896 genes 
(http://eugenes.org/) and the expression and alternative splicing 
of mRNAs indicates that humans may be able to produce 106 
different proteins [15]; meanwhile, it has been estimated that a 
typical eukaryotic organism contains between 4,000 and 20,000 
metabolites (approximately 7,900 metabolites for humans) [16]. 
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 Metabolic profiling is more inexpensive and expeditious than 
proteomics and transcriptomics analyses. This favors high-
throughput analysis. It is estimated that metabolomics 
experiments cost two-to-three times less than proteomics and 
transcriptomics experiments [17]. 
 Unlike a transcript or a protein, a metabolite is the same for every 
organism that contains it.  
 Finally, the technology involved in metabolomics is more generic 
and versatile. 
 One major problem in the analysis of metabolites in comparison 
with the analysis of proteins and genes is the lack of totally 
comprehensive approaches. Here, it is important to design the analytical 
method according to the final aim of the metabolomics experiment, which 
may vary from the quantitative profile of few metabolites to the complete 
elucidation of the existing metabolic profile (metabolome) of one or a 
given set of biological samples under certain physiological conditions.   
 
3.  Strategies of analysis in metabolomics  
 
 There is a controversy about the use of the terms metabonomics 
and metabolomics. Metabonomics was formally defined in 1999 by J. 
Nicholson et al. [18] as: “the quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to 
patophysiological stimuli or genetic modifications”. On the contrary, the 
term metabolomics was introduced by Oliver Fiehn in 2001 [19] and 
defined differently as “a comprehensive and quantitative analysis of all 
metabolites in a system”, which means that while metabonomics is 
mainly focused on changes of certain metabolite levels with external 
stimuli, metabolomics deals with the non-biased identification of all 
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metabolites in the biological system. Although some differences in the 
concept still remain, there is now an overlap in methodologies and the 
two terms are often used interchangeably by scientists. 
 The information provided by both disciplines would lead to the 
complete metabolome, which is defined as the quantitative complement 
of low-molecular-weight metabolites present in a biological fluid, cell or 
organism under a given set of physiological conditions or under different 
perturbations (e.g., genetic variations, pathological states or responses to 
external stimuli) [20,21].  
 Metabolomics analysis encompasses different strategies depend-
ing on the situation under study [17]: 
(1) targeting analysis [22,23], which aims at qualitative and 
quantitative study of one or, more frequently, a small group of 
chemically similar metabolites; 
(2) global metabolomics profiling [24,25], which allows detection 
of a broad range of metabolites by using a single analytical 
platform or a combination of complementary analytical platforms 
—based on GC–MS, LC–MS, capillary electrophoresis (CE)–MS or 
NMR— to obtain a comprehensive profile of the metabolome; and 
(3) metabolomics fingerprinting [26,27], a high-throughput, rapid 
strategy for analysis of biological samples that provides 
fingerprints for sample classification and screening. 
 Figure 3 shows the differences between the three strategies in 
terms of data quality and number of covered metabolites. Data quality 
encompasses overall sensitivity, accuracy, precision of quantification, 
and metabolite identification rate [30]. Metabolite coverage is defined as 
the total number of detected candidates to metabolites (features), 
identified or not, achieved by one or various analytical platforms from a 
target biological sample. 
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 Therefore, targeting analysis calls for highly selective and 
sensitive methods, as the information required is eminently quantitative. 
The most sensitive and precise analyses are typically those for single 
metabolites. Targeted methods for metabolite analysis provide high-
quality data on a single class of compounds using dedicated and 
optimized methods. Depending on the field of application, it covers 
classical analytical methods used in many areas, e.g., in clinical analysis, 
quantification of biomarkers in biological fluids such as urine or plasma, 
or in food analysis, for target quantification of highly-valuable 
compounds such as antioxidants in food matrices. Thanks to its 
enormous development, there is a wide range of available analytical 
techniques as well as, in many cases, reference methods for validation.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Comparison of metabolomics approaches through the binomial 
data quality-number of covered metabolites [24]. 
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 Unlike targeting analysis, global metabolomics profiling can cover 
around several hundreds of metabolites, with concentrations 
encompassing several orders of magnitude. The purpose of metabolomics 
profiling is usually to obtain qualitative information, although 
quantitative or semi-quantitative analyses are also possible when 
different subjects or biological states are compared [31].  Broad 
metabolite profiling provides data for a wide range of chemical classes, 
but the methods represent a compromise and do not provide the same 
data quality for all of the metabolites covered. Therefore, analysis 
methods are preferably non-selective so as to cover the maximum 
number of detected compounds notwithstanding their chemical 
properties. These methods may be semi- or quantitative, but sensitivity is 
needed to be of several orders of magnitude. One of the main downside of 
global profiling is that available technology is usually more expensive and 
complex than for target analysis as more resolution capability is 
required. 
 On the other hand, the scope of metabolomics fingerprinting is to 
compare patterns, signatures or ‘‘fingerprints’’ of metabolites that change 
in response to external stimuli (e.g., toxin or drug exposure, or 
environmental or genetic alterations [32]). For this purpose, selective 
(never specific) and quantitative information about metabolites is not 
necessarily provided. Metabolomics fingerprinting is a promising tool in 
clinical diagnosis, drug screening and toxicology studies [33,34]. 
Metabolite-fingerprinting approaches also offer the widest coverage, but 
profiles, and not metabolite levels, are compared by these approaches, 
and the methodologies can be subject to artifacts that undermine the 
quantitative assessment of the data. Thus, metabolic fingerprinting can 
be used as a diagnostic tool, for example, by evaluating a patient’s 
metabolic fingerprint in comparison to healthy and diseased subjects. In 
addition, the success of treatment strategies can be monitored by 
observing if the metabolic phenotype shifts back to the healthy state or, 
in other words, if a sample after treatment falls in the cluster of healthy 
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subjects. However, using metabolomics exclusively for fingerprinting 
without identifying the metabolites that cause clustering of experimental 
groups will provide only a classification but not directly contribute to 
biochemical knowledge and understanding of underlying mechanisms of 
action [35]. In a recent attempt to overcome this problem, multivariate 
discriminant analysis together with high resolution analysis techniques 
are being currently combined. 
 
4.  Analytical processes in metabolomics 
  
 Identification, detection and quantification of large numbers of 
metabolites present at widely differing concentrations require the 
operating conditions of metabolomics methods to be optimized. In 
addition, variability in chemical and physical properties makes unfeasible 
to analyze the whole metabolic profile by using a single analytical 
platform. Figure 4 shows the general scheme followed in analytical 
chemistry, which also applies to metabolomics experiments with certain 
peculiarities depending on the used approach.  
 
 
Figure 4. General workflow of an analytical process. 
 
 Firstly, sampling involves selection of the most suitable biological 
material for the aim of the analysis and should seek to obtain 
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representative analytical samples and ensure to preserve them. Sample 
preparation comprises extraction of the metabolites into a suitable 
solvent, preconcentration, clean up, and/or derivatization. These steps 
must be compatible with the detection step and their complexity varies 
with sample nature and technique used. Sample preparation deserves 
particular consideration due to its importance in metabolomics analyses. 
For this reason, Chapters 1 and 2 of this Thesis are devoted to critically 
review the existing sample preparation methodologies and their 
peculiarities in metabolomics with regards to the nature of the sample 
and type of approach followed.  
 Not less importantly, detection techniques used in metabolomics, 
mainly NMR [36−38] and MS [35,39,40], have been widely reviewed in 
literature. Both are the most widespread detection techniques in 
metabolomics.  
 The main analytical techniques used in the experimental 
development of this Thesis are discussed in the following sections. 
 
5.  Detection techniques 
 
 Nuclear magnetic resonance spectrometry and mass spectrometry 
are the prevailing techniques in metabolomics thanks to their sensitivity 
and resolution capabilities. The latter technique usually requires to be 
hyphenated to another technique for separation of the metabolic 
components such as GC, usually after chemical derivatization, or LC. The 
use of CE coupled to MS has also shown to be promising. Other more 
specialized techniques such as Fourier transform infrared (FT-IR) 
spectrometry and fluorescence spectrometry are currently being 
exploited, but applications are by far less extended.   
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5.1.  NMR spectrometry 
 
5.1.1.  Principles of NMR 
 In NMR spectrometry, liquid (or solid) samples are placed inside a 
detection coil, and exposed to an external, static and homogeneous 
magnetic field referred as to Bo (z-axis). NMR process is depicted in Fig. 5 
[41]. The magnetic moments in the sample align along Bo according to a 
Boltzmann distribution (a). According to quantum mechanics, magnetic 
moments can only align parallel or anti-parallel with respect to this 
external field, leading to a macroscopic magnetic moment M. After a short 
application of a high frequency B1 field orthogonal to Bo (b), the 
magnetization is aligned with the rotating B1 field. Thus M, now aligned 
along x-direction (c), preccesses with a resonance frequency fo , which is 
proportional to Bo ( ). This preccessing process induces a 
voltage, Uind, modulated with fo (d) [42,43].    
 Due to the diamagnetism of the electron clouds of the molecules 
the local magnetic field experienced by a spin is changed by a small 
amount compared to Bo. Thus, the frequency fA measured for spin A 
directly reports the electronic/chemical neighborhood of the nucleus 
observed. The value (fA-fo)·106/fo, measured in parts per million with 
respect to Bo, is the chemical shift of this spin. This chemical shift is 
independent of Bo, thus data obtained at different values of field strength 
can be compared easily [44].  
 Detection of NMR signals can be only from atomic nucleuses 
possessing unpaired number of electrons (responsible for the resultant 
spin of these atoms, which align parallel or anti-parallel to the applied 
magnetic field), property termed as paramagnetism. In the absence of 
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magnetic field, nucleuses are rotating with randomized trajectories, but if 
a suited magnetic field is applied these nucleuses are aligned with it.  
 
 
 
   
 Most elements have at least one isotope with a magnetic spin 
number greater than zero, necessary for the NMR effect. In the case of 
biological samples, the two more common nucleuses, 1H and 13C, give 
place to the two most frequent NMR techniques, 1H-NMR and 13C-NMR. 
1H-NMR spectrometry is the most sensitive technique because of the 
natural presence of this nucleus. Thus, magnetization of hydrogen atoms 
experiencing a magnetic field of 14.1 T will rotate at 600 MHz aligned 
with the magnetic field. Such a spectrometer is called a 600 MHz 
equipment. This is the reason why NMR spectrometers are normally 
classified in frequencies. With the same magnet, a 13C spin will precess at 
about 150 MHz due to the natural presence of this nucleus (1.1%). 
Nowadays, there are available NMR magnets up to 1 GHz available, as the 
recently launched by Bruker [45] that operate at magnetic field strengths of 
23.5 Tesla and  proton NMR frequency of 1000 MHz with tremendously high 
field stability. 
Figure 3. NMR process. (a) A sample with unpaired spins is placed inside a strong 
magnetic field Bo (yellow) along z-direction. After short application of B1 (b), 
magnetization is aligned along x (c) and starts to precess around B, inducing a voltage 
U detected in the detection coil. 
(a) (b) 
Figure 5. NMR process. (a) A sample with unpaired spins is placed inside a 
strong magnetic field Bo (vertical arrow) along z-direction. After short 
application of B1 (b), magnetization is aligned along x (c) and starts to 
precess around B, inducing a voltage U detected in the detection coil (d). 
 
 
(c) (d) 
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 An NMR spectrum is composed by spectral amplitude plotted 
versus chemical shift. This method, called 1D-NMR, allows the 
determination of composition of a sample only if there is no severe 
overlap of signals. A method called 2D-NMR is used to overcome this 
limitation. It consists of a sequence of B1 pulses under systematic 
variation of an inter-pulse delay, leading to a 2Dmap where the 
amplitude is plotted as a function of two frequency dimensions. A cross-
signal in this map indicates a pair of spins with a transfer of 
magnetization during the pulse sequence. This allows determining 
related signals of the spectrum (such as signals corresponding to a same 
molecule). 2D-NMR spectrometry can encompass homonuclear and 
heteronuclear techniques if the couplings are between the same or 
different nucleuses such 1H–1H and 1H–13C, as the most frequent 
couplings. 
 
5.1.2.  Characteristics of NMR 
 Benefits and downsides of NMR spectrometry with respect to its 
use in metabolomics are depicted in Table 1. The great advantages of 
NMR are the potential for high throughput fingerprinting, minimal 
requirements for sample preparation, and the non-discriminating and 
non-destructive nature of the technique. In fact, 1H-NMR spectra can be 
acquired rapidly in 3–15 min with minimum sample preparation that 
usually just entails buffering and internal standard addition [46]. 
Furthermore, 1H-NMR has been largely used to unequivocally determine 
metabolite structures and, perhaps due to its non-invasive nature, is 
more commonly used in mammalian systems than mass-spectrometry 
technologies. However, only medium-to-high abundance metabolites will 
be detected with this approach and the identification of individual 
metabolites based on multivariate analysis of signals that cause sample 
clustering is difficult in complex mixtures. Indeed, the 1H-NMR spectrum 
of a complex sample is composed of several hundred resonances (with 
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chemical shifts between 0–10 ppm), which are estimated to arise from a 
hundred or more metabolites, resulting in a highly congested spectrum, 
given that each compound usually provide more than one signal each 
with a certain multiplicity. On the other hand, the reduced sensitivity of 
13C-NMR has practically limited its application to the study of metabolic 
fluxes in cells and tissues by suited fed with isotopically labeled 
metabolites, thus given place to fluxomics.  
 
Table 1. Strengths and weaknesses of NMR for its use in metabolomics. 
 
Limitations of 1D-NMR have been partly overcome by the use of 
2D-NMR and by the recently developed ultrahigh-field NMR 
spectrometers, which allow increasing spectral dispersion and reduce 
STRENGTHS WEAKNESSES 
 Rapid and simple sample 
preparation required. 
 Does not require chromatographic 
separation.  
 High reproducibility. 
 Relatively high throughput in 1D-
NMR experiments. 
 Useful for identification purposes. 
 Versatility. Possibility of direct 
analysis of solids and in-vivo 
studies. 
 Non-destructive. 
 Difficult automatization despite 
robotized systems.                    
 Relatively poor resolution in 
complex samples. 
 Poor sensitivity and selectivity. 
 Very low throughput in 2D-NMR 
experiments. 
 Difficult to unequivocally assign 
signals. 
 Useful for fingerpringting, less 
suitable for global profiling and 
target analyses. 
 Large sample volume (0.5 mL). 
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strong coupling-associated distortions. This has allowed its use in global 
profiling analysis. 
 Together with ultrahigh-field equipment, the development of a 
technique called high resolution magic angle spinning (MAS), NMR 
spectrometry has broadened versatility of NMR in metabolomics. This 
technique is based on a rapid spinning of the sample (at 4─6  kHz) at an 
angle of 54.7º to the applied magnetic field, reducing peak broadening 
caused by nuclear dipole-dipole interaction. The reduction of this effect, 
which is more acute in solids, also reduce effects caused by sample 
heterogeneity; thus allowing direct analysis of tissues [47,48].  
 Finally, it is generally accepted that sensitivity in 1H-NMR is lower 
than in MS. This depends on magnetic field strength, with higher field 
magnets providing greater signal-to-noise ratio. This ratio can be increased 
by increasing acquisition time, which means increasing the number of scans. 
On the other hand, integration can be directly carried out by comparison 
with an internal standard by simple integration. Although recent 
methodologies that couple NMR to liquid chromatography and solid-phase 
extraction columns to improve separation and sensitivity have been 
reported [30,49,50], it is unlikely that NMR will attain the sensitivity of mass 
spectrometry. 
   
5.1.3   Applications and perspectives of NMR 
 In-vivo NMR analysis is probably the most outstanding application of 
NMR in metabolomics due to its use in diagnosis of diseases such as cancer. 
Interestingly, in-vivo NMR could result in ‘‘metabolite mapping’’ of tissues 
after biopsy or before local ablative procedures. As an example, 1H-NMR 
analysis of breast biopsy samples have been used to identify over 30 
endogenous metabolites in breast tissue. In addition, breast carcinogenic 
tissue reliably showed elevated total choline (tCho) levels (resulting from 
increased phosphocholine), low glycerophosphocholine, and low glucose 
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compared with benign tumors or healthy tissue [51−53]. Thus, when 1H-
NMR of the breast is in-vivo performed before biopsy, precise differentiation 
of cancer and benign tissue is possible based on choline detection, which 
could lead to biopsy prevention on the choline-negative tissue. Similar to 
breast cancer, prostate cancer exhibits a distinct metabolic profile 
characterized by high tCho and phosphocholine levels, along with an 
increase in the glycolytic products lactate and alanine [54−56].  
 Metabolomics fingerprinting by NMR has proved to be an excellent 
approach to discover metabolic changes associated with diseases in humans 
[57] and genetic manipulation in plants [58]. NMR fingerprinting has been 
used for many years to authenticate foodstuffs, especially in the beverage 
industry. A recent study has employed the method to investigate grape 
quality [59]. The aim was to investigate the effect on grape berry skin 
metabolites of three cultivars grown over three seasons at five different 
geographical locations. Using standard methods of 1H-NMR data collection, 
followed by principal component analysis (PCA) and partial least squares 
(PLS) methods, the predictive modelling was able to pinpoint the spectral 
areas responsible for a separation according to vintage.  
 Another remarkable application of 1H-NMR fingerprinting is to 
identify unintended effects from genetic modifications (GMs) in plants. Thus, 
1H-NMR fingerprinting with multivariate analysis has been used to identify 
and classify maize seeds obtained from transgenic plants into different 
classes according to changes in metabolites [60]. Prediction to latent 
structures-discriminant analysis methods were used to build a predictive 
model that could identify GMs material by means of only 13 variables that 
explained over 90% of the variability. 
 Metabolite profiling by 1H-NMR has recently been used for a genetic 
study of strawberry fruit quality, a functional study of tomato transformants 
and a study of Arabidopsis thaliana phosphoenolpyruvate transformants 
[61]. In the tomato study, a comparison of the roots of transformants with 
wild types showed that environmental factors significantly modified the 
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metabolic profile of plants, masking the expression of a given genetic 
background. Studies on the Arabidopsis transformants showed that a 
decrease in phosphoenolpyruvate carboxylase activity impacted on 
metabolic profile without compromising the plant growth. 
 Although 1D-NMR studies are extremely useful in classifying similar 
groups of samples, it hinders unequivocal identification due to problems 
with large numbers of overlapping peaks, making actual identification of 
large numbers of metabolites difficult, and thus limiting its use for metabolic 
profiling. In 2D-NMR spectra, overlapping resonances are spread into a 
second dimension. There are various alternatives to carry out 2D- 
measurements, the most commonly employed being the Correlation 
Spectroscopy (COSY), Total Correlation Spectroscopy (TOCSY), 
Heteronuclear Single-Quantum Correlation Spectroscopy (HSQC), 
Heteronuclear Multiple-Bond Correlation Spectroscopy (HMBC) and Nuclear 
Overhauser Effect Spectroscopy (NOESY). The main limitation of these 
experiments is the high acquisition time required, tipically within 16–20 
hours to achieve a comparable sensitivity to 1D spectra. This is not clearly 
feasible when hundreds of samples must be processed, but appears to be 
useful for identification and quantification and, thus, to develop target and 
global profiling analyses. However, it could be stated that identification in 
complex mixtures is still more difficult than in MS and requires large user 
interpretation. The use of 2D-NMR for metabolomics is usually restricted to 
the characterization of unidentified compounds from the 1D spectra. 
Alternatively, the increased resolution provided by the second dimension 
can allow characterization of components in a non-fractionated or partially 
fractionated mixture. Examples of this include the characterization of 
tomato juice [62] and the identification of the phenylpropenoids produced 
by methyl jasmonate treated Brassica rapa [63] and Arabidopsis thaliana 
[64]. 
 Even with the improved resolution of 2D-NMR techniques, complete 
characterization of complex mixtures such as plant extracts by NMR is often 
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impossible. Hyphenating NMR to LC alleviates some of the problems by 
allowing NMR data to be collected on individual components of a mixture. 
Such on-flow NMR has been used as a means of screening the LC profiles of 
crude lipophilic extracts of aquatic plants for potential algacides [65,66]. The 
compounds of interest could not be completely identified from the LC–NMR 
analysis. However, it did give good clues as to the chemical nature of the 
constituents of the extract, thereby allowing targeted isolation of the most 
interesting compounds (labdane diterpenes) to be carried out. 
 The routine use of on-flow LC–NMR for phytochemical analysis is 
limited by its lack of sensitivity and low throughput (the previous examples 
used LC runs of > 12 h). The advent of automated solid-phase extraction 
(SPE) peak trapping [67] has circumvented this problem and allowed LC–
NMR to achieve its full potential. The technique has been used to investigate 
the composition of an African medicinal plant Kanahia ianiflora [68]. 
Alcoholic extracts of the plant were investigated by analytical scale LC–SPE–
NMR using multiple peak trapping, to give sufficient of each of the major 
peaks to allow their complete characterization using 1D- and 2D-NMR 
techniques. Four flavanol-glycosides and three 5α-cardenolides were 
successfully identified. 
 Despite its relatively low sensitivity, targeting NMR analysis is 
gaining increased attention thanks to the broad range of applications that 
has recently appeared. In fact, quantification of biomarkers related to 
diseases or human metabolism, including schizophrenia [69], multiple 
sclerosis [70], diabetes [71], organ rejection [72], and rheumatoid 
arthritis [73] have already been published and exploited. Interestingly, 
NMR-based serum-lipoprotein quantification is now a mainstream 
clinical diagnostic tool. In-vivo identification and quantification is 
nowadays well implemented, with more than 80 papers published on the 
subject [74]. 
 Currently, NMR-based metabolomics allows semi-automated 
identification and quantification of metabolites with concentrations as low 
                                   
 36 
  Nuevas plataformas analíticas en metabolómica 
as 1 μM. This means that up to 20 different metabolites can be detected (in-
vivo) in certain tissues and up to 100 metabolites (in-vitro) in certain 
biofluids. Given that the metabolome of many biofluids and tissues is of the 
order of thousand of metabolites [75,76], a major future challenge will be to 
find ways of increasing that number. In addition, provided that quantitative 
NMR metabolomics is carried out almost exclusively in aqueous conditions, 
it is not surprising that most of the quantifiable metabolites are water 
soluble, thus limiting considerably its applicability. Among its strengths, 
quantitative NMR has been applied in-vivo, with negligible sample 
preparation. In addition, no internal standard addition, apart from D2O (to 
serve as a frequency lock signal) and a chemical-shift reference standard 
(DSS or TSP) are required. 
 It is worth mentioning the use of quantitative NMR for in-vivo 
applications. This approach was used for the first time to quantify brain 
metabolites [77] (glutamine, glutamate and gamma butyric acid) in patients 
suffering from epilepsy, that were proved to increase as compared to 
controls [78]. In other study, precise quantification of the major brain anti-
oxidants (vitamin C and glutathione) at μM levels is described, given that 
altered antioxidant profiles in the brain have been linked to schizophrenia 
[79]. Analysis of N-acetyl aspartate, creatine, choline and myo-inositol 
concentrations in the spinal cord are shown to significantly differ from those 
found in the brain stem. This may have implications in the diagnosis of 
multiple sclerosis and the monitoring of spinal cord injuries [80]. 
 
5.2.   Mass spectrometry 
 
5.2.1.  Principles of MS 
 Mass spectrometry is a detection technique based on the 
differential displacement of ionized molecules through vacuum by 
applying an electrical field. Simplistically, a mass spectrometer consists 
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of an ion source, a mass analyzer, a detector and a data system. Sample 
molecules are inserted to the ion source, where they become ionized. The 
ions, which are in the gas phase, are separated according to their mass-
to-charge ratio (m/z) in the mass analyzer and are then detected. Mass 
spectrometers are usually coupled to a separation unit, either 
chromatograph or capillary electrophoresis equipment [81−83].   
 To generate the gas-phase ions, there are different types of 
ionization sources, such as electron ionization (EI) and chemical 
ionization (CI), frequently used in GC–MS, while electrospray ionization 
(ESI) and atmospheric pressure chemical ionization (APCI) are frequently 
employed in LC–MS. Polar and ionic compounds are best suited for this 
type of ionization. For the purpose of this research, electrospray 
ionization analyzers have been mainly used. This type is particularly 
useful to be coupled to LC as ionization occurs at atmospheric pressure. 
Polar and ionic compounds are best suited for this type of ionization. In 
ESI, the sample is sprayed from a metal or fused silica capillary. An 
electrospray is achieved by raising the potential on the spray capillary to 
4 kV in positive or negative ionization modes. The resulting spray of 
charged droplets is directed toward a counter electrode at a lower 
electrical potential, where the droplets lose solvent leading to ionic 
species into the gas phase. The counter electrode contains an orifice 
through which ions are transmitted into the vacuum chamber of the mass 
spectrometer, traversing differentially pumped regions via skimmer 
lenses [84]. 
 Once the sample has been ionized, it is transported to the mass 
analyzer via an electric or magnetic field. There is currently a wide range 
of available mass analyzers. The most relevant to the research developed 
in this Thesis are here briefly described. 
 
i) Triple quadrupole mass spectrometers 
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 A diagram of the design of a Triple Quadrupole MS is shown in 
Figure 6 [85]. 
 
Figure 6. General scheme of a Triple Quadrupole Mass Spectrometer.  
 
 The triple quadrupole mass spectrometer consists of an ion 
source (usually ESI source) followed by ion optics that transfer the ions 
to the first quadrupole. The quadrupole is formed by four parallel rods to 
which specific DC and RF voltages are applied. These rods filter out all 
ions except those of one or more particular m/z values as determined by 
the voltages applied. The applied voltage is variable so that ions with 
other m/z values are allowed to pass through. Afterwards, selected ions 
reach a collision cell where they are fragmented. The collision cell is 
typically called the second quadrupole, but it is actually a hexapole, filled 
with an inert gas such as nitrogen or argon. The fragment ions formed in 
the collision cell are then sent to the third quadrupole for a second 
filtering stage to enable a user to isolate and examine multiple precursor 
to product ion transitions. This is called selected reaction monitoring or 
SRM. Since the fragment ions are pieces of the precursor, they represent 
portions of the overall structure of the precursor molecule.The voltages 
applied to the collision cell must be different from those applied to the 
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quadrupoles to enhance the movement of all of the product ions toward 
the third quadrupole.  
 Due to the low-mass accuracy achieved with respect to other mass 
analyzers, triple quadrupole spectrometers are preferably used for target 
analyses, as they allow quantify with high sensitivity and selectivity in 
SRM mode. The most sensitive mode of operation for the triple 
quadrupole MS instrument is to fix both belts and only monitor a specific 
precursor ion and a specific product ion (SRM). In normal operation, a 
triple quadrupole MS instrument involves running multiple SRMs for the 
same precursor ions.  
 
ii) Quadrupole-Time-of-Flight mass spectrometers 
Figure 7 shows the diagram of the instrument used in the 
research of this Thesis [86].  
 
 
 
 
 
 
 
 
 
Figure 7. General scheme of a Quadrupole Time-of-Flight Mass Spectrometer. 
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The Q–TOF mass analyzer is based on the same configuration as 
the QqQ but replacing the last quadrupole by an acceleration tube as 
mass analyzer (usually in orthogonal configuration) to filter out ions 
according to the equation of kinetic energy. The Q–TOF can operate in MS 
mode with the TOF by taking benefit from the high mass accuracy or in 
MS/MS mode for structural elucidation. 
This hybrid mass analyzer offers better selectivity than triple 
quadrupoles, meanwhile sensitivity is considerably lower. On the other 
hand, thanks to its great mass accuracy (below 2 ppm) highly reliable 
identification can be carried out, thus allowing its use for global 
metabolic profiling.  
 
5.2.2 Characteristics of MS 
 Benefits and downsides of MS with respect to NMR for its use in 
metabolomics are depicted in Table 2. The strongest point of MS is its 
sensitivity. In fact, mass spectrometry-based metabolomics offers 
quantitative analyses with high selectivity and sensitivity and the 
potential to identify metabolites with high mass accuracy, taking into 
account that sensitivity in MS is affected by both ionization and type of 
detector but, in general terms, it is much more sensitive than NMR. ESI 
ionization sources have sensitivities within the range of high femtomole 
to low picomole, with some nanoESI techniques having sensitivities as 
low as high zeptomole. MALDI and APCI sources have sensitivities within 
the femtomole range. CI and EI sources are less sensitive, with picomole 
sensitivities [87,88]. 
 On the other hand, quantification requires suitable internal 
standards with similar ionization and fragmentation efficiencies.  
Quantitative information on a metabolite peak can be obtained in one of 
three ways: (i) by integrating it against a reference sample of the same 
compound (this requires the identity of the metabolite to be known and 
                                  
                                                                                                                      41 
Introduction 
compared between separate runs, which can introduce error); (ii) by 
comparing the relative ratios of a set of peaks across a series of spectra; 
and, (iii) by addition of a stable-isotope version of the metabolite of 
interest to the sample. Concerning qualitative analysis, tandem MS 
fragmentation patterns can give clues as to the connectivity and the 
presence of specific functional groups in an unknown metabolite. 
Identification of metabolites is often expedited by comparison to internal 
standards and searching against mass spectral libraries. Fragmentation 
of compounds under a certain applied voltage is very reproducible, thus 
MS/MS measurements are highly selective. 
 
STRENGTHS WEAKNESSES 
 Highly sensitive in its different 
modes. 
 Very selective (especially in 
MSn). 
 Suitable for quantitative target 
analysis, global profiling and 
fingerprinting. 
 Structural information 
throughout fragmentation 
patterns ( MSn). 
 Accurate m/z measurements 
ideal for identification of 
metabolites. 
 Excellent resolution (improved 
by separation). 
 Detection depends on 
ionization efficiency. 
 More efficient when coupled 
to separation techniques. 
 Quantification requires 
chemically-related internal 
standard. 
 Destructive, particularly 
complicated for analysis of 
valuable samples. 
 Limited to liquid samples or 
extracts isolated from solid 
samples. 
 Laborious sample 
preparation protocols.  
Table 2. Strengths and weaknesses of NMR for its use in metabolomics. 
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 Although MS measurements are rapid, the overall run time 
depends on the chromatographic step, that may vary from minutes to 
hours (but never to days, as in 2D-NMR). However, combination with 
chromatographic or electrophoretic equipment reduces the complexity of 
mass spectra due to metabolite separation in a time dimension, besides 
delivering additional information on the physicochemical properties of 
metabolites. 
  Among the weakest points, mass spectrometry-based techniques 
usually require sample preparation, which can cause metabolite losses. 
Complexity of sample preparation steps depends on the type of mass 
spectrometer but, on the whole, it is more tedious than in NMR. Thus, 
MALDI–MS techniques require the sample to be mixed with a suitable 
matrix prior to analysis. In liquid spray ionization sources, choice of 
solvent is important: ESI requires use of volatile organic solvents to aid in 
evaporation. GC–MS requires, most times, samples to be derivatized prior 
to detection. Furthermore, LC–MS is, by nature, unsuitable for in-vivo 
analysis.  
  On the other hand, global profiling may be limited by the 
ionization type, due to the fact that specific metabolite classes may be 
discriminated based on the sample introduction system and the 
ionization efficiency. Despite of this fact, mass spectrometry is currently 
the most reliable platform for identification.  
Comparatively, it can be stated that mass spectrometry-based 
metabolomics is characterized by a number of annual publications 
exceeding those based on NMR.  
 
5.2.3 Applications and perspectives of MS 
 Mass spectrometry has also been used as detection technique in 
metabolomics fingerprinting and global profiling, apart from being the 
preferred technique for target analysis in several areas (i.e., pharmaceutics, 
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clinics, forensics, food, agriculture, etc.). MS is a powerful technique for 
molecular identification, especially through the use of tandem MS. The 
recent introduction of highly accurate mass spectrometers (Orbitrap and 
TOF analyzers) has enabled its use for global profiling with a relatively high 
throughput. Mass-spectrometric metabolic profiling has been countless used 
for diagnosis of metabolic disorders in different biofluids. Thus, the analysis 
of the urinary metabolome for diagnostics of metabolic disorders using GC–
MS has recently been reviewed by Kuhara [89]. In addition, electrospray 
ionization with tandem mass spectrometry (MS/MS) has become an 
important tool for the assessment of disorders of amino acids metabolism, 
fatty acids, and organic acids biosynthesis, among others. Several reviews 
have recently been published, describing in detail the methodology and 
biochemical interpretation of data [90,91].  
 One of the stronger features of MS for global profiling is the 
possibility to characterize the non-polar fraction, and particularly, the lipidic 
fraction, that is generally termed as ‘lipidomics’. The lipidome, comprising 
lipid classes, subclasses, and lipid signaling molecules, is an important sub-
compartment of the metabolome and has been well studied through mass 
spectrometry [92] giving insights in biochemical mechanisms of lipid 
metabolism, lipid–lipid and lipid–protein interactions. As an example, 
metabolic profiling of eicosanoids, a class of lipid signaling molecules, was 
recently termed eicosanomics [93]. Target analysis usually requires sample 
preparation based on preconcentration and cleanup steps, which should be 
performed automatically by fully automated systems as the handly 
development is  tedious, in addition to  be properly optimized and validated.  
 GC coupled to MS and other detectors has been used extensively for 
metabolomics and analysis of metabolites in a variety of samples, especially 
from plants [95]. However, the nature of GC makes its use only suitable for 
volatile compounds, or those derivatized to be volatile. Thus, non-volatile 
and thermally labile molecules are better analyzed by LC–MS (or by one of 
the other atmospheric pressure ionization modes) or by MALDI–MS. 
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Nevertheless, the application of suitable derivatization methods allows a 
significant proportion of the metabolome to be observed by GC–MS. Despite 
the need for derivatization, GC–MS offers a number of advantages over LC–
MS. GC columns still offer higher resolution than conventional LC columns, 
and spectra obtained by using an electron ionization (EI) detector contain a 
wealth of structural information. The existence of extensive libraries of EI 
spectra (for example, http://www.nist.gov/srd/nist1a.htm), and 
reproducible retention indices often make compound identification easier 
by GC–MS than by LC–MS. A disadvantage of GC–MS when using EI is that the 
molecular ions may be minor or absent from the spectra; thus, information 
on the molecular weight of the starting molecule is absent. This can be 
overcome by recording chemical ionization (CI) spectra, where [M+H]+ or 
[M+NH4]+ ions, for example, tend to dominate. 
 
5.3.  Other techniques 
 
 Although usually ignored in most of the reviews devoted to 
metabolomics, there are other detection techniques extensively exploited 
for metabolomics purposes. For instance, spectrophotometric techniques 
have traditionally been used for target analysis in an endless number of 
applications, including clinical routine analysis.  
 Fluorescence and infrared spectrometries are briefly discussed 
here for their application in this Thesis. 
 
5.3.1. Fluorescence spectrometry 
 The key advantages of fluorescence detection for its use in 
metabolomics are high sensitivity, suitability for kinetics studies due to the 
rapid analytical response of instruments, possibility to use in probe format, 
nondestructive nature, and high-throughput. The main limitation of 
                                  
                                                                                                                      45 
Introduction 
fluorescence detection is that only very few metabolites can be analyzed 
directly by native fluorescence, making unsuitable this technique for global 
profiling. In most cases, fluorometric detection has been applied in targeted 
analysis of small-molecule compounds [95,96]. For example, An et al. [97] 
developed a method for label-free quantitative analysis of intracellular 
carotenoids in cells of red yeast (Phaffia rhodozyma) based on the intrinsic 
fluorescence of these compounds. Nevertheless, fluorescence detection 
usually requires derivatization, and chromatographic or electrophoretic 
separation.  
 The use of laser-induced fluorescence (LIF) is quite extended in 
targeted analysis due to the high sensitivity of this technique, required for 
the low concentration of most of the existing metabolites. In an early study 
by Kennedy et al. [98], amino acids could readily be analyzed in extracts 
from individual neuron cells obtained from snails by CE with LIF detection 
after chemical derivatization. In other study, LIF detection was used to 
quantify gangliosides (large molecular-weight sphingolipids) in pituitary 
tumor cells [99] with acceptable sensitivity. 
 As a novel and promising trend in metabolomics, vibrational-based 
spectroscopic techniques are rapidly gaining popularity in metabolomics. To 
date, the vast majority of metabolomic studies undertaken using vibrational 
spectroscopy have been carried out with FT-IR spectroscopy. However, 
some work has been carried out using Raman and, in terms of metabolomics, 
this is an emerging technology with significant potential for monitoring 
metabolites [100,101]. 
 
5.3.2. Infrared spectrometry (IRS) 
 FT-IR spectrometry is a well established analytical technique which 
allows for the rapid, high-throughput, non-destructive analysis of a wide 
range of sample types. FT-IR is based on the principle that when a sample is 
excited with an infrared beam, the functional groups within the sample will 
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absorb the infrared radiation and vibrate in one of a number of ways, either 
stretching, bending, deformation or combination vibrations. These 
absorptions/vibrations can then be correlated directly to (bio)chemical 
species and the resultant infrared absorption spectrum can be described as 
an infrared ‘fingerprint’ characteristic of any chemical or biochemical 
material [17]. 
 With the requirements for a routine spectroscopic approach that 
could be made portable, minimum or null sample preparation and non-
invasive, IR spectrometry appears as a candidate to metabolomics studies, 
particularly for disease diagnosis. Whilst selectivity and sensitivity are poor 
as compared with NMR and MS, the rapidity and reproducibility of FT-IR 
cannot be overstressed and it has been recognised as a valuable tool for 
metabolic fingerprinting/footprinting due to its ability to analyze 
simultaneously carbohydrates, amino acids, fatty acids, lipids, proteins and 
polysaccharides. In addition, portable FT-IR instruments are also available, 
allowing the analyst much scope in terms of spectral collection in a variety of 
environments. However, FT-IR does have some drawbacks, such as intense 
IR absorption of water and the need for external calibration.  
 Most of metabolites give signals in the mid-IR (from 4000–600 cm-1) 
and near-IR (14000–4000 cm-1), both including fundamental vibration, 
overtones or harmonics. However, one potential disadvantage of mid-IR is 
that the absorption of water is very intense; problem that can be overcome 
in one of several ways such as; dehydration of samples (impractical in most 
of biological samples), subtraction of water signal, or by application of 
attenuated total reflectance (ATR) [102]. 
 IR spectrometry has been widely used in metabolic fingerprinting 
applied to different areas. Therefore, it has been used in microbiology for the 
rapid and accurate identification of bacteria to the sub-species level [103] 
differentiation of clinically relevant species [104] and discrimination or 
identification of a range of bacterial genera [105]. Clinical applications of 
NIRS include analysis of faeces [106], follicular fluids to provide a biomarker 
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for oocyte quality [107], and synovial fluid to aid in the diagnosis of arthritic 
disorders [108]. In terms of analysis of serum, IR spectra could be used to 
discriminate between type 1, type 2 diabetes and healthy donors [109]. 
Metabolic profiling of athletes to detect doping and overtraining has also 
been investigated using a variety of body fluids, demonstrating that FT-IR 
could be applied to routine clinical analyses [110].  Attempts at cancer 
diagnostics include analysis of cell maturation in cervical tissue [111] and of 
colorectal adenocarcinoma [112]. 
 On the other hand, quantitative target analysis is restricted to 
relatively abundant metabolites, due to the inherent low sensitivity of the 
technique. In addition, quantitative data can only be obtained by calibration 
using other techniques. As an example, it has been used to quantify lactate in 
human blood [113]. With respect to global profiling, there is little chance to 
use IR spectrometry for metabolite identification. Thus, applicability of IR is 
almost limited to fingerprinting [17]. 
  
6.  Data treatment techniques and databases  
 
6.1.  Data treatment techniques 
 
 Metabolomics studies typically generate large amounts of data that 
complicates the use of univariate statistical analysis. However, if the 
concentration of a particular metabolite is found to be significantly altered 
through multivariate analysis, univariate analysis can be used to test the 
statistical significance of the change. This typically involves the use of the 
Student’s t-test or one-way analysis of variance (ANOVA). 
 A more useful statistical approach is multivariate analysis, which can 
be applied to reduce large volumes of data into a few dimensions for 
classification and prediction of outcomes. It is worth noting that the 
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predictive power of multivariate analysis comes from patterns in the data, 
and identification of specific metabolites is not necessary to discriminate 
different classes of data. Both unsupervised and supervised learning 
methods have been devised [114]. 
 In unsupervised strategies, no prior knowledge of the data is built 
into the statistical model. In contrast, supervised learning techniques 
require a training set of data to be used for prediction and classification. 
However, this also requires a separate set of data to test the predictions of 
the model, which can sometimes be problematic when not enough 
independent data to build both training and validation sets are available. 
This can be circumvented by using a data-splitting method such as 
crossvalidation, where the data are continually split into training and 
validation sets and the predictions of the data sets are averaged [115]. 
 The most common unsupervised technique for identifying patterns 
and trends in metabolomics data is PCA, and this is often used as a starting 
point for analysis. PCA attempts to reduce multi-dimensional data so that it 
can be plotted in a two- or three-dimensional Cartesian coordinate system, 
with the axes (principal components) representing the greatest variations in 
the data. The popularity of this technique stems from the easy graphical 
interpretation of the data, with clustering often observed between data 
points based on class-type (age, gender, etc.). Contributions of individual 
variables to the separation of samples can be identified by corresponding 
loading plots, which plot the contribution of each variable based against 
selected principal components.  
 PCA is usually followed by a supervised learning technique, such as 
partial least squares discriminant analysis (PLS-DA), which attempts to 
maximize the covariance between the independent and dependent variables 
to discriminate amongst samples. This method often discriminates between 
classes better than PCA does. Moreover, the lack of class information when 
determining the principal components in PCA can lead to discrimination of 
samples based on factors non related to the classes of interest. A specialized 
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form of PLS-DA is orthogonal projections to latent structures (OPLS), in 
which non-correlated systematic variance is removed from the model. Other 
less extended supervised learning techniques such as support vector 
machines (SVMs), artificial neural networks (ANNs) and classification and 
regression trees (CARTs) are by far less extended in metabolomics, although 
they find some applications [56,87]. 
 
6.2.  Standardization and database indexing  
 
 The whole metabolomics experiment has a direct impact on the 
quality of the generated information, so it should be planned and validated 
as an integrated unit [116]. It is also important to consider that loads of 
metabolomics data are generated daily. In order to facilitate the exchange of 
information and the creation of databases, all metabolic profiling analyses 
should ideally be performed by a standardized method using identical 
instruments and operating conditions, as recommended by the the 
Metabolomics Standard Initiative (MSI). This initiative led to the MIAMET, or 
Minimum Information About a Metabolomics Experiment, which would act 
as an equivalent of MIAME for microarrays in transcriptomics 
(http://www.mged. org/Workgroups/ MIAME/miame.html).   
 In contrast to genomics and proteomics where a number of 
databases are currently available, metabolomics databases are still growing. 
Biochemical databases can be used to identify unknown metabolites, for 
example, to identify structures from known elemental compositions, or to 
determine the biological function of the identified metabolite. Information 
about biochemical pathways and metabolites involved in given pathways are 
available in the KEGG (http://www.genome.jp/kegg/) and BioCyc 
(http://biocyc.org/) databases. More specific lipidomics databases exist, 
such as LipidMaps (http://www.lipidmaps.org/data/index.html), 
SphinGOMAP (http://sphingomap.org/), and Lipid Bank 
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(http://lipidbank.jp/index00.shtml), which contains structural and 
nomenclatural information as well as standard analytical protocols. General 
information about physico-chemical properties of metabolites can be 
obtained by searching general chemical databases such as PubChem or CAS. 
The development of specific metabolomics mass spectrometry databases is 
also in progress. The Golm metabolome database (GMD) 
(http://csbdb.mpimp-golm.mpg.de/csbdb/gmd/gmd.html) contains 
publicly available mass spectra and retention index metabolite (MSRI) 
libraries and GC–MS metabolic profiles of plant samples. The METLIN 
database (http://metlin.scripps.edu/) catalogues metabolites, MS/MS 
spectra, and LC–MS profiles, and also NMR spectra of human plasma and 
urine metabolites. To date, existing metabolomics databases aim primarily 
at the structural identification of metabolites in various biological samples. 
However, once a better annotation of the metabolome in various organisms 
is achieved, the generation of databases containing quantitative metabolite 
data can be expected. An example for this type of database is the human 
metabolite database that contains more than 1,400 metabolites found in the 
human body. Each metabolite is described by a MetaboCard designed to 
contain chemical data, clinical data and molecular biology/biochemistry 
data (http://www.hmdb.ca/) [117].  
 
7.  Applications and future trends 
 
 Until recently, most of the studies devoted to metabolomics have 
mainly focused on clinical or pharmaceutical applications such as drug 
discovery, drug assessment, clinical toxicology, and clinical chemistry, 
cellular assays, environmental studies and plant metabolomics. However, 
over the past few years, metabolomics has also emerged as a field of 
increasing interest to many other areas, such as food chemistry and 
nutrition. Although the fields of application of metabolomics are 
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enormous, the most interesting with regards to this Thesis are 
highlighted below.  
 
7.1. Plant metabolomics 
 
 Plant metabolomics has been used in diverse applications 
including phenotyping of species, fingerprinting of genetically or 
environmentally modified plants, identification of metabolic differences 
between genetically modified and parental lines of crops, quantitative 
analysis of nutraceuticals or other potentially interesting compounds for 
human health or food industry. Main uses of metabolomics in plants 
analysis have been summarized in Figure 8. 
 One of the most challenging aspects of plant metabolomics is to 
characterize the large number of metabolites present in plants, which are 
estimated to produce, across the plant kingdom, up to 200,000 different 
metabolites [11]. This global profiling approach, traditionally called 
phenotyping, has been used to study the metabolic profile of genetically 
modified plants such as tomato or potato. From an analytical point of view, 
global metabolic profiling usually requires complicated sample preparation 
steps as occurs in solid sample, especially in plant tissues as cells are 
surrounded by a thick wall that is necessarily broken before metabolite 
extraction. 
As for metabolic profiling of genetically modified plants, the 
potential for crop improvement by genetically modified traits is also 
enormous as has recently been demonstrated in studies on the so-called 
genetic metabolomics (linking metabolic profiles with genomic 
modification) [118]  using Arabidopsis and tomato [119,120]. In Arabidopsis, 
F1 progeny derived from a same-species ecotype cross were surprisingly 
shown, when analyzed using LC–MS, to contain approximately 30% new 
mass peaks that were not present in either parent. These extensively new 
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chemical signatures, simply resulting from different intra-specific allelic 
combinations (transgressive segregation), reveal how variable genotypes 
are and the enormous potential of metabolomics to detect transgressive 
segregants before a trait is expressed. Another use of genetic metabolomics 
is to help to identify functions of genes. In the legume Medicago both 
isoflavonoid and triterpine pathways have been elucidated using LC–MS-
based metabolomics [121,122]. 
 
Figure 8 . Applications of plant metabolomics. 
 
 Fingerprinting in plant analysis has been extensively used for sample 
classification. The aim was usually to evaluate environmental factors on 
plant growth such as fluctuating growth conditions [123], exposure to 
cadmium [124] and herbicides, as well as to compare ecotypes, i.e., of 
Arabidopsis thaliana [125], between wild-type and transgenic genotypes of 
tomato [126]. Fingerprinting has also been applied to plant-derived 
products, for instance, to assess the authenticity of cocoa, used to produce 
high quality chocolate, or to detect adulterations or classify varieties of 
plant-derived products such as wine, juice [127] or oil. In plant 
fingerprinting studies, IR and NMR spectrometries are the outstanding 
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techniques due to the low sample preparation requirements and the 
possibility of direct analysis [128].   
 Applications of plant metabolomics aim to assess the quality of crops 
by evaluating both their safety and nutritional values. One of the key issues 
in the safety evaluation of transgenic crop plants is whether so-called 
‘unintended effects’ may have occurred in plants as a result of genetic 
engineering, which could affect the safety or nutritional status of the crop or 
derived products. This is based on the hypothesis that potentially 
unintended effects of genetic modifications on human health or the 
environment will be connected to changes in metabolite composition. 
 With regards to the nutritional value, it has been generally accepted 
the use of target analysis of highly valuable compounds (nutraceuticals) so 
as to improve crops quality. The capacity of some plant-derived foods to 
reduce the risk of chronic diseases has been in part associated to the 
occurrence of secondary metabolites (phytochemicals) that have been 
shown to exert a wide range of biological activities. 
 Tomato has been selected in this Thesis as a model plant material for 
plant metabolomics due to its impact on Mediterranean diet and its well-
known nutraceutical properties. Thus, tomato (Solanum lycopersicum) is 
widely consumed and well known for its health benefits, many of which have 
been associated with its high content in antioxidants. In fact, tomato is rich 
in carotenoids (lycopene), provitamins (provitamin A), polyphenols 
(flavonoids) and some vitamins (ascorbic acid). The large consumption of 
tomatoes implies a high production and also an increasing demand of 
quality. In this sense, tomato quality can be defined by both nutritional and 
organoleptics features, which are directly associated to metabolite 
composition. Therefore, the quality of tomato has a direct relationship with 
its metabolic profile, which is affected by different factors such as the 
variety, environmental effects, cultivating conditions, ripening stage and 
post-harvest storage. Phenotyping and target analysis of antioxidant 
compounds have been carried out with the final aim of obtaining a complete 
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profile of tomato metabolites by using different analytical techniques and by 
optimizing sample preparation. As tomato is rich in both polar and non-
polar fractions, it is important to evaluate the effect of metabolites 
extraction on the final coverage of compounds. 
 On the other hand, the continuous development of sensitive 
techniques makes necessary the implementation of more suitable target 
analysis protocols for antioxidant species, which have been traditionally 
carried out by non-selective photometric methodologies.   
 
7.2. Nutrimetabolomics 
 
 Over the past century great strides have been made by food 
scientists and biochemists in identifying the essential nutrients needed 
for human growth and health. Improved dietary guidelines and mandated 
food supplementation with essential minerals and vitamins has been 
remarkably successful in treating most nutritional ‘‘deficiencies’’. 
Nowadays, nutritional scientists are challenged with finding new ways of 
treating or preventing diseases brought on by nutritional 
‘‘oversufficiencies’’ such as obesity, diabetes, chronic inflammation and 
cardiovascular diseases. It should also be worthwhile identifying 
bioactive food components that potentially increase life expectancy, 
reduce weight, enhance physical or mental performance and prevent 
diseases such as atherosclerosis, heart disease, cancer and arthritis. 
[129]. There should be highlighted some particular characteristics to be 
considered in nutrimetabolomics: 
 There is a chemical transformation of food constituents after foods 
are cooked or digested. In addition, food intake may have an impact 
over metabolism of endogenous metabolites (i.e., fat mobilization) 
that may be reflected in the metabolic profile. 
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 The effect of gut microflora is often associated only with the large 
bowel, but, depending on the biofluid, the roles of the oral microflora 
and of gastric colonization by Helicobacter pylori may also need to be 
factored into nutritional metabolomics. The microflora can change 
constituents in food and make them available to themselves or to the 
host for additional metabolism. 
 The number of different molecules in the food supply that are not 
nutrients outweigh the number that are nutrients by orders of 
magnitude. For example, plants accumulate secondary metabolites 
for defense, reproduction, and so forth; however, none of these are 
essential nutrients. In traditional nutrition, these phytochemicals 
were mostly ignored until recently, when the potential metabolic 
effects of plant compounds were noted. 
 Certain foods are known to produce obvious changes in urine in 
some individuals, which indicates a genotype interaction. For 
instance, in some individuals, beetroot produces red urine; in others, 
asparagus give rise to malodorous urine.  
 The effect of food intake will persist over a certain period of time and 
may be different among metabolites. For example, metabolites of 
coffee are detected in urine collected 4–5 h after coffee ingestion, 
whereas heterocyclic amines from grilled meat persist after 48–72 h 
after intake [130]. 
 There are three main approaches in nutrimetabolomics: (1) food 
component analysis; (2) food quality/authenticity detection; (3) changes 
caused by diet intervention studies. 
 The most challenging and unexploited area in nutrimetabolomics 
is probably its use for monitoring diet intervention. This would be used 
to asses metabolic changes related to administration of certain nutrients 
that have an impact on human health throughout changes in metabolic 
profiles of biofluids. In fact, metabolism alterations derived from these 
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treatments can be effectively monitored through metabolic alterations in 
biological fluids, such as urine or serum. Metabolomics fingerprinting has 
been used to determine the effects of drug administration and diet 
variations on metabolism. Thus, the scheme followed in these studies 
entails: 
 Selection of an adequate food material for diet intervention as 
well as the appropriate population to participate in the study. In 
order to obtain statistically representative results, sample size 
and inclusive criteria for both the action and control groups have 
to be preselected. Another key aspect is to establish the 
appropriate sample collection time after intervention. 
 Analysis of biofluids after drug or diet intake. This analysis 
involves the group of patients, besides untreated individuals 
(control group) under the same analysis conditions. 
 Supervised or non-supervised statistical analysis to find diet-
related differences between groups. 
 Determination of analytical features responsible of these 
differences. These may be a region in the NMR or NIR spectra or 
m/z from mass spectra. Identification of related metabolites and 
(relative) quantification of the resulting compounds, which 
implies to query against available databases. 
 Elucidation of metabolic pathways in order to give as much 
biological information as possible.  
  As an example, an NMR-based metabolomics analysis was used to 
demonstrate the metabolic impact of chronic cysteamine (CS) 
supplementation in rats [131]. CS has been successfully applied for many 
years to treat children with cystinosis. It may also be used as an 
endogenous regulator of immune system activity and it is also a potential 
therapeutic agent for the treatment of Huntington disease. Examination 
of PC loadings and subsequent inspection of the corresponding 1H NMR 
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spectra of urine samples enabled identification of endogenous 
metabolites, whose levels were perturbed by CS exposure. Thus, the 
approach allowed for the identification of biochemical markers related to 
CS supplementation. A key observation in this study is the impact of CS 
on intermediary metabolism in rats. Of the identified differential 
metabolites in the CS treatment group, succinate, an important 
intermediate in the tricarboxylic acid (TCA) cycle, was decreased. This 
suggests that the TCA cycle is downregulated by CS supplementation, 
which also implies decreased levels of citrate, another intermediate in 
the TCA cycle. 
 In this Thesis, metabolomic fingerprinting has been used to explore 
the effect of the intake of different oils-rich meals on the organism. The aim 
was to determine if oils composition and, particularly, if the presence of 
antioxidants, would affect metabolism and how it is reflected in the urinary 
profile. The presence of antioxidants, naturally existing (or added), such as 
sterols, fatty alcohols, triterpenic dialcohols and unsaturated fatty acids, are 
known to exert a protective effect against coronary heart disease. 
Particularly olive oil, the principal source of fat in the Mediterranean diet, is 
known to have an adequate fatty acid profile and a rich composition in 
antioxidants [134]. Although benefits of olive oil and, concretely, of its 
antioxidants are gaining interest, the mechanisms involved in this protective 
effect are still unknown. Therefore, it could be worth exploring how 
metabolism is affected by oils intake and, particularly, how olive oil 
contribute to coronary heart disease (CHD) prevention. 
 One of the main challenges pursuit in this research was to explore 
the composition of biological fluids that has not been received much 
attention in metabolomics. Thus, within the nutrimetabolomics context, 
biological fluids such as plasma, serum and urine [132,133] have been 
commonly used, as they are easily and non-invasively collected, directly 
reflect the global state of an individual and/or the response to drug 
treatment, and usually require the application of simple sample preparation 
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protocols. In contrast to the vast literature devoted to urine and blood 
metabolomics, there is a gap in studies on the analysis of other biological 
fluids, such as saliva, maternal milk, semen or cerebral spinal fluid. The main 
contributions of this Thesis to nutrimetabolomics have just been the 
metabolic profiling of biofluids that have been scarcely studied but with 
great potential in human nutrition, e.g., saliva and maternal milk.  
 Particularly, maternal milk is the main or unique source of feeding 
for children during early stages of growing, which are marked by a rapid 
development and continuous intake of nutrients. Therefore, its high 
nutritional value should reflect a rich and varied composition; so 
metabolomics of maternal milk could be of great interest to assess its 
nutritional value, to identify biomarkers of certain diseases or to monitor its 
variability as a consequence of lactation state, food, supplementation, drugs 
intake or circadian variations. 
 On the other hand, the use of saliva for metabolic profiling in 
order to identify candidate biomarkers has also been proposed. Saliva is 
not widely used in human nutrition research, but its inclusion could open 
new perspectives. In fact, saliva is a readily attainable biofluid that is rich in 
hormones such as 17-OH progesterone, testosterone, estradiol, and free 
cortisol. Its fatty acid composition has been used as a biomarker of plasma 
arachidonic acid, and it has been extensively studied for its antioxidant 
capacity [135]. Although saliva has not been used in metabolomic studies, its 
potential for distinguishing between metabolic profiles and for monitoring 
changes induced by diet would be worth exploring. The limited number of 
studies with this biofluid is reflected by the absence of databases and the 
limited bibliography, only target analyses have been addressed to date. 
This leads to the possibility to explore the global profile of saliva to 
complete current knowledge of the human metabolome [136]. 
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Figure 9. Workflow of metabolic fingerprinting to identify differences between 
control and action groups. 
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7.3.  Clinical analysis  
 
 Metabolomics, with its impressive and ever increasing coverage of 
endogenous compounds and its intrinsic high-throughput capacity, provides 
a much more comprehensive assessment of human health and can be used 
in the identification, qualification, and development of biomarkers. An ever 
increasing number of metabolomics studies are used to identify 
pathomechanisms of complex diseases, to characterize phenotypes, and to 
develop diagnostic biomarkers [4].  
 Applications of this Thesis to the clinical area have been focused on 
the target analysis of biomarkers in human biofluids.  Folic acid (vitamin B9) 
is a water-soluble vitamin involved in a broad variety of biological 
processes, as long as it acts as enzymatic cofactor in transference of methyl-
group reactions [137]. It is known that severe deficiency of folate leads to 
numerous diseases associated to hindered cell division processes and 
deficiency of Red Blood Cells (RBCs), such as megaloblastic anemia, bone 
marrow, or fetal diseases (spina bifida, neural tube defects, etc.) [138]. Folic 
acid deficiency has also been associated to an increased risk factor for 
cardiovascular disease, atherosclerosis, and coronary heart disease 
[139,140].  
 Among the target analysis in clinics, lipids have been the bottleneck 
due to their particular characteristics. Lipids are eminently non-polar 
compounds that play widely diverse roles in metabolism, as expected by the 
chemical differences in this family.  The importance of lipids is so enormous 
that lipidomics has evolved as a separate discipline because of the 
extraordinary structural diversity of lipids and their key roles in the 
pathophysiology of diseases. Lipidomics has been defined as the full 
characterization of lipid molecular species and their biological roles 
concerning expression of proteins involved in lipid metabolism and function, 
including regulation [139]. Although still an emerging field, lipidomics has 
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already provided promising new research possibilities; nevertheless, 
technological challenges remain. Here are some key aspects to consider 
about lipidomics analyses: 
 Cellular lipids are widely diverse among species, cells organs and 
cellular microdomains. This class comprises eminently non-polar 
compounds with great differences in their chemical structures 
and concentrations. This complicates enormously lipidomics 
analyses. 
 The lipidome of a given species varies dynamically depending on 
nutritional state, health conditions, lifestyle, exercise and 
disease. Lipids are usually present at very low concentrations.  
 Most of the currently available analytical platforms are by nature 
unsuitable to non-polar compounds. For instance, analytical 
methods that involve reconstitution of a metabolite extract into 
an aqueous HPLC solvent are likely to be strongly discriminatory 
against its lipid content, for the simple reason that many lipids 
are not soluble in aqueous solvents. 
 The aforementioned problems have made mandatory the 
development of dedicated target methods rather than global profiling 
approaches. Contributions of this Thesis to lipidomics have been focused on 
the target analysis of two lipid families, i.e., estrogens and sphingolipids: 
 Estrogens: estrogens and progestogens are a group of female sterol 
lipid hormones derived from cholesterol, which are widely distributed in 
animals and humans. These hormones have mainly reproductive functions, 
being thus mainly distributed in breast, ovary, vagina and uterus [141]. 
Endogenous estrogens have a protective function against various diseases, 
such as osteoporosis, atherosclerosis and cardiovascular and neuro-
degenerative diseases [142,143].  The analysis of steroid hormones in 
biological samples can be employed as a diagnostic tool in diseases 
promoted by disorders in the steroids profile. One of the main problems of 
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existing methods is that estrogens are usually excreted in a wide variety of 
conjugated compounds (mainly sulfates and glucuronides). This makes 
necessary a hydrolysis step to release the free forms before target detection.  
 Sphingolipids: sphingolipids (SLs) are a family of lipidic compounds 
endowed with a long amino-alcohol chain, known as sphingoid base.  
Sphingolipids exert different functions in signal transmission and cell 
recognition. Sphingoid precursors —sphinganine (Sa) and sphingosine 
(So)— act as structural and signalling molecules in membranes [144]. 
Sphingosine 1-phosphate, commonly present in human plasma and platelets, 
is an intermediate of sphingolipids catabolism [145], which inhibits the 
reproduction of certain tumoral cells, and also plays a key role both in the 
mobilization of intracellular calcium [144,146] and in cellular growth, 
differentiation, senescence, and apoptosis [147]. Few methods have been 
reported for simultaneous determination of sphingoid bases and phosphate 
derivatives. Current analytical methods for target analysis of sphingoid 
precursors are manual and, in many cases, they require large reagent and 
sample consumption, adding the complexity of a derivatization step when 
needed. For this reason, automation and miniaturization of sample 
preparation is desirable.  
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 En este apartado de la Memoria se describen someramente los 
diferentes instrumentos y aparatos usados durante el desarrollo 
experimental de la Tesis. En los capítulos se incluye una explicación más 
detallada de los que se han utilizado en cada uno de ellos. 
 
1. Sistemas automáticos y/o continuos para la 
preparación de muestra 
 
 En el bloque 2 de la Memoria se ha tratado de enfatizar el uso de 
sistemas continuos para el tratamiento de muestra en el análisis orientado 
(targeting analysis) de distintas familias de metabolitos. Estos sistemas 
permiten llevar a cabo de manera reproducible, parcial o totalmente 
automatizada y con a veces drástica reducción del volumen de muestra y 
reactivos, esta etapa crucial del proceso analítico, que es una de las 
principales fuentes de error de los métodos analíticos cuantitativos. 
 Para la extracción líquido–sólido asistida por ultrasonidos de ácidos 
haloacéticos de muestras vegetales (Capítulo 7) se utilizó un sistema de 
inyección en flujo (FIA, actualmente FI), por el cual, mediante el paso de 
extractante en repetidos ciclos por la cámara de extracción durante la 
irradiación con ultrasonidos, se consiguió aumentar la eficacia del proceso. 
Se emplearon bombas peristálticas y válvulas de inyección y de selección 
(siempre de baja presión) y tubos de teflón para la construcción del sistema 
FIA. La muestra, mezclada con arena inerte para evitar la compactación y la 
formación de caminos preferenciales, se situó en una cámara de extracción 
de acero inoxidable. La bomba peristáltica trabajaba en los dos sentidos de 
circulación del extractante para evitar sobrepresión en el sistema. La sonda 
de ultrasonidos utilizada fue una Branson 450 digital, que permite la 
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selección de la amplitud de la radiación así como el modo irradiación, 
continuo o discontinuo. 
 Para el análisis de estrógenos (Capítulos 3 y 4) y esfingolípidos 
(Capítulo 5) se utilizó un sistema de “laboratorio en válvula” (lab-on-valve, 
LOV) para la preconcentración y limpieza de la muestra basado en 
extracción en fase sólida (SPE). Los sistemas LOV constituyen la tercera 
generación de las técnicas de inyección en flujo (progresivamente FIA, SIA y 
LOV), y están basados en la inyección secuencial de muestra y reactivos en el 
sistema, utilizando volúmenes entre 100 µL y 1 mL. Por este motivo el 
sistema se denomina “meso-fluídico” por utilizar volúmenes a niveles 
“meso” de muestra, entre micro- y mililitros. El sistema LOV utiliza los seis 
puertos de una válvula multiposición como canales de entrada y salida del 
flujo, que pueden usarse de forma secuencial, permitiendo al usuario 
programar de forma sencilla todas las etapas requeridas para la preparación 
de muestra; lo que lo dota de una particular versatilidad. El sistema está 
constituido por una microjeringa de un volumen máximo de 1 mL, que 
permite aspirar, dispensar, parar, acelerar y ralentizar el flujo; una válvula 
de 6 canales de plexiglás, en la que los puertos están conectados entre sí y 
con la posición central de la válvula; un bucle de llenado entre la bomba y la 
válvula y una válvula de selección de dos vías para la introducción de un 
flujo adicional de disolvente portador o “carrier”. La secuencia de pasos está 
completamente automatizada y optimizada mediante el software FIAlab 5.0 
para Windows. Una válvula externa adicional, también controlada por el 
software FIAlab, se usó para la recolección del eluido después de la SPE en el 
sistema. Las columnas de extracción fueron fabricadas en el laboratorio a 
partir de tubo Peek y material sorbente y se conectaron a uno de los puertos 
del LOV. 
 Un sistema más sofisticado para llevar a cabo SPE es el Prospekt-2, 
que se usó para el pretratamiento de muestra en el análisis de folato y sus 
catabolitos, como se recoge en el Capítulo 6. Además de trabajar en modo 
dinámico, la elución directa con la fase móvil cromatográfica y la posibilidad 
                                            
83 
Herramientas analíticas y equipos 
 
de trabajar a alta presión permite la conexión en línea de este sistema con el 
conjunto cromatográfo/detector. De esta forma se consiguió la 
automatización completa del método analítico. El sistema Prospekt está 
compuesto por tres módulos, un muestreador (MIDAS), una unidad de 
extracción en fase sólida (ACE) y una bomba de alta presión dispensadora de 
disolventes de 2 mL de capacidad (HPD).  
 
2. Sistemas no continuos para la preparación de 
muestra 
 
 Dada la naturaleza no selectiva, semi- o no cuantitativa de las 
plataformas analíticas empleadas en los bloques 3 y 4 de la Tesis (dedicados 
al análisis metabólico global y mediante huella dactilar, respectivamente), se 
enfatizó el empleo de métodos con mínima o nula preparación de muestra, 
no haciéndose uso, por tanto, de sistemas continuos de pretratamiento de 
muestra. En estos casos, el pretratamiento de muestra se basó en etapas de 
centrifugación, extracción e hidrólisis asistida por ultrasonidos o 
preconcentración mediante  evaporación a vacío. 
 
3. Separación cromatográfica y/o detección 
 
 Durante el desarrollo experimental de esta Tesis Doctoral se han 
desarrollado métodos basados en separación cromatográfica de líquidos y 
gases, y en detección mediante espectrometría de masas, de resonancia 
magnética nuclear y mediante detectores ópticos (espectrometría de 
reflectancia en el infrarrojo y de fluorescencia molecular inducida por láser), 
así como en captura electrónica. 
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 Así, en los Capítulos 3 y 4, dedicados al análisis orientado de 
estrógenos y progestágenos, en el Capítulo 6, para la cuantificación de 
metabolitos del ácido fólico, y en el Capítulo 8, para compuestos 
nutraceúticos de tomate (carotenoides y fenoles), la separación por 
cromatografía líquida y posterior detección por espectrometría de masas en 
tándem por triple cuadrupolo se llevó a cabo con un cromatógrafo Agilent 
1200 Series LC equipado con una bomba binaria, un desgasificador, un 
automuestreador y un compartimento de columna termostatizados, y un 
espectrómetro de masas Agilent 6410 con una fuente de ionización por 
electrospray (ESI). El software Agilent MassHunter Workstation se usó para 
la toma de datos y el análisis cuali- y cuantitativo. En el Capítulo 6, el análisis 
de folatos se realizó con el mismo equipo; mientras que en métodos de 
análisis de estrógenos y progestágenos, fenoles y carotenoides se usaron 
columnas cromatográficas con fase estacionaria reversa C-18; para la 
separación de folatos se utilizó una fase estacionaria de interacción hidrófila 
—HILIC—, especialmente diseñada para compuestos polares o iónicos que  
tienen poca o ninguna retención en las columnas de fase reversa.  
 En los métodos dedicados al perfil metabolómico (metabolomic 
profiling) de muestras de saliva (Capítulo 9) y leche materna (Capítulo 10), y 
en el método utilizado para obtener huellas dactilares a partir de muestras 
de orina (Capítulo 13) se utilizó un equipo de HPLC acoplado a un detector 
de masas de tiempo de vuelo de alta resolución, Agilent 6540, en todos los 
casos utilizándose separación cromatográfica en fase reversa. En todos los 
casos se usó el software MassHunter para la adquisición de espectros, el 
análisis cualitativo y semicuantitativo y la identificación de metabolitos. 
 En el Capítulo 5, dedicado al análisis de esfingolípidos, se utilizó un 
cromatógrafo µ-LC Agilent 1100, compuesto por una bomba binaria capilar, 
una columna micro en fase reversa (C-18), una válvula de inyección 
automática y un detector de diodos en fila. El sistema estaba conectado por 
tubos capilares y se usaron micro-volúmenes de muestra y de fase móvil. 
Tras la salida de la célula de flujo del detector DAD, el sistema se conectó a 
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un detector de fluorescencia inducida por láser (Zetalif 2000 con un láser de 
He-Ne, longitud de onda de emisión de 325 nm). El control del sistema 
cromatográfico y los detectores y la integración de las señales se llevaron a 
cabo mediante el software Chemstation de Agilent. 
 En cuanto a la cromatografía de gases se utilizó acoplada a un 
detector de captura electrónica para el análisis de ácidos haloacéticos 
(Capítulo 7), y a un detector de masas de trampa iónica para el análisis de 
azúcares del tomate (Capítulo 8), ambos de Varian y en los dos casos usando 
el software de Varian de control de sistema e integración de señales. 
 En los métodos de análisis no cromatográficos se utilizaron un 
detector de resonancia magnética nuclear (RMN) de 500 MHz y un detector 
espectrofotométrico de reflectancia en el infrarrojo cercano (NIR) ambos de 
Bruker, para el análisis de “huellas dactilares” (fingerprinting) de muestras 
de orina, llevados a cabo en el Instituto de Estudios Biofuncionales de la 
Universidad Complutense de Madrid y en el Servicio Central de Apoyo a la 
Investigación de la Universidad de  Córdoba, respectivamente. 
 
4. Técnicas quimiométricas 
 
 De acuerdo con la importancia que ha adquirido la quimiometría en 
los métodos usados en metabolómica, en la tesis doctoral se han utilizado 
extensamente herramientas quimiométricas, tanto para el desarrollo y 
optimización de métodos analíticos como para el tratamiento de datos. La 
metodología del diseño de experimentos se ha utilizado, cuando ha sido 
posible, en la optimización de algunas etapas de la extracción en fase sólida, 
aunque la naturaleza de algunas variables, generalmente discontinuas, hizo 
que su optimización fuera obligatoriamente univariante. La precisión de los 
métodos propuestos para el análisis cuantitativo (targeting analysis) de 
familias de compuestos se estudió como reproducibilidad dentro del 
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laboratorio y repetibilidad mediante series de experimentos por triplicado 
usando análisis de varianza (ANOVA) a diferentes niveles de concentración 
de los analitos.  
 El tratamiento de datos se realizó con distintos programas 
informáticos: Statgraphics, The Unscrambler, Mass Profiler Professional y 
MatlAb, necesarios para realizar estudios univariantes mediante regresión 
lineal simple y regresión logística simple, así como estudios de tratamientos 
multivariantes, mediante regresión logística multivariante, análisis por 
componentes principales y regresión por mínimos cuadrados parciales, este 
último en dos modalidades diferentes: Análisis discriminante (PLS-DA) o 
modelado de clases (PLS-CM). Todos los estudios anteriormente citados se 
explican con mayor detalle en los siguientes capítulos de esta Tesis.  
 
5. Bases de datos 
 
 Existe una extensa variedad de bases de datos de metabolitos a 
disposición del usuario que contienen información para la identificación y 
caracterización de compuestos presentes en diversas matrices biológicas. 
Así, las bases de datos Metabolites and Tandem MS Database (METLIN) y 
Human Metabolome Database (HMDB) se han usado para la identificación 
de compuestos presentes en biofluidos (saliva, leche materna y orina) a 
partir de los datos espectrales obtenidos mediante espectrometría de masas 
y de resonancia magnética nuclear en las partes 3 y 4 de esta Memoria. 
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PART 1: 
Sample preparation in 
metabolomics 
 
 
 
 
 
   
  
 
 
 
 
 
   
 
 
  
 Esta Parte I de la Memoria recoge investigación no experimental 
realizada por la doctoranda mediante documentación bibliográfica 
fundamentalmente con tres propósitos: (i) Conocer la situación actual de las 
etapas que preceden a la detección en metabolómica, un aspecto al que 
generalmente se le concede poca importancia en los ámbitos no analíticos y 
que no se hallaba sistematizado en ninguna publicación. (ii) Sistematizar la 
investigación existente de forma crítica y poner de manifiesto los aspectos 
de interés, los pobremente desarrollados y las lagunas existentes en otros. 
(iii) Ofrecer una visión crítica de la forma de resolver los problemas 
detectados en esta área, bien con ejemplos basados en la investigación 
desarrollada por la doctoranda, o con proposiciones de desarrollo de nueva 
investigación a realizar en este campo. 
 Con estos criterios, y dada su extensión, el tema a tratar se dividió en 
dos partes: La primera dedicada a los aspectos previos a la preparación de la 
muestra propiamente dicha (es decir, a la selección de la muestra, clave para 
la obtención de unos resultados representativos del problema en estudio, y 
la forma de almacenamiento de la muestra para una conservación apropiada 
de las especies de interés). La segunda dedicada a la preparación de la 
muestra en sí que, al tratarse siempre de muestras biológicas, entraña una 
gran complejidad y puede verse afectada por numerosas fuentes de 
variabilidad. 
 
 
 
 
 
 
   
  
 
                                                                                                                               
                                                                                                                      
 
 Part I of this book is devoted to the non-experimental research 
carried out by the PhD student, with three main purposes: (i) to know the 
forefront in sample preparation and other key steps developed in 
metabolomics prior to detection, aspects to which little importance is 
traditionally given; therefore, it had not been systematically studied in 
publications in the field. (ii) to critically systematize the existing research, 
clearly showing the interesting aspects, those poorly developed and the 
existing gaps in others. (iii) to offer a critical overview of the ways to solve 
the problems detected in this area, either with examples based on the 
research carried out by the PhD student or with proposals for the 
development of new research in this field. 
 With these premises and taking into account the large extent of the 
subject, it was divided into two parts: the first (Chapter 1) was devoted to 
the steps prior to sample preparation (viz. sample selection, a key aspect to 
obtain representative results on the target problem; and sample storage for 
proper preservation of the target species). The second part (Chapter 2) was 
devoted to sample preparation as such that, in this case —always biological 
samples— entails a great complexity and can be affected by a number of 
sources of variability. 
 
 
 
 
 
 
 
 
   
  
 
  
 
 
 
 
CHAPTER 1: 
Metabolomics analysis I: Selection 
of biological samples and practical 
aspects preceding sample 
preparation 
 
 
 
   
 
 
 
 
  
 
 
Metabolomics analysis I: Selection 
of biological samples and practical 
aspects preceding sample 
preparation 
 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
Department of Analytical Chemistry, University of Córdoba, Annex C-3 
Building, Campus of Rabanales, E-14071 Córdoba, Spain; and, Institute of 
Biomedical Research Maimónides (IMIBIC), Reina Sofía Hospital, University of 
Córdoba, E-14071 Córdoba, Spain 
 
 
Trends in Analytical Chemistry, 29 (2010) 111–119 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                         
99 
Chapter 1 Trends Anal. Chem., 29 (2010) 111–119 
 
 
Metabolomics analysis I:  
Selection of biological samples and practical 
aspects preceding sample preparation 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
 
 Metabolomics is one of the most recently emerged ‘‘-omics’’ sciences. 
Its significance in systems biology is gaining interest to levels similar to 
proteomics, transcriptomics and genomics. One of the main limitations in 
metabolomics analysis is the lack of totally comprehensive approaches and 
in-depth studies, as individuals or laboratories with different skill sets 
usually develop these. This variability particularly affects sample 
preparation due to the extensive heterogeneity of biological samples. The 
first part of this chapter focuses on analytical criteria for sample selection 
and operations that precede sample preparation. 
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1.  Introduction 
   
 One major problem in metabolomics analysis is the lack of totally 
comprehensive approaches, given the diversity and complexity of biological 
systems. Identification, detection and quantification of large numbers of 
metabolites present at widely differing concentrations require the operating 
conditions of metabolomics methods to beoptimized. The most widespread 
strategy for addressing these problems involves integration of various 
analytical platforms [e.g., gas chromatography combined with mass 
spectrometry (GC-MS), liquid chromatography combined with MS (LC-MS) 
and nuclear magnetic resonance (NMR)] in order to improve metabolite 
coverage and expand the range of identification.  
 Great efforts are currently being made to improve the steps of 
detection and identification as well as the treatment of data generated to 
obtain biological information. However, other steps in the general workflow 
on metabolomics analysis have not received the same attention. These steps 
fall within the concept of sample preparation, which continues to be the 
bottleneck in the development of analytical methods. 
 The main drawback of sample preparation in metabolomics is the 
lack of reference or conventional approaches to be applied. This can be 
justified by the heterogeneity of applications based on, e.g., sample diversity, 
variability of stimuli or perturbations, and metabolite composition. One 
example is found in protocols for interrupting metabolism in cell cultures 
that have to be optimized for each cell line in order to preserve the integrity 
of cellular membranes [1]. It is evident that there is a demand for the 
development of robust strategies for preparation of biological samples to be 
reproduced in different laboratories. The purpose of this chapter is to offer a 
guide about the main steps to be followed in preparing biosamples for 
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detection (or separation–detection if a chromatographic or electrophoresis 
step is implemented). 
 In contrast to sample preparation, the detection step has been 
reviewed for techniques {e.g., NMR [2] and MS (also combined with 
chromatography and capillary electrophoresis) [3]} applied to 
metabolomics analysis. This chapter aims at covering this unjustified gap in 
the metabolomics field and to show researchers in this field the need for 
more in-depth studies. Due to the heterogeneity of target samples in 
metabolomics experiments, sample preparation is an extensive topic. For 
this reason, those steps required for sample selection and operations prior 
to sample preparation are reviewed in this first part, and those steps 
involved in sample preparation prior to metabolite detection in the second 
part. 
 Figure 1 illustrates a general workflow of the main steps involved in 
conventional metabolomics analysis. An experiment in metabolomics starts 
with selection of the biological material – usually biofluids (e.g., blood or 
urine, cells, and, less frequently, tissues) – and sampling, which is usually the 
limiting step in metabolomics and, ideally, should seek to be non-invasive 
and ensure representativeness. In addition, significant variations in chemical 
and physical properties or in the concentration of metabolites must be 
avoided. Although direct analysis is an ideal option pursued for 
characterization of liquid and solid samples, it is an infrequent option mostly 
linked to metabolomics fingerprinting, so most analytical methods applied 
to metabolomics involve a sample-preparation protocol, which is usually 
initiated with a rapid interruption (quenching) of the metabolism, 
particularly when working with cell cultures or biological materials that can 
be affected by enzyme action. Quenching provides a real snapshot of the 
metabolic state [1]. 
 After metabolic quenching, cells are separated from the surrounding 
medium (containing extracellular metabolites) and, subsequently, 
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intracellular metabolites are extracted by effective permeation of the cell 
membrane. 
 
Figure 1. General workflow of the main steps involved in conventional 
metabolomics analysis. 
 
 Solid samples (e.g., tissues or plant material) require an extraction 
step for the metabolites of interest (target metabolites or profiling analysis). 
When working with biological fluids, liquid-liquid extraction is commonly 
employed to isolate metabolites, with optional steps for preconcentration 
and clean up [e.g., solid-phase extraction (SPE)]. The aim of SPE or 
equivalent tech techniques is to improve sensitivity and/or selectivity and 
SPE can also be applied to extracts from solid samples [4]. 
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 The complexity of the analytical method clearly depends on the 
purpose of the metabolomics study. If the goal is to develop a targeted 
method, it is evident that sample preparation should focus on the 
metabolites of interest. By contrast, global metabolomics profiling is 
generally carried out by non-selective methods in order to maximize 
coverage. 
 After sample preparation, the resulting solutions are analyzed, 
analytical techniques such as NMR or MS being used most frequently [5,6]. 
Direct analysis by MS and NMR [7] are amenable for fingerprinting analysis 
without exhaustive, time-consuming sample-preparation steps. However, 
global and target metabolomics analyses usually require metabolite 
separation prior to detection, typically by conventional LC or the 
ultraperformance LC (UPLC) [8], or by GC after derivatization [9,10]. Less 
frequently used, capillary electrophoresis is considered a promising tool in 
metabolomics as it provides complementary information to that obtained by 
chromatographic techniques [11,12]. 
Elucidation of the metabolome is still a difficult task with unclear 
results. The complexity of the metabolome underlies the wide range of 
compounds with different physic chemical properties that makes unlikely 
obtaining reliable results from a single analytical platform. The metabolome 
for various well-studied organisms has been estimated from their genome. It 
is supposed to be approximately 800 metabolites for Escherichia coli [13], 
600 metabolites for Saccharomyces cerevisiae [14], and up to 200,000 
metabolites for the plant kingdom [15,16]. However, these estimates can be 
far from the real metabolome size, as there are still many genes with 
unknown functions [17].  
 The most feasible approach for comprehensive analysis of an 
organism metabolome is to integrate the information obtained from 
different analytical methodologies, aiming to increase metabolite coverage. 
The wide range of metabolites —which include ionic (organic acids), polar, 
neutral (sugars) and non-polar (lipid) compounds— usually demand 
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application of complementary sample-preparation protocols. This results in 
several ‘‘analytical samples’’ [18] to be subjected to the detection step after 
individual separation, if required. 
 Figure 2 shows a Venn diagram of the number of metabolites 
obtained using four different extraction procedures: methanol, ethanol, 
chloroform–methanol and potassium hydroxide. The diagram includes 
information about the number of metabolites detected with each protocol 
independently and with different protocols simultaneously for the 
metabolome analysis of E. coli [19]. The integrated analysis of all the results 
obtained by different methodologies obtains more complete results. Thus, a 
total of 264 peaks were obtained by combining the extraction methods. 
Similarly, the separation capability achieved by different chromatographic 
separation techniques (e.g., reversed-phase LC, hydrophilic interaction 
chromatography (HILIC) or normal-phase LC [20]) can be combined. The 
ionization source and polarity in MS analysis can also influence metabolite 
coverage. In general terms, the coverage achieved by electrospray ionization 
(ESI) is wider than by atmospheric pressure chemical ionization (APCI), but 
the overall coverage is considerably improved (estimated to be about 30% 
higher) when the results provided by both techniques are combined [21]. 
It is clear that metabolomics coverage is always a compromise 
between quality of data and throughput of analysis. Thus, while global 
metabolic profiling and metabolic fingerprinting are tools for large-
metabolite coverage, the quality of the data is lower than in targeted 
profiling, where the method developed is exclusively optimized for one 
metabolite or a few metabolites [22]. However, a large volume of data is 
required for high coverage, which is clearly opposed to high-throughput 
analysis. 
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Figure 2. Venn diagram of the coverage obtained with different extraction 
protocols for the analysis of E. coli. 
 
 
2. Sample selection as the starting point of 
metabolomics analysis 
 
 One of the critical steps in metabolomics is sample selection, as the 
results generated will depend on its suitability. Thus, metabolomics analysis 
requires previous knowledge ofthe biological system, in some cases 
obtained from predictive models by means of metabolic modeling [23], 
which is based on existing databases (http://www.husermet.org) created 
from -omics data, and on informatics and chemometrics tools [24]. This 
information aids in the design of a suitable analytical protocol based on the 
nature and the particular characteristics of the sample. 
 The existence of more than one biological material available for 
sampling enables the selection of the sample most suited for the analytical 
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problem under study. As an example, most clinical analyses are performed 
on biological fluids. Specifically, plasma, serum and urine have traditionally 
been used for prognosis or diagnosis of many diseases, as they are easily 
collected, reflect directly the global state of an individual and allow the 
biological response to drug therapy to be monitored. In addition, plasma and 
urine provide complementary information about the state of an organism 
[25]. Thus, plasma gives an ‘‘instantaneous’’ readout of the metabolic state at 
the time of collection, and its composition directly reflects catabolic and 
anabolic processes occurring in the whole organism. However, urine 
provides an ‘‘averaged’’ pattern of easily-excreted polar metabolites 
discarded from the body as a result of catabolic processes. There are also 
other biofluids (e.g., saliva [26], amniotic fluid [27], cerebral spinal fluid 
[28], breast milk, synovial fluid, seminal plasma [29], bile, digestive fluids, or 
breathing air) that can provide valuable information, especially in the 
discovery of biomarkers for certain diseases. This is the case of monitoring 
biomarkers in cerebrospinal fluid for the diagnosis of ictus and in seminal 
serum for the diagnosis of male infertility [30]. It is worth mentioning that, 
although metabolic profiling of these biofluids is a challenging task, as they 
potentially provide complementary information to that from serum, plasma 
or urine, there are few reported attempts to date on this subject [28,31,32]. 
As an example, the brain is a challenging organ to work with due to its 
complex location. It is encapsulated within the blood-brain barrier, a 
membrane that limits the passage of many metabolites. In fact, it is 
questionable whether a biomarker produced within the brain may be 
detected in easily accessible biofluids, such as blood or urine [33].  
 Within the field of tissue metabolomics, the analysis of these 
materials offers particular benefits over biofluids as the spatial description 
of metabolite distribution can be accomplished. For example, direct study of 
tumor tissues results in the profile of existing metabolites distributed in the 
affected tissue. Monitoring some drugs in certain tissues (e.g., brain) gives 
information about their mechanisms of action and effects [34]. In the field of 
biomarkers, the greatest chance of discovering a novel biomarker resides in 
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its screening within the target tissue [35]. Some remarkable drawbacks of 
tissue metabolomics are sample heterogeneity, the small availability of 
tissues and the invasive character of sampling techniques. An alternative can 
sometimes be to use microdialysates. 
 The study of cell cultures is one of the most extended approaches in 
metabolomics. Metabolome analysis of cells usually distinguishes between 
extracellular and intracellular metabolites, which constitute the 
endometabolome and the exometabolome, respectively [36]. Thus, the 
samples are separated into two fractions, usually by a filtration step. 
Analysis of the liquid fraction obtains the profile of extracellular 
metabolites; meanwhile the separated cells, containing the intracellular 
metabolites, are subjected to extraction steps.  
 Concerning plant metabolomics, the large variety of available 
samples [e.g., leaves, roots, sap, fruits, stalks, tubers, flowers, derived 
materials (e.g., oil, wine, resins)] and species is reflected in the wide number 
of reported studies in this field [37–39]. Thus, plants synthesize compounds 
in roots that are transported to shoots via the xylem sap. Some of these 
compounds are vital for signaling and adaptation to environmental stress, 
such as drought. The analysis of sap has therefore proved crucial to 
understanding how alterations in composition may lead to changes in 
development and signaling during adaptation to drought [40]. Another 
example is the analysis of fruits to elucidate the spatial metabolite analysis 
(e.g., the study developed by Biais et al. on melon [41]). Direct 1H NMR 
profiling of juice or GC-TOFMS profiling of tissue extracts collected from 
different locations in the fruit flesh revealed several gradients of 
metabolites, which can be related with differences in metabolism. 
 The final aim of metabolomics is to integrate raw data into databases 
that serve as potent tools for diagnosis or development of predictive models. 
Accordingly, the management of a large number of samples is required in 
order to obtain robust, transferrable results to establish comparisons 
between organisms. In addition, this involves minimizing the main sources 
   
108 
Nuevas plataformas analíticas en metabolómica 
of variability between samples [25], which can be due to intraindividual or 
inter-individual factors —mainly caused by physiological state, or dietary, 
environmental, genetic or pathophysiological conditions. Variability 
between subjects is more noticeable in some types of biological samples. 
Some matrices (e.g., plasma, serum, tissues and cerebral spinal fluid) are 
physiologically regulated by homeostatic control, the metabolite profile 
being relatively constant within healthy specimens. However, composition 
of urine samples can widely vary inter-individually and even intra-
individually, depending on urine volume, water and food intake and other 
physiological conditions (e.g., age, sex, weight and environment) [42]. 
 
3.  Sample storage and preliminary operations 
 
 The control of the potential sources of variability exposed above is 
crucial to avoid errors in data interpretation. After inter-individual and 
intra-individual variations, the main source of error in metabolomics is 
associated with sampling and post-collection procedures (e.g., freeze-thaw 
cycles or inadequate storage conditions [42]). It is known that unsuitable 
sampling and samplepretreatment protocols can lead to biased results due 
to conversion or degradation of metabolites [43]. There is increased interest 
in rapid collection and handling of samples for metabolomics purposes, 
while turnover kinetics of some metabolites is known to be extremely fast. 
For example, for intermediates in energy metabolism (e.g., ATP, ADP and 
glucose 6-phosphate), turnover rates are 1.5–2.0 s for Saccharomyces 
cerevisiae [44]. Thus, sampling techniques, particularly in the case of cells 
and tissues, need to be fast enough to ensure that the metabolic profile 
reflects in vivo conditions. Accordingly, the time window between sampling 
and analysis has to be as short as possible. In some cases, rapid inactivation 
of metabolism (also known as quenching) is performed with this aim. 
Nevertheless, immediate analysi of the samples is impossible in some 
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occasions so storage is required (e.g., in banks of biological samples for 
research purposes). 
 Sample storage is another critical reason for errors in metabolomics 
analysis. Most metabolites are preserved if samples are immediately frozen 
at below -80°C (e.g., by using liquid nitrogen). However, it is worth noting 
that differences in storage time or frequent thaw/freeze cycles may have a 
strong influence on the development of metabolomics models. As an 
example, Lauridsen et al. found that human-urine samples can be stored at 
or below 25°C for 26 weeks without changes in the 1H NMR fingerprints. 
Formation of acetate, presumably due to microbial contamination, was 
occasionally observed in samples stored at 4°C without addition of a 
preservative. 
 Freeze-drying of urine and reconstitution in D2O at pH 7.4 resulted 
in the disappearance of the creatinine CH2 signal due to deuteration [57]. 
The influence of sample storage has been widely studied in biofluids (e.g., 
serum and plasma). The strategies for sampling and storage of biofluids for 
metabolomics studies are especially important, compared to proteomics and 
transcriptomics. This is justified by the metabolic activity time-scale 
(metabolic reaction halflives are often <1 s). Metabolic activity during 
sampling and storage requires stopping or minimizing changes in the 
metabolic profile either in concentration or structure. For this purpose, 
reduced temperatures during sample preparation (4°C) and storage (-80°C) 
are common [20,25]. 
 It is important to keep in mind the purpose of metabolomics analysis. 
Thus, the variability associated with sample storage or preliminary 
operations can be critical in targeted metabolomics approaches focused on a 
restricted set of metabolites that could be seriously affected. However, small 
changes observed for a reduced number of metabolites in a global profiling 
analysis can be considered acceptable in studies involving large sample 
sizes. This can be justified by greater inter-individual variability than that 
associated with sample storage and preparation. 
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 A well-planned study based on global profiling with GC–TOF/MS has 
been performed by the UK Biobank to assess the stability of serum and urine 
[45]. The study comprised analysis of biofluids stored at 4°C for two 
different time periods (0 and 24 h) before storing at -80°C. The profiling 
analysis involved the detection of more than 700 metabolite peaks, which 
were studied by statistical analysis to assess possible changes in the urine 
metabolome. Figure 3 illustrates the combination of metabolomics analysis 
for serum and urine samples subjected to this study. Principal components 
analysis showed metabolic differences for a small number of serum and 
urine samples. Nevertheless, univariate analysis revealed that these 
differences were not statistically significant, as they were associated with a 
small number of metabolites. As a result, the variance in the metabolome of 
a single subject stored at -80°C or 4°C for 24 h is small, when compared with 
the variance in the metabolomes of 40 healthy volunteers. This inter-
individual variance can be ascribed to genotypic differences, but also to 
many phenotypic factors (e.g., diet, health and lifestyle, and diurnal and 
estrus cycles). The concluding report of this research was that the UK 
Biobank sample collection, transport and fractionation protocols, involving 
the storage of serum and urine samples at 4°C for 24 hours and well-
controlled UKbased transport, are suitable for high-resolution metabolomics 
studies. 
 The scenario changes completely in the analysis of a group of target 
metabolites. The potential effects of pre-analytical variables associated with 
storage and pretreatment of human blood were studied for analysis of 
endocannabinoids and metabolites. Storing fresh blood at 4°C selectively 
enhanced the concentration of ethanolamide without altering 
monoglycerides and nonesterified fatty acids (e.g., arachidonic acid). By 
contrast, ethanolamide and monoglyceride concentrations were not altered 
through three plasma freeze/thaw cycles, whereas plasmatic arachidonic 
acid increased, probably due to reflection of ongoing metabolism [46]. 
                                                                                                                         
111 
Chapter 1 Trends Anal. Chem., 29 (2010) 111–119 
 
 Similar studies have been carried out to evaluate the influence of 
preliminary steps. Saude et al. [47] found that metabolite composition of the 
sample is maintained throughout the collection and analytical process with 
the addition of a bacteriostatic preservative (e.g., sodium azide). Urine 
filtration enhanced metabolite preservation, as ascribed to removal of 
bacterial contamination. Finally, freeze/thaw cycles should be avoided in 
metabolomics protocols. For samples with high-humidity content (e.g., those 
from plants), lyophilization (drying under vacuum at reduced heating) is 
recommended to improve sample stability. Lyophilized samples stored for a 
preset time should be lyophilized again before analysis as these samples can 
absorb moisture during storage. 
 
4.  Conclusions 
 
 Sample preparation has not received enough attention in 
metabolomics compared to detection, particularly by NMR and/or MS. 
However, metabolomics analysis cannot be efficiently completed without a 
well-planned sample-preparation protocol. We have reviewed preliminary 
steps to be considered in a metabolomics analysis by encompassing the 
different criteria for sample selection and storage and those operations to be 
carried out prior to analysis. The relevance of these steps to the quality of 
the final results is evident. These preliminary steps are an important part in 
MIAMET (Minimum Information About METabolomics Experiment) [53] 
reports to ensure the reproducibility of results. 
 
 
 
   
112 
Nuevas plataformas analíticas en metabolómica 
 
 
 
 
 
Acknowledgments 
 
Figure 3. (a) Global metabolomics profiling of serum and urine analyzed with GC–
TOF/MS by the UK Biobank to assess the stability of biofluids. (b) Principal 
Components Analysis scores (PC) plots from 40 volunteers obtained by analysis of 
GC–TOF/MS profiles. The two sets of samples were stored at 4 ºC (0 h and 24 h) 
before storage at –80 ºC. PC 1 and 2 represent 8% and 5% of the variance, 
respectively. c) Loadings plots for Principal Components PC1 and PC2 for serum 
samples. Shaded area indicates the metabolites responsible for the erroneous 
samples in the PC loadings plot. (Reproduced with permission of Oxford University 
Press, Reference [60]). 
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Metabolomics analysis II: Preparation of 
biological samples  prior to detection 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
 
 After discussing the significance of preliminary operations, such as 
selection or storage of biological samples, we critically review the other 
steps of the analytical process prior to metabolite detection. First comes 
interruption of metabolism or quenching, which is of crucial importance in 
the analysis of biological samples. Then, we consider quantitative extraction 
of metabolites (selective or total for targeted or global metabolomics 
analysis, respectively) as a function of sample characteristics: solid or liquid 
samples and cell culture. Finally, we comment on additional steps, such as 
preconcentration of metabolites, clean up of extracts and fractionation for 
metabolite separation, and discuss their inclusion in analytical methods. 
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1.   Introduction 
 
 As discussed in the previous chapter, great efforts are currently 
devoted to improving the detection and identification steps as well as the 
bioinformatics and statistical treatment of data generated to obtain 
biological information. As an example, metabolomics has taken 
extraordinary benefits from the accurate mass measurements and high 
resolving power of recent mass analysers such as LTQ-Orbitrap. The 
combination of these high-performance features with MS/MS capabilities 
further facilitates the identification and structure elucidation of a large 
number of metabolites providing extra information about the biochemical 
connectivity between them [1]. Similarly, the recent developed ultra-high-
field NMR (at 900 MHz and beyond) gives new potential to overcome 
limitations associated to other instruments operating at lower frequencies 
by increasing spectral dispersion and reducing strong coupling-associated 
distortions [2].  
 Despite these advances in analytical instrumentation, the major 
cause of errors in the generation of analytical results is still linked to sample 
preparation for metabolites detection. In fact, sample preparation protocols 
used in metabolomics are almost exclusively based on conventional steps 
such as maceration or solid–liquid extraction by stirring for solid samples, 
and liquid–liquid extraction for liquid samples. The lack of homogeneous 
standard protocols for sample preparation means also a barrier to compare 
results among laboratories and reproduce metabolomics experiments. The 
MIAMET (Minimum Information About a METabolomics experiment) 
program [3] represents a first positive step in the direction of 
standardization of metabolomics analysis to ensure comparability of results. 
In this sense, the role played by sample preparation in metabolomics 
analysis is expected to be reduced by MIAMET reports.    
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 In the previous chapter a practical guide about particular 
considerations for selection and storage of biosamples as well as for 
operations developed prior to metabolomics analysis was described. This 
chapter deals with the different analytical operations carried out prior to 
metabolites detection for identification and/or quantification.  
 
2.  Fast sampling and metabolism quenching  
 
 Sample representativeness in metabolomics can only be achieved 
when metabolism is efficiently interrupted during the sampling process. 
This enables to provide a snapshot view of the metabolic state and to assess 
a reliable metabolite profile. Quenching aims at stopping instantly the 
metabolism by inhibition of endogenous enzymes. In this way, changes in 
the metabolic profile during sampling processes are suppressed.
 Quenching strategies should fulfil the following requirements [4]:  
 Inactivation of the metabolism should be faster than metabolic 
changes occurring in the sample. The effectiveness of the quenching 
process is crucial since the turnover rates of many primary 
metabolites are usually in the range of 1 mM s-1 (taking into account 
that concentration of metabolites vary from few molecules per cell, 
as in the case of certain signalling molecules, to milimolar 
concentrations for some primary metabolites such as glucose) [5,6];  
 The sample integrity should be carefully preserved during the 
process, particularly in the case of cells (i.e. preservation of the cell 
envelope) where leakages of intracellular metabolites should be 
avoided or minimized;  
 Quenching should not induce significant variations in chemical and 
physical properties or in the concentration of metabolites;  
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 The resulting quenched sample should be amenable to the 
subsequent steps of the analytical process. 
 Quenching of biological fluids, such as blood, usually refers to the 
storage of the samples at low temperatures (<20 ºC) [7,8]. In most cases, the 
serum must be rapidly separated from the blood cells prior to the storage, 
which is usually accomplished by centrifugation or fast filtration under 
vacuum. Both procedures require low temperatures (4 ºC) to slow down the 
enzymatic activity and the releasing of intracellular metabolites during the 
process. Freezing of samples during centrifugation must be avoided as it 
may cause the disruption of cell envelopes as a consequence of the 
formation of ice crystals.  
 On the other hand, metabolism deactivation is particularly critical in 
the analysis of cells and tissues aiming at elucidating the metabolic profile 
inside (endometabolome) and outside (exometabolome) the cell. The 
common strategies for quenching of cells and tissues are based on a rapid 
modification of sample conditions, usually pH or temperature. In the former 
case, quenching is achieved by instantly changing to extreme pH, either to 
high alkali (e.g. by addition of KOH or NaOH) or to high acid pH (e.g. by 
addition of perchloric, hydrochloric or trichloroacetic acid) [4]. Concerning 
temperature, quenching is mainly carried out by cooling at values usually 
lower than –20 ºC, assuming that sample integrity is not endangered by the 
cold shock [7]. The most popular method is cold methanol quenching, which 
allows a rapid interruption of the metabolism in the sub-second time scale 
[8] and can be implemented in protocols destined to discrimination of intra- 
and extracellular metabolites [8]. This approach has been extensively 
applied to yeast [8,10,11], but it is also suitable for application to other 
microorganisms, such as bacteria, unicellular algae or filamentous fungi, 
and, less frequently, to mammalian cells. The quenching solution is normally 
constituted by an aqueous–methanol mixture precooled at low temperature 
(usually –40 ºC or lower). Methanol seems to be the perfect organic solvent 
to prepare quenching solutions as it is miscible with water, possesses a low 
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freezing-point (much lower than ethanol or glycerol) [11], and methanol–
water solutions are not very viscous. For these reasons, other organic 
solvents are rarely used in quenching protocols [12]. One of the main 
limitations of the cold methanol method is the possibility of affecting cellular 
membranes with metabolite leakages [9]. In fact, some types of cells (i.e. 
bacterial cells) are known to be highly sensitive to osmotic changes of the 
surrounding medium, with subsequent changes in the concentration of 
intracellular metabolites by cellular membrane disruption [12]. Many 
protocols include a quenching buffer (e.g. tricine, HEPES or ammonium 
carbonate [5,8]) in order to control the ionic strength, thus avoiding 
damages to the cell envelopes. 
 One other quenching approach based on temperature change is the 
use of liquid nitrogen (–196 ºC). This approach is specially applied to animal 
and plant cells, but also to bacteria [13]. In an optimization study performed 
by H. Hajjaj et al., cold methanol and liquid nitrogen quenching methods 
were compared for the fungus Monascus ruber. The cold methanol 
quenching solution was 10 mM HEPES in 60% methanol/water solution pre-
cooled at –40ºC. For the nitrogen quenching method, the sample was 
transferred directly from the fermentor into liquid nitrogen. The comparison 
was made by using the concentration of piruvate metabolites, which were 
extracted after the quenching step with a boiling ethanol solution (75% 
(v/v) ethanol with 10 mM HEPES at 80 ºC). The conclusion of this study was 
that the quenching efficiency of both methods was similar, but the cold 
methanol quenching method its easier and allows sampling within a time 
window of milliseconds [14]. Nevertheless, cellular envelopes could also be 
damaged using this alternative due to the formation of ice crystals during 
freeze/thaw cycles [4]. 
 Interruption of the metabolism has scarcely been performed by a 
heating shock with a fast increase of temperature. One example can be the 
addition of ethanol at 90 ºC [5]. However, this method seems not to be a 
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competitive alternative due to potential degradation of thermolabile 
metabolites and increased cell permeability [9,15]. 
 Apart from in batch protocols, a variety of approaches for automated 
quenching has recently been reported [16,17]. These are based on on-line 
coupling of a fast-sampling device to a bioreactor where the metabolism is 
stopped. One example is found in Fig. 1, in which a heat exchanger was used 
for sampling and quenching of mammalian cells [17], which is a field 
characterized by a lack of validated methods. With this automated approach, 
the sampling device is pre-cooled at −50 ºC by filling the container with the 
quenching mixture (methanol/water 60:40, v/v) and the pressure is 
reduced to 200 mbar. This device is on-line coupled to the bioreactor, which 
enables the development of sampling and quenching steps simultaneously 
without metabolite losses.  
 
Figure 1. Automated approach for quenching of mammalian cells by on-line 
coupling of a a heat exchanger used as fast-sampling device to a bioreactor 
where the metabolism is stopped (Reproduced with permission of Springer-
Verlag, Reference [17]). 
                                    
                                                                                                                      127 
Chapter 2 Trends Anal. Chem., 29 (2010) 120–128 
 It is worth mentioning that there are significant physico-chemical 
differences between cell envelopes of eukaryotic and prokaryotic organisms. 
This fact explains that metabolite leakages caused by quenching with 
organic solvents are less severe for eukaryotic cells than for prokaryotic 
ones [5,18,19]. For this reason, quenching protocols cannot be directly 
transferred among different organisms and require proper optimization and 
validation as a function of the target organism [4,19]. One example is found 
in the study developed by Faijes et al. for metabolome analysis of 
Lactobacillum plantarum [5], in which four different aqueous quenching 
solutions, all containing 60% methanol (1, 60% MeOH; 2, 60% MeOH 70 mM 
HEPES; 3, 60% MeOH and 0.85% NaCl; 4, 60% MEOH and 0.85% w/v 
ammonium carbonate pH 5.5), were tested to compare their efficiency. Only 
solutions containing either 70 mM HEPES or 0.85% (w/v) ammonium 
carbonate provoked less than 10% cell leakage and the energy charge of the 
quenched cells (estimated by ATP measurement in the supernatant after 
quenching) was severe, indicating rapid inactivation of the metabolism. Five 
different extraction protocols (based on, (i) cold methanol, (ii) perchloric 
acid, (iii) boiling ethanol, (iv) 1:1 chloroform–methanol, and (v) 
1:1chloroform–water) were compared for isolation of metabolites from L. 
Plantarum. Targeting quantification of representative intracellular 
metabolites showed that the best extraction efficiencies were achieved with 
cold methanol, boiling ethanol or perchloric acid. 
 In most cases, quenching is followed by division of the sample in two 
fractions, usually by fast filtration or cold centrifugation. This step allows 
minimizing the dilution effect of cells in the supernatant and quantifying 
separately intra- and extracellular metabolites from cells and supernatant, 
respectively [20]. Fast filtration has been widely used, either as a separation 
step after quenching or as a fast sampling mode. The last option is not 
frequently used due to the relatively long time required for sample filtration; 
therefore, this sampling method is limited to the analysis of metabolites with 
turnover rates from minutes to hours and high intracellular levels (i.e. amino 
acids or tricarboxilic acid metabolites). Interestingly, the risk of leakages or 
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cellular damage is considerably lower than in the methanol-quenching 
method [8]. It is worth emphasizing that the washing solution has to be 
properly selected, as this step is probably the bottleneck of fast filtration 
regarding to leakage effects. Finally, an extraction step is usually performed 
aiming at permeabilizing the membrane and extracting intracellular 
metabolites with the highest efficiency and minimum degradation [12].  
 Extraction can be performed with organic solvents at high or low 
temperatures, either pure (e.g. ethanol, methanol) or in mixture (e.g. 
methanol–cloroform) or by acid or basic solutions. The extraction efficiency 
of the former is limited by the solubility of the metabolites in the organic 
solvent, the posibility of side-reactions or by degradation of the metabolites 
[5,15]. However, these methods can be of interest for the extraction of target 
compounds (e.g. organic acids with KOH). With these premises, alcohols 
(particularly methanol) are the most suitable extractants for this step as 
they precipitate proteins, effectively permeate cells, are easy to evaporate–
concentrate and do not add undesirable salts in mass spectrometry analyses. 
 
3.  Metabolites extraction 
 
 Metabolite extraction is a key step in the metabolomics analytical 
process and its effectiveness directly affects the quality of the final data. 
Ideally, metabolite extraction aims to:  
(i) efficiently release metabolites from sample  
(ii)  remove interferents that may difficult the analysis, such as salts and 
proteins 
(iii) make the extract compatible with the analytical technique and,   
(iv) when necessary, concentrate trace metabolites before analysis.  
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As previously mentioned, the required selectivity of the extraction step 
will depend on the aim of the study. Therefore, while targeting 
metabolomics calls for a highly selective extraction that provides clean and 
concentrated extracts, extraction is eminently non-selective in metabolic 
profiling, so, only salts and macromolecules (e.g. proteins) are considered 
potential interferents to be removed in this step. 
 The extraction protocol mainly depends on the target biological 
sample, which, in the case of solids, is performed by solid–liquid extraction 
(e.g,. maceration, Soxhlet extraction, Folch extraction, supercritical fluid 
extraction, ultrasound-assisted extraction or microwave-assisted 
extraction). On the other hand, metabolites from liquid samples are mainly 
extracted by liquid–liquid extraction (LLE), solid-phase extraction (SPE) or 
solid phase microextraction (SPME). These approaches are described below. 
 
3.1. Liquid samples 
 
 Most biological fluids are aqueous, so they can be directly analysed 
by MS or LC–MS (also CE–MS) with minimum sample preparation [21]. This 
is the case of urine, microdyalisates and digestive fluids, for which sample 
preparation usually entails buffering, dilution or evaporation and 
centrifugation [22,23]. Direct analysis minimizes metabolite losses, but the 
high-salt content can cause ionization suppression, lead to adduct formation, 
and also negatively affect the instrument performance by the presence of 
non-volatile residues. These aspects can be minimized by including, when 
possible, an effective extraction step, such as LLE [24] or SPE [25] to clean 
and desalt the target sample. Concerning NMR, direct analysis is the most 
suited alternative with minimum sample preparation such as buffering with 
deuterated solutions [26]. 
 On the other hand, the analysis of serum or plasma samples is 
limited by the presence of a large number of proteins that interfere in mass 
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spectra. This makes the analysis of low-molecular weight metabolites 
difficult, as long as most of them are present at very low concentrations. 
Although possible, direct analysis of plasma by NMR or MS is rarely 
performed, and an extraction step is usually included in the analytical 
process for high efficient removal of proteins. Deproteinization can be 
achieved by lowering the pH or using organic solvents such as acetonitrile or 
methanol [27,28]. The number of detected metabolites is higher with the 
latter, which is usually the preferred choice.  
 Interestingly, classical extraction techniques such as LLE or SPE are 
of great relevance in metabolomics analysis of liquid samples. Liquid–liquid 
extraction enables extraction of metabolites in two fractions that separately 
contain polar and non-polar compounds, which can be independently 
analysed by NMR, LC–MS or GC–MS [6]. Solid-phase extraction in its 
different formats is widely used for selective extraction of target compounds 
from biological samples with excellent results in terms of precision and 
sensitivity [29,30]. Solid-phase microextraction is a widely extended 
approach for analysing volatile metabolites. For instance, SPME has been 
used for the extraction of volatile compounds in human sweat aiming at 
establishing the metabolic basis of the human odour [31], and for the 
extraction of volatile metabolites from wine for characterizing flavour and 
aroma [32]. Due to their selectivity, SPE and SPME are widely implemented 
in targeting metabolomics methods [16,17]. 
 
3.2. Solid samples 
 
 As mentioned before, the first step of sample preparation is to 
quench the metabolism by using one of the alternatives exposed in section 
“Fast sampling and quenching of metabolism”. Then, the next step is to mill 
the sample to obtain a homogeneous powder. This step is critical, especially 
in plant tissues in which cells are surrounded by a thick wall that is 
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necessarily broken before metabolite extraction. The most common 
procedures for plant-cell wall-breakage and homogenization are performed 
by a mortar and pestle [33], ball mill [34], vibration mill [35], Ultra Turrax 
[36], ultrasonic probe and thermomixer. When possible, this step is 
performed under liquid nitrogen to prevent tissue defrosting. Finally, the 
powder is lyophilized and stored at low temperatures until analysis.  
 Although there are some methods in which the powder is directly 
analysed by MS or NMR [37], an extraction step prior to analysis is usually 
necessary. Accordingly, solid–liquid extraction (better expressed as leaching 
or lixiviation) is performed in order to permeate the membrane and extract 
the metabolites with the highest efficiency and minimum degradation. With 
this aim, a suitable extractant is added to the solid material, and the contact 
between them is favoured by shaking, vortexing or magnetic stirring for a 
preset time. Conventional protocols of leaching (such as Soxhlet or Folch 
extraction) are well established for the extraction of metabolites from solid 
samples, and their usefulness has been extensively proved [38,39]. The 
extraction time may vary from minutes to hours, depending on the 
characteristics of the sample, so the extraction process can be accelerated by 
means of microwaves, ultrasound or by supercritical fluids [40,41]. 
Particularly, Focused Microwave-Assisted Soxhlet Extraction (FMASE) has 
proved to be highly efficient for the extraction of weakly polar and non-polar 
metabolites in biological solid samples [42]. Thus, while conventional 
extraction requires several hours for quantitative extraction of the target 
metabolites, FMASE is efficiently performed within minutes.  
 Due to the complexity of solid samples, their preparation protocols 
must be necessarily optimized in order to avoid degradation or modification 
of metabolites during this step, caused either by extraction conditions or by 
enzymatic activity. The best extraction conditions depend on the aim of the 
analysis. In metabolic profiling, due to the large variety of metabolites and 
their differences in physical and chemical properties, there is no one ideal 
procedure that allows simultaneous extraction of all metabolites with high 
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efficiency. There are some reported studies on the metabolome of solid 
samples (especially in plant metabolomics) in which various extraction 
procedures are compared in order to maximize metabolite coverage [43]. In 
most of them, extraction is performed with organic solvents at high or low 
temperatures, either pure (e.g. ethanol, methanol, acetonitrile, chloroform, 
hexane), in mixture (e.g. methanol–cloroform) or by acid–basic solutions. 
The efficiency of the extraction with organic solvents is limited by solubility 
of the metabolites in the extractant, possibility of side-reactions or 
degradation of the metabolites [32]. It is worth mentioning that deuterated 
solvents are required for metabolites extraction when NMR is the 
determination technique [44]. On the other hand, extraction with perchloric 
acid is widely used prior NMR analysis either after a quenching step or 
during cell inactivation [45]. Although this extractant is highly efficient to 
precipitate proteins and to extract some hydrophilic metabolites, acidic 
treatment is limited to the extraction of acid-stable metabolites. With these 
premises, alcohols (particularly methanol) and acetonitrile have 
demonstrated to be the best extractants for metabolic profiling as they 
precipitate proteins, effectively permeate the cell, are easy to evaporate–
concentrate and they do not add salts, undesirable in mass spectrometry 
analyses. In addition, they are likely to extract a wide range of metabolites 
when used in mixtures. For instance, methanol–water–chloroform mixtures 
have been successfully used for simultaneous extraction in a single step of 
polar, weakly apolar and non-polar metabolites [46]. Hydrophilic 
metabolites such as sugars, amino acids and organic acids are extracted in 
the methanol–water phase, while lipophilic compounds, such as lipids, 
chlorophylls and waxes are extracted in the chloroform phase. After 
extraction, the two phases, separated by simple centrifugation, are treated 
and analysed separately by LC–MS or NMR and GC–MS, respectively [47,48].  
 As previously mentioned, solid biological materials are likely to give 
an insight of the spatial distribution of metabolism in complex organisms. 
Accordingly, the use of solid samples is not limited to the field of plant 
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metabolomics, being also noteworthy the existing protocols for the 
treatment of organ tissues (such as brain, liver and tumoural tissues), faeces 
or whole organisms such as earthworms. The sample preparation method 
developed by Lin et al. [43] for the study of the metabolome of different 
organ tissues (namely salmon muscle and liver) reflects the main steps that 
are usually performed in the treatment of organ tissues. The process starts 
with a quenching step, which is carried out by freezing the samples in liquid 
nitrogen. Then, tissues are lyophilized, effectively disrupted and milled to 
homogeneity, keeping the temperature constant throughout the process. 
Metabolites are then extracted and the extract is dried and reconstituted 
into an appropriate solution for NMR analysis, which consists of buffered 
D2O and a chemical shift standard such as 3-(trimethylsilyl)proprionate-2-2-
3-3-d4, TMSP. The method was optimized by comparing different tissue 
disruption procedures and different extractant mixtures. As in the case of 
plant tissues, a mixture of water–methanol–chloroform was the best 
extractant with regards to the number of covered metabolites.  
 
3.3. Cells 
 
 Determination of metabolite levels in intact cells has been performed 
by NMR or MALDI-TOF-MS [49]. Although NMR provides in vivo data for 
well-established conditions [50], the low sensitivity achieved by this 
technique restricts its use to abundant metabolites and/or to high cell-
density cultures [49]. Thus, like in solid samples, determination of 
intracellular metabolites is performed after an extraction step. 
 Extraction from cells can be performed by two approaches [3], the 
main difference between them being that quenching and extraction are 
either simultaneous or sequential. In the former, the quenching solution also 
serves as extractant, while in the latter, cells are separated from the 
surrounding medium and then metabolites are isolated from cells with an 
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appropriate extractant. Figure 2 shows the scheme for the steps involved in 
each approach [51]. In the sequential mode, quenching is followed by 
division of the sample in two fractions, usually by fast filtration or cold 
centrifugation. This step allows diminishing the dilution effect of cells in the 
supernatant and separately quantifying intra- and extracellular metabolites 
from the cell and the supernatant, respectively.  
 
Figure 2. Scheme of the steps followed in the simultaneous or sequential 
approaches used for extraction of metabolites from cells (Reproduced with 
permission of the American Chemical Society, Reference [51]). 
 
 Cold centrifugation [52] is usually the preferred option due to the 
relatively long time required for fast filtration. After cells isolation, an 
extraction step is usually performed in a way similar to that applied to solid 
samples, using a cold or hot extractant (e.g. methanol, ethanol, methanol–
                                    
                                                                                                                      135 
Chapter 2 Trends Anal. Chem., 29 (2010) 120–128 
water or methanol–water–chloroform), acid or basic solutions (e.g. 
perchloric acid, acetic acid, KOH solutions). 
 In the simultaneous mode, intra- and extracellular metabolites are 
determined together, without leakage problems. Nevertheless, the exo- and 
endometabolome of cells cannot be distinguished, and detection and 
quantification of many metabolites is difficult, as they are extremely diluted 
in the large volume constituted by the extracellular medium and quenching 
solution, which also contains a high salt concentration [53]. Shaub et al. 
developed a simple method for the simultaneous quenching and extraction 
of metabolites from polysaccharide-producing bacteria using cold ethanol 
[51]. After extraction, an evaporation step was performed in order to 
concentrate the extracts prior to analysis.  
 
4.  Other additional steps of the metabolomics  
analytical process 
 
 After extraction, metabolites are usually diluted in large volumes of 
solvent that are necessarily removed, either partially or totally, aiming at 
concentrating the extract prior to determination. Accordingly, a solvent 
evaporation step is usually performed, either by rotary evaporation, 
centrifugal concentration or lyophilization.  
 It should be emphasized that the whole sample preparation process 
is designed around the analytical platform, which, in some cases, demands 
for additional preliminary steps. As an example, 1H NMR analysis comprises 
dilution of the extracts in deuterated solvents for providing a frequency lock 
for the spectrometer [54]. On the other hand, the low volatility of many 
metabolites makes necessary a derivatization step prior to GC–MS analyses, 
which is usually performed by silylation [55]. By this method, functional 
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groups containing active hydrogen atoms, such as –OH, NH, –COOH and –SH 
are trimethylsilylated by a silylation reagent, usually N-methyl-N-trimethyl-
silyltrifluoroacetamide (MSTFA) or N,O-bis trimethylsilyltrifluoroacetamide 
(BSTFA). Therefore, very common metabolites such as organic acids, amino 
acids, sugars, fatty acids, and steroids, among others, can be determined by 
GC–MS.  
 Even though an extensive discussion of the chromatographic 
techniques used in metabolomic experiments is out of the scope of this 
review, it is noteworthy the implementation of new chromatographic 
approaches with promising perspectives in metabolomics. Therefore, 
despite traditional GC and LC separations has been extensively used in 
metabolomics so far [56], the use of new chromatographic phases, such as 
monolithic capillary columns [57] or ultra performance liquid 
chromatography (UPLC) columns, as well as new chromatographic formats, 
such as comprehensive multidimensional chromatography or preparative 
chromatography, are gaining importance in the recent investigations. This 
can be justified by the need of an extremely high resolution power, 
demanded by the large number of compounds present in biological samples.  
 In UPLC the use of chromatographic columns with smaller particle 
sizes and higher pressures leads to an increased resolution and sensitivity as 
compared to conventional HPLC. Grata et al. developed a UPLC–MS method 
for the metabolite fingerprinting of the plant Arabidopsis Thaliana obtained 
after subjected to stress conditions [58]. The hyphenation of the UPLC with a 
TOF mass spectrometer allowed the tentative identification of the stress-
induced ions, which can be potentially used as biomarkers. In other study, 
the robustness and repeatability of the UPLC–MS methodology was 
evaluated [59] to ensure the comparability of the data obtained from the 
analysis of more than 7000 serum samples within several years, in a long-
term study which is planned to be performed by the Human Serum 
Metabolome Project (HUSERMET). 
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 One other alternative is to combine two or more separation 
techniques in a single analysis, usually GCxGC [22] LCxLC and, less 
frequently, LCxCE, which is known as comprehensive multidimensional 
chromatography [60]. Well implemented in proteomics, multidimensional 
chromatography is gaining attention in the field of metabolomics in the last 
years as long as it offers tremendous resolution capability and, in some 
cases, increased sensitivity as compared to one-dimensional 
chromatography. In fact, the maximum resolution achieved in an orthogonal 
approach (which is performed when the separation mechanism of the two 
dimensions is essentially different) is equal to the product of the individual 
peak capacities of each independent dimension. In GCxGC, the sample 
components are separated throughout two GC columns, which are in series 
connected by means of a temperature-controlled interface. Thus, the sample 
is firstly loaded on a conventional high resolution capillary column, which is 
usually non-polar. Then, small fractions of eluate are sequentially 
transferred via a cryogenic trap, called modulator, to a second column, 
which is usually polar and notably shorter than the former. Lu et al. have 
developed a method for the analysis of cigarette smoke condensates by 
GCxGC–TOF/MS [61], which allowed identification of over 1000 compounds 
present in the exhaled smoke. Comprehensive GCxGC has also been used in 
the separation of complex samples such as herbal oils [62]. On the other 
hand, multidimensional liquid chromatography offers potential versatility 
thanks to the large variability of stationary phases available for LC 
separations [60]. However, applications of multidimensional liquid 
chromatography are by far less exploited than those of GC, which is probably 
attributed to the lack of MS libraries, and the less resolution capability 
associated to this technique.  
 
5. Conclusions  
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 The different steps involved in preparation of biosamples in 
metabolomics experiments have been reviewed here. These steps have 
encompassed from sample selection, a critical task to extract the maximum 
level of biological information, to isolation of metabolites, derivatization or 
concentration prior to detection. Practical considerations have been 
provided for each step with significant examples for different types of 
biosamples: solids, liquids or cells. With the recent evolution experienced by 
detectors such as MS or NMR, it is expected that special attention will be 
paid to sample preparation in order to reduce its decisive impact on the 
quality of the final results.  
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En esta Parte II de la Memoria se recoge la investigación realizada 
utilizando una de las estrategias características de la metabolómica que 
permite profundizar en el conocimiento de un metabolito o, más 
comúnmente, un grupo concreto o una familia de metabolitos que 
comparten una ruta o son característicos de un determinado 
comportamiento del sistema en estudio. Esta estrategia se orienta al análisis 
cualitativo y/o cuantitativo y recibe en inglés el nombre de “targeted 
analysis” o "targeting analysis", pero es difícil de expresarla con sólo dos 
palabras en español, por lo que, en lo sucesivo y por brevedad, se adoptará la 
terminología inglesa. 
 La investigación realizada utilizando esta estrategia ha permitido el 
desarrollo de un total de 6 métodos analíticos, con sus correspondientes 
aplicaciones, que ha dado lugar a otras tantas publicaciones. Estas 
aplicaciones se han ordenado atendiendo al tipo de matriz en el que se ha 
llevado a cabo el “targeting analysis”: Así, en una matriz compleja, como es la 
orina, se han determinado hormonas esteroideas femeninas utilizando 
cromatografía de líquidos y espectrometría de masas en tándem, con 
analizador de triple cuadrupolo para la separación y la detección, haciendo 
hincapié en la etapa de preparación de muestra. En concreto, se ha 
pretendido innovar en las etapas de limpieza de la muestra y 
preconcentración de los analitos de forma automática y en línea con la etapa 
de separación–detección (Capítulo 3), o en la hidrólisis enzimática, 
acelerándola mediante la utilización de ultrasonidos como energía auxiliar 
(Capítulo 4). En dos matrices biológicas (suero y orina) se han determinado 
precursores de esfingolípidos  mediante separación por microcromatografía 
y detección por fluorescencia inducida por láser, tras las etapas de 
extracción en fase sólida y derivatización in situ realizadas en un sistema 
LOV (“lab-on-valve”) (Capítulo 5).  
 Tres han sido las matrices (suero, orina y leche humana) en las que 
se han analizado vitamina B9 y sus catabolitos mediante un sistema de 
extracción en fase sólida automático, conectado en línea con un 
cromatógrafo de líquidos y un detector de masas en tándem (Capítulo 6). 
   
  
También se ha realizado “targeting analysis” en matrices vegetales, como en 
el método desarrollado para la determinación de ácidos haloacéticos en 
acelgas y espinacas, basado en lixiviación asistida por ultrasonidos con 
derivatización in situ previa a la separación mediante cromatografía de 
gases y detección por captura electrónica (Capítulo 7); así como en el 
estudio dedicado al tomate, en el que se han determinado carotenos, fenoles, 
ácido ascórbico y carbohidratos. Esta amplia gama de compuestos requirió, 
tras su lixiviación asistida por ultrasonidos, la separación mediante 
cromatografía de gases o de líquidos, con detección en ambos casos 
mediante espectrometría de masas (Capítulo 8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                               
                                                                                                                      
 
 
 
Part II of this book contains the research developed using one of the 
strategies characteristic of metabolomics that allows to go in depth into the 
knowledge of a metabolite or, more frequently, a given group of metabolites, 
or a family of them which shares a metabolic pathway, or are characteristic 
of the behavior of the system under study; that is: targeting analysis.  
The developed research based on this strategy has resulted in 6 
analytical methods and their corresponding applications, which have given 
place to equal number of publications. The applications have been ordered 
as a function of the type of matrix to which targeting analysis has been 
applied. Thus, in a complex matrix as urine, female steroid hormones have 
been determined using liquid chromatography and in-tandem mass 
spectrometry (triple quad analyzer) for separation and detection, and 
making special emphasis on sample preparation. In fact, the main aim in 
Chapter 3 was innovation both in sample cleanup and analytes 
preconcentration in an automatic manner and in-line with the separation–
detection step; while in Chapter 4 acceleration of enzymatic hydrolysis by 
using ultrasound as auxiliary energy was the main achievement. Sphingoid 
precursors have been determined in two biological matrices such as serum 
and urine by microchromatography separation and detection by laser-
induced fluorescence, both after solid-phase extraction and in situ 
derivatization carried out in an LOV (lab-on-valve) system, as shows Chapter 
5.  
 Vitamin B9 and their catabolites have been determined in three 
matrices (serum, urine and breast milk) by using an automatic solid-phase 
extraction system on-line connected to a liquid chromatograph and tandem 
mass detector (see Chapter 6). Also targeting analysis has been the strategy 
applied to vegetal matrices, as in the method for determination of haloacetic 
acids in chard and spinach, based on ultrasound-assisted leaching with in 
situ derivatization prior to gas-chromatography separation and electron-
capture detection, which is the subject of Chapter 7. In addition, a vegetable 
   
  
matrix (tomato) has been the sample for determination of carotenes, 
phenols, ascorbic acid and carbohydrates; a game of compounds that made 
necessary two types of chromatography (liquid and gas chromatography) 
with mass spectrometry detection in both cases, and after ultrasound-
assisted extraction, as Chapter 8 shows.  
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Automated solid-phase extraction for concentration 
and clean-up of female steroid hormones prior to liquid 
chromatography–electrospray ionization–tandem mass 
spectrometry: An approach to lipidomics 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract  
 A method for determination of free and glucuronide-conjugated 
female steroid hormones in urine at the pg mL−1 level is here presented. For 
this purpose, a dual approach with or without β-glucuronidase hydrolysis 
has been developed to succeed in this analysis. The target analytes were two 
progestogens —progesterone and pregnenolone— and three endogenous 
estrogens —estradiol, estriol and estrone—. Separation and detectionwere 
carried out by liquid chromatography electrospray ionization and tandem 
mass spectrometry (LC–ESI–MS/MS) with a triple quadrupole (QqQ) mass 
detector. The determination stepwas optimized by multiple reaction 
monitoring for highly selective identification and sensitive quantification of 
female hormones in a complex sample such as human urine. As these 
compounds are present in urine at very low concentration (ngmL−1 level), a 
preconcentration and clean-up step by solid-phase extraction was 
automatically carried out prior to the chromatographic step in order to 
improve the sensitivity of the method. This sample pretreatment was 
performed using a lab-on-valve (LOV) manifold which provided 
preconcentration factors ranging from 59.1 to 72.3 for 10 mL urine. The 
detection and quantification limits were in the ranges 1.8–18 pg and 6–61 pg 
on-column, respectively, with precision values from 1.93 to 10.99%, 
expressed as relative standard deviation. These results enable to conclude 
the suitability of the LOV–LC–QqQ approach for determination of the 
lipidomic profiling of the main female steroid hormones in a difficult matrix 
as human urine. The method can be potentially applied to the clinical and 
other metabolomic areas. 
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1.  Introduction  
 
 Systems biology, which involves the integration of genomic, 
transcriptomic and proteomic techniques, provides a powerful approach to 
understand mechanisms of diseases and develop new therapeutic agents 
[1,2]. Even in simple systems, statistical relationships between gene 
expression and protein levels can be considerably weak [3]. This fact has 
stimulated the use of metabonomics to provide quantitative measurement of 
the multivariate metabolic responses of multicellular systems to 
pathophysiological stimuli or genetic manipulations [4]. In metabonomics, 
lipidomics has evolved as a separate discipline because of the extraordinary 
structural diversity of lipids and their key roles in the pathophysiology of 
diseases. Lipidomics has been defined as the full characterization of lipid 
molecular species and their biological roles concerning expression of 
proteins involved in lipid metabolism and function, including regulation [5]. 
Although still an emerging field, lipidomics has already provided promising 
newresearch possibilities; nevertheless, technological challenges remain 
unsolved. Crucial differences between different biological states can be 
distinguished mainly by quantitation of overall or targeted lipids profiling. 
 Estrogens and progestogens are a group of female sterol lipid 
hormones [6] derived from cholesterol, which are widely distributed in 
animals and humans. The highest levels of these hormones are found in 
tissues with reproductive function, such as breast, ovary, vagina and uterus 
[7]. Estrogens exert diverse biological functions in female organisms, i.e. 
female sexual differentiation, arterial vasodilatation and maintenance of 
bone density [8]. In addition, endogenous estrogens have a protective 
function against various diseases, such as osteoporosis, atherosclerosis and 
cardiovascular and neurodegenerative diseases [9,10]. Progesterone plays a 
key role in the female menstrual cycle (mainly produced after ovulation) and 
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during pregnancy, when its production causes suppression of further 
ovulation and provides the correct environment for the developing embryo 
[11]. Pregnenolone, together with other steroids, is found at high 
concentrations in certain areas of the brain, where it acts as a 
neuroprotective agent, affects synaptic functioning and enhances 
myelinisation [12]. 
 The steroidogenesis of female sex hormones from cholesterol 
(Figure 1) involves the participation of six isoforms of cytochrome-
dependent monooxygenase (CYP) and two hydroxysteroid dehydrogenases 
[13]. The first step is the cleavage of the side chain of cholesterol mediated 
by CYP11A to form the C21 steroids pregnenolone and progesterone. The 
C19 steroids, named androstenedione (precursor of testosterone) and 
dehydroepiandrosterone, are formed by hydroxylation and subsequent 
cleavage of the two-carbon side chain of their precursors with the 
participation of the CYP17 isoform, which have 17-hydroxylase and C17–20 
lyase activity. Finally, estrone and estradiol are formed by aromatization of 
androstenedione and testosterone, catalyzed by the aromatase CYP19. The 
steroidogenesis pathway may occur in different tissues such as those 
forming the ovary, testis or placenta. Steroids are liberated to the 
bloodstream bound to plasma proteins or as conjugated forms, particularly, 
sulphates or glucuronides [14]. Biotransformation of estrogens to their 
conjugated forms occurs in the liver and renders to molecules less lipophilic, 
which are more easily excreted in urine and bile.  
 The analysis of steroid hormones in biological samples can be 
employed as a diagnostic tool in diseases promoted by disorders in the 
steroids profile. Thus, the determination of estrone aids the diagnosis of 
Turner’s syndrome [15]. The determination of estradiol is used in the 
diagnosis of precocious puberty in girls, amenorrhea and to monitor the 
follicle development in the ovary in the days prior to in-vitro fertilization 
[16]. Estriol, along with other hormones, enables to assess fetal diseases 
during pregnancy, such as Smith-Lemli-Opitz syndrome [17], or steroid 
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sulfatase deficiency [18]. Progesterone is suitable to be monitored during 
treatment of infertility [19]. Elevated levels of pregnenolone can be 
produced in polycystic ovarian disease [20] and hyperplasia [21].   
 Exogenous estrogens and progestogens have been administered for 
years in hormone replacement therapy aiming at the treatment of hormonal 
disorders, i.e. during menopause. Estrogens are also used in the treatment of 
several other diseases such as infertility or endometriosis, and in menstrual 
disorders, among others [22]. In addition, estrogens have encountered other 
applications in treatment and/or prevention of diseases that affect women 
in a major extension, or in the case of Alzheimer disease [23–25]. One of the 
most negative effects of the administration of exogenous estrogens is their 
contribution to the development and evolution of breast cancer and 
endometrial cancer [8,26,27]. Therefore, monitoring steroid levels in urine 
throughout hormone therapy or during pregnancy is also of clinical interest. 
 In most cases, the biological samples used for determination of 
female steroid hormones are serum and urine. Due to the ease of collection 
and the abundant presence of metabolites, urine is an ideal bio-fluid for 
human and animalmetabolomic studies [28]. The purpose of this research is 
the development of a method for determination of glucuronide-conjugated 
and free steroids in human urine by a dual approach with or without β-
glucuronidase hydrolysis. This application, marked by the low concentration 
of steroids in urine and the complexity of this sample matrix, demands for 
the development of highly selective and sensitive analysis methods. The 
method proposed here is based on liquid chromatography tandem mass 
spectrometry (LC–MS/MS) with a triple quadrupole mass detector (QqQ). 
Before separation, an automated preconcentration and clean-up step has 
been optimized by solid-phase extraction (SPE) with a laboratory-on-valve 
(lab-on-valve or LOV) device. The automation of sample preparation enables 
to scaledown this step and improves precision by minimizing human 
intervention [29]. 
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2.  Experimental 
 
2.1.  Reagents and samples 
 
 Acetonitrile and ammonia of LC–MS grade (Scharlab, Barcelona, 
Spain) and deionized water (18Ωcm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) were used for preparation 
Figure 1. Principal pathway of steroid hormone biosynthesis in the human 
ovary. Cytochrome P450 isoforms: CYP11A1 (cholesterol side chain cleavage), 
CYP17 (17α-hydroxylase), CYP19 (aromatase), CYP17 (17,20-lyase). 17β-HSD: 
17β-hydroxysteroid dehydrogenase; 3β-HSD: 3β-hydroxysteroid 
dehydrogenase. 
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of chromatographic phases. HPLC grade methanol and water acidified with 
phosphoric acid (pH 4.5) were used in the SPE step. β-Glucuronidase from 
Escherichia coli (200 UmL−1) was provided by Boehringer (Mannheim GmbH, 
Germany). Estrone, estradiol, 5-pregnen-3β-ol-20-one, estriol and 
progesterone were fromSigma–Aldrich (St. Louis, MO, USA). (E)-
Diethylstilbestrol, also from Sigma–Aldrich, was used as internal standard. 
Stock standard solutions 1000 µgmL−1 of each steroidwere prepared in 
methanol and can be stored at −20 °C in the dark for a month without 
alteration. Individual and multistandard solutions of steroids for the 
optimization study were daily prepared by dilution of the stock standard 
solutions also in methanol. 
 Urine samples were voluntary donated by healthy women aged 23–
28. The samples were collected in sterile containers, buffered with 1mL of 
2Msodium acetate buffer (pH 4.8), stored at 4 °C until analysis within 24 h 
after collection. 
 
2.2. Instruments and apparatus 
 
 Analyses were carried out by reversed-phase liquid chromatography 
(RP-LC) followed by electrospray ionization (ESI) and tandem mass 
spectrometry detection. Separation was carried out with an Agilent (Palo 
Alto, CA, USA) 1200 Series LC system equipped with a binary pump, vacuum 
degasser, autosampler and thermostated column compartment, and 
detection with an Agilent 6410 Triple Quadrupole mass detector. An Agilent 
Zorbax Eclipse XDB-C18 (4.6mm×150mm, 5µm particle size) 
chromatographic column was used for separation. Agilent Mass 
HunterWorkstation was the software for data acquisition, qualitative and 
quantitative analysis. The lab-on-valve manifold for sample preparation was 
a FIAlab 3000 sequential injection analyzer (Medina, WA, USA), equipped 
with a bi-directional microsyringe pump (1000 µL), a six-way selector valve, 
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a PVC monolithically structured LOV mounted on-top of the six-way selector 
valve, and an external 10-port twoposition selection valve (VICI, Valco, 
Houston, USA). The manifold is fully automated and controlled by the FIAlab 
for Windows version 5.0 software. Homemade mini-columns (50 mm×1.5 
mm) packed with 0.05 g Chromabond C18 or C18-Hydra® (Macherey Nagel, 
Dürem, Germany) as sorbent material (30–40 µm particle diameter) were 
used for clean-up and preconcentration of the target analytes by SPE. 
Polyetheretherketone (PEEK) tubing (0.5 mm and 0.8 mm inner diameter) 
was used to connect the manifold components to the ports of the selection 
valve, including the SPE column. The total volume of the LOV system was 
300 µL. A thermostated water bath from Selecta (Barcelona, Spain) was used 
to develop the enzymatic hydrolysis step. A centrifuge (Selecta) was used 
after the hydrolysis step. 
 
2.3. Sample preparation 
 
 The approach for determination of free and glucuronideconjugated 
steroids is schematized in Figure 2A. The protocol for determination of 
glucuronides and total steroids required an enzymatic hydrolysis with β-
glucoronidase (40 µL) by heating at 37 °C for 18 h [30]. The determination of 
steroids was initiated by centrifuging 10mL urine at 3000rpm for 5 min in 
order to facilitate the performance of the SPE mini-column. Then, the 
internal standard (10 ngmL−1) was added to follow with the SPE step. 
 The automated SPE process was carried out in the LOV manifold 
shown in Figure 2B. The operational sequence for automatic SPE in the LOV 
manifold can be summarized as follows: (1) activation of the mini-column 
with 2 mL methanol and conditioning with 1 mL carrier (both steps at 3 
mLmin−1); (2) equilibration of the column with 1 mL carrier solution at 1.2 
mLmin−1; (3) loading 10 mL sample at 1.2 mLmin−1; (4) washing the mini-
column with 2 mL carrier and flushing of air to eliminate the rest of the 
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sample matrix; (5) elution of steroids with 150 µL methanol in order to 
solubilise them. Urine samples were handled with the special care required 
for analysis of biological samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Approach for determination o  free and glucuronide-conjugated steroids. 
(A) Flow diagram for determination of the target analytes. (B) Configuration of the 
LOV manifold used for the SPE step. C, carrier; SP, syringe pump; SPV, syringe pump 
valve; HC, holding coil, S, sample; W, waste; A, air; E, eluent; C, mini-column; SV, 
switching valve. 
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2.4. LC–MS/MS separation–determination method 
 
 Mobile phases A and B were 0.1% ammonia in water and 0.1% 
ammonia in 95:5 acetonitrile–water (v/v), respectively. After sample 
injection (20 µL), a linear gradient was programmed for 12 min from 80:20 
A–B to obtain 20:80 A–B composition, which was held for 1 min. Then, the 
concentration of B was increased to 95% in 0.5 min and held for 6.5 min. 
The total analysis time was 20 min while 4 min was required for re-
establishing and equilibrating the initial conditions. The flow rate was set at 
1 mLmin−1 during the chromatographic process and the temperature of the 
analytical column was 12 °C. The entire eluate was electrosprayed, ionized 
and monitored by MS–MS detection in MRM mode. Ionization was positive 
for progesterone and pregnenolone, and negative for estrone, estriol, 
estradiol and diethylstilbestrol. For this purpose, the MS polarity was 
switched by time segments according to the retention of the target analytes. 
The flow rate and temperature of the drying gas (N2) were 13 Lmin−1 and 
350 °C, respectively. The nebulizer pressure was 35 psi and the capillary 
voltage 4000 V. The dwell time was set at 200 ms. 
 
3. Results and discussion 
 
3.1. Optimization of the determination method 
 
 The lack of methods for determination of female hormones in human 
urine has been ascribed to the low concentrations at which these 
compounds are found in this biological fluid. Therefore, the application of 
highly selective and sensitive detection techniques is crucial to achieve the 
low concentration levels of these hormones to be determined. Mass 
spectrometry after gas chromatography separation has provided excellent 
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results for determination of estrogens in sediments [31,32], water [33,34] or 
urine [35,36]. However, a derivatization step prior to chromatographic 
separation is mandatory for most of these compounds because they are 
thermally unstable, non-volatile or polar [35]. Derivatization makes sample 
preparation laborious and time-consuming, and may lead to losses [37,38] 
or degradation of the target steroids [39]. LC–MS/MS can be a competitive 
option because of the recent improvements in this hyphenated technique, 
particularly in interface performance. The use of a triple quadrupole mass 
detector together with the multiple reaction monitoring (MRM) mode 
enables the development of methods with low detection and quantification 
limits and a great identification capability even in complex samples. For this 
reason, this was the alternative selected in this research. This combination is 
based on the selection of transitions for each analyte from the precursor ion 
to its most characteristic product ions resulting in highly selective methods. 
Thus, the identification of a certain compound is based on the presence of 
these transitions in its mass spectrum; transitions which are optimized in 
order to select the most intense for quantification of the target analytes and 
favoured by practical removal of background noise in the chromatograms. 
The optimization study was carried out with a steroid multistandard under 
the chromatographic conditions explained in Section 2, which enables 
complete separation within 20 min. (E)-Diethylstilbestrol, used as internal 
standard, was also considered in this optimization. The criteria for selection 
of diethylstilbestrol were its physical and chemical properties similar to 
those of the analytes and its absence in the samples. 
 A parallel study was carried out to test the influence of the ionization 
mode for each analyte. This study was performed with the multistandard 
solution in scan mode in which only the second mass filter is operating to 
detect ions within a limited mass range between 100 and 1000 m/z with a 
scan time of 500 ms. Total ion chromatograms corresponding to this study 
are shown in Figures 3 A y B, from which it can be concluded that 
progesterone and pregnenolone should be monitored in positive mode, 
while negative ionization was better for estriol, estrone and estradiol. Table 
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1 shows the precursor and product ions for each steroid as well as the 
optimum values of MS–MS parameters: voltage of the first quadrupole for 
isolation of the precursor ion and collision energy for efficient 
fragmentation. Figure 4 shows the MRM chromatograms obtained with 
amultistandard solution and the quantification transition. The study of the 
detection step finished with the selection of the dwell time, tested within the 
range 10–250 ms, being 200 ms the best value. The application of the MRM 
approach enables identification and confirmation of the presence of the 
target steroids in a urine sample. Thus, monitoring the three most 
characteristic transitions for each analyte provides an extra level of 
selectivity. Table 1 shows the strategy to be followed for confirmatory 
analysis of the target female hormones in urine just before quantitative 
analysis. 
 
Table 1. (A) Optimization of the MS–MS step for qualitative (confirmatory 
analysis) and (B) quantitative analysis of female steroid hormones in human 
urine by multiple reaction monitoring. 
(A) 
 
q1: first quadrupole 
 
Analyte 
Voltage q1 
(V) 
Precur
sor ion 
(m/z) 
Collision 
voltage 
(V) 
Product ions 
(m/z) 
Quantification 
transition 
Estriol 120 287 60 255/171/145 287→145 
Estradiol 140 271 50 239/183/145 271→183 
Estrone 140 269 45 253/183/145 269→145 
IS 140 267 35 237/222/131 267→222 
Progesterone 120 315 20 273/160/109 315→109 
Pregnenolone 120 317 20 256/159/109 317→109 
 164 
Nuevas plataformas analíticas en metabolómica                                                                                    
(B) 
 
Precursor 
ion (m/z) 
Qualifier for 
steroid 
identification 
Female 
hormone 
Qualifier for 
confirmatory 
analysis 
Qualifier for 
confirmatory 
analysis 
Confirmatory 
analysis 
287 145 Estrogen 255 171 Estriol 
271 145 Estrogen 239 183 Estradiol 
269 145 Estrogen 253 183 Estrone 
315 109 Progestogen 273 160 Progesterone 
317 109 Progestogen 256 159 Pregnenolone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. (A) Total ion chromatograms obtained with a 10 µgmL−1 standard 
solution in full scan mode with positive (A) and negative (B) ionization. 
 
(B) 
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3.2. Optimization of the solid-phase extraction step 
 
 An automated SPE step was the selected approach for clean-up and 
preconcentration of steroids from urine prior to determination by LC–MS–
MS. Several studies based on SPE for isolation and enrichment of steroid 
hormones have previously been reported [38,40]. Different sorbent 
materials have been tested in these studies concluding that octadecyl-C18 
phase provides the best results. In this research, two types of C18 sorbents, 
conventional C18 and C18-Hydra®, were compared to assess the location of 
silanol active groups. While silanol active groups are randomly distributed 
in conventional C18, C18-Hydra® is characterized by higher activity of 
silanol groups located on the silica surface.  
 Figure 4. Multiple reaction monitoring chromatograms obtained with a standard 
solution (10 ngmL−1, including internal standard) at the most sensitive transition 
for each analyte (working conditions, under Section 2). 
 167 
                      J. Chromatogr. A, 1207 (2008) 46–54 Chapter 3 
 The main variables involved in the SPE step were optimized in order 
to study their influence on the clean-up and preconcentration efficiency. The 
variables were sample volume, sample loading flow-rate, washing-solution 
volume, eluent flow-rate and elution volume. Table 2 shows these variables, 
the ranges studied and the resulting optimum values. Acetonitrile, methanol 
and ethanol were tested for elution of the retained compounds from the SPE 
column, methanol providing a more uniform elution. The fraction of eluate 
collected for chromatographic analysis was another key variable in the SPE.  
 
 
 
 The elution profile was studied by LC–MS/MS analysis of consecutive 
50 µL fractions of the eluate. The elution was homogeneous in the first 150 
µL of eluate and, for this reason, this fraction was isolated for analysis. No 
elution of the target analytes was observed in the subsequent fractions and, 
thus, these fractions were discarded. Under the optimum working 
conditions, preconcentration factors for 10 mL urine were from 59.1 to 72.3, 
as shows Table 3. This concentration parameter was estimated with spiked 
samples by comparison with direct analysis without hormones enrichment. 
 
3.3. Optimization of the hydrolysis step 
 
Variable Tested range Optimum value 
Sorbent C18, C18-Hydra® C18-Hydra® 
Loading flow-rate (mLmin-1) 0.3−1.8 1.2 
Sample volume (mL) 5−50 10 
Washing volume (mL) 0−5 2 
Washing flow-rate (mLmin-1) 0.6−6 3 
Volume of eluate (mL) 50−1000 200 
Elution flow-rate (mLmin-1) 0.3−3 0.3 
Table 2. Optimization of the solid-phase extraction variables. 
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 Estrogens can be excreted in the urine as glucuronides or sulphate-
conjugated forms. Nevertheless, the content of sulphates estrogens in 
human urine is really low. Therefore, the determination of total or 
glucuronide-conjugated steroids requires implementation of a hydrolysis 
step prior to other steps of the analytical process. Non-specific chemical 
hydrolysis with hydrochloric acid and heating at 70 °C for 1 h in a 
thermostatic water bath has been reported for total estrogens. The 
alternative is the use of β-glucuronidase for specific hydrolysis of steroids 
conjugated with glucuronic acid. The procedure for enzymatic hydrolysis is 
described in Section 2. The main limitation of this procedure is the time 
required for hydrolysis completion (18 h). This reaction is performed under 
physiological conditions preserving in this way the integrity of the sample 
[39]. 
 
3.4. Characterization of the method 
 
 Calibration plots were run under the optimum working conditions 
with eight spiked samples at different concentrations of analytes using the 
relative peak area (peak area of each compound vs. that of the IS) as a 
function of the concentration of each compound. The regression coefficients 
for the dynamic ranges are shown in Table 3. As can be seen, they range 
from 0.9937 to 0.9999. The limits of detection (LODs) and quantification 
(LOQs) were calculated from the MRM chromatograms obtained with urine  
samples on the basis of a minimal accepted value of the signal-to-noise (S/N) 
ratio of 3 and 10, respectively. The background noise was estimated by the 
peak-to-peak baseline near each analyte peak. 
 As shows Table 3, LODs range from1.8 to 18 pg on-column while 
LOQs are from 6 to 61 pg. In order to evaluate the precision of the proposed 
method, intra-day and inter-day variability were evaluated in a single 
experimental set-up with duplicates [41]. 
 169 
                      J. Chromatogr. A, 1207 (2008) 46–54 Chapter 3 
 
 
  
 The experiments were carried out using 10 mL of urine sample 
spiked with 2 ngmL−1 of each of the target analytes under the optimum 
working conditions. Two measurements per day were performed on seven 
days. As can be seen in Table 3, the results obtained, expressed as relative 
standard deviation (RSD), are from 1.93 to 5.05% for intra-day variability 
and from 4.04 to 10.99% for inter-day variability. The absence of reference 
materials for the determination of steroids in urine led to spike urine 
samples with the target analytes in order to test the suitability of the 
proposed method. With this aim, stock standard solutions were added to 
three aliquots of urine at 2 ngmL−1. Three aliquots of a non-spiked sample 
were also analysed. As can be seen in Table 3, the spiked steroids were 
quantified at all concentrations with an error below 6% resulting in 
recoveries indexes from 95.29 to 103.1%. 
 
3.5. Application of the method to urine samples 
 
 In order to demonstrate the applicability of the proposed method, 
urine samples from five volunteer women were analysed following the 
procedure here proposed. For each sample, six replicates were analysed in 
order to obtain the content of free and glucuronide female steroids. Table 4 
 
Preconcentration 
factor 
LOD 
(pg) 
LOQ 
(pg) 
R2 
Recovery 
±SDa (%)  
Intra-day 
variability 
(%) 
Inter-day 
variability 
(%) 
Estriol 72.3 5.4 17.9 0.9988 99.7±1.3 3.22 6.73 
Estradiol 71.4 18.3 61.1 0.9982 98.7±0.7 1.93 4.04 
Estrone 70.9 8.6 29.8 0.9968 95.3±5.8 3.41 5.35 
Pregnenolone 60.7 1.8 5.9 0.9999 103.1±6.1 5.05 10.99 
Progesterone 59.1 10.5 35.1 0.9987 96.2±4.1 4.09 8.41 
a SD: standard deviation. 
 
Table 3. Characterization of the method. 
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shows the results found for each analyte in the five samples. Pregnenolone 
was the only hormone detected as free form in one of the samples. The 
absence of free hormones is justified by biotransformation of these 
compounds in the liver for its excretion.  
 Therefore, this method is able to detect abnormal values, thus 
resulting in an interesting tool for clinical diagnosis. On the other hand, 
estrone and pregnenolone were quantified in most of the samples as 
conjugated forms. Figure 5 shows the TIC chromatogram for one of these 
samples after enzymatic hydrolysis to quantify glucuronide-conjugated 
steroids. 
 
 
Figure 5. Total ion chromatogram provided by a urine sample using the 
proposed MRM method. 
        
 
Estriol Estrone Pregnenolone Progesterone Estradiol 
Free 
Free + 
glucuronide 
conjugated 
Free 
Free + 
glucuronide 
conjugated 
Free 
Free + 
glucuronide 
conjugated 
Free 
Free + 
glucuronide 
conjugated 
Free 
Free + 
glucuronide 
conjugated 
N.D. 0.184 ± 0.010 N.Q. 2.2386± 0.050 N.Q. 
5.3934 ± 
0.15 
N.Q. 0.486 ± 0.015 N.Q. 0.741± 0.005 
N.D. N.Q. N.D. N.Q. N.D. N.Q. N.Q. N.Q. N.D. N.D. 
N.D. N.Q. N.D. 1.319 ± 0.030 N.Q. 4.9112 ± 0.2 N.Q. 0.303 ± 0.006 N.D. N.Q. 
N.D. N.Q. N.D. 0.329 ± 0.009 2.224 ± 0.050 3.271 ± 0.08 N.Q. N.Q. N.D. N.Q. 
N.D. N.D. N.D. 0.837 ± 0.011 N.Q. 2.189 ± 0.10 N.Q. N.Q. N.D. N.Q. 
Table 4. Concentration of steroids in urine samples (ngmL–1 ±SDa) 
 172 
Nuevas plataformas analíticas en metabolómica                                                                                    
4. Conclusions 
 
 A method allowing identification and quantification of estrogens and 
progestogens in urine at low ngmL−1 levels has been here proposed. It 
should be emphasized that the use of a lab-on-valve approach led to 
automated sample preparation with minimum human intervention. Thus, 
the contact with biological samples as well as contamination and 
irreproducibility problems are practically avoided by precise delivery of 
small volumes. 
 The high selectivity and sensitivity of the method demonstrate its 
suitability for determination of these compounds in urine samples. 
 This can be of interest to study the status of these hormones or their 
metabolic evolution in the human body. Thus, it constitutes a useful method 
in studies of fertility, variability of the endogenous hormones within a 
menstrual cycle or during hormone replacement therapy, and also in disease 
diagnosis, i.e. in the diagnosis of endocrine disorders. The method can also 
be applied to any biological fluid after modification of the sample 
preparation step, if required. 
 The present research is an example of how the improvements in 
mass spectrometers interfaced to LC (e.g., MALDI−TOF equipment [42]) 
increase the availability of these detectors to characterize a number of lipids 
with minimal sample preparation, of great interest to study the profound 
influence of these compounds on systems biology. 
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Chapter 4 
Ultrasound-enhanced enzymatic hydrolysis of 
conjugated female steroids as pretreatment for 
their analysis by LC–MS/MS in urine 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
A fast, selective and sensitive method is here proposed for the analysis of 
female steroid hormones as conjugated forms (mainly, glucuronides and 
sulfates). The method implements an enzymatic hydrolysis (β-glucuronidase 
with sulfatase activity) kinetically enhanced by ultrasonic energy in order to 
generate the free steroid forms. This enables a drastic shortening of the time 
required for this step as compared with conventional protocols (from 12–18 
h to 30 min). After hydrolysis, the free steroid hormones were isolated and 
preconcentrated by automated solid-phase extraction and the eluate was 
subsequently analysed by liquid chromatography–tandem mass spectro-
metry (LC–MS/MS). The target analytes were confirmed and quantified by 
multiple reaction monitoring (MRM). The detection and quantification limits 
were within 0.06–0.8 ng mL-1 and 0.19–2.69 ng mL-1, respectively. The 
precision of the method, expressed as intra-day and inter-day variability, 
ranged between 2.1 and 5.2% and between 4.9 and 8.0%, respectively. A 
complementary study was carried out to assess the storage conditions of 
urine samples. This study is crucial in those applications involving metabolic 
processes as the integrity of the sample has to be preserved. 
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1.  Introduction  
 
 Estrogens and progestogens are a group of steroid-sex hormones 
with essential functions in female metabolism. In the body, these are all 
derived from cholesterol in a biosynthetic pathway,1 which mainly occurs in 
the ovaries, corpus luteum and placenta and, in a lesser extent, in liver, 
adrenal glands and breast.2  
The three major naturally present estrogens in women are estradiol, 
estriol and estrone. Endogenous estrogens mainly exert reproductive 
functions as they promote the development of female secondary sex 
characteristics, and are also involved in the thickening of the endometrium 
and other aspects of menstrual cycle regulation.3 Exogenous estrogens are 
frequently administrated as part of oral contraceptives, in estrogen 
replacement therapy of postmenopausal women and in treatment of 
menstrual disorders.4,5  
Progesterone is the most abundant progestogen in metabolism, 
secreted by the corpus luteum and the placenta. Progesterone is required in 
embryo implantation, pregnancy maintenance and development of 
mammary tissue for milk production.3 Progesterone is also an intermediate 
in the steroidogenesis of estrogens, androgens and adrenal corticosteroids. 
Pregnenolone, the metabolic precursor of progesterone, belongs to the 
group of neurosteroids, which are found in high concentrations in certain 
areas in the brain, where they affect the synaptic functioning, are 
neuroprotective and enhance myelinization.6 Furthermore, pregnenolone 
potentially improves cognitive and memory functioning. 
Female steroid hormones are present in urine almost exclusively as 
conjugated metabolites such as glucuronides, sulfates, diglucuronides, 
disulfates and sulfoglucuronides.7 Conjugation of endogenous steroids 
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(excepting progesterone as the hydroxyl group is substituted by a ketone 
group) constitutes an important metabolic pathway of female hormones 
biotransformation.1 The purpose of this metabolic pathway is to increase the 
polarity of steroids in order to favour their transport into biological fluids. 
The most abundant conjugated derivatives are sulfates and glucuronides 
(estrone sulfate is found at concentrations about ten-times higher than 
unconjugated estrone8). As they are less active ligands for steroid receptors 
(SR), conjugated forms are considered as hormone precursors, suitable to 
cross cellular membranes of target tissues via organic ion transporters, 
being hydrolyzed by intracellular membrane-bound enzymes. Finally, its 
union to SR causes transcriptional activation by SR-activated union to 
especific DNA sequences. Conjugated female steroids also exert regulatory 
effects by means of sulfation–desulfation within target tissues.  
Despite the free steroids are the active forms of these metabolites, 
the analysis of the conjugated hormones is of great interest to assess their 
metabolism. However, due to the lack of a complete profile of conjugated 
standards and the variety of existing forms, determination of total steroid 
hormones requires hydrolysis prior to other steps of the analytical process.8 
Hydrolysis has traditionally been carried out by enzymatic incubation. This 
step usually takes 12–18 h,5,9−11 being performed under physiological 
conditions in order to preserve sample stability. Non-specific chemical 
hydrolysis has also been reported.12 which is simpler and less time-
consuming than enzymatic hydrolysis. However, the reaction is usually 
carried out with hydrochloric acid by heating at 70 °C for 1 h in a 
thermostatic water bath. Under these drastic conditions, either the stability 
of the target analytes and sample integrity are not ensured. 
One alternative to enhance enzymatic hydrolysis is the assistance 
with ultrasonic energy,15 still an emerging field. The mechanism through 
which ultrasound enhances enzymatic reactions has not been elucidated. 
Nevertheless, cavitation seems to promote the reaction rates by an 
increased analyte transport from the bulk to the enzyme surface, which 
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leads to an effective contact between substrate and active sites of the 
enzyme.16 There are few precedents in the literature on the application of 
ultrasound to accelerate enzymatic reactions. Most of the reported 
methodologies aim to liberate protein-bonded compounds by means of 
protease digestion with unspecific bonds breaking.17−22 The drastic 
reduction in the analysis time and the simplicity of the methodology justify 
the extension of ultrasound-assisted enzymatic reactions to other analytical 
methodologies. With these premises the applicability of ultrasound energy 
to accelerate the enzymatic hydrolysis of conjugated estrogens present in 
female urine is here tested. To achieve this goal the optimization of the main 
variables involved in the enzymatic step and kinetic characterization of the 
ultrasound-assisted reaction are mandatory steps. 
Apart from enzymatic hydrolysis, other limitation in the analysis of 
female steroids hormones is their low concentration in urine (ng mL–1 level). 
Matrix effects associated to urine samples can also be problematic. There is 
a clear demand for methods implementing both preconcentration/clean-up 
steps as well as highly selective and sensitive detection. The coupling 
between solid-phase extraction (SPE) and LC–MS/MS is a powerful solution 
because of its possibilities being selected in this research. Multiple reaction 
monitoring (MRM) mode in MS/MS was used for confirmatory and 
quantification analysis of female steroid hormones.  
  
2.  Experimental  
 
2.1.  Instruments and apparatus 
 
 Figure 1 shows an overview of the pre-treatment steps including 
ultrasound-assisted enzymatic hydrolysis of female steroids and lab-on-
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valve (LOV) preconcentration. The eluate was subsequentlly individual 
determination by HPLC–triple quad. 
 
 
 
 
 
  
 
 
 Ultrasonic irradiation was applied by means of a Branson 450 digital 
sonifier (20 KHz, 450 W) with tunable amplitude and duty cycle, which was 
equipped with a cylindrical titanium alloy probe (12.70 mm in diameter). 
The sample was placed in a 20-mL container with the probe tip placed at a 
fixed distance from the bottom (2 mm), totally immersed into the solution in 
order to avoid formation of aerosol and foam that create dead zones where 
cavitation does not occur.15 The temperature was kept at 37 °C during the 
enzymatic hydrolysis by means of a thermostated water-bath. 
A FIAlab 3000 sequential injection analyzer (Medina, WA, USA) was 
used for sample preparation, The manifold was equipped with a bi-
directional microsyringe pump (1000 µL), a six-way selector valve, a PVC 
monolithically structured lab-on-valve (LOV) mounted on-top of the 6-way 
selector valve, and an external 10-port 2-position selection valve (VICI, 
Valco, Houston, USA). The manifold is fully automated and controlled by the 
FIAlab for Windows version 5.0 software. Chromabond C18 Hydra®, 30–40 
µm particle diameter, (Macherey Nagel, Dürem, Germany) was used as 
sorbent material in the SPE step. Polyetheretherketone (PEEK) tubing (0.5 
mm and 0.8 mm inner diameter) was used to connect the manifold 
Figure 1. Workflow of the sample pretreatment. 
                                   Nuevas plataformas analíticas en metabolómica                                                                                   
186 
components to the ports of the selection valve, including the SPE column. 
Polytetrafluorethylene (PTFE) tubing (1.5 mm inner diameter) from Análisis 
Vínicos (C. Real, Spain) was used for making the minicolumn.  
The analyses were carried out by reversed-phase liquid 
chromatography (RP-LC) followed by electrospray ionization (ESI) and 
tandem mass spectrometry detection. The separation was carried out with 
an Agilent (Palo Alto, CA, USA) 1200 Series LC system equipped with a 
binary pump, vacuum degasser, autosampler and thermostated column 
compartment, and detection with an Agilent 6410 Triple Quadrupole mass 
detector. An Agilent Zorbax Eclipse XDB-C18 (4.6 x 150 mm, 5 µm particle 
size) chromatographic column was used for separation. Agilent MassHunter 
Workstation was the software for data acquisition, qualitative and 
quantitative analysis.  
A thermostated water-bath from Selecta (Barcelona, Spain) was used 
to develop the overnight incubation for the optimization of the hydrolysis 
step. A centrifuge (Selecta) was used for cleaning the sample after 
hydrolysis.  
 
2.2.  Reagents and samples  
 
 Acetonitrile and ammonia of LC–MS grade (Scharlab, Barcelona, 
Spain) and ultrapure water (18 mΩ·cm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) were used for preparation 
of the chromatographic phases. HPLC grade methanol and water acidified 
with phosphoric acid (pH 4.5) were used for SPE. 
Pure standards of steroids ―estrone, estradiol, 5-pregnen-3β-ol-20-
one, estriol and progesterone― and internal standard ―diethylstilbestrol― 
were from Sigma−Aldrich. Individual stock solutions of 1000 μg mL-1 were 
prepared in methanol and can be stored at −20 °C in the dark for a month 
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without alteration. Individual and multistandard solutions of steroids for the 
optimization study were daily prepared by dilution of the stock standard 
solutions also in methanol. β-Glucuronidase from Helix Pomatia (Type H-1), 
of 21900 kU g-1 and ≥10,000 U g-1 sulfatase activity from Sigma−Aldrich (St. 
Louis, MO, USA) was dissolved in 5-mL 1 M ammonium acetate (pH 5).   
Urine samples were obtained from premenopausal women. All 
participant subjects were healthy and non-pregnant. No considerations 
about life style, intake of contraconceptives or stage within the menstrual 
cycle were made. The samples were collected in sterile containers, buffered 
with 1-mL 2 M sodium acetate buffer (pH 5) and stored at −20 °C in the dark 
until analysis. Calibrations were run with blank male urine, collected and 
stored as described. For optimization of the hydrolysis step, 100-mL urine 
from seven women was pooled and stored at −20 ºC for a week. 
 
2.3.  Ultrasound-assisted enzymatic hydrolysis (USAEH) 
 
 Aiming at performing the USAEH, 10-mL human urine were mixed 
with 1-mL sodium acetate buffer (0.15 M, pH 5), 10 µL internal standard 
(stock solution 1000 ng mL–1 in methanol) and the appropriate volume of 
enzyme solution (500 U mL–1 urine) was added; then, the mixture was 
immersed in a thermostated water-bath at 37 °C. The ultrasonic probe was 
dipped into the bulk solution, with the tip horn at the minimum distance 
from the bottom of the container without contacting it. Hydrolysis of 
conjugated steroids was performed under ultrasonic irradiation for 30 min 
at 35% duty cycle (fraction of ultrasound application per each second), and 
output amplitude 50% (converter applied power 400 W).  
For convencional hydrolysis of conjugated estrogens, the incubation 
mixture was prepared as described for the USAEH procedure, and incubated 
at 37 ºC for 18 h. After the hydrolysis step, the sample was centrifuged at 
3000 rpm for 5 min and the supernatant subjected to the SPE step. 
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2.4.  Solid-phase extraction (SPE) 
 
 The SPE minicolumn was made by packing 0.05 g of C18-hydra in an 
8-cm PTFE tubing (3 mm E.D.). The SPE step was performed as follows: (1) 
activation of the mini-column with 2-mL methanol and conditioning with 1-
mL carrier (both steps at 3 mL min-1); (2) equilibration of the column with 1-
mL carrier solution at 1.2 mL min-1; (3) loading of 10-mL sample at 1.2 mL 
min-1; (4) washing of the minicolumn with 2-mL carrier and flushing air to 
eliminate the rest of sample matrix; (5) elution of steroids with 150 µL 
methanol.  Steps (1) and (2) enables the renewal of the column for analysis 
of next sample. In this way, cross-contamination effects are avoided. 
  
2.5.  Chromatographic separation and detection 
 
 Mobile phases A and B were 0.1% ammonia in water and 0.1% 
ammonia in 95:5 acetonitrile–water (v/v), respectively. Initially, the mobile 
phase was 80:20 A−B. After sample injection (20 µL), a linear gradient was 
programmed for 12 min to obtain a 20:80 A–B composition, which was held 
for 1 min. Then, the concentration of B was increased up to 95% in 0.5 min 
and held for 6.5 min. The total analysis time was 20 min, while 4 min was 
required for re-establishing and equilibrating the initial conditions. The flow 
rate was set at 1 mL min-1 during the chromatographic process and the 
temperature of the analytical column was 12 °C.  
The entire eluate was electrosprayed, ionized and monitored by 
MS/MS in MRM mode. Ionization was positive for progesterone and 
pregnenolone, and negative for estrone, estriol, estradiol and 
diethylstilbestrol. For this purpose, the MS polarity was switched by time 
segments according to the retention of the target analytes. The flow rate and 
temperature of the drying gas (N2) were 13 L min-1 and 350 °C, respectively. 
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The nebulizer pressure was 35 psi and the capillary voltage 4000 V. The 
dwell time was set at 200 ms.  
 
3.  Results and Discussion 
 
3. 1.  Optimization of the SPE and LC–MS/MS steps 
 
 The conditions for the SPE and LC–MS/MS steps were optimized 
using urine samples hydrolysed by the conventional enzymatic protocol. The 
optimum results for both steps are shown in Table 1. Different volumes of 
sample were tested in order to assess the capacity of the home-made 
column, which provided an excellent behaviour up to 10 mL of sample. The 
elution of the retained target steroids was tested with different solvents 
such as acetonitrile, methanol or ethanol because of the non-polar 
properties of the analytes after hydrolysis. The optimum elution was 
performed with 150 µL of methanol, which was dried in a speed-vac with 
subsequent reconstitution in 20 µL methanol. Although methanol was used 
as reconstitution solvent for chromatographic analysis, the performance was 
not affected because of the low injection volume. Figure 2, which 
corresponds to the analysis of the urine pool using the conventional 
enzymatic protocol shows this fact.  
 
 
 
 
 
 
Figure 2. Total ion chromatogram with negative and positive 
ionization modes for estrogens and progestogens, simultaneously. 
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Figure 3.  Analysis of the urine pool using the conventional enzymatic protocol 
for hydrolysis of the conjugated steroids: MRM chromatograms for each free 
steroid generated with the quantitation transition (operating LC–MS/MS 
conditions described under “Experimental Section”). 
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 Figure 3 shows the MRM chromatogram for each compound 
obtained with the transition used for quantification. The transitions that 
were monitored for confirmatory analysis of the target analytes are included 
in Table 1. In this way, the conjugated steroids can be determined with a 
high level of sensitivity and selectivity. 
 
Table 1. Optimum working conditions of the SPE and MS/MS detection steps. 
   
 
 
 
 
 
 
3.2.  Analytical features of the determination method 
  
Calibration plots were obtained by using the standard peak–internal 
standard peak ratio as a function of the standard concentration. Calibration 
runs were performed with spiked male urine with no detectable levels of 
SPE   
Sorbent  C18 Hydra (0.05 g) 
Eluant Methanol (150 µL) 
Sample volume* 10 mL 
Analyte Voltage 
q1 (V) 
Polarity  Collision 
voltage 
(V) 
Qualitative ions 
(m/z) 
Quantification 
transition ( m/z) 
Estriol 120 Negative 60 255.1/171.1/144.9 287.1→145.1 
Estradiol 140 Negative 50 238.9/183.1/145.1 271.1→183.1 
Estrone 140 Negative 45 253.2/183.2/145.1 269.1→145.1 
Diethylstilbestrol 
(IS) 
140  Negative 35 237.1/222.0/131.7 267.1→222.0 
Progesterone 120 Positive 20 273.1/160.0/109.4 315.0→109.2 
Pregnenolone 120 Positive 20 256.0/158.8/109.4 317.0→109.2 
MULTIPLE REACTION MONITORING MS/MS MODE 
 
*Initial sample volume. Volume used for SPE, 11 mL. 
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female hormones, which was proved by applying the proposed method to 10 
mL of urine to the overall process. Ten concentration levels ―between 0.1 
and 500 ng mL-1― were used to build the calibration curves by subjecting 
them to the complete analytical process. The regression coefficients 
(between 0.992 and 0.999) and the linearity range for all the steroids are 
shown in Table 2.  
 
Table 2. Features of the proposed method. 
 
The limits of detection (LOD), expressed as the mass of analyte 
which gives a signal that is 3σ above the mean blank signal (where σ is the 
standard deviation of the blank signal) ranged between 0.06 and 0.8 ng mL-1 
(1.2–16 pg on column), as shows Table 2. The limits of quantification, 
expressed as the mass of analyte which gives a signal 10σ above the mean 
blank signal, ranged from 0.19 to 2.69 ng mL-1 (3.8–53.8 pg on column).  
 
3.3.  Multivariate optimization of ultrasound-enhanced enzymatic 
hydrolysis (USAEH) 
 
 β-Glucosidase is an enzyme commonly used for hydrolysis prior to 
the analysis of metabolites in urine. As previously indicated, the main 
limitation of this conventional protocol is the time required for hydrolysis 
Analyte R2 
LOD  
(ng mL-1) 
LOQ  
(ng mL-1) 
Linear dynamic 
range (ng mL-1) 
Estriol 0.9976 0.66 2.23 2.23−100 
Estradiol 0.9983 0.36 1.12 1.12−200 
Estrone 0.9996 0.06 0.19 0.19−200 
Pregnenolone 0.9997 0.81 2.69 2.69−100 
Progesterone 0.9956 0.12 0.39 0.39−100 
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completion which usually ranges from 12 to 18 h. We performed a kinetics 
study of the evolution of the hydrolysis process in the conventional protocol 
using the urine pool. Figure 4 shows this evolution for all steroids but 
progesterone, which is not conjugated. As can be seen, 5.5 hours were 
required for hydrolysis of all compounds except for estrone that needed 18 
hours. This can be explained by the high concentration of estrone. 
The alternative proposed here is based on the assistance of the 
hydrolysis process with ultrasound energy. The optimization sequence 
followed consists of a multivariate approach to find the significant variables 
involved in the enzymatic hydrolysis. A half-fraction type-V resolution 
design allowing three degrees of freedom and involving 8 randomized runs 
plus 3 centre points was built for a screening study of the main factors 
affecting the USAEH step, namely: ultrasound radiation amplitude, 
percentage of duty cycle of ultrasound exposure, reaction time and enzyme 
concentration (Table 3). The upper and lower values given to each factor 
were selected from preliminary experiments. 
 The conclusions of this first screening study were that the 
percentage of duty cycle of ultrasound, irradiation time and radiation 
amplitude were not statistically influential factors within the ranges under 
study. However, the results showed better efficiencies with the maximum 
values of radiation amplitude, namely 50%, thus selected for further 
experiments. The working value of duty cycle was fixed at 35%, as no effect 
on the reaction efficiency was observed by changing this variable.  
 
Table 3. Tested ranges in the half-fraction type-V design and optimal values of 
the variables involved in the USAEH. 
Factor 
Half-fraction 
design 
Univariate  
design 
Optimum  
value 
Duty cycle (%) 10−50 35 35 
Radiation amplitude (%) 20−50 50 50 
[β-Glucuronidase] (U mL-1 urine) 100−400 400−600 500 
Hydrolysis time (min) 30−90 0−80 30 
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Figure 4. Kinetics of the conventional enzymatic protocol for hydrolysis of 
conjugated steroids using the urine pool. 
 
  The effect of the enzyme concentration was studied by a 
univariate design within the range 400−600 U mL-1, after fixing the other 
variables at their optimum values. The irradiation time was fixed at 60 min. 
The results from this study showed that hydrolysis was complete with 500 U 
mL-1 of enzyme, without shortening of the hydrolysis time at higher values. 
Thus, 500 U mL-1 was fixed at optimum value. 
   A kinetics study was made testing different irradiation times in order 
to determine the time necessary for total hydrolysis of the target 
compounds. One mL of sodium acetate buffer, 10 µL of internal standard 
(stock solution 1000 ng mL-1 in methanol) and the appropriate volume of 
enzyme solution (500 U mL-1 urine) were added to 10 mL of pooled urine. 
Each sample was irradiated under the optimum working conditions (50% 
radiation amplitude, 35% duty cycle) at different sonication times within 
0−80 min. The extraction efficiency was calculated as the ratio between the 
area obtained by the USAEH and that obtained by overnight incubation al 
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37°C. As can be seen in Figure 5, the reaction was complete in 10 min for 
estriol, in 20 min for estrone and in 30 min for pregnenolone and estradiol. 
In view of these results, 30 min was selected and used for subsequents 
experiments as times longer than those required for their hydrolysis do not 
affect to the other steroids.  
 
 
Figure 5.  Kinetics of the ultrasound-enhanced enzymatic protocol for analysis 
of conjugated steroids in the urine pool. 
 
 The conclusion of this study is that ultrasound-assisted hydrolysis is 
complete at the optimum irradiation time as the reaction efficiency is 
similar, o even higher, for all the target analytes. Figure 6 corresponds to the 
chromatogram provided by analysis of the urine pool with the ultrasound-
assisted protocol under optimized conditions.  
 As can be seen, there is no modification caused by the assistance 
with auxiliary energy as compared to that obtained with the conventional 
protocol. 
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Figure 6. Total ion chromatogram provided by analysis of the urine pool after 
application of the ultrasound-assisted protocol under optimized conditions. 
  
3.5.  Complementary  studies 
 
 Additional experiments were performed in order to prove the effect 
of ultrasound over the enzymatic hydrolysis. Firstly, free estrogens were 
determined in the pooled urine, for which 10 mL of urine, 1 mL of  sodium 
acetate buffer and 10 µL of internal standard (10 ng) were mixed and 
directly subjected to the overall process without enzymatic hydrolysis. The 
results showed that only progesterone can be quantified in the pooled 
sample form as this progestagen is not conjugated. In addition, levels of 
estrone were detected below the quantification limit.  
One other experiment consisted of the application of ultrasonic 
irradiation under the optimum operation conditions in the absence of 
enzyme. The conclusion of this study was that no bond-breaking takes place 
in the absence of enzyme as only free progesterone was found. 
 
3.6.  Study of sample stability  
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 Urine analysis has proved a useful tool for the assessment of 
metabolism both for specific group of compound and in global terms. In 
most studies involving urine, the samples were stored at 4 °C and analysed 
within the day of collection. For optimization studies, sample storage at −20 
°C was necessary, being a week the maximum storage time.  
These considerations make necessary a study of the storage 
conditions in order to ensure sample integrity and thus reliability of the 
results. With this aim, 250 mL of fresh female urine were stored at −20 °C. 
Aliquots were daily analysed for a week. The results of this study were that 
the analytes are stable under the storage conditions, as shows Figure 7.A. In 
a second test, aliquots of urine were stored at 4 °C and analysed every two 
hours within a day. Figure 7.B shows that variations in the concentration of 
analytes throughout a day were not found when stored at 4 °C. 
 
3.7.  Application of the method 
 
 The usefulness of the proposed method was demonstrated by 
application to female urine samples. With this aim, first morning urine was 
obtained from six female voluntaries. Ten mililiter aliquots were separately 
analysed in triplicate (results shown in Table 4). The results indicate that 
estrone and pregnenolone were the most abundant estrogens in all cases. 
Progesterone and estradiol were also found in most samples. 
 
Sample Estriol Estradiol Estrone Pregnenolone Progesterone 
1 3.62 ± 0.15 1.58 ± 0.03 7.18 ±  0.18 5.23 ± 0.30 0.48 ± 0.02 
2 4.47 ± 0.18 1.45 ± 0.05 3.92 ± 011 10.15 ± 0.15 0.59 ± 0.02 
3 2.68 ±0.09 0.73 ± 0.01 4.66 ± 0.15 7.64 ± 0.32 0.52 ±0.05 
4 0.89 ± 0.05 0.31 ± 0.01 2.66 ± 0.08 2.62 ± 0.10 0.45 ± 0.05 
5 8.95 ± 0.12 1.16 ±  0.02 5.98 ± 0.06 4.22 ± 0.20  0.17 ± 0.01 
6 2.07 ± 0.12 0.55 ± 0.03 4.12 ± 0.09 4.20 ± 0.08 0.60 ± 0.04 
Table 4. Concentration(ng mL-1) of female hormones in urine. 
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In order to evaluate the precision of the proposed method, intra-day 
and inter-day variability were evaluated in a single experimental set-up with 
duplicates.25 The experiments were carried out using 10 mL of female urine 
buffered with 1 mL of sodium acetate (0.15 M, pH 5), with internal standard 
at 10 ng mL-1, and under the optimum working conditions. Two 
mesurements per day were performed on seven days. The results obtained, 
Figure 7. Study of urine stability for analysis of conjugated steroids. (A) Daily 
analysis of samples stored at −20 ºC for one week. (B) Analysis every two hours of 
samples stored at 4 ºC within a day. 
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expressed as relative standard deviation (RSD), ranged from 2.15 to 5.16 % 
for intra-day variability and from 4.90 to 8.01 % for inter-day variability. 
 
4. Conclusions 
 
 An ultrasound-assisted enzymatic hydrolysis method has been 
proposed for deconjugation of estrogens in human urine samples. A drastic 
shortening of the time required for complete reaction is achieved as 
compared with traditional methods based on enzymatic incubation, which 
usually require 12–18 h. Extraction of free estrogens from urine is carried 
out automatically by SPE, while quantification is performed by LC−MS/MS 
with multiple reaction monitoring. 
After a multivariate optimization of the variables involved in the 
USAEH, a kinetics study showed that the hydrolysis reaction of all 
conjugated steroids is complete in only 30 min. The study included stability 
experiments of urine stored at 4 ºC and −20 ºC.  
Since estrogens and progestogens are involved in the development 
of some diseases such as breast cancer, the profile of these compounds can 
be used to assess the metabolism of this compounds. For this reason, 
rapidity, sensitivity and selectivity are desirable properties for 
determination of these compounds in biological fluids, which makes the 
proposed method suitable for clinical analysis. 
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Targeted analysis of sphingoid precursors in 
human biofluids by solid phase extraction with 
in situ derivatization prior to µ-LC−LIF 
determination  
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
A method for determination of two relevant sphingoid precursors 
such as sphingosine and sphinganine and the corresponding conjugates 
sphingosine 1-phosphate and sphinganine 1-phosphate in human urine and 
serum is here presented. The method is characterized by a solid phase 
extraction step with in situ derivatization of the sphingolipids in the eluate 
(o-phtaldialdehyde derivatives) to obtain fluorescent compounds. In this 
way, sample preparation was completely performed in a single automated 
step by means of a lab-on-valve system. Derivatized analytes were injected 
into a liquid chromatography system operating at micro regime and 
detected by laser induced fluorescence. For determination of sphingoid 
phosphates, they were enzymatically converted to free sphingoids to obtain 
stable fluorescent derivatives. The detection limits were in the range 4.2–
10.2 ng mL-1 for serum and 0.56–1.36 ng mL-1 for urine, with repeatablility 
ranging from 3.9 to 6.2 % expressed as relative standard deviation. The 
method was validated by direct infusion tandem mass spectrometry in 
multiple reaction monitoring (MRM) to compare results provided by 
analysis of biofluids and to confirm the identity of the target compounds. 
Sensitivity and precision were better than or similar to those provided by 
the confirmatory method. The automation of sample preparation enables to 
scale-down this step and improves precision by minimization of human 
intervention, being thus suitable for clinical analysis.  
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1.  Introduction 
 
Sphingolipids (SLs) are a family of lipidic compounds endowed with 
a long amino-alcohol chain, known as sphingoid base. Sphingolipids are 
components of biological membranes, being widely distributed in certain 
tissues, such as brain and nerve tissue. Sphingolipids exert different 
functions in signal transmission and cell recognition. Sphingoid precursors 
—sphinganine (Sa) and sphingosine (So)— act as structural and signalling 
molecules in membranes [1]. Sphingosine 1-phosphate, commonly present 
in human plasma and platelets, is an intermediate of sphingolipids 
catabolism [2], which inhibits the reproduction of certain tumoral cells, and 
also plays a key role both in the mobilization of intracellular calcium [1,3] 
and in cellular growth, differentiation, senescence and apoptosis [4−6]. 
Sphingolipids metabolism involves a number of synthesis and 
degradation pathways, as expected from the variety of sphingolipids present 
in cells.  Sphingoids are present in the organism by degradation of complex 
sphingolipids (gangliosides, ceramides, etc.) or by de novo synthesis [7]. The 
latter starts with the formation of sphinganine from palmitoyl CoA and 
serine. Sphinganine is then acylated to form dihydroceramide, which is 
desaturated to form ceramide. Ceramide can undergo sereval pathways, one 
of them being a breakdown to generate sphingosine. The sphingoid 
phosphate metabolites, sphingosine 1-phosphate and sphinganine 1-
phosphate are formed by phosphorilation via two kinases, sphingosine 
kinase types 1 and 2 [8]. The main group of diseases associated to 
sphingolipid metabolism are sphingolipidoses [9], which entail alterations in 
the catabolism of these compounds as a consequence of genetic disorders, 
leading to the storage of free or glucide-bonded sphingolipids inside cells. 
Sphingoids are also involved in diseases related with apoptosis and cellular 
signalling, such as diabetes, neuropathies, Alzheimer's disease, Parkinson's 
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disease, atherosclerosis or cancer [10]. Therefore, the role of sphingoid 
precursors as potential metabolites to correlate their concentration levels 
with the diagnosis or prognosis of these diseases should be emphasized. The 
detection of sphingoid precursors as free or conjugated forms in plasma 
makes this biofluid specially suited for quantitative analysis. However, the 
non-invasiveness of urine sampling and the presence of sphingoid 
precursors in this biofluid justifies its alternative or complementary use for 
sphingoids analysis.   
Few methods have been reported for simultaneous determination of 
sphingoid bases and phosphate derivatives. The most consolidated approach 
involves a derivatization step with o-phtaldialdehyde (OPA) to form isoindol 
derivatives prior to chromatographic separation with fluorescent detection 
[9,11−14]. With this strategy, sensitive and selective methodologies can be 
developed. However, phosphate OPA derivatives are not kinetically stable, 
which involves a significant source of irreproducibility. Caligan et al. used 
EDTA buffer as derivatization solvent to obtain stable phosphate OPA 
derivatives for 5 h if the samples are stored below 4 ºC [5]. However, the 
derivatives were not stable at room temperature, which is a considerable 
limitation. Additionally, the pH of the samples has to be modified by dilution 
with the EDTA buffer that could alter the integrity of the sample. Another 
way to proceed is to take benefit from enzymatic selectivity of alkaline 
phosphatase by a dual determination with and without enzyme hydrolysis. A 
less frequent approach for detection of sphingoid bases and phosphates is 
the use of radio-labeled substrates [15], which increases considerably the 
cost of the analysis. Recently, new methodologies based on LC−MS/MS 
detection have been developed [16–18], although mass analyzers are not 
always present in routine laboratories —additionally, the structure of 
sphingoid precursors does not seem to be ideal for optimum fragmentation 
by tandem mass spectrometry.  
Due to the non-polar nature of sphingoids and their low 
concentration in biological fluids, sample preparation is usually the 
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bottleneck of sphingoids analysis. In fact, most of the methods developed so 
far have been based on liquid–liquid extraction, evaporation of the organic 
solvent and reconstitution in a suitable phase prior to LC separation 
[12−14]. The use of solid-phase extraction (SPE) allows obtaining clean 
extracts with high concentration factors, leading to a considerable increase 
of sensitivity [19]. However, these methods are manual and, in many cases, 
they require large reagent and sample consumption adding the complexity 
of a derivatization step when this is needed. For this reason, automation and 
miniaturization of sample preparation is desirable to avoid all limitations 
associated to long protocols. A promising manifold that allows attaining the 
benefits associated to automation and miniaturization is the lab-on-valve 
(LOV). This system is considered the third generation of Flow-Injection 
Analyzers (FIA), that clearly revolutionized the analysis automation. Thus, 
the applicability of LOV configurations in clinical analysis has been widely 
discussed [20].     
A method for determination of sphingosine (So), sphinganine (Sa), 
sphingosine 1-phosphate (So-1P) and sphinganine 1-phosphate (Sa-1P) in 
human biofluids is here proposed. The low concentration of sphingoids in 
urine and serum and the complexity of both types of biofluids demand for 
the development of highly-selective and sensitive analysis methods. The 
proposed method enables to extract the target compounds with in situ 
derivatization during elution with OPA, generating the fluorescent 
derivatives in a fully-automated format. Separation of sphingoids, carried 
out by LC at micro scale is coupled to laser-induced fluorescence detection 
(LIF).  
 
2. Experimental 
 
2.1. Instruments and apparatus 
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Figure 1 illustrates the experimental setup used for the development 
of this analytical method. The extraction and derivatization of the 
sphingolipids were automatically performed in a single step using a 
sequential injection (SI) lab-on-valve (LOV) microfluidic system.  
 
 
 
 
 
 
 
 
 
The LOV manifold consists of an 1-mL microsyringe pump, which 
allows aspirating and dispensing micro-volumes of sample and reagents; a 
6-port valve made of Plexiglass, in which the ports are interconnected and 
also with the syringe pump by a center port; a holding coil between the 
syringe pump and the 6-port valve; and a 2-position selection valve. 
Polyetheretherketone (PEEK) tubings (0.5 mm x 0.8 mm inner diameter) 
were used to connect the manifold components to the ports of the selection 
valve. Polytetrafluorethylene (PTFE) tube (1.5 mm inner diameter) from 
Análisis Vínicos (C. Real, Spain) was used as minicolumn. Chromabond C18 
(30–40µm particle diameter) from Macherey-Nagel (Dürem, Germany) was 
used as sorbent material in the SPE step. Other sorbent materials tested 
were Chromabond C18 Hydra, Bond elut NH2 (Varian, Palo Alto, USA), 
Chromabond HR-P and C8 Strata (Phenomenex, Torrance, California, USA). 
An external 10-port 2-position selection valve (VICI, Valco, Houston, USA), 
Figure 1. Experimental workflow of the LOV system. 
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connected to the microcolumn channel, enables the collection of the eluate 
after the SPE sequence. The LOV and the external selection valves are fully 
automated and controlled by the FIAlab for Windows version 5.0 software.  
Separation of sphingolipids was performed by an Agilent (Palo Alto, 
CA, USA) 1100 micro liquid chromatograph (µ-LC ) equipped with a binary 
capillary pump and an automatic injection valve (1-µL sample loop) and a 
diode array detector (200–800 nm). The analytical column was a reversed-
phase Zorbax SB-C18 (150 mm × 0.5 mm I.D., 5µm) from Agilent. The overall 
system was mounted on capillary tubes 75 µm i.d. × 375 µm O.D. from 
Análisis Vínicos. After chomatographic separation, the derivatized analytes 
were detected by a Zetalif 2000 325 nm/CE laser-induced fluorescence (LIF) 
detector from Picometrics (Toulouse, France). The µ-LC was connected to 
the LIF detector by a 75 µm i.d. × 375 µm capillary tube in which the 
detection window, of 5 mm length, was made for collecting the overall 
emitted light. The signal acquisition from the LIF detector is monitored and 
integrated by the Agilent Chemstation software.  
Validation of the proposed method was performed by direct infusion 
to an Agilent 6410 triple quadrupole mass analyzer. An Agilent 1200 Series 
system furnished with a binary pump, a vacuum degasser, and an 
autosampler were used for injecting the sample and pumping the carrier 
solution. The data were processed using a MassHunter Workstation 
Software for acquisition, qualitative and quantitative analysis. 
 
2.2.  Chemicals, reagents and working solutions  
 
 D-Sphingosine (So), D-erythro-dihydrosphingosine (sphinganine, Sa), 
sphingosine 1-phosphate (So1P), D-erythro-dihydrosphingosine 1-phosphate 
(sphinganine 1-phosphate, Sa1P) and tocopherol acetate were purchased 
from Sigma Aldrich. Stock standard solutions at 1000 µg mL-1 (So and 
tocopherol acetate), 500 µg/mL (Sa) and 200 µg mL-1 (So1P and Sa1P), were 
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prepared in 25:75 cloroform–acetonitrile. Multistandard solutions were 
prepared by diluting the stocks in a 90:10 acetonitrile−water mixture. All 
the above solutions were stored at −20 ºC in glass vials and kept in the dark 
until use. 
 Deionized water (18 MΩ·cm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) was used to prepare all 
aqueous solutions. Acetonitrile of LC−MS grade from Panreac (Barcelona, 
Spain) and cloroform from Scharlau (Barcelona, Spain) were used for 
standard stock solutions. The carrier solution for preconditioning the 
cartridge in the solid phase extraction was deionized water acidified with 
phosphoric acid (pH=3). Acetonitrile of LC grade (Panreac) and deionized 
water were used for chromatographic mobile phases. Ammonium formate 
was used as additive in the carrier solution to enhance ionization required 
for mass spectrometry detection. 
Free sphingoids were eluted and derivatized with 250 µg mL-1 of o-
phthaldialdehyde from Sigma–Aldrich in 0.1% 5-mercaptoethanol (Merck, 
Darmstadt, Germany) and 90:10 acetonitrile−10 mM boric acid (pH 10.5). 
This reagent was daily prepared and stored at 4 ºC until use due to its 
instability. For the optimization of the chromatographic separation and LIF 
detection, a multistandard solution at 100 ng L-1 was prepared and stored at 
4 ºC in the dark until use. Alkaline phosphatase from bovine intestinal 
mucosa (Sigma–Aldrich) was prepared in buffer Tris-HCl 200 mM pH 7.4 
(400 U mL-1). The reaction buffer for the enzymatic dephosphorilation was 
200 mM Tris−HCl (pH 7.4), 75 mM MgSO4  in 2 M glycine buffer (pH 9). 
 
2. 3. Sample collection and preparation of spiked samples 
 
Urine samples were obtained from volunteers, collected in sterile 
containers, and stored at −20 ºC in the dark until analysis. For optimization 
purposes, 100 mL of sample from five volunteers was pooled and divided 
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into 1.5-mL aliquots. 0.5-mL sodium phosphate 50 mM (pH =7) was added 
to each aliquot and all them were stored at −20 ºC.  
Venous blood was collected into a Vacutainer® tube (Becton 
Dickinson). The tube was placed in ice or kept refrigerated until processed. 
Blood samples were centrifuged at 4000×g for 10 min. All steps from blood 
extraction to analysis were performed in compliance with the guidelines 
dictated by the World Medical Association Declaration of Helsinki (2004), 
which were supervised by the ethical committee of Reina Sofia Hospital 
(Córdoba, Spain) that approved the experiments. Individuals selected for 
this study were informed to obtain consent prior to this research. The 
resulting serum was divided into 1-mL aliquots in sterile containers and 
stored at −20 ºC in the dark. 200-µL serum aliquots were diluted to a final 
volume of 2 mL with 10 mM phosphate buffer (pH= 7) in order to prevent 
protein precipitation, being thus ready for the SPE step. 
Samples were spiked with 50 ng mL-1 tocopherol acetate as external 
standard (final amount injected into the chromatograph 1 µL). After 
vortexing for 10 min, the samples were subjected to the overall method. 
Analyses were carried out within 24 h of sample preparation. One aliquot of 
the sample was directly analyzed whereas a second one was used to 
hydrolyze phosphate derivatives. In the latter, sphingolipids So1P and Sa1P 
were hydrolyzed by means of an alkaline phosphatase in order to release 
free sphingolipids, So and Sa, respectively. With this aim, the sample aliquot 
was mixed with 200 µL of reaction buffer and 125-µL alkaline phosphatase 
(50 U) and incubated for 30 min at 37 ºC under agitation. 
 
2.4.  Solid-phase extraction and derivatization step  
  
Before chromatographic separation, derivatization of the target 
compounds was performed to obtain fluorescent products suitable to be 
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measured by LIF. In this method, derivatization was carried out in situ with 
elution from the sorbent cartridge by means of a LOV automatic manifold, in 
a sequence of programmed steps that can be summarized as follows: (a) 
activation of the mini-column (prepared by packing 0.05 g of C18-hydra in 
80 mm PTFE tubing) with 2-mL 90:10 acetonitrile–water solution and 
conditioning with 1-mL carrier (both steps at 3 mL min-1); (b) equilibration 
of the column with 1-mL carrier solution at 1.2 mL min-1; (c) loading of 
sample (2 mL diluted urine and serum) at 1.2 mL min-1; (d) washing of the 
mini-column with 0.5-mL carrier and flushing air to eliminate the rest of 
sample matrix; (e) 400 µL of eluant (90:10 acetonitrile–water mixture in 
which the OPA reagent was dissolved) was passed through the mini-column 
and discarded to prevent dilution of the analytes; (f) switching the external 
selection valve and (g) elution with 200 µL of eluant at 5 µL min-1.  
 
2.5.  Chromatographic separation and detection  
 
The extract was loaded into the microinjection valve by filling of the 
sample loop (total volume, 1 µL). Separation was performed by µ-LC. Mobile 
phase (90:10 acetonitrile/water) was maintained at 10 µL min-1 isocratically 
during the chromatographic run (9 min). The excitation wavelength for LIF 
detection was 360 nm. The external standard was on-line monitored by 
diode array detection and quantified at 360 nm.  
 
2.6.  Mass spectrometry analysis  
 
Validation of the proposed method was carried out by direct 
injection–tandem mass spectrometry (di-MS/MS) with electrospray 
ionization (ESI) in positive mode. 5-µL aliquots were injected and pumped to 
the triple quadrupole mass detector by means of a 90:10 acetonitrile–water 
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2 mM ammonium acetate and 0.1% formic acid carrier solution, which was 
pumped at 1 mL min-1. The electrospray ionization source was operated at a 
capillary voltage of 4000 V. The working conditions of the mass 
spectrometer were: nebulizer pressure 35 psi and drying gas (N2) conditions 
at 10 mL min-1 flow-rate and 300 ºC temperature. The mass detector was 
operated in multiple reaction monitoring (MRM) mode. Table 1 summarizes 
the working conditions for the di-MS/MS mehod. Precursor ions 
corresponded to [M+H]+ ions for sphingosine and sphinganine metabolites, 
which were preferentially fragmented to generate [M+H−(H2O)]+ by 
dehydratation and [M+H−(H2O)−(CH2OH)]+ by fragmentation of the 
alcoholic group.    
 
Table 1. MRM parameters for sphingosine, sphinganine and the IS (tocopherol 
acetate). 
 
A calibration curve was built by injecting pure standards at different 
concentrations ranging from limits of quantification to 8000 ng mL-1. For the 
analysis of serum and urine samples, 5-µL of eluate from the solid-phase 
extraction step was injected under the optimum working conditions, in 
which the analytes were eluted with 200 µL of 90:10 acetonitrile–water. 
 
 
Compound 
Molecular 
weight 
MRM 
transitions 
 
Fragmentor 
Voltage 
(V) 
Collision 
energy 
(eV) 
Dwell 
time 
(ms) 
Sphingosine 
(So) 
299.5 
300.3  282. 3 
300.3  252.3 
100 
100 
7 
7 
20 
Sphinganine 
(Sa) 
301.5 
302.3  284.3 
302.3  254.3 
120 
120 
10 
10 
20 
Tocopherol 
acetate (IS) 
472.7 490.5  207.1 100 18 20 
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3.  Results and discussion 
 
3.1.  Optimization of the derivatization–extraction step 
 
 Taking into account the particularity of the process and the 
involvement of discontinuous variables, a univariant strategy was selected 
to study the sample preparation process. The variables under study, the 
tested range and the optimum value are shown in Table 2. For this study, 
human biofluids were spiked with the analytes at 10 µg mL-1 each (50 µg mL-
1 external standard). In addition, non-spiked samples were analysed under 
the resulting optimum operating conditions to evaluate accuracy of the 
method. A strategy based on direct analysis of biofluids was selected for this 
research, which demanded for two different dilution factors according to the 
sample matrix. Thus, an 1:10 dilution factor was needed for serum analysis 
owing to the high concentration of proteins, which were not previously 
precipitated. On the other hand, urine was practically analysed without 
dilution except for the addition of buffer solution to adjust the pH. The 
optimization study was divided into two parts: first, those variables involved 
in the SPE step were initially optimized with subsequent off-line 
derivatization and LC–LIF analysis; then, the variables affecting 
derivatization were studied with the optimum SPE variables. Thus, the first 
study included the optimization of the sorbent material, sample loading rate, 
pH of the sample, volume of discharged eluate, elution volume and 
composition of eluant.  
 The first study aimed at obtaining the most suitable sorbent for the 
SPE. Six sorbents were tested taking into account the chemical properties of 
the analytes under study, namely: C18 (45 µm particle size), a non-encapped 
octadecyl modified silica phase; C18 Hydra (45 µm), a non-endcapped 
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octadecyl phase for relatively low polar analytes; C8 strata (45 µm), an octyl-
phase based on non-specific retention of non-polar compounds with the 
surface endcapped to minimize secondary polar silanol interactions; 
aminopropyl NH2 BondElut (40 µm–120 µm particle size), a very polar 
sorbent based on both hydrogen bonding and anion exchange interactions; 
HR-P (50–100 µm) highly porous resin based on polystyrene-
divinylbenzene (PS/DVB); and Chromabond SB (45 µm), strongly basic 
anion exchanger. 
 
Table 2. Optimization of the SPE step with in situ derivatization of 
sphingolipids 
 
 
 
  
 
 
 
 
 The home-made cartridges were prepared and fixed by packing 0.05 
g of sorbent material in a 80 mm PTFE tubing, which perfectly suited to the 
lab-on-valve system without overpressure. Due to the lipidic character of the 
target analytes and their small molecular size, the best results regarding 
retention capability were obtained with C18, particularly for urine because 
of the high efficiency to remove salts and polar interferences. Another key 
variable was the pH of the sample. To test its influence, the pH of the sample 
was adjusted with different buffer solutions, namely: 100 mM ammonium 
acetate (pH =5), 100 mM potassium phosphate (pH=7), 200 mM sodium 
Variable Tested  range Optimum 
value 
Sample loading rate (µL min-
1) 
0 – 
 
60 5 
pH of sample 2 − 
 
10 7 
Volume of eluate discharged (µL) 0−1000 400 
Elution volume (µL)  50 − 
 
1000 200 
Concentration of OPA (mg mL-1) 0.05 − 1 0.125 
Composition of eluant (% acetonitrile)  50 − 
 
100 90 
Sorbent C18, C18 Hydra, C8 strata, DMA, NH2 
BondElut, HR-P, Chromabond SB 
C18 
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borate (pH= 9), 1 M sodium carbonate (pH= 10), being pH 7 the optimum 
value.  After this study, the concentration of OPA was optimized together 
with the volume of discharged eluate, the elution volume and the 
composition of eluant to check if they influenced the derivatization of 
sphingoids. The optimum values for each variable are included in Table 2. 
The volume and the number of the eluate fraction were tested by off-line 
analysis of 200-µL fractions together with the non-retained material after 
sample loading. Figure 2 illustrates the elution profile resulting from the 
analysis of the different fractions. As can be seen, the maximum recovery 
was obtained in the third fraction with isolation of approximately 85% of 
the initial amount spiked. These high recovery values can be ascribed to the 
in situ derivatization step that favors a uniform elution profile as concluded 
from this test. The target compounds were not detected in the non-retained 
material after the retention step. Therefore, the first 400 µL were discharged 
to avoid dilution of the target analytes. It is worth emphasizing that similar 
recoveries were obtained for serum and urine. These results were combined 
with the analysis of non-spiked samples to verify the recoveries obtained 
with spiked biofluids, which assesses accuracy of the method (85%). These 
results also demonstrate the absence of matrix effects with both types of 
biofluids and, for this reason, calibration plots can be built with standard 
solutions. 
 Tocopherol acetate was selected as external standard due to its 
similar non-polarity to the target metabolites with an aliphatic chain in its 
structure. Additionally, this compound is not physiologically present in 
humans.  
 
3.2. Optimization of the laser-induced fluorescence detection 
 
 Concerning the laser device, the excitation wavelength was set at 325 
nm, close to the optimum excitation wavelength for the OPA derivatized 
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sphingolipids, which is 340 nm [1−3]. On the other hand, the whole 
fluorescence emitted from the flow-cell was collected. The LIF instrument 
works in three different detection ranges, namely 0–2, 0–20 and 0–200 
relative fluorescence units (RFU). The lower RFU range was selected for 
analysis to avoid saturation of the detection system. Figure 3 shows the 
chromatograms obtained with two serum aliquots, without (A) and with (B) 
hydrolysis catalized by alkaline phosphatase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
(A) 
(C) 
 
Figure 2. Optimization of the elution volume in the SPE step. Chromatograms 
obtained for the elution of the first (A) second (B) and third (C) fraction. 
 
Time (min) 
Time (min) Time (min) 
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3.3. Features of the method 
 
As a dual analysis with an enzymatic hydrolysis step is required for 
complete analysis of the target sphingolipids, the sphingoid phosphates So1P 
and Sa1P were quantified by the difference between concentrations 
corresponding to So and Sa after and before hydrolysis. Thanks to the 
absence of matrix effects calibration plots were run by using the standard 
Figure 3. Chromatograms obtained with two 50 ng mL-1 spiked serum 
aliquots, without (A) and with (B) phosphatase alkaline hydrolysis. 
(A) 
(B) 
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peak area–external standard peak area ratio as a function of the standard 
concentration. Calibration was performed with multistandard solutions at 
ten concentration levels —within 5 and 10000 ng mL-1— which were 
analyzed in triplicate. The regression coefficients and the linear range are 
shown in Table 3. The sensitivity of the method was evaluated for each 
studied biofluid according to its dilution factor. In any case, the limits of 
detection (LOD) and quantification (LOQ) were expressed as the mass of 
analyte which gives a signal that is 3σ and 10σ, respectively, above the mean 
blank signal (where σ is the standard deviation of the blank signal). Thus, 
LODs ranged between 4.2–10.2 ng mL-1 (or pg on-column) in the case of 
human serum, while LOQs ranged between 13.9 and 34.1 ng mL-1 (or pg). As 
there was no concentration factor with serum, LODs and LOQs practically 
coincided with those obtained with standard solutions. In the case of urine, 
there was a concentration factor of 7.5 that influenced positively the 
sensitivity of the analysis. Therefore, LODs ranged between 0.56–1.36 ng 
mL-1 for human urine, while LOQs ranged between 1.85 and 4.55 ng mL-1.     
Precision was assessed by analysis of five aliquots of urine and 
serum samples spiked at 100 ng mL-1 in a single experimental set. As can be 
seen in Table 3, the results obtained, expressed as relative standard 
deviation (RSD), were within 3.9 and 6.2%, which are quite acceptable for 
clinical analysis. It is worth emphasizing that similar precision levels were 
found for both biofluids. 
 
3.4. Application of the method to human biofluids 
 
The proposed method was tested by application to the two most 
frequent biofluids used in clinical analysis: serum and urine. Preparation of 
serum samples is limited by the presence of proteins while the high 
concentration of salts is the main obstacle for urine analysis. Therefore, the 
cleanup effect associated to the preparation approach is critical to succeed 
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in the quality of the results. An experimental strategy was designed for 
analysis of two sets of three independent replicates with and without 
alkaline phosphatase treatment for each biofluid (n=3). Table 4 shows the 
mean value and the standard deviation obtained for the target compounds in 
each sample. 
 
Table 3. Features of the proposed method. 
Analyte 
Linear 
regression 
LOD 
serum  
LOQ 
serum  
LOD    
urine 
LOQ    
urine 
Linear 
dynamic 
range 
Precision 
(R2) (ng mL-1) (ng mL-1) (ng mL-1) (ng mL-1) (ng mL-1) (RSD, % ) 
So 0.9935 5.2 17.4 0.69 2.32 LOQ−8000 3.9 
Sa 0.9987 4.2 13.9 0.56 1.85 LOQ−8000 4.5 
Sa1P 0.9979 9.1 30.5 1.21 4.07 LOQ−6000 6.2 
So1P 0.9898 10.2 34.1 1.36 4.55 LOQ−2500 5.1 
 
The sphingoid phosphate So1P was the most abundant metabolite in 
serum, which can be justified because the conjugate is the suited form to be 
transported in serum and also because serum does not contain the enzymes 
for So1P degradation [21]. Concentrations reported in the literature for 
sphingoid precursors and phosphate derivatives in serum are characterized 
by a great variability, as can be seen in Table 4 [12,22−25]. Thus, levels 
detected in this research were within the range reported by previous 
studies. Lower values reported in some cases are below LOQs determined 
with the proposed method. However, LOQs could be considerably decreased 
by implementation of an additional preconcentration step by evaporation 
since the injection volume into the chromatograph was only 1 µL while the 
elution volume was 200 µL. In addition, So was the only sphingoid quantified 
in urine, while Sa was detected but at concentration below the LOQ. To 
complete this analysis, the amount of the sphingoid phosphates in urine was 
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negligible (below the LOD). According to literature, this fact can be 
explained by the catabolic reaction pathway of So-1P based on its 
degradation in the liver by the action of a lyase, giving ethanolamine 
phosphate and a fatty aldehyde as final products for secretion in urine 
[21,26,27].  
 
 
  
* below the LOQ, - below the LOD 
 
3.5. Validation of the reported method by comparison with the di-MS/MS 
method 
 
The results obtained by the method reported in this research were 
validated with those from the analysis by di-MS/MS. With this aim, ten 
Biofluid Sphingosine (ng mL-1) Sphinganine (ng mL-1) 
Serum 
Found Reported Found Reported 
145.0 
(11.3) 
3−206 [23,24] 36.8 (11.0) 
31−85 
[22,24] 
Urine 
16.8 
(2.6) 
0.03−12.5 [23] *   
0.006−3.5 
[23] 
Biofluid Sphingosine 1-P (ng mL-1) Sphinganine 1-P (ng mL-1) 
Serum        Found Reported Found Reported 
 
184.7 
(29.1) 
10−320 
[12,24,25] 
143.5 (4.5) 6−66 [24] 
Urine - - - - 
Table 4. Mean concentration of sphingoid precursors found in human serum 
and urine from volunteers (mean, n=3, SD in brackets) and range of 
concentration reportedin bibliography. 
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calibration solutions were prepared and analyzed in triplicate with the 
method based on mass spectrometry detection. The LOD and LOQ, 
expressed as the mass of analyte which gives a signal that is 3σ and 10σ  
above the mean blank signal (where σ is the standard deviation of the blank 
signal), ranged between 2.6 and 6.1 and 8.6 and 20.3 pg injected amount, 
respectively, which are similar to those obtained with the proposed method. 
Three replicates of urine and serum aliquots spiked at 100 ng mL-1 were 
analyzed by both the proposed method and the di-MS/MS.  Differences 
between the results obtained by both methods were not significant as 
checked by application of the statiscal t-value test (P=0.05), which enables to 
validate the reported approach. 
 
4. Conclusions 
 
The proposed method allows determining sphingoid precursors in 
two human biofluids: urine and serum. For this purpose, a simple and 
automated sample preparation protocol based on SPE has been developed. 
In this step, the elution and derivatization of the analytes are simultaneously 
developed in an LOV manifold, thus shortening the overall time of analysis. 
The LOV manifold is automated and fully computer-controlled, thus avoiding 
contact of the operator with biological samples, which is crucial in clinical 
analysis. The developed LOV application proves the utility of this manifold in 
clinical analysis by following previous generation of injection analyzers. 
Derivatized sphingolipids were injected to a μ−LC, which had been 
hyphenated to an LIF detector. This allows management of very low volumes 
of sample and organic solvents with a high sensitivity, as required by 
biological samples.  
The simplicity, sensitivity and precision of the developed method are 
key characteristics for determination of these compounds in urine and 
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serum samples. This application can be of interest to correlate the levels of 
sphingoid precursors with diseases related with the sphingolipid 
metabolism. Validation has been carried out by tandem mass spectrometry 
with direct infusion of treated samples. 
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Automated determination of folate catabolites in 
human biofluids (urine, breast milk and serum) by on-
line SPE–HILIC–MS/MS 
 
B. Álvarez-Sánchez, F. Priego-Capote , J. M. Mata-Granados, M.D. Luque de 
Castro 
 
 
Abstract  
A rapid, precise and fully-automated method for analysis of folate 
(vitamin B9) and its catabolites (viz. p-aminobenzoylglutamate, and its 
acetamide derivative) in biofluids is here presented. The method is based on 
on-line hyphenation of solid-phase extraction (SPE) by a Prospekt-2 system 
with hydrophilic interaction liquid chromatography–tandem mass 
spectrometry (HILIC–MS/MS). The method was analytically characterized 
by estimation of repeatability (RSD, n=5, between 0.5 and 4.1%), accuracy 
(between 96 and 105%), and sensitivity (limits of quantification between 
0.3 and 8.3 ng/mL (1.1 and 18.8 pmol/mL) or 0.03 and 0.83 ng (0.11 and 
1.88 pmol). The proposed method is suited for routine analysis of folate 
catabolites as biomarkers to monitor deficiency of vitamin B9.  
 
 
 
 
 
 
 234 
Nuevas plataformas analíticas en metabolómica                                                                                    
 
1.  Introduction 
 
Folic acid (vitamin B9) is a water-soluble vitamin involved in a broad 
variety of biological processes, as long as it acts as enzymatic cofactor in 
transference of methyl-group reactions [1]. Folic acid is responsible for the 
synthesis of DNA bases and chains; therefore, it is essential for the formation 
of new cells, especially during periods of rapid cell division and growth, such 
as infancy and pregnancy [2]. Folic acid is also involved in the synthesis of 
the haeme group of haemoglobin, being required for growth and maturation 
of red blood cells (RBCs) [3]. Accordingly, severe deficiency of folate leads to 
numerous diseases associated to hindered cell division processes and 
deficiency of RBCs, such as megaloblastic anemia, bone marrow, or fetal 
diseases (spina bifida, neural tube defects, etc.) [4]. On the other hand, folate 
takes part in the synthesis of amino acids serine and methionine. In this 
sense, there is also evidence of the relationship between folate deficiency 
and accumulation of homocystein, which is the substrate in the folate-
mediated synthesis of methionine. This is currently considered an increased 
risk factor for cardiovascular disease, atherosclerosis and coronary heart 
disease [5,6].  
Folic acid, mainly present as folate under physiologically normal 
conditions, is excreted in urine as more polar catabolites [7,8]. Catabolic 
transformation of folate involves reduction to its chemically unstable 
tetrahydro form, easily transformed to p-aminobenzoylglutamate (pABGA). 
The final product of the folate catabolism is the acetamide derivative of p-
aminobenzoylglutamate (a-pABGA), the most abundant folate metabolite in 
urine and other biofluids, as it lacks of metabolic activity.  
The metabolic profile of folate catabolites in biological fluids can 
provide valuable clinical information about the abundance of this essential 
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vitamin in humans. This can be of especial interest in individuals with 
increased risk of deficiency, such as neonates or pregnant women. In fact, 
levels of folate catabolites pABGA and a-pABGA have been found 
considerably increased in serum and urine during pregnancy [1], when the 
metabolism of this vitamin is enhanced.  
Determination of folic acid has been classically performed by 
microbiological assays [9,10]. However, these methods are not able to 
discriminate between different folate species and are also affected by the 
presence of interferences, including growth inhibitors and some antibiotics 
[11]. Most of the chromatographic methods developed so far are based on 
reversed-phase liquid chromatography−tandem mass spectrometry (RP-LC–
MS/MS) [12–15]. However, due to their relatively polar nature, folate 
catabolites are weakly retained in RP chromatographic columns and poor 
separation is achieved. Hydrophilic interaction liquid chromatography 
(HILIC) is gaining popularity in metabolomics since biofluids are mainly 
aqueous and, therefore, likely to contain polar compounds such as 
carbohydrates, their phosphorylated derivatives, glycolytic intermediates 
and organic acids [16]. From the best of our knowledge, only one method for 
determination of folates by HILIC–MS/MS has so far been reported and 
applied to human plasma after in-batch sample preparation steps, including 
standard addition, protein precipitation, filtration, evaporation and 
reconstitution [17].  
Here we present a fully-automated method for the analysis of folate 
and catabolites, pABGA and a-pABGA, in biofluids. This method is based on 
the on-line hyphenation of a solid-phase extraction step, automatically 
carried out by a Prospeckt-2 system, with HILIC–MS/MS chromatographic 
separation and detection. This hyphenation allows complete automatic 
performance of the analytical method with a drastic reduction of the 
analysis time.  
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2.   Materials and methods 
 
2.1.  Reagents 
 
LC–MS grade acetonitrile (Panreac, Barcelona, Spain), ammonium 
formate (Sigma-Aldrich, St. Louis, MO, USA), and deionized water (18 
MΩ·cm) from a Millipore Milli-Q water purification system (Millipore, 
Bedford, MA, USA) were used for preparation of the chromatographic phase.  
Pure standards of folic acid (FA), its metabolite N-(p-aminobenzoyl)-
L-glutamic acid (pABGA) and the internal standard (IS) ―aminopterin― 
were from Sigma–Aldrich. Individual stock solutions were prepared by 
dissolving 10 mg of standard in 10-mL 0.2 M potassium phosphate buffer, 
pH 7.3, containing 0.03% ascorbic acid [17]. The acetamide derivative was 
prepared from the pABGA metabolite with total conversion [7] by adding 
140 µL 50% acetic acid (Panreac) in deionized water (v/v) and 20 µL acetic 
anhydride (Panreac) to 10 mg pABGA. The reaction mixture was vortexed in 
the dark at room temperature for 1 h. The remaining acetic acid was 
evaporated under nitrogen at room temperature, and the a-pABGA standard 
was reconstituted in 10-mL 0.2 M potassium phosphate buffer, pH 7.3, with 
0.03% ascorbic acid. Multistandard solutions were daily prepared for 
optimization of the analytical steps by dilution of the stock standard 
solutions in deionized water or 80:20 acetonitrile–water v/v. Standard 
solutions were stable at −20 ºC for at least one month. 
 
2.2.  Sample handling 
 
 Samples were kindly donated by healthy volunteers. No restrictions 
about diet, life style, sex or age were taken into account. Venous blood was 
   
237 
Chapter 6 J. Chromatogr. A, 1217 (2010) 4688–4695 
 
collected into a BD Vacutainer® Plus SST tube containing spray-coated silica 
and polymer gel for serum preparation (Becton Dickinson). The tube was 
not opened to ambient air and placed in ice or kept refrigerated until 
processing. Blood samples and milk samples were centrifuged at 4000×g for 
10 min at 4 ºC. The resulting serum was divided into 1-mL aliquots in sterile 
containers and stored at −20 ºC. Ascorbic acid was immediately added 
(0.03% w/v) to prevent oxidation of metabolites. For urine samples, the pH 
was adjusted to 7.3±0.1 with 3 M NaOH or 1 M HCl and ascorbic acid was 
added (0.03% w/v) to 1-mL urine aliquots, which were also frozen at −20 ºC 
until analysis without further preparation.  
 
2.3.  Instruments 
 
A centrifuge from Selecta (Barcelona, Spain) was used to separate 
serum from milk and blood samples. A Prospekt-2 system (Spark Holland, 
Emmen, The Netherlands), equipped with a MIDAS autosampler, an 
automatic solid-phase extraction unit (automatic cartridge exchanger, ACE) 
and a high pressure dispenser syringe  (HPD), was used for automated solid-
phase extraction. Hysphere MM anion exchange (10 mm×2 mm, 25–35 µm 
particle size) cartridges from Spark Holland were used for the SPE step. A 
Hysphere method development tray, also from Spark Holland, was used to 
optimize the type of sorbent used in the SPE protocol. The Prospekt-2 
system was on-line connected to an Agilent (Palo Alto, CA, USA) 1200 Series 
LC system, which consists of a binary pump, a vacuum degasser and a 
thermostated column compartment. After chromatographic separation, 
detection was performed by means of an Agilent 6410 triple quadrupole 
mass detector (QqQ), furnished with an electrospray ion (ESI) source. 
Agilent MassHunter Workstation was the software for data acquisition, 
qualitative and quantitative analysis, while the Sparklink System controller 
v. 2.1 Software was used to control the Prospekt units. 
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Chromatographic separation was carried out by hydrophilic 
interaction liquid chromatography, using a Luna HILIC column (100×4.6 
mm, 3 µm particle size) from Phenomenex Inc. (Torrance, California, USA), 
furnished with a HILIC 2×4 mm (5 µm particle size) Guard Cartridge System.  
 
2.4. Solid-phase extraction 
 
 After addition of the internal standard to a final concentration of 20 
nmol/mL, biological fluids were placed at the MIDAS tray, being ready for 
analysis without further preparation. The entire procedure was 
automatically performed, in a sequence of steps schemed in Figure 1 and 
summarized as follows: (A) the sample loop (100 µL) is filled by passing 200 
µL sample,  the cartridge is clamped into the ACE unit, which is then solvated 
and equilibrated by means of the HPD unit with 1 mL methanol at 5 mL/min 
(step 1) and 2 mL loading solution (2 mM potassium phosphate, pH 7.3±0.1)  
at 5 mL/min, respectively;  then, 1-mL loading solution is passed through 
the cartridge at 0.5 mL/min (step 2); (B) after switching the autosampler 
valve, the sample is loaded by passing 1-mL loading solution at 0.5 mL/min 
through the sample loop and then through the SPE cartridge (step 3 
 
 
 
 
 
 
 
 
(A) 
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(B) 
(C) 
Figure 1: General scheme of the automatic steps in the Prospeckt 2 system: (A) 
cartridge loading and solvatation and equilibration, (B) sample loading and 
cartridge washing (C) elution and washing. HPD: high pressure delivery unit, 
AV: autosampler valve, ACE automatic cartridge exchange unit, SV: selection 
valve. 
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the cartridge is subsequently washed with 1-mL of 10% acetonitrile–water 
at 2 mL/min (step 4); an input/output signal is established between the 
Prospekt module and the HPLC system (step 5), which is waiting for an 
external start,(C) the elution starts by switching the ACE valve 1 to the load 
position; thus, the chromatographic mobile phase passes through the SPE 
cartridge and the analytes are eluted to the chromatographic column; after 
2-min elution (step 6), the ACE valve 1 is switched again; a cleaning step of 
the cartridge, with 2-mL methanol (step 7) and 2-mL water (step 8) is finally 
performed. Thus, the SPE cartridge is ready for reuse. Each SPE cartridge 
was used for three analyses. The whole SPE process is performed at room 
temperature in 10 min. The SPE and chromatographic steps are 
synchronized in order to increase the throughput analysis, which is 5 
samples/h. 
 
2.5.  Chromatographic separation and mass-spectrometry detection 
 
 Chromatographic separation was performed isocratically in 14 min. 
The mobile phase was 20 mM ammonium formate in 80:20 (v/v) 
acetonitrile–water (pH 7.3). The flow rate and column oven temperature 
were set at 1 mL/min and 35 ºC, respectively. Analyses were carried out in 
multiple reaction monitoring (MRM) positive ionization mode with nitrogen 
as drying and nebulizing gas. The operating conditions of the ESI–QqQ, were: 
flow rate and temperature of drying gas 10 mL/min and 300 ºC, 
respectively, nebulizer pressure 45 psi, capillary voltage 4000 V, dwell time 
200 ms and delta EMV (potential of the electron multiplier) 700 V. The 
quantification transition for each compound was: 266.8119.9 m/z for 
pABGA, 308.8162.0 m/z for a-pABGA, 441.2294.2.2 m/z for FA and 
442.2295.1 m/z  for aminopterin (IS). The mass spectra obtained with the 
individual standard solutions pABGA (A) and a-pABGA is shown in Figure 2.  
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 Figure 2. Mass spectra obtained with individual standards (A) pABGA and 
(B) a-pABGA. 
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3.  Results and discussion  
 
3.1. Optimization of chromatographic separation and mass 
spectrometry detection 
 
 Study of the chromatographic separation was performed in positive 
fullscan detection mode, being the peak separation and shape the 
parameters considered for optimization. Due to the polar character of the 
target compounds, HILIC was selected for chromatographic separation as 
long as it provided an optimum retention and separation. Separation in the 
HILIC column is performed under high-organic mobile-phase conditions, 
giving an enhanced ESI performance, which leads to an increased sensitivity 
and precision. Subsequently, the ionization agent, flow rate and temperature 
of the column oven were optimized. With this aim, ammonium formate, 
ammonium acetate and formic acid were tested as ionization reagents, over 
the concentration range of 5–20 mM. The best results in terms of peak area 
were obtained with 20 mM ammonium formate in 80:20 acetonitrile–water, 
which was used further on. The pH of the mobile phase strongly affects the 
chromatographic separation; thus, pH values between 3 and 9 were 
investigated, being 7.3 pH the optimum value. Flow rates between 0.5 and 
1.5 mL/min and temperatures between 20 and 40 ºC were also tested, being 
1 mL/min and 40 ºC, respectively, the optimum values.  
The influence of the operating conditions of the mass spectrometer 
—namely the temperature of the drying gas, capillary voltage and nebulizer 
pressure— on the peak area was studied by a multivariate design in order to 
take into account possible dependence relationships of these variables, 
being the optimum 250 ºC, 3700 V and 45 psi, respectively. Optimization of 
the best MRM transitions for the analytes and the internal standard was 
performed with 10 µg/mL multistandard solutions in a sequence of steps 
that involved the selection of the polarity, precursor and product ions, 
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voltage of the first quadrupole, collision energy and dwell time. The 
optimization of detection is summarized in Table 1.  
 
Table 1. Optimization of mass spectrometry operation parameters for the 
multiple reaction monitoring. 
Analyte 
Molecular 
weight 
(g/mol) 
Q1 
m/z 
Q3 
m/z 
Retention 
time 
(min) 
Cone 
voltage 
(V) 
Collision 
Energy 
(eV) 
Dwell 
time 
(ms) 
FA 441.4 442.2 295.1 8.5 140 17 200 
p-ABGA 266.0 266.8 119.9 5.0 120 15 200 
ap-ABGA 308.0 308.8 162.0 5.2 120 8 200 
Aminopterin(IS) 440.4 441.2 294.2 10.5 140 22 200 
 
 
3.2. Optimization of solid-phase extraction and on-line elution to the 
liquid chromatograph 
 
The complexity of biological fluids demands for a suitable sample 
preparation protocol able to remove the effect of potential interferences 
prior to chromatographic separation. In this sense, analysis of urine samples 
is marked by its high-salt content that causes ionization suppression and 
also negatively affect the instrument performance due to the formation of 
non-volatile residues. On the other hand, analysis of serum and milk samples 
is limited by the presence of a large number of proteins that interfere in the 
chromatographic separation and mass detection if they are not removed 
[18]. This interference makes the analysis of folate and catabolites especially 
difficult as long as they are present at very low concentrations. Accordingly, 
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direct analysis of biofluids is rarely performed. Garbis et al. developed a 
method for determination of folates in human serum based on direct 
analysis after deproteinization, filtration, vacuum evaporation and 
reconstitution of the sample [17]. However, the manual performance of 
these steps enhances the risk of contamination and analyte losses as 
biological materials are directly handled in all operations. Solid-phase 
extraction provides clean and concentrated extracts and the possibility of 
fully-automated on-line implementation. 
 Optimization of the SPE is summarized in Table 2. Firstly, selection of 
the SPE sorbent was carried out with the following cartridges: silica-based 
cyanopropyl phase (CN-SE), silica-based ethyl phase (C2-SE),  end-capped 
silica-based octyl phase (C8 EC-SE), high-density end-capped silica-based 
octadecyl phase (C18 HD), polydivinyl-benzene phase (Resin GP), strongly 
hydrophobic polystyrene-divinylbenzene phase (Resin SH) and mixed-mode 
phase containing a strong anion exchange functional group (MM anion). This 
study was performed with both 10 µg/L multistandard solutions and spiked 
samples in order to check the influence of matrix effects. The poorest 
retention was obtained with CN-SE, C2-SE, Resin SH and Resin GP, while MM 
anion gave the best results in terms of area and peak shape, as the analytes 
are present as anionic species at weakly basic pH. The MM anion phase is 
specially suited for extraction of organic acids since it combines a dual 
interaction based on ionic and polymeric mechanisms responsible of a high 
retention capacity.  
 Other relevant parameters optimized were those related with the 
selection of the sample loading conditions such as pH, concentration of 
acetonitrile and loading flow rate. For optimization of the sample pH, values 
within 3 and 9 were tested, for which the appropriate amounts of formic 
acid, ammonium phosphate buffer (0.2M pH 7.3) or NaOH were added. The 
maximum retention capability was at pH values above 6. Therefore, 
physiological blood and milk serum pH at 7.3 was selected. In case of urine 
samples with a pH range from 4 to 8, samples were buffered to pH 7.3 by 
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adjusting with NaOH or formic acid. On the other hand, many protocols for 
analysis of serum and milk include the addition of acetonitrile or other 
reagents that favor proteins precipitation. Pre-precipitation of proteins was 
tested by adding  different amounts of acetonitrile to biofluid samples 
spiked with the target compounds. However, similar results were obtained 
with and without protein precipitation, which suggests that proteins do not 
interfere in the extraction process, so this step was not required. Finally, the 
influence of the flow rate for sample loading was studied by testing flow 
rates between 0.2 and 2 mL/min, being 0.5 mL/min the optimum value.  
 Optimization of the washing step involved the selection of the 
optimum flow rate, volume, and composition of the solution. Flow rate and 
volume were not influential, so that they were fixed at 2 mL/min and 1 mL. 
The washing solution was 10% acetonitrile in water, in order to improve the 
effectiveness of the washing step without analyte losses. Concerning 
recovery of the target compounds from the SPE cartridge, the elution time 
was studied within 0.2 and 4 min. The recovery was approached to 100% 
with 2-min elution times and levelled off for longer times, thus, being 
minimized to 2 min. 
 Characterization of SPE protocol was completed by assessment of 
the breakthrough volume. For this purpose, multistandards at increased 
concentrations of the target compounds were analysed by using an 
experimental setup with two cartridges in an on-line configuration. For this 
purpose, a second MM anion cartridge was clamped in series by means of an 
additional selection valve [19]. Thus, the breakthrough volume, expressed as 
the maximum mass of compounds that can be loaded without giving a 
quantifiable signal in the elution of the second cartridge, was 10 µg for folic 
acid, 30 µg for pABGA and a-pABGA and 5 µg for the internal standard. The 
same study applied to the target biofluids limited the sample loop volume at 
100 µL in order to preserve the retention capability. 
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Table 2. Optimization of the main variables involved in the SPE step 
 
3.3. Features of the method 
 
Recovery was also evaluated with the double-cartridge 
configuration. Firstly, the cartridges were conditioned and equilibrated 
prior to sample loading. If the analytes were not completely retained in 
cartridge 1 or saturation is produced, retention in cartridge 2 occurs. Then, 
the second valve is switched and the mobile phase is loaded through 
cartridge 1 onto the chromatographic column. Valve 2 is finally switched for 
elution of the analytes from the second cartridge. Therefore, the maximum 
recovery is obtained when the MRM signals from the elution of the second 
cartridge are minimized. Figure 3 shows the chromatograms obtained with a 
Variable Tested range 
Optimum 
condition 
Selected 
condition 
SPE sorbent 
CN-SE, C2-SE, C8 
EC-SE, C18 HD, 
resin GP, resin SH, 
MM anion and MM 
cation 
MM anion MM anion 
pH 4-9 Above 6 7.3 
Amount of acetonitrile in 
the sample (%) 
0–30 Non-influential 0 
Loading flow rate 
(mL/min) 
0.2−2 0.5 0.5 
Amount of acetonitrile in 
the washing solution (%) 
0–30 10 10 
Washing volume (mL) 0–3 Non-influential 1 
Washing flow rate 
(mL/min) 
0.2–2 Non-influential 2 
Sample loading flow rate 
(mL/min) 
0.2–2 0.5 0.5 
Elution time (min) 0.2–4 2 2 
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1 µg/mL multistandard solution from the first (A) and second (B) cartridge 
elution.  
Signals obtained from the second cartridge were not quantifiable; 
thus, the retention capability was supposed to be 100% for all the target 
compounds. As Figure 3(A) illustrates, a band broadening effect is observed 
in FA peak signal, which can be ascribed to the mixed interaction of MM 
anion phase. 
 
 
 
 
 
 
 
 
 
Figure 3. Chromatograms obtained with a 1 µg/mL multistandard solution 
from the first (A) and second (B) cartridge elution. 
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On the other hand, Figure 4 shows the chromatograms obtained with 
a mustistandard solution at concentrations above the breakthrough volume 
(20 µg/mL of each analyte) from the first and the second cartridge. In this 
case, retention in the first cartridge was not complete as detected in the 
chromatogram generated by analysis of the elution fraction from the second 
cartridge. In order to assess the recovery, urine samples spiked at two 
concentration levels —50 and 250 ng/mL— and a blank were analysed. 
Accuracy was investigated by comparing theoretically and experimentally 
measured analyte concentrations obtained from spiked samples at the two 
levels. The results obtained for both parameters are summarized in Table 3. 
Calibration plots were run by using the standard peak–internal 
standard peak ratio as a function of the standard concentration. Calibration 
was performed with multistandard solutions at ten concentration levels —
between 0.1 and 10000 ng/mL— which were analysed in triplicate. The 
regression coefficients and the dynamic range are shown in Table 3. The 
lower limits of detection (LLOD), expressed as the mass of analyte which 
gives a signal that is 3σ above the mean blank signal (where σ is the 
standard deviation of the blank signal) ranged between 0.3 and 5.5 pmol/mL 
(0.03 and 0.55 pmol on column). The lower limits of quantification (LLOQ), 
expressed as the mass of analyte which gives a signal that is 10σ above the 
mean blank signal, ranged between 1.1 and 18.8 pmol/mL (0.11 and 1.88 
pmol on column). 
Precision, expressed as repeatability, was estimated by analysis of 
five aliquots of spiked samples at 50 ng/mL (FA: 0.12 nmol/mL, pABGA: 0.19 
nmol/mL and a-pABGA: 0.16 nmol/mL) and 250 ng/mL (FA: 0.60 nmol/mL, 
pABGA: 0.94 nmol/mL and a-pABGA: 0.81 nmol/mL)  in a single working 
session. As can be seen in Table 3, the results obtained, expressed as relative 
standard deviation (RSD), were from 2.5 to 4.1% and 1.5 to 3.8% for the low 
and high level, respectively. 
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Figure 4. TIC MRM chromatograms obtained with a multistandard solution at 
20 µg/mL of each analyte eluted from the first (A) and the second cartridge 
(B). 
  
 
 
 
Table 3. Features of the proposed method. 
 
1 low level: urine pool spiked at 50 ng/mL (FA: 0.12 nmol/mL, pABGA: 0.19 nmol/mL and a-pABGA: 0.16 nmol/mL). 
2 high level: urine pool spiked at 250 ng/mL (FA: 0.60 nmol/mL, pABGA: 0.94 nmol/mL and a-pABGA: 0.81 nmol/mL). 
3 Accuracy (%): 100 x (measured concentration – blank concentration) / spiked concentration.  
 
Analyte 
LLOD 
(pmol/mL) 
LLOQ 
(pmol/mL) 
Linear 
regression 
(r2) 
Dynamic 
range  
Precision at 
low level1 
(RSD%, n=5) 
Precision at 
high level2 
(RSD%, n=5) 
Accuracy 
at low 
level1(%) 
Accuracy 
at high 
level2 (%) 
pABGA 0.3 1.1 0.9999 103 2.5 1.7 96 100 
a-
pABGA 
0.6 1.9 0.9996 103 3.2 3.8 102 100 
FA 5.5 18.8 0.9998 104 4.1 2.8 101 105 
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3.4. Application of the method to human biofluids  
 
The proposed method was tested by application to human biofluids 
in order to check its suitability for clinical analysis. Three biofluids such as 
serum, urine and human milk were selected for analysis following the 
developed method. Five independent replicates were made for each biofluid 
(n=5). Table 4 shows the mean value and the standard deviation obtained 
for the target compounds in each sample, where all the folates were present 
at quantifiable levels. Most studies dealing with folate deficiency have been 
carried out by radioimmunoassay kits for serum analysis. The application of 
these kits has set a deficiency cut-off for folate concentrations below 11 
pmol/mL [20]. As indicated in the introduction section, these assays are not 
specific and, therefore, respond to associated metabolites. Therefore, taking 
into account LLODs and LLOQs reported here for folate and metabolites, the 
proposed method is specially suited for serum analysis. As shows Figure 
5(A), folates were successfully analysed in serum without chemical effect of 
interferences caused by high concentration of proteins. Similarly, the 
proposed method can be applied to human breast milk as Figure 5(B) 
proves. In both cases, a-pABGA was the metabolite found at higher 
concentration.  
Folic acid is predominantly excreted in urine as more polar 
catabolite. Therefore, the analysis of folates in this biofluid could be 
interesting. Urine is a representative biological matrix with a high salt 
content and, for this reason, sample preparation is a critical task. As Figure 
5(C) shows, cleaning and desalting were efficiently performed by the SPE-
based approach proposed here. Mass spectrometry analysis was not affected 
by ionization suppression.  
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(A) 
 
(B) 
(C)
 
 
Figure 6. MRM chromatograms provided by blood serum (A), milk serum (B) 
and urine (C) samples analysed by the proposed method. 
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4. Conclusions 
A method for analysis of folic acid and its main catabolites, p-
aminobenzoylglutamate and the acetamide derivative in biofluids has been 
developed. The method, based on the on-line hyphenation of a solid-phase 
extraction step with HILIC–MS/MS chromatographic separation and 
detection, is fully automated, and no in-batch operations, such as protein 
precipitation or filtration, were required. 
The entire analytical process has been carefully optimized and 
characterized. Subsequently, it has been applied to the analysis of the target 
compounds in urine, breast milk and serum samples. Although the target 
analytes were present in the three biofluids, the most abundant folate 
catabolite in all samples is a-pABGA. On the other hand, the highest 
concentration of folic acid is found in serum. In fact, it is well established 
that serum is likely to reflect the metabolic state of an organism as a 
consequence of both catabolic and anabolic processes occurring in the whole 
organism, while excreted biofluids, such as urine, provides readout of 
catabolic processes, in which polar metabolites without metabolic activity 
are more readily discarded from the body. 
A metabolic profile of these compounds in the target samples offers 
valuable information about the abundance of this essential vitamin in 
humans. This can be of especial interest in groups of individuals with 
increased risk of deficiency (such as neonates or pregnant women). 
Comparison between the levels of these related catabolites in the three 
types of biofluids gives a realistic readout of the occurrence and fate of this 
water-soluble vitamin in humans. 
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Ultrasonic enhancement of leaching and in situ 
derivatization of haloacetic acids in vegetable foods 
prior to gas chromatography–electron capture 
detection 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
 
 A continuous ultrasound-assisted approach to enhance the 
extraction of nine haloacetic acids (HAAs) from vegetables with in situ 
derivatization to methyl esters for their gas chromatography (GC) analysis is 
presented. The optimization of simultaneous extraction (using acidic 
methanol as extractant) and derivatization enabled the completion of both 
steps in 15 min. Ultrasound assistance has proved to enhance both linked 
steps, which results in a considerable shortening of the overall analysis time 
(i.e. 552.1 and 552.3 EPA methods for analysis of these compounds in 
drinking water require 1 and 2 h, respectively, only for derivatization). After 
sample preparation, the esterified HAAs were isolated by liquid–liquid 
extraction with n-hexane and analyzed by GC–electron capture detection. 
The proposed method is an interesting alternative to present methods for 
the determination of HAAs in vegetable foods. This is an area unjustifiably 
forgotten by reference laboratory organisms as proves the absence of official 
methods for analysis of the target compounds in these samples. The 
proposed method can be applied to the analysis of HAAs in any solid sample 
after optimization of the main variables involved in the extraction–
derivatization step. 
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1.  Introduction 
 
Haloacetic acids (HAAs) are a group of chlorinated, brominated and 
mixed bromo–chlorinated organic compounds included in the category of 
“disinfection by-products” (DBPs). This category includes a heterogeneous 
variety of compounds with significant differences in polarity, volatility and 
chemical structures. Haloacetic acids are commonly formed in water as a 
result of the reaction between organic matter, naturally present in water, 
and oxidizing compounds formed during disinfection with chlorine gas (Cl2) 
—e.g. hypochlorous acid (HOCl) [1]. Disinfection is a common treatment for 
water pre-conditioning in order to avoid the spread of diseases, such as 
cholera or poliomyelitis. Chlorination is the most extended alternative to 
obtain drinkable water because of its low level of chlorine residuals, 
protection against microbial recontamination and relative low cost [2,3]. 
Despite chlorinated derivatives are the most common DBPs, brominated 
organic compounds can also be formed due to reaction between 
disinfectants and bromine ions present in water. The formation of 
brominated by-products in water is favoured by high bromine levels [4]. 
There are epidemiological evidences of a positive relationship 
between consumption of chlorination by-products in drinking water and 
bladder, liver or rectal cancer in humans [5,6]. For this reason, the 
Environmental Protection Agency (EPA) has set strict regulatory limits for 
the sum of five HAAs (chloroacetic, dichloroacetic and trichloroacetic acids, 
and bromoacetic and dibromoacetic acids) in water [7,8].   
Concerns about HAAs are exclusively focused on their presence in 
drinking water. However, there are other potential contamination sources 
for humans and animals such as direct exposition of foods to disinfected 
water. For instance, irrigation can be a way to expose humans to these 
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carcinogenic agents. Despite the toxic effects and potential contamination of 
HAAs, methods for the determination of haloacetic acids in foods have not so 
far been reported, probably due to the difficulty to handle solid samples. In 
fact, most of the developed methods for the determination of haloacetic 
acids are based on extraction from an aqueous sample to an organic 
extractant, derivatization with diazomethane or acidic methanol and 
determination of the methyl esters by gas chromatography (GC) coupled 
with either mass spectrometry (MS) [9−11] or electron capture detection 
(ECD) [12−14]. The GC–ECD coupling has provided higher sensitivity than 
GC–MS [1] and, for this reason, constitutes the basis for 552 [15] and 552.2 
[16] EPA Methods, and standard method 6251B [17].  
Ultrasonic-assisted leaching has proved to be an effective way to 
extract a number of analytes from different types of solid samples [18−20]. 
This high extractive power can be ascribed to two main reasons: (1) the 
localized influence of extremely high temperatures and pressures under 
cavitation, which increases solubility and diffusivity of target analytes, and 
also favours penetration and transport at the interface between a solution 
and a solid matrix; and (2) the oxidative energy of species created during 
sonolysis of the liquid phase (H• and OH• and hydrogen peroxide in water) 
[21]. In this research, the aim was to study the influence of ultrasonic energy 
on the extraction of HAAs from vegetable foods, but also on their in situ 
derivatization to methyl esters. This dual ultrasound assistance enables 
displacement of the leaching equilibrium by esterification of the leached 
compounds. This is expected to result in a high leaching efficiency together 
with a considerable shortening of the time for sample preparation. A 
dynamic manifold was designed to accomplish this objective. After sample 
preparation, the extract was subject to liquid–liquid extraction (LLE) prior 
to analysis by GC–ECD as the EPA Methods suggest. Figure 1 illustrates the 
workflow of the method proposed in this research and that used in the EPA 
Method 552.2 for analysis of HAAs in drinking water. 
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2.  Materials and methods 
 
2.1. Instruments and apparatus 
 
Ultrasonic irradiation was applied by means of a Branson 450 digital 
sonifier (20 KHz, 450 W) with digital timer, temperature controller and 
tunable amplitude and duty cycle, which was equipped with a cylindrical 
titanium alloy probe (12.70 mm in diameter), immersed into a water bath.  
The sample was placed in the extraction–derivatization chamber, 
which consists of a stainless steel cylinder (10 cm x 10 mm i.d.) closed with 
screw-caps at either end, thus permiting circulation of the leaching fluid 
through it. Sea sand, which was previously washed with hydrochloric acid 
and calcined, was used in order to avoid sample compaction in the 
extraction chamber. 
Figure 1. Workflow of the proposed method and EPA Method 552.2. MTBE: 
metyl-terc-butyl-ether; GC−ECD: gas chromatography−electron capture 
detection.  
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A Gilson Miniplus-3 peristaltic pump, fitted with PTFE 0.8 mm i.d. 
tubing, was programmed for changing the rotation at preset intervals. A 
Rheodyne 5041 low-pressure injection valve and Teflon tubing were used to 
build the dynamic manifold shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
A Varian star 3400 CX gas chromatograph (Varian, Palo Alto, CA, 
USA) equipped with a 63Ni electron capture detector (ECD) and a Varian 
8200 CX autosampler was used to separate and quantify the analytes. The 
chromatographic column was a Factor Four Capillary Column (VF-5ms 60 m 
× 0.25 mm) i.d. DF = 0.25) from Varian. Helium and nitrogen (from Carburos 
Metálicos, Spain) were used as carrier and make-up gases, respectively.  
A conventional meat grinder (Moulinex, Barcelona, Spain) was used 
to homogenize the vegetable foods. A thermostated water bath and electrical 
stirrer from Selecta (Barcelona, Spain) were also used.  
 
Figure 2. Experimental set-up for dynamic ultrasound-assisted extraction (USAE) 
and derivatization of haloacetic acids in vegetable foods. PPP: programmable 
peristaltic pump; SV: switching valve; LC: leaching carrier; ER: extract reservoir; 
UP: ultrasonic probe; EC: extraction chamber; WB: water bath; C: coil; GC: gas 
chromatograph; ECD: electron capture detector. PC: personal computer. 
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2.2. Reagents and solutions  
 
 Deionized water (18 Ω•cm) from a Millipore MilliQ water 
purification system (Bedford, MA, USA) was used to prepare the water–
methanol extractant mixtures. Methanol and hexane of Hplc grade were both 
from Scharlau (Barcelona, Spain), while sulphuric acid was supplied by 
Panreac (Barcelona, Spain). Acids monochloroacetic (MCAA), 
monobromoacetic (MBAA), dichloroacetic (DCAA), dibromoacetic (DBAA),  
bromochloroacetic (BCAA), trichloroacetic (TCAA), tribromoacetic (TBAA), 
chlorodibromoacetic (CDBAA), bromodichloroacetic (BDCAA) were 
obtained at a purity higher than 98% from Supelco (Madrid, Spain). The 
stock solutions of haloacetic acids were prepared by dissolving 0.05 g of 
each standard in 50 mL of hexane, except for bromodichloroacetic acid, 
prepared at a concentration of 500 µg/mL. Anhydrous Na2SO4 from Merck 
(Darmstadt, Germany) was used as drying agent after the liquid–liquid 
extraction step. All standard solutions were stored at 4 ºC in glass containers 
to minimize losses by volatilization or adsorption, as recomended by EPA 
method 552.2 [1,13]. 
 
2.3. Samples  
 
Vegetable foods ―chard and spinach― were obtained from a local 
market. Samples were milled and kept at –20 ºC in dark until use. Spiked 
samples were prepared by adding 800 µl of standard solution at the suitable 
concentration to 2 g of milled sample; then shaked vigorously for 2 h in a 
mechanical stirrer until evaporation of the organic solvent.  
 
2.4. Ultrasound-assisted extraction of HAAs with in situ derivatization 
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The experimental set-up for dynamic ultrasound-assisted extraction 
(USAE) and derivatization of haloacetic acids is depicted in Figure 2. Two 
grams of milled vegetable food was placed in the extraction chamber (EC) 
and three glass balls were added to avoid clogging and thus high-pressure 
problems. Then, the extraction chamber was assembled to the dynamic 
system and filled with 10% sulphuric acid in methanol ―extractant and 
derivatizing reagent (EDR)― by means of the peristaltic pump (PP). The 
dynamic system becomes a closed circuit by switching the selection valve 
(SV). After filling the system, the extraction chamber was immersed into the 
water bath (WB) at 35 ºC. The extractant carrier was then circulated 
through the solid sample under ultrasonic irradiation (duty cycle 0.4 s, 
output amplitude 20% of the converter applied power) for a 10-min preset 
time with the probe (UP) placed at the minimal distance to the top surface of 
the extraction cell, but without contacting it. During extraction, the direction 
of the leaching carrier (at flow-rate = 2 mL/min) was changed each two min 
to minimize increased compactness of the sample in the extraction chamber 
that could cause overpressure in the system. After the extraction time was 
elapsed, the selection valve was switched and the extract collected for 
subsequent analysis steps. 
 
2.5. Analysis of target compounds by gas chromatography–electron 
capture detection  
 
After the ultrasonic-assisted step, the extract was subject to LLE for 
solvent exchange and cleanup prior to injection into the gas chromatograph. 
First, the methanol extract was mixed with 1 mL hexane and shaken for 2 
min in a mechanical electrical stirrer with subsequent isolation of the 
organic phase.  Then the hexane extract was cleaned with 1 mL water for 
three times. Then, the resulting organic phase was dried with Na2SO4 before 
individual separation of the target analytes by GC and detection by ECD. 
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The carrier gas employed was helium (99.999% purity) at a flow-
rate of 1.6 mL/min. Nitrogen (99.999% purity) was used as the ECD make-
up gas, at a flow-rate of 30 mL/min. Splitless injections were made by 
injecting 1.5 µL of extract. The injection port temperature and detector were 
set at 200 and 260 ºC, respectively. The oven temperature program for the 
chromatographic separation was as follows: initial temperature of 35 ºC, 
held 9 min, increased to 40 ºC at 1 ºC/min, held 3 min, and then to 220 ºC at 
6 ºC/min, and then to 205 ºC at 20 ºC/min, then kept at this temperature for 
7 min.  
 
3. Results and Discussion 
 
The development of the method proposed here was initiated with 
the optimization of the chromatographic analysis and the optimization of the 
leaching–derivatization steps in the sample-preparation manifold. Then, the 
method was characterized in terms of sensitivity and precision. Finally, a 
validation study was developed by using spiked samples. 
 
3.1. Optimization of the chromatographic analysis of the target 
compounds 
  
Because of the polar nature and acidity of HAAs, they cannot be 
directly injected into the GC column, so a derivatization step is mandatory. 
This step is usually carried out by esterification of the carboxylic group 
―typically methylation with diazomethane or acidic methanol― prior to 
liquid–liquid extraction to an organic phase for chromatographic separation 
[18]. In this research, acidic methanol was selected for derivatization, as 
suggested in the EPA Method 552.2, instead of diazomethane, which has 
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proved to be highly toxic. Identification of HAA esters and optimization of 
their individual separation was carried out using standard solutions, which 
were derivatized with the protocol employed in this EPA method. The 
experimental chromatographic variables were optimized resulting in the 
operating conditions described in Section 2. Splitless and split injections 
were tested to check the influence of the split ratio on the GC–ECD analysis. 
Injection without split-flow provided the best sensitivity, which is a key 
factor in the analysis of these compounds taking into account their low 
allowable levels in water. Identification of the chromatographic peaks was 
accomplished by comparison of retention times provided by standard 
solutions of each HAA. Complete separation of them was achieved in less 
than 30 min. 
 
3.2. Optimization of the variables involved in the ultrasound-assisted 
extraction with in situ derivatization of haloacetic acids from vegetable 
foods 
 
The composition of the liquid phase (extractant) was crucial for the 
simultaneous extraction and derivatization to methyl esters of the target 
acids. Therefore, this study was aimed at the assessment of the influence of 
the main variables involved in the sample-preparation approach for 
isolation of HAAs from vegetable foods. The influencial variables were the 
composition of the liquid phase (expressed as percentage of sulphuric acid 
in methanol), flow-rate of the liquid phase in the dynamic system, duty cycle 
of ultrasound irradiation, sonication amplitude, temperature of the water 
bath where the extraction chamber is immersed, and sonication time. A 
multivariate approach was applied in order to take into account possible 
dependence relationships of these variables. The response factors were the 
peak areas of the GC chromatograms obtained after analysis of the 
derivatized analytes. Therefore, the objective was to maximize the response 
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factors resulting from high efficiencies of the extraction and derivatization 
steps without degradation or losses of the target compounds. The vegetable 
food selected for the optimization study was spinach, although the resulting 
optimal conditions were tested with other vegetable foods observing a 
similar behaviour. 
A Plackett–Burman design 26x3/16 type III resolution allowing eight 
degrees of freedom and involving 12 randomized runs plus three centre 
points was built for a screening study of the seven factors. The upper and 
lower values for each factor were set according to preliminary experiments. 
The tested range and the optimum value for each variable are shown in 
Table 1. The conclusions of this first study were that the concentration of 
sulphuric acid in methanol and the sonication time were the most influential 
factors on this dual-step sample preparation approach. Both factors have a 
positive effect on all HAAs, except for dibromoacetic acid, for which the 
sonication time was not significant in the range studied. For this reason, 
higher values of these two variables were tested in a second study. 
 
 
VARIABLE 
STUDIED RANGE 
OPTIMUM 
VALUE 
Plackett-Burman 
design 
Full factor 
design 
Bath temperature (ºC) 25−35 35 35 
Duty cycle (%) 20−60 40 40 
Radiation amplitude (%) 20−60 20 20 
Flow-rate (mL/min) 1−3 1 1 
[H2SO4] (%) 5−15 15−25 20 
Extraction time (min) 5−15 10−25 10 
 
Table 1. Optimization of the variables involved in the ultrasonic leaching with 
in situ derivatization step. 
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Concerning the other variables, the flow-rate was not a significant 
variable within the studied range for any analyte showing a negative effect 
in all cases. Therefore, low flow-rates are required to ensure a better 
sample–liquid phase contact. For this reason, 1 mL/min was selected for 
subsequent experiments. The irradiation amplitude showed a similar 
behaviour to that of the flow-rate, so its optimum value was set at 20%. In 
the case of duty cycle, no effect was observed by changing the duty cycle, so 
an intermediate value, 40%, was selected that means 0.4 s of ultrasound 
irradiation per second. The last non-significant variable was the water bath 
temperature, the increase of which, in contrast to the previous ones, yielded 
a positive effect favouring the performance of this approach.  
In the second step, higher values for the sonication time and 
concentration of sulphuric acid were tested using a two-level full factorial 
design involving eight randomized runs plus three centre points. The 
concentration of sulphuric acid was significant with a positive effect. 
However, the increase from 15 to 20% sulphuric acid was accompanied by 
fast degradation of both the pump tubes and seals in the dynamic system. 
For this reason, its value was set at 15% for further experiments. Also the 
sonication time was positively significant.  
 After setting the optimum values of the other variables, a kinetics 
study was carried out by testing different sonication times. The results, 
which enable to monitor the evolution of the extraction–derivatization 
process, are shown in Figure 3.  As can be seen, the kinetic curves have the 
same behaviour for all the target compounds, having a maximum at 5 min 
for monochloroacetic acid, dibromoacetic acid and monobromoacetic acid, 
and at 10 min for bromodichloroacetic acid, dichloroacetic acid, 
trichloroacetic acid, tribromoacetic acid, bromochloroacetic acid, 
chlorodibromoacetic acid.  After 10 min, a considerable reduction of the 
signal is observed for some HAAs, probably due to degradation or re-
absorption of the target analytes in the sample matrix. In view of these 
results, ten minutes was selected as the operating sonication time. Figure 4 
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shows a chromatogram obtained after application of the proposed method 
to a chard sample spiked with the target analytes at 10 µg/mL. 
 
 
Figure 3. Kinetics study of the extraction–derivatization step. MCAA: 
monochloroacetic acid; MBAA: monobromoacetic acid; DCAA: dichloroacetic 
acid; DBAA: dibromoacetic acid; BCAA: bromochloroacetic acid; TCAA: 
trichloroacetic acid; TBAA: tribromoacetic acid, CDBAA: chlorodibromoacetic 
acid; BDCAA: bromodichloroacetic acid. 
 
3.3. Characterization of the method for quantification of haloacetic acids 
 
Calibration plots were obtained by using the peak area of each 
compound as a function of the concentration of the standard conentration. 
Seven concentration levels were used to build the calibration curves. The 
regression coefficients (between 0.983 and 0.999) for all analytes are shown 
in Table 2.  
The limit of detection (LOD) for each analyte was estimated from 
vegetable samples spiked with the target HAAs, and expressed as the mass 
of analyte which gives a signal that is 3σ above the mean blank signal (where  
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σ is the standard deviation of the blank signal). The LODs obtained ranged 
between 0.4 and 9.7 ng/g. The limits of quantification, expressed as the mass 
of analyte which gives a signal 10σ above the mean blank signal, ranged 
from 1.6 to 34.3 ng/g.  
Table 2. Limits of detection (LOD), limits of quantification (LOQ) and 
regression coefficients (R2) for the proposed method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4. Applicability of the proposed method to spiked vegetable samples 
 
The absence of both reference methods for analysis of HAAs in 
vegetable foods and certified materials made mandatory the use of spiked 
food samples in order to demonstrate the applicability of the proposed 
method. Two different types of vegetable ―spinach and chard― were spiked 
at two concentration levels, 2 and 10 µg/mL, and analysed in triplicate with 
the proposed method. Previous analyses proved that none of the tested 
Analyte LOD (ng/g) LOQ (ng/g) R2 
MCAA 9.7 34.3 0.992 
MBAA 4.9 15.8 0.997 
DCAA 0.5 1.9 0.999 
TCAA 1.0 3.1 0.997 
BCAA 0.7 2.3 0.997 
DBAA 0.5 1.9 0.989 
BDCAA 1.1 3.3 0.995 
CDBAA 0.4 1.6 0.983 
TBAA 0.5 1.8 0.996 
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samples contained detectable levels of the target analytes according to the 
determination method used in this research. The results obtained are shown 
in Table 3 for each sample and concentration level. As can be seen, the 
values found were in agreement with the concentrations spiked for each 
sample. The recoveries ranged from 80 to 115% for the target HAAs, which 
demonstrates the utility of the overall method for analysis of these 
compounds. The assessment of the precision provided acceptable values in 
terms of within-day variability. These values were similar for both vegetable 
foods, ranging from 1.97 and 4.93% for 2 µg/mL and from 2.42 to 6.12% for 
10 µg/mL, expressed as relative standard deviation. 
 
 
Figure 4. Chromatogram obtained after application of the proposed method to 
a chard sample spiked with the target analytes at 10 µg/mL. MCAA: 
monochloroacetic acid; MBAA: monobromoacetic acid; DCAA: dichloroacetic 
acid; DBAA: dibromoacetic acid; BCAA: bromochloroacetic acid; TCAA: 
trichloroacetic acid; TBAA: tribromoacetic acid, CDBAA: chlorodibromoacetic 
acid; BDCAA: bromodichloroacetic acid. 
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4.  Conclusions 
 
 The sample preparation approach proposed allows leaching of 
HAAs from vegetable foods with in situ derivatization to methyl esters. The 
target analytes were isolated by ultrasound-assisted leaching in a dynamic 
system, then converted into methyl esters. Ultrasound energy provided an 
enhance ment over both linked steps resulting in an acceleration effect that 
completes the process in only 10 min (it is worth noting that EPA methods 
for analysis of these compounds require at least 1 h for quantitative 
derivatization). After this treatment, the esterified HAAs are transferred to a 
hexane phase by liquid–liquid extraction for subsequent analysis by GC–
ECD. The overall results qualify the proposed method as suitable for routine 
analysis of these compounds in vegetable foods as it is endowed with 
remarkable characteristics such as short extraction times, low energy and 
acquisition costs and low handling of toxics and hazardous organics and 
reagents.  
The method has been applied to two vegetable foods, spinach and 
chard, although it can also be applied to the analysis of HAAs in any solid 
sample after optimization of the main variables involved in the extraction–
derivatization step.  
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Sample 
Spiked 
concentration 
Found MCAA MBAA DCAA TCAA BCAA DBAA BDCAA CDBAA TBAA 
Spinach 
2 µg/mL  
Concentration  
(µg/mL) 
2.2 
(2.65) 
2.0 
(3.92) 
2.1 
(4.14) 
2.2 
(3.97) 
2.0 
(3.15) 
2.3 
(1.97) 
2.1 
(3.05) 
2.1 
(3.25) 
2.1 
(4.21) 
Recovery (%) 110 100 105 110 100 115 105 105 105 
Chard 
Concentration 
(µg/mL) 
1.8 
(3.65) 
2.2 
(4.92) 
1.9 
(3.58) 
1.8 
(4.80) 
1.9 
(3.32) 
1.6 
(2.98) 
2.2 
(3.22) 
2.1 
(4.35) 
2.2 
(4.93) 
Recovery (%) 90 110 95 90 95 80 110 105 110 
Spinach 
10 µg/mL  
Concentration 
(µg/mL) 
8.8 
(5.13) 
9.0 
(5.58) 
9.2 
(6.12) 
9.8 
(4.15) 
10.9 
(5.35) 
9.7 
(2.42) 
9.5 
(5.14) 
10.5 
(3.95) 
10.6 
(5.80) 
Recovery (%) 88 90 92 98 109 97 95 105 106 
Chard 
Concentration 
(µg/mL) 
8.9 
(4.78) 
9.2 
(5.75) 
9.8 
(2.89) 
9.9 
(4.95) 
10.9 
(4.24) 
10.8 
(3.12) 
10.4 
(5.6) 
9.6 
(4.55) 
9.5 
(5.08) 
Recovery (%) 89 92 98 99 109 108 104 96 95 
Table 3. Determination of haloacetic acids in spiked vegetable food samples at different concentrations by the 
proposed method (n = 3 replicates) and corresponding error in brackets expressed as percentage. 
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Quantitative targeted profiling of compounds with 
nutraceutical interest in tomato by mass-spectrometry-
based analytical methodologies 
B. Álvarez-Sánchez, F. Priego-Capote , M.D. Luque de Castro* 
 
Abstract 
Introduction – Tomato (Solanum lycopersicum) is a widely consumed-fruit 
rich in nutraceuticals such as carotenoids, provitamins, vitamins or phenolic 
compounds, which are well-known because of their phytochemical and 
organoleptical properties.  
Objective – Quantitative analysis of a panel of compounds with contribution 
to the nutritional quality of tomato species has been carried out. These 
compounds may be used as potential markers for selection of cultivars and 
harvest time to improve the quality of fruits in tomato breeding programs. 
Monitored metabolites were carotenes (hydrophobic nutraceuticals), 
phenols and ascorbic acid (hydrophilic nutraceuticals) and carbohydrates 
(organoleptical properties).  
Methodology – The methodologies used were based on liquid 
chromatography–mass spectrometry for the analysis of carotenoids, 
ascorbic acid and phenols, and on gas chromatography–mass spectrometry 
for the analysis of sugars. The target compounds were isolated by 
ultrasound-assisted extraction.  
Results – Analytical methods of interest in tomato breeding programs were 
reported for quantitation of nutraceuticals in fruits. High selectivity and 
sensitivity levels were attained by hyphenating MS detectors to gas- or 
liquid chromatographs.  
Conclusion – The sensitive and selective methods reported here for analysis 
of the target compounds may be used to assess the nutritional value of 
tomato fruit. 
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1.  Introduction 
 
 Tomato (Solanum lycopersicum), a main source of natural 
antioxidants, is a widely consumed fruit present in many healthy diets 
including the Mediterranean diet. In fact, tomato is rich in nutraceuticals 
such as carotenoids (lycopene), provitamins (provitamin A), vitamins 
(ascorbic acid) and phenols (flavonoids), among others. The term 
"nutraceutical" was coined in 1989 by DeFelice from "nutrition" and 
"pharmaceutical". According to DeFelice, nutraceutical can be defined as, "a 
food (or part of a food) that provides medical or health benefits, including 
the prevention and/or treatment of a disease" (Kalra, 2003). 
 Among nutraceuticals present in tomato, the main antioxidants are 
carotenoids, a family constituted by over 600 compounds, among which the 
most abundant are lycopene, α-carotene, β-carotene, lutein, and zeaxanthin 
(Roldán-Gutiérrez, Luque de Castro, 2007). They are natural fat-soluble 
pigments present in fruits and vegetables, but also synthesized by other 
plants, algae and photosynthetic organisms. Chemically, carotenoids are 
formed by eight isoprene units and, thus, comprise a long central chain of 
conjugated double bonds and could have a hydrocarbon ring in one or both 
ends. Along with their antioxidant activity, some carotenoids also exert 
other essential biological functions (i.e. acting as retinol precursors, 
immunoresponse modulators and gap-junction communication inducers). 
Carotenoids have a protective effect against some human diseases such as 
cancer, heart disease, macular degeneration and cataracts (Rao and Rao, 
2007). Furthermore, carotenoids have also been used in the treatment of 
photosensitivity disease (Oliver and Palou, 2000). 
 Other remarkable group of natural compounds is that of phenols, 
secondary metabolites synthesized in plants where they act as phytoalexins, 
antioxidants, UV light protectors and natural pigments (Slimestad and 
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Verheul, 2009). The most abundant phenolic compounds in tomato are 
flavonoids, constituted by two aromatic rings linked by a three-carbon chain. 
This aromatic-based conjugated structure renders flavonoids, good 
hydrogen and electron donors, and, therefore, good antioxidants. In 
addition, flavonoids have proved to protect against allergies, inflammation, 
hypertension and arthritis. Moreover, they are thought to reduce the 
proliferative activity of certain types of tumor cells and be involved in the 
apoptosis of HL-60 leukemia cells, as proposed by Surh (1998) and 
Verhaegen et al. (1995).  
 Vitamin C, also known as ascorbic acid, is a water-soluble vitamin 
non-synthesized by humans, being hence obtained through diet (mainly by 
citric fruits and tomato). Vitamin C is involved in many physiological 
processes such as the synthesis of bile acids from cholesterol (Rock et al., 
1996), the regeneration of vitamin E after oxidative processes, or the 
synthesis of the amino acid carnitine (Rebouche, 1991). Low or nil intakes of 
vitamin C are known to cause scurvy. Moreover, numerous reports have 
shown that vitamin C is involved in the prevention of oxidative stress-
related illnesses such as cancer, cardiovascular diseases and the capillary 
plugging processes produced in sepsis, as recently suggested by Wilson 
(2009). Seasonal variations of vitamin C concentration in tomato are related 
to light exposure together with sugar content (Massot, 2010). In this sense, 
low-molecular weight sugars are held to participate in vitamin C 
biosynthesis both by acting as substrate and as signaling molecule in the 
regulation of gene expression of enzymes involved in vitamin C metabolism 
(Wheeler et al., 1998).  
 Besides participating in ascorbic acid synthesis, carbohydrates are 
an important fraction to be quantified in tomato as they contribute to both 
organoleptic (sweetness) and nutritional properties, particularly reducing 
sugars, due to their ability to react with amino acids and proteins to form 
Maillard Reaction Products (MRPs) (Morales and Jiménez-Pérez, 2001). 
Despite MRPs are known to negatively affect some organoleptic and 
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nutritive properties of edible plants (i.e. browning or chelation of 
micronutrients such as trace metals), they are endowed with antioxidant, 
antimicrobial or cytotoxic activities (Chevalier et al., 2001). From the best of 
our knowledge, there are scarce reports on the analysis of sugars in tomato, 
none of them devoted to their individual quantification (Massot et al., 2010). 
 Tomato breeding programs have been mainly focused on genetic 
research to improve yield and resistance to diseases. However, in the last 
years an increasing attention has been paid to quality by improving flavor, 
organoleptical properties and nutritional quality (Mathieu et al., 2009; 
Eybishtz et al., 2009; Comlekcioglu et al., 2010). In this sense, the proposals 
of strategies to evaluate the nutritional quality by monitoring panels of 
nutraceutical compounds are well-received. Selective and sensitive MS-
based methods for the analysis of ascorbic acid  and carotenoids (Garrido 
Frenich et al., 2005; Mertz et al., 2009) in tomato are still scarce, as recently 
reviewed by Gómez Romero et al. (2007), while the GC–MS/MS and LC–
MS/MS determination of phenols in a variety of plants, including tomato, has 
been well-implemented (Gómez Romero et al., 2007). In fact, most of the 
existing methods applied to the quantitative targeted analysis of tomato are 
exclusively devoted to the analysis of this fraction. A recent study has 
characterized the phenolic fraction extracted from three tomato varieties by 
LC–TOF/MS with quantitative analysis of a panel of characteristic 
compounds (Gómez Romero et al., 2010). To the authors' knowledge no 
analytical methods based on MS have been reported for determination of 
sugars in tomato fruits. In the present study, the quantitative profiling of 
tomato compounds with nutraceutical properties as potential markers for 
cultivar selection and harvesting has been carried out. The sensitive and 
selective analysis of the target compounds may give a complete insight of 
the nutraceutical potential of tomato and assess its nutritional value, thus 
becoming a potential tool to be used in tomato breeding programs. 
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2.  Materials and methods 
 
2.1. Instruments and apparatus 
 
 Ultrasonic irradiation was applied by a Branson 450 digital sonicator 
(20 kHz, 450W) with tunable amplitude and duty cycle, equipped with a 
cylindrical titanium alloy probe (12.70 mm in diameter), which was directly 
immersed in the extraction beaker. A centrifuge from Selecta (Barcelona, 
Spain) and a rotary-evaporator Büchi R-200 equipped with a heating bath 
Büchi B-490 (Büchi, Switzerland) were used after extraction to separate the 
extract and remove the solvent, respectively. An Eppendorf Vacufuge 
Concentrator was used to evaporate the extractant in aliquots of tomato 
extracts prior to the chromatographic steps. 
Analyses of carotenoids, phenols and ascorbic acid were performed 
by reversed-phase LC followed by MS detection, depending on the case. 
Chromatographic separation was performed with an Agilent (Palo Alto, CA, 
USA) 1200 Series LC system, which consists of a binary pump, a vacuum 
degasser, an autosampler and a thermostated column compartment. 
Detection and quantification were carried out with an Agilent 6410 Triple 
Quadrupole (QqQ) mass analyzer. Data were processed by a MassHunter 
Workstation Software from Agilent for qualitative and quantitative analysis. 
An Inertsil ODS-2 C18 analytical column (4.0 mm i.d. × 250 mm; 5 µm 
particle size, GL Sciences Inc., Tokyo, Japan) was used for chromatographic 
separation.  
Gas chromatography–mass spectrometry analyses were carried out 
by a Varian CP 3800 gas chromatograph coupled to a Saturn 2200 ion trap 
mass spectrometer (Sugar Land, TX, USA) equipped with a FactorFour 
capillary column (VF-5 ms 30 m × 0.25 mm, 0.25 µm) from Varian (Palo Alto, 
USA). Helium at a constant flow rate of 1 mL/min was used as carrier gas. 
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2.2.  Reagents and samples 
 
Daniela variety tomato samples (Lycopersicum esculentum) were 
purchased in a local market. Upon acquisition, samples were milled, pooled 
and lyophilized; then, the product was vacuum-packed and stored at –80 ºC 
until analysis. 
The leaching agent for the solid–liquid extraction step was a 3:1 
(v/v) mixture of LC-grade tetrahydrofuran and methanol (Panreac, 
Barcelona, Spain). Chromatographic-grade methanol, acetonitrile, 
tetrahydrofuran (Panreac), and Milli-Q water (Millipore, Bedford, MA, USA) 
were used for the LC mobile phases. Acetic acid and ammonium formate 
(Sigma–Aldrich, St. Louis, MO, USA), used as ionization agents in the 
LC−MS/MS analyses, were of MS grade. Derivatization-grade 
N,O−Bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchloro-
silane (TMCS) from Sigma–Aldrich and pyridine from Merck (Darmstadt, 
Germany) were used in the derivatization step prior to GC−MS analyses, for 
which appropriate safety precautions (gloves, hood-fume, etc.) were taken.  
 Lycopene, β-carotene, lutein and xanthophylls such as neoxanthin, 
violaxanthin, mutatoxanthin, antheraxanthin, zeoxanthin, β-criptoxanthin 
and cantaxanthin were acquired from Carotenature (Lupsingen, 
Switzerland).  Pure standards of quercetin, myricetin, catechin, rutin, 
quercetin 3-β-D-glucoside, and acids dihydroxybenzoic (procatechuic), 
chlorogenic, caffeic, p-coumaric, ferulic and ascorbic were from Sigma. Stock 
individual solutions were prepared by dissolving the appropriate amount of 
each compound in methanol to a final concentration of 2000 µg/mL. 
Carbohydrate standards D-(+)-arabinose, D-(β)-xylose, D-(β)- mannose, D-
fructose, D-(+)-galactose, D-(β)-glucose, D-(β)-sucrose, D-(β)-lactose, were 
also from Sigma–Aldrich. 
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2.3. Solid–liquid extraction  
 
 In this step, 0.5 g of the lyophilized sample and 25 mL of leaching 
solvent (a 3:1 tetrahydrofuran–methanol mixture) were poured into a 100-
mL beaker. Extraction was performed by direct immersion of the ultrasonic 
probe tip into the mixture at a fixed distance of 1 cm from the bottom. The 
sonication amplitude and duty cycle were set at 30% of the nominal value of 
the ultrasonic converter (450 W) and 0.5 s/s, respectively. The extraction 
process was repeated, and the resulting 50-mL extract was rota-evaporated 
to dryness and reconstituted in 2-mL 3:1 tetrahydrofuran–methanol. The 
extract was stored at −20 ºC in dark until analysis. 
 
2.4. Quantification of carotenoids by LC−MS  
 
 For the analysis of carotenoids, 100 µL of extract was evaporated to 
dryness and reconstituted in 1000-µL 5 mM ammonium formate in 10% 
water–acetonitrile, from which 10 µL was injected. Chromatographic mobile 
phases were 5 mM ammonium formate in 10% water–acetonitrile (mobile 
phase A) and tetrahydrofuran (mobile phase B). Initially, 100% mobile 
phase A was maintained isocratically for 6 min. Then, a linear gradient of 7 
min was programmed to 75% mobile phase B, and to a final composition of 
100% in 1 min, which was maintained 11 min and, finally, a post-run of 4 
min was programmed to re-establish the initial conditions. The flow rate and 
the column oven temperature were set at 1.5 mL/min and 30 ºC, 
respectively. Analyses were carried out by MS in single ion monitoring (SIM) 
mode after ionization in positive mode. Nitrogen was used as drying and 
nebulizing gas. The operating conditions of the ESI–Q were: flow rate and 
temperature of drying gas 10 mL/min and 350 ºC, respectively, nebulizer 
pressure 35 psi, capillary voltage 4000 V, dwell time 10 ms and delta EMV 
(potential of the electron multiplier) 700 V. The quantification ions and 
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quadrupole voltage for each carotenoid are shown in Table 1. The rest of 
carotenoids included under “Reagents and samples” were not found in 
tomato extracts. 
 
Table 1. Mass spectrometry parameters based on SIM for the analysis of 
carotenoids by LC–MS. 
Compound 
Quantitative ion 
(m/z) 
Filtering Q voltage 
(V) 
Violaxanthin 600.4 180 
Lutein 568.4 180 
Cryptoxanthin 552.8 220 
Lycopene 536.4/537.4 60 
β-Carotene 536.4 60 
 
 
2.5. Quantification of phenols and ascorbic acid by LC−MS/MS 
 
  Prior to LC/MS analysis of phenols, 100 µL of extract was 
evaporated to dryness and reconstituted into 100 µL of initial mobile phase, 
and 10 µL of the reconstituted extract was injected. Chromatographic 
separation was performed in 71 min, being the mobile phases A and B 0.4% 
formic acid in water and 50% acetonitrile–methanol, respectively. The flow 
rate and the column oven temperature were set at 1 mL/min and 25 ºC, 
respectively. The chromatographic program was as follows: the initial 
mobile phase was set at 4% of B, which was increased to 50% in 40 min and, 
then, to 60% B in 5 min. Finally, B was raised up to 100% in 3 min, and 
maintained 17 min. A re-equilibration step of 6 min was programmed after 
each chromatographic run. Analyses were carried out in selected reaction 
monitoring (SRM) after ionization in negative mode with nitrogen as drying 
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and nebulizing gas. The operating conditions of the ESI–QqQ, were as 
follows: flow rate and temperature of drying gas 10 mL/min and 325 ºC, 
respectively, nebulizer pressure 40 psi, capillary voltage 2700 V and dwell  
time 200 ms. The quantification transition and the operating conditions for 
each phenol are shown in Table 2.  
Table 2. Quantification ions and MS/MS operating parameters for analysis of 
phenols and ascorbic acid. 
 
2.6. Quantification of mono- and disaccharides by GC−MS/MS 
 
 Before GG–MS analysis, the target compounds were silylated, for 
which an 150-µL aliquot of extract was evaporated to dryness and 
Compound 
Precursor 
ion (m/z) 
Product 
ion (m/z) 
Fragmentor 
(V) 
Collision 
Energy (eV) 
Rutin 609 300 220 45 
609 151 220 52 
Myricetin 317 179 100 30 
317 151 100 30 
317 137 100 30 
Quercetin 301 151 100 30 
301 121 100 30 
301 107 100 30 
Quercetin 3-β-D glucoside 463 300 200 30 
Catechin 289 203 140 20 
289 123 140 30 
289 109 140 30 
Ferulic acid 193 178 120 15 
193 134 120 15 
p-Coumaric acid 163 119 80 15 
163 93 80 20 
Procatechuic acid 153 109 120 15 
Chlorogenic acid 353 191 100 10 
Caffeic acid 179 135 120 15 
Ascorbic acid 175 115 80 8 
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reconstituted in 150-µL of the derivatization solution, which consisted of 50-
µL pyridine, 98-µL BSTFA and 2-µL TMCS. The reaction mixture was 
vortexed at room temperature for 1 h, thus being ready for GC–MS analysis. 
As for the GC–MS conditions, the temperature program for the gas 
chromatographic separation started at 50 ºC, held for 2 min; then, a 
temperature gradient of 4 ºC/min to 300 ºC, and, finally, held for 10 min, as 
reported by Gómez-González et al. (2010). Therefore, the overall time for 
each chromatographic run was 74.5 min. Qualifiers and quantifiers for each 
compound were monitored in SRM mode using the conditions described in 
Table 3. 
 
Table 3. Working parameters of the GC–MS method used for the analysis of 
mono- and disaccharides. 
Compound 
Retention 
time (min) 
Quantifier 
ion (m/z) 
Excitation 
storage  
(m/z) 
Excitation 
amplitude 
(V) 
Qualifier  
ions (m/z) 
D-(-)-Arabinose 19.69 217 76.5 60 129, 143, 147 
D-(-)-Galactose 20.3 435 120 60 218, 305,331 
D-(+)-Mannose 22.85 204 71 50 149, 151, 163 
D-(-)-Fructose 23.29 437 120 60 229, 257, 345 
D-(+)-Glucose 24.83 204 71.8 50 143, 152, 163 
D-(+)-Sucrose 35.15 362 96 70 155, 183, 271 
 
3.  Results and Discussion 
 
3.1. Optimization of the ultrasound-assisted extraction 
 
 Solid–liquid extraction was selected in this research for sample 
preparation to isolate the compounds of interest. The extraction process was 
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assisted by ultrasound to enhance the leaching kinetics. Ultrasonic energy 
was chosen instead of microwaves as auxiliary energy to avoid a significant 
increase of temperature of the leaching medium that could promote analytes 
degradation. In fact, ultrasonic-assisted extraction is frequently referred as 
“cold extraction” because of the reduced effect of irradiation on the medium 
temperature. Optimization of the main variables involved in this step was 
carried out to ensure the precise and quantitative extraction of the target 
compounds. Prior leaching, tomato samples should be lyophilized since the 
water content in this fruit can reach levels from 90 to 95%. In this way, 
extraction efficiency can be expressed as dry weight and enzyme activity is 
minimized.  
Due to differences in polarity of the target compounds (from non-
polar character of carotenoids to polar character of ascorbic acid), the 
optimum leaching extractant composition was properly optimized to obtain 
the maximum leaching efficiency in a single extraction step. Mixtures of THF 
and methanol have been reported as suited extraction media for isolation of 
carotenoids from different types of food (Dias et al., 2010; Garrido-Frenich 
et al., 2005). Additionally, methanol seems to be one of the most efficient 
solvents for extraction of phenolic hydrophilic antioxidants from vegetable 
foods (García-Salas et al., 2010). Similarly, THF and ethanol–water mixtures 
have been used as leaching media prior to quantification of small organic 
carboxylic and dicarboxylic acids (oxalic, succinic, glycolic and malonic 
acids) (Dietzen et al., 1997) and water-soluble vitamins (Gentili et al., 2008), 
respectively. Therefore, THF–alcoholic mixtures should lead to quantitative 
extraction of ascorbic acid at normal concentrations in tomato. With these 
premises, THF–methanol mixtures within 25 and 90% were tested to 
evaluate the optimum composition for isolation of lipophilic and hydrophilic 
antioxidants from lyophilized tomato. As response variables, the 
concentrations of the different compounds monitored in this research 
grouped into families (phenols, carotenoids, carbohydrates and ascorbic 
acid, which was independently evaluated) were used. Two trends in 
extraction efficiency were observed which discriminated two groups of 
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compounds: on the one side, non-polar carotenoids and, on the other side, 
phenols and ascorbic acid. A statistical significant extraction of carotenoids 
was reported at THF concentrations above 75% (95% confidence level). 
However, higher concentrations of THF led to a decrease in extraction 
efficiency of phenols and ascorbic acid. For this reason, the extractant 
composition was set at 75:25 (v/v) THF–methanol.  
Apart from extractant composition, other optimized factors were the 
probe position (distance of the tip to the water-bath bottom) by immersion 
in the leaching medium, percent of ultrasound exposure or duty cycle 
(fraction of each second during which ultrasonic irradiation is applied), 
ultrasound amplitude and irradiation time. No statistical influence was 
observed for probe position (from 1 to 3 cm) and duty cycle (from 0.5 to 1.0 
s/s) on the extraction of antioxidants and sugars by comparison of total 
concentrations. The amplitude of ultrasound irradiation was significant for 
isolation of carotenoids affecting negatively to their stability. By contrast, 
there was no statistical significance of ultrasonic amplitude to extract 
phenols and sugars in the range studied (from 10 to 70% amplitude). 
Nevertheless, there was a positive effect of ultrasonic amplitude to extract 
sugars from 50% ultrasonic amplitude as compared to lower amplitudes. 
After evaluation of these results, a compromise solution was established by 
setting the amplitude at the maximum value without potential degradation 
of carotenoids, which was 30%.  
Under the compromised conditions (0.5 s/s duty cycle, 30% 
amplitude, probe position 1 cm from the bottom, 3:1 THF–methanol 
extractant), a kinetics study of the extraction of carotenoids was carried out. 
No degradation of carotenoids was observed up to 10 min extraction, when 
a slight degradation of lycopene and carotene was observed. For this reason, 
the sample was extracted for this period and three equal cycles were 
repeated to check leaching completion. Two cycles under the optimized 
conditions were required for quantitative extraction of the compounds of 
interest, which was visualized by tomato decoloration.  
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3.2.  Characterization of nutraceuticals in tomato  
 
 A panel of metabolites was used for quantitative analysis of 
nutraceutical compounds in tomato, the selection of which met the following 
criteria: (a) the compounds are known to be present in most of the tomato 
varieties according to the information gathered from the literature; (b) they 
are known to be involved in phytochemical properties of tomato, thus being 
of interest from a nutritional point of view; (c) they contribute to the 
antioxidant activity of tomato. Quantitation of compounds was supported in 
all cases by triplicate analysis. 
 
Carotenoids. The absence of stable product ions for carotenoids in tandem 
mass spectrometry justifies the optimization of an SIM method for their 
analysis. Calibration plots for quantification were run by using the peak area 
of the extracted ion chromatogram for each monitored ion as a function of 
the standard concentration. Calibration was performed with multistandard 
solutions at ten concentrations —between 30 ng/mL and 1000 µg/mL. The 
limits of detection (LODs), expressed as the mass of compound which gives a 
signal that is 3σ above the background noise signal (where σ is the standard 
deviation of the background noise signal) ranged between 0.01 and 0.05 
µg/g. The limit of quantification, expressed as the mass of compound which 
gives a signal 10σ above the background noise signal, was within 0.03 and 
0.16 µg/g. Table 4 shows the analytical features of the method for 
determination of carotenoids in tomato. 
 The method was applied to characterize the levels of carotenoids in 
tomato. For this purpose, the concentration of carotenoids in the extract was 
obtained by interpolation within the linear portion of the given calibration 
curve by triplicate experiments. Figure 1 shows the extracted ion 
chromatogram in SIM mode for the target carotenoids. Lycopene was clearly 
the most concentrated carotenoid in extracts from lyophilized tomato with a 
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concentration of 935 µg/g. This level is in agreement with other studies 
previously reported in the literature such as those developed by Olives et al. 
(2006), and Toor et al. (2005). At a second level, β-carotene, which is widely 
used as supplemental nutraceutical, was found at 29.0 µg/g. Although the 
lycopene-to-carotene ratio varies within tomato varieties, lycopene is found 
at considerably higher concentrations than carotene (Gómez-Romero et al., 
2007). Other quantified xanthophylls were violaxanthin, lutein and 
cryptoxanthin found at 7.3, 6.6 and 4.5 µg/g dry matter, respectively. Other 
studies, such as those carried out by Müller (1997) and Burns et al. (2003), 
have also reported representative concentrations of these xanthophylls in 
tomato extracts, although cryptoxanthin was only detected in tomato fruits 
obtained from plants cultivated in greenhouses.     
 
Hydrophilic phenols and ascorbic acid. At least two transitions from 
precursor to product ions were used for detection of hydrophilic 
antioxidants monitored in this research, except for quercetin-3-β-D-
glucoside, 3,4-dihydrobenzoic acid, chlorogenic acid, caffeic acid and 
ascorbic acid (Table 2), which were detected with only one transition. 
Similarly to lipophilic antioxidants, ten multistandards at concentrations 
ranging from 0.01 to 1000 µg/mL were used to run the calibration curves 
for quantification of hydrophilic antioxidants. By the same way, these 
analyses enabled to estimate LODs, which ranged from 13 to 312 ng/g. 
Concerning LOQs, they were from 40 to 1039 ng/g, setting the lower level of 
the calibration curve for each analyte. These results can be seen in Table 5, 
which lists the quantitation transition for each hydrophilic antioxidant 
together with quantitative parameters such as calibration curve, LODs and 
LOQs. Table 5 also includes the concentration of the hydrophilic antioxidants 
found in tomato extract expressed as dry weight taking into account that 
tomato was lyophilized. Figure 2 illustrates a chromatogram obtained by 
analysis of lyophilized tomato extract. Compounds are organized as 
flavonoids, phenolic acids and, finally, ascorbic acid representing a polar 
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vitamin. In fact, ascorbic acid was the unique non-phenol analysed in this 
method and, particularly, the most concentrated hydrophilic antioxidant 
detected, with a concentration above 1 mg/g dry weight. Lyophilization of 
the original sample allowed analysis of ascorbic acid in tomato extract with 
minimum degradation. Ascorbic acid concentration level found in this 
characterization emphasizes the nutraceutical properties of tomato based 
on the antioxidant capacity of this compound.  
 
 
Figure 1. Extracted ion chromatogram in single ion monitoring (SIM) mode for 
the target carotenoids from a tomato extract. 
 
The main phenolics detected in tomato extracts were flavonoids 
catechin, quercetin and a conjugated form of the latter such as rutin 
(quercetin-3-O-rutinoside), with concentrations ranging from 81.8 to 89.9 
µg/g dry weight; and phenolic acids such as chlorogenic acid at 119.1 µg/g 
and caffeic acid at 51.7 µg/g both expressed as dry weight. It is worth 
mentioning the relationship between chlorogenic acid and caffeic acid since 
the former is formed by esterification of acids caffeic and quinic (1,3,4,5-
tetrahydroxycyclohexanecarboxylic acid). These results are fairly consistent 
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with other studies previously reported in bibliography pointing out the 
relevance of rutin and chlorogenic acid as two of the most abundant phenols 
in different studied tomato species (Caris-Veyrat, et al., 2004; Martínez-
Valverde et al., 2002; Muir et al., 2001). In fact, most of the antioxidant 
activity of the phenolic fraction of tomato is ascribed to these two 
compounds (Bénard et al., 2009), which are mainly distributed in tomato 
peel tissue. Apart from caffeic acid, other hydroxycinnamic acids such as 
ferulic acid and p-coumaric acid were also detected in lyophilized tomato 
extracts although at lower concentrations than the other monitored phenolic 
acids. Similarly, other conjugated forms of quercetin, quercetin-3-β-D-
glucoside and myricetin were found at low concentrations as compared to 
rutin, quercetin and catechin. 
 
3.3 Characterization of sugars as compounds with organoleptical 
properties 
 
 The selection of highly-valuable sugars for their quantitative analysis 
was based on their contribution to tomato organoleptic properties, 
particularly to the sweetness and aroma, but also to their connection with 
the antioxidant activity of tomato (reducing sugars) and metabolism of 
vitamin C (mainly sucrose). Additionally, it is known that non-structural 
carbohydrates, among other solutes, act as osmoregulators and 
osmoprotectors of the tolerance response to abiotic stresses (Gómez-
González  et al., 2010).  Similarly to LC–MS analyses, calibration plots for GC–
MS determination of sugars were run by using the peak area of the standard 
as a function of standard concentration. Multistandard solutions at ten 
concentrations between 0.1 and 150 μg/mL were analysed after silylation by 
using the derivatization protocol previously described. The calibration 
equations and regression coefficients are shown in Table 6. 
   
Table 4. Quantitation of carotenoids in tomato extracts obtained under conditions described under “Experimental”. 
 
Table 5. Quantitation of hydrophilic antioxidants in tomato extracts obtained under the conditions described in the 
experimental section. 
Compound 
Quantitative 
transition (m/z) 
Concentration 
(µg/g mean, n =3) 
SD (%) Calibration curve 
Regression 
(R2) 
LOD 
(ng/g) 
LOQ 
(ng/g) 
Rutin 609  300 89.92 4.36 y= 18.21x – 1196.7 0.994 100 336 
Myricetin  317  179 1.24 3.95 y=1922.9x + 458.37 0.9998 46 154 
Quercetin  301  121 81.80 0.48 y=5936.7x + 335.12 0.9999 31  102 
Quercetin 3-β-D glucoside 463  300 10.33 0.15 y= 4.2x – 1935.7 0.9962 312 1039 
Catechin 289 203 83.26 4.16 y=  1023.2x + 520.83 0.9997 20 67  
Ferulic acid 193  134 19.24 5.00 y= 3490.7x – 576.5 0.9999 86 287 
p-Coumaric acid 163 119 11.35 1.68 y= 40.217x – 30.57 0.9981 58 193 
Procatechuic acid 153  109 6.40 5.83 y = 1522.3 x + 440.7 0.9997 13 44 
Chlorogenic acid 353  191 119.13 2.85 y= 25.3 x – 146.7 0.9999 66 219 
Caffeic acid 179  135 51.72 0.25 y= 17.21x – 1040.57 0.9993 52 173 
Ascorbic acid 175  115 1031 6.17 y= 25635.4x – 1482 0.9937 62 208 
Compound Calibration curve R2 LOD 
(µg/g) 
LOQ 
(µg/g) 
Concentration 
(µg/g) 
Standard 
deviation (%) 
Violaxanthin y= 155191x+ 6440.1 0.9987 0.01 0.03 7.3 2.10 
Lutein y = 7817.5x + 1884.2 0.9995 0.05 0.16 6.6 2.36 
Cryptoxanthin y=6243x + 29128 0.9959 0.01 0.03 4.5 3.12 
Lycopene y = 309832x + 2929.3 0.9931 0.01 0.03 935.2 4.38 
β-Carotene y = 120355x + 6464.7  0.9930 0.01 0.03 29.0 3.85 
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The LODs, expressed as for phenols, ranged between 0.06 and 1.2 μg/g. The 
LOQs, also expressed as for phenols, ranged between 0.2 and 4 μg/g. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Multiple reaction monitoring (MRM) chromatogram of phenols and 
ascorbic acid from a tomato extract. 
 
 Figure 3 shows the time segments for the identified compounds in 
SRM mode, reported by analysis of a tomato extract after silylation. Table 6 
shows the mean concentration value and the standard deviation for the 
target carbohydrates found in the pooled tomato by triplicate analysis. 
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Table 6. Features of the method and concentration of carbohydrates in tomato 
fruit. 
 
These ranged from 28.2 to 2020.6 µg/g dry weight and from 2.12 to 
5.95 %, respectively. As the table shows, the most abundant sugars were two 
monosaccharides: glucose (the primary photosynthetic product) and 
fructose, which are the main responsible for tomato sweet flavour and 
contribute significantly to osmotic adjustment (Handa et al., 1983). The 
fructose and glucose content is known to be strongly related to maturation 
state and growing (particularly to light exposure), ripening and storage 
conditions (Massot et al., 2010). In fact, the glucose-to-fructose ratio varies 
through fruit growth, being approximately two during the initial stages of 
development, but decreasing to less than unity when approaching to 
maturity (Massot et al., 2010). Sucrose is the less abundant sugar, also 
responsible for sweet flavor and with seasonal variation (Dumas et al., 
2003). Minor sugars (e.g. mannose, galactose and arabinose) were found at 
concentrations about tenfold lower than fructose and glucose. Variations in 
concentrations of some of these monosaccharides in tomato as a 
consequence of plant treatment have also been reported (Stakhova et al., 
2001). 
 
Compound Concentration 
(µg/g) 
Standard 
deviation 
(rsd,%) 
Calibration curve R² LOD 
(µg/g) 
LOQ 
(µg/g) 
Arabinose 72.0 2.79 y = 12012x + 8968 0.986 0.30 1 
Galactose 123.2 5.15 y = 1729x – 2925 0.997 0.30 1 
Mannose 267.8 3.92 y = 601.7x + 642,4 0.993 1.21 4 
Fructose 1519.6 5.95 y = 452.3x + 11432 0.968 0.12 0.4 
Glucose 2020.6 4.87 y = 1189.x + 11256 0.983 0.06 0.2 
Sucrose 28.2 2.12 y = 9578.x + 15524 0.967 0.06 0.2 
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Figure 3. Time segments in single reaction monitoring (SRM) obtained 
from the analysis of a tomato extract. 
 
4.  Conclusions 
 
 Quantitative analysis of nutraceutical valuable compounds present in 
tomato has been carried out. Firstly, an ultrasound-assisted solid–liquid 
extraction step was performed to leach the target compounds. Liquid 
chromatography−mass spectrometry was used for the quantitative analysis 
of phenols, carotenoids and ascorbic acid, while gas Chromatography–mass 
spectrometry was employed for the analysis of sugars. The sensitive and 
selective analysis by MS methodologies may give a representative insight of 
the nutraceutical potential of tomato to assess its nutritional value with 
possibilities of implementation in tomato breeding programs. 
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 La Parte 3 de la Memoria (Capítulos 9 y 10) abarca la investigación 
realizada en el ámbito de perfiles metabolómicos, estrategia que 
proporciona una información  global, no cuantitativa, de los metabolitos 
existentes en la muestra. Esta herramienta es la más adecuada para obtener 
una primera aproximación de la composición metabólica de muestras 
desconocidas o poco estudiadas, entre las cuales, y considerando los fluidos 
biológicos, se encuentran la saliva y la leche materna. Ambos fluidos 
biológicos están ganando interés por ser una fuente reconocida de 
potenciales biomarcadores de ciertas enfermedades, en el caso de la saliva, y 
por el valor nutricional en una etapa clave de desarrollo, en el caso de la 
leche materna. 
 La tarea primordial para obtener un perfil óptimo de muestras poco 
estudiadas es desarrollar un protocolo para su preparación que permita, 
tras la aplicación de la plataforma analítica correspondiente, obtener un 
perfil lo más rico posible en metabolitos. Esta tarea ha constituido la base de 
la investigación recogida en los Capítulos 9 y 10, dedicados a saliva y leche 
materna, respectivamente. Tras el desarrollo exhaustivo de los protocolos 
de preparación de la muestra, la utilización de la plataforma LC–TOF/MS en 
ambos casos (suplementada con la plataforma NMR en el caso de la leche) ha 
proporcionado unos excelentes perfiles de estas muestras, que ponen de 
manifiesto la calidad de los protocolos de preparación de muestra 
desarrollados. 
   
  
 
 
 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                                                                                               
                                                                                                                      
 
 
 Part 3 of this Thesis, which covers Chapters 9 and 10, deals with the 
research developed in global profiling of different types of biological 
samples. This analytical strategy provides global, non-quantitative 
information of the metabolites present in biological samples. This is of 
particular interest for exploring samples such as saliva and breastfeeding 
milk, taking into account the gap in the hitherto metabolomics studies of this 
biofluid, in contrast to the vast literature devoted to urine and blood 
metabolomics. Both biofluids are gaining special interest because of being a 
known source of potential biomarkers for certain diseases, in the case of 
human saliva, and the nutritional value in a key growing step for 
breastfeeding milk. 
 The main task for obtaining a reliable global profile is to develop a 
non-selective analytical protocol to cover the maximum number of 
metabolites. Therefore, the aim of the research in Chapters 9 and 10 was, on 
the one hand, to obtain a suitable sample preparation protocol for global 
profiling of saliva (Chapter 9) and human breast milk (Chapter 10) so as to 
achieve the maximum metabolite coverage, and, on the other hand, to apply 
the resulting method to obtain accurate identification of salivary and breast 
milk metabolites. LC–TOF/MS was used in both cases (together with NMR in 
the case of breast milk) providing complete profiles and ensuring that the 
proposed method complies the requisites for global profiling. 
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Human salivary metabolomics profiling by LC–TOF/MS 
in accuracy mode 
 
B. Álvarez-Sánchez*, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
 
 Saliva is a biological fluid produced in the salivary glands with a 
composition marked by a 99% of water and several minor components 
including electrolytes (mainly sodium, potassium, calcium, magnesium, 
bicarbonate, and phosphate salts), a variety of proteins such as 
immunoglobulins, hydrolases or mucins, and other low-molecular weight 
components such as urea and ammonia. Saliva has recently gained 
popularity as a potential tool for diagnosis and biomarkers monitoring. In 
fact, unlike blood drawing, saliva sampling is easy by virtue of its non–
invasiveness character and does not require health care personnel. In 
addition, saliva composition may potentially reflect plasma metabolite levels 
and, therefore, may be used as an indicator of the physiological state. The 
aim of the present study is to optimize the sample preparation protocol to 
obtain a metabolite profiling analysis of human saliva by Liquid 
Chromatography–Time-of-Flight/Mass Spectrometry (LC–TOF/MS) in high-
accuracy mode. Under the optimum sample preparation conditions, 
identification of potential molecular features was carried out. This resulted 
in 12 identified compounds in negative mode and 91 in positive mode with a 
mass tolerance window below 10 ppm from the acidic extract, whilst 13 in 
negative mode and 52 in positive were identified from the alkaline extract. 
Amino acids, sugars, lipids antioxidants and other potentially interesting 
biomarkers such as polyamines, vitamin B3, and ethylphosphate have 
been identified. This study covers the gap of knowledge about this 
biofluid and opens new possibilities for the selection of saliva as source 
of metabolite biomarkers representative of specific disorders.  
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1.  Introduction  
 
 Saliva is a biological fluid produced in salivary glands marked by a 
composition with 99% water and several minor components including 
electrolytes (mainly sodium, potassium, calcium, magnesium, bicarbonate, 
and phosphate salts), a variety of proteins (i.e. immunoglobulins, hydrolases 
or mucins), and other low-molecular weight components (i.e. urea and 
ammonia) [1]. These components carry out a variety of functions such as 
digestion, lubrication, buffering, cleansing, aggregation of microorganisms to 
form plaque, and acting as immune protective against exogenous pathogens 
[2]. Therefore, saliva is critical to preserve and maintain the health of oral 
tissues.  
 Saliva composition is affected by physiological, pathological, and 
environmental factors. Thus, mastication, food intake, nutritional changes, 
age [3], circadian and circannual variations [4], and medication intake [5] 
may cause changes in the flow and composition of saliva. These variations 
affect the metabolite profile and, therefore, make the readout obtained from 
its analysis unrealistic.  
 Saliva is gaining popularity as a complementary or a standalone 
sample for target analysis of certain biomarkers due to the fact that 
concentration of several metabolites directly reflects plasma levels. 
Moreover, unlike blood drawing, saliva sampling is non-invasive, more cost-
effective and does not require health personnel care. Therefore, saliva could 
be used to diagnose certain disorders, monitor the evolution of pathologies 
or to adjust the dosage of medicines [6,7]. On the other hand, saliva has been 
largely overlooked for metabolic profiling [8], with the exception of an 
extremely limited number of studies [9]. In fact, the human metabolome 
database (HMDB) does not include common salivary metabolites within its 
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data index [10]. Therefore, the study of the global profile of salivary 
constituents is justified.  
 In general terms, the final goal of metabolomics is to obtain a 
reproducible and reliable insight of the metabolite composition, either 
referred to a defined set of compounds (target analysis) or to the whole set 
of small-molecular weight metabolites (global metabolic profiling). In the 
latter, the main problem is the vast number of components and their wide 
variety in chemical properties [11]. The two main platforms used in 
metabolomics are nuclear magnetic resonance spectroscopy (NMR) and 
mass spectrometry (MS) [12]. NMR allows direct analysis of most types of 
samples, including tissues; allows the recovery of samples for further 
analyses, and provides detailed information on molecular structure [13]. 
However, NMR is characterized by a poor sensitivity as compared to mass 
spectrometry-based techniques, and spectra can be very difficult to interpret 
for complex mixtures as biological samples due to overlapping among 
metabolite signals [14−16]. On the other hand, mass spectrometry possesses 
high sensitivity and selectivity and accurate mass measurements thanks to 
recent improvements of mass analyzers. This technique, usually coupled 
with upstream separation methodologies like gas chromatography (GC) [17] 
or liquid chromatography (LC) enables unequivocal identification of 
compounds and structure elucidation of a large number of metabolites, 
providing extra information about the biochemical relationship between 
them [18]. 
 Despite these advances in analytical instrumentation, the major 
source of errors in metabolomics is still linked to sample preparation and 
the lack of optimized methods designed for each type of biological sample. In 
this sense, if a complete elucidation of the metabolome or, more realistically, 
the widening of the metabolite coverage is intended, the ideal sample 
preparation protocol should allow to cover the largest range of metabolites 
regardless their chemical characteristics and differences in concentration.  
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The aim of the present study was to optimize the analytical sample 
preparation protocol to obtain a metabolite profile by LC–Time-of-
Flight/Mass Spectrometry (LC–TOF/MS) of human saliva. Additionally, 
identification of the maximum number of extracted features or potential 
metabolic peaks is also addressed. The present study aims to cover the 
existing gap in metabolomics experiments devoted to saliva, which could be 
of interest in the study of saliva composition variability and identification of 
potential biomarkers as a biofluid complementary to serum. 
 
2.  Materials and methods  
 
2.1.  Reagents and samples 
 
 LC–MS grade acetonitrile, MS-grade formic acid (Scharlab, Barcelona, 
Spain) and deionized water (18 MΩ·cm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) were used in sample 
preparation and to prepare the chromatographic phases. Chloroform and 
methanol from Scharlab were used in the optimization of sample 
preparation.  
 Five volunteers were recruited to provide samples; no one of them 
referred any disease or health disorder and were not subjected to any drug 
treatment. These subjects ranged in age from 21 to 29 yrs (mean age ± 
standard deviation, 25.4±3 yr). Samples corresponded to a whole day, taken 
each six hours. Owing to the presence of food debris and solid matter, a 
previous centrifugation step was needed. This was performed at 12000 g for 
15 min, at 6 ºC. Then, samples were aliquoted in 2-mL Eppendorfs and 
stored at −20 ºC until analysis. For the optimization study, samples were 
pooled to a final volume of 1 mL and stored at −20 ºC. 
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2.2.  Instruments and apparatus 
 
 Ultrasonic irradiation was applied by a Branson 450 digital sonicator 
(20 kHz, 450 W) with tunable amplitude and duty cycle, equipped with a 
cylindrical titanium alloy probe (12.70 mm in diameter), which was directly 
immersed in the extraction beaker. Centrifugation was carried out with a 
thermostated centrifuge Thermo Sorvall Legend Micro 21 R from Thermo 
(Thermo Fisher Scientific, Bremen, Germany). A Vacufuge centrifugal 
vacuum concentrator  from Eppendorf (Eppendorf, Inc., Hamburg, 
Germany) was used to evaporate samples to dryness. 
 All samples were analyzed using a 1200 Series HPLC system (Agilent 
Technologies, Waldbronn, Germany) equipped with a binary pump, a 
degasser, a well plate autosampler, a thermostated column compartment, 
and coupled to an Agilent 6530 TOF/MS provided with Jetstream ESI source. 
 MassHunter Workstation Data acquisition software (Agilent 
Technologies) was used to control the instrument. Data were processed 
using MassHunter Qualitative Analysis software (Agilent Technologies). 
Extraction of unknown features from raw data was carried out with the 
Molecular Feature Extraction (MFE) algorithm in Mass Hunter Qualitative 
analysis software. Analyses were processed using MassHunter Qualitative 
software and compound identification was performed using the METLIN 
Personal Metabolite Database and Molecular Formula Generation software 
(Agilent Technologies). 
 
2.3. Sample preparation protocols 
 
 Different experimental protocols were compared in order to obtain 
the maximum metabolite coverage. On the one hand, hydrolysis of saliva 
could release metabolites from proteins and cells present in saliva. Thus, 
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two different hydrolysis conditions were tested, acidic and mild basic 
conditions, so as to compare the effect of pH. With this aim, 100-µL aliquots 
were mixed 1:1 with 0.1 M NaOH or HCl in water and vortexed at room 
temperature for 30 min, then, evaporated to dryness and reconstituted with 
mobile phase A. 
 On the other hand, it has been previously demonstrated that 
ultrasound (US) irradiation aids hydrolysis reactions [19,20], helping to 
release metabolites that are linked to proteins or other sample constituents, 
and making them amenable for subsequent LC–MS analysis. Therefore, US 
has been previously used with different types of biological samples, such as 
urine [21] and hair [22], increasing hydrolysis efficiency. Therefore, both 
acidic and basic hydrolysis protocols were repeated with US irradiation for 
which the tip of the US probe was immersed directly in a 5-mL vial 
containing, 2-mL saliva mixed with 2-mL 0.1 M NaOH or HCl. Conditions for 
US irradiation were: irradiation time, 10 min; 50% of total output amplitude, 
and 50% duty cycle. After hydrolysis, 100 µL of the resulting solution was 
evaporated to dryness and reconstituted in mobile phase A before injecting 
into the LC–MS analyzer. Finally, a preconcentration step (3:1) was carried 
out in order to increase the overall coverage. 
 
2.4.  Liquid Chromatography–Mass Spectrometry 
 
 Chromatographic separation was carried out with a Zorbax Eclipse 
XDB-C18 column (4.6x150 mm, 5 µm particle size). 10 µL of sample was 
injected in each chromatographic run. Mobile phases, delivered at 1 
mL/min, consisted of 0.1% formic acid either in water (A) or in acetonitrile 
(B). The chromatographic gradient was as follows: 2% B  5 min followed by 
a gradient to 100% B in 55 min and an isocratic step at 100% B for 10 min.  
The ESI Jetstream source operated in positive and negative 
ionization, using the following conditions: needle voltage set at +/− 4 kV, 
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nebulizer gas at 40 psig, drying and sheath gas flow rate and temperature at, 
8 and 11 L/min and 325 and 350 ºC, respectively.  
 Data were acquired in both centroid and profile mode at a rate of 1 
spectrum per s in the extended dynamic range mode (2 GHz). The mass 
range and detection window were set at m/z 100–1100 and 100 ppm, 
respectively. Reference mass correction on each sample was performed with 
a continuous infusion of agilent tof biopolymer analysis mixture containing 
purine (m/z 121.0508) and hexamethoxyphosphazyne (m/z 322.0481) with 
resolution of 45 000.  
 
2.5.  MS data processing 
 
 Once the samples were analyzed by LC–MS, data were extracted into 
features and the calculated neutral mass was used to calculate the molecular 
formula by the Molecular Formula Generator Software. Features extraction 
was based on the molecular feature extraction algorithm (MFE), that locates 
and groups all ions related to a same neutral molecule. This relation is 
referred as to the covariance of peaks within the same chromatographic 
retention time, the charge-state envelope, isotopic distribution, and/or the 
presence of adducts and dimers. The MFE took all ions exceeding 500 counts 
into account, with charge state limited to a maximum of two and a peak 
spacing tolerance of 0.0025 m/z (plus 7 ppm). Each feature was given by a 
minimum of two ions. The extraction algorithm was based on a common 
organic model with chromatographic separation. The allowed positive ions 
were protonated species and sodium, potassium, formic acid and 
acetonitrile adducts, and the negative ions formed by formate adducts and 
proton losses. Dehydratation neutral losses were also allowed.  
 Molecular formulas were generated using the Molecular Formula 
Generator algorithm. Both mass accuracy and isotope information 
(abundance and spacing) were considered to limit the number of hits. Only 
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the common elements C, H, N, O, P and S were considered in the generation 
of formulas. The calculated neutral mass of each feature was queried against 
the METLIN database [23] for matching to compounds within mass 
tolerance window of a maximum of 10 ppm. The METLIN database matched 
the neutral mass to the monoisotopic mass value calculated from the 
empirical formula of compounds in the database. Identified compounds 
were eventually contrasted against the Human Metabolome Database 
(HMDB) [24] to confirm their occurrence in humans. 
 
3.  Results and discussion 
 
3.1.  Comparison of acidic and basic hydrolysis  
 
 In a first approach, the saliva pool was directly analysed by LC–
TOF/MS in positive and negative ionization modes after reconstitution in the 
chromatographic mobile phase A. This analysis enabled the detection of 5 
and 40 potential molecular features in negative and positive ionization 
modes, respectively. This low-detection capability could be ascribed to the 
need for optimizing sample treatment that would expectedly improve 
metabolite coverage. With this regard, different steps encompassing 
hydrolysis and preconcentration were tested. 
 It is well-known that acidic natural pH of saliva has the role of 
helping to hydrolyze nutrients such as sugars, which are usually forming 
polymers, as a first step of food digestion. In addition, certain metabolites 
bonded to proteins, acting as cofactors or as a result of posttranslational 
modifications, would be released after suited hydrolysis. On the other hand, 
hydrolysis is a common procedure in drug analysis as it leads to the release 
of the target species bounded to polar compounds to increase their polarity 
and facilitate their excretion, for instance, as glucuronide-linked compounds. 
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In this sense, hydrolysis is a common step in preparation of biological 
samples. Therefore, a hydrolysis study was planned with the aim of 
increasing metabolite coverage. 
 Both acidic and basic hydrolysis reactions were tested in order to 
maximize metabolite identification in saliva. The protocol selected for this 
study was based on the incubation of 100-µL saliva aliquots in 1:1 
proportion with 0.1 M NaOH or HCl aqueous solution at room temperature 
for 30 min. The resulting solutions were evaporated and reconstituted in 
mobile phase A as a preconcentration step prior chromatographic analysis. 
Acidic hydrolysis led to a total of 48 and 74 molecular features in negative 
and positive ionization modes, respectively; while basic hydrolysis provided 
27 and 80 features in negative and positive, respectively. The results from 
both types of hydrolysis were compared with those from the protocol non-
based on hydrolysis (5 and 40 features obtained in negative and positive 
ionization). Results from this study were used to build the Venn diagram, 
shown in Figure 1(A) (negative ionization) and (B) (positive ionization) to 
compare the metabolites profile of both approaches. As can be seen, 4 
common features for all the experiments were obtained in negative mode, 
while basic and acidic hydrolysis provided 23 and 44 unique features. 
 The number of common features (23) is higher in positive 
experiments, while the number of new features with respect to the non-
hydrolyzed sample is greatly enhanced, giving 47 and 55 features ascribed 
to hydrolysis. Thus, the implementation of a hydrolysis step is justified to 
increase the metabolite coverage. Attending to these results, the 
identification capability could be increased with a dual analysis involving 
hydrolysis both in acid and alkaline media. 
 
3.2.  Ultrasound assisted hydrolysis 
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 As previously stated, the use of auxiliary energies to enhance 
hydrolysis reactions in biological samples is gaining popularity, as the 
reaction kinetics are considerably enhanced. In this study, the aim was to 
evaluate the incidence of ultrasound assistance to the hydrolysis process in 
terms of number of metabolites identified. Thus, both hydrolysis protocols 
(acid and basic hydrolysis) were tested by application of US energy under 
moderate irradiation conditions (10 min, 50% of total output amplitude and 
50% duty cycle). 
(A)                                                                 (B) 
 
 
 
 
 
 
 
 
 
 
  
 Results obtained from this study in positive mode are shown in 
Figure 2.  While US energy does not have any impact on the number of 
detected features in negative ionization, these is a considerably increase of 
detected features in both acidic and basic hydrolyses in positive mode. Thus, 
US-assisted hydrolysis led to 38 unique features in basic hydrolysis, in 
contrast to 16 entities obtained from the hydrolysis without US assistance 
(A). On the other hand, 36 and 11 unique features were obtained in acidic 
Figure 1. Venn diagram of the extracted features from the analysis of 100-µL 
saliva after basic and acidic hydrolysis as compared with a non-hydrolyzed 
sample:(A) negative ionization;(B) positive ionization. 
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hydrolysis with and without US assistance, respectively (B). With these 
results, US-assistance reduces the hydrolysis processing time, but apart 
from that, increases the metabolites coverage.  
(A)                (B) 
 
Figure 2. Venn diagram of features obtained from the analysis of 100-µL saliva 
after ultrasound-assisted hydrolysis reactions (basic and acidic) as compared 
with a non-hydrolyzed sample. (A): negative ionization, (B): positive 
ionization. 
 
 Therefore, its implementation for characterization of saliva 
metabolome is of great interest. Figure 3 shows the total compound 
chromatogram obtained with US-assisted basic (black line) and acidic (grey 
line) hydrolysis in positive mode showing a considerably higher number of 
unique peaks in the acidic hydrolysis in the first 14 mins of the 
chromatogram.   
 
3.3.  Preconcentration 
 When compared with other biological fluids, the number of detected 
features from saliva is relatively small, which can be due to the low 
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concentration at which the target compounds are present (99% of saliva 
composition is water). These low levels make necessary to include a 
preconcentration step. For this reason, the US-assisted hydrolysate was 
preconcentrated in a 4:1 initial–final ratio. This resulted in an increase to 
174 molecular features in positive and 84 in negative mode for acidic 
hydrolysis and to 150 and 70 for basic hydrolysis. Identification was done 
with the features extracted from these experiments, the sample preparation 
conditions of which were proved to be the optimum.  
 
Figure 3. Total ion chromatogram obtained with an acidic (grey) and basic 
(black) hydrolysate from saliva in positive ionization mode. 
 
3.4.  Identification of features 
 
  In order to elucidate the salivary metabolome, a final identification 
step was carried out for which the extracted features were queried against 
the METLIN database, which includes endogenous metabolites found in 
plasma besides common human drugs and their metabolites. Finally, further 
identification of the resulting features was done by searching in the HMDB 
by comparing the experimental base peak mass against the M+H or M–H 
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peaks as well as other adducts from the database. The HMDB database, that 
includes over 7900 metabolites found in human biofluids and tissues 
according to literature results, does not include information about salivary 
composition. This complicates interpretation of the results obtained in the 
present research. In addition, it is a major issue to distinguish between 
metabolites from food intake or resulting from endogenous salivary 
compounds. 
 The results of the database search are summarized in Tables 1-to-4, 
which include the molecular formula, the detected adduct mass, matching 
tolerance, and the numeric reference in HMDB. A total of 12 compounds in 
negative mode and 91 in positive mode with a mass tolerance window 
below 10 ppm were found from the acidic extract, whilst 13 in negative 
mode and 52 in positive were identified from the alkaline extract.  
 Among the identified metabolites, sugars, hormones, lipids, amino 
acids, antioxidants and other minor components were identified. The 
occurrence of these compounds in saliva is further discussed here. 
 
3.4.1. Sugars  
 Various chromatographic peaks corresponding to C6H12O6 
compounds were found in chromatograms from both experiments, which 
might correspond to the isomers D-fructose, D-galactose, D-glucose, D-
mannose, scyllitol or myoinositol. Salivary sugars are highly related to caries 
and teeth demineralization. Thus, sugars provide substrate for the actions of 
oral bacteria, lowering plaque and salivary pH, resulting in teeth 
demineralization [25]. In previous studies, galactose, glucose, mannose, 
fucose, glucosamine and galactosamine have been found in human saliva 
[26]. Besides sugars, the sweetener aspartame has been detected; this is an 
artificial, non-carbohydrate additive in foods and beverages chemically 
formed by esterification of the amino acids aspartic acid and phenylalanine. 
Disaccharides such as sucrose and lactose, maltose or the synthetic 
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sweetener aspartame, which are likely to be obtained from food, were also 
found in the acidic extract. 
 
3.4.2. Lipids 
 Among the lipids present in saliva, the arachidonic acid derivatives 
11-hydroxyeicosatetraenoate glyceryl ester (11(R)-HETE) 12-hydroxy-
heptadecatrienoate glyceryl ester (12(S)-HHTrE) and 2-(14,15-epoxy-
eicosatrienoyl) glycerol  and derivatives from HEPE, KETE and EpETE, were 
identified. 11(R)-HETE is produced from arachidonic acid by two 
cyclooxygenases, while 12(S)-HHTrE is one of the primary arachidonic acid 
metabolites of the human platelets. Presence of these compounds in saliva 
has not been previously reported and their biological role is uncertain. On 
the other hand, an amide of the fatty acid oleic acid, oleamide, was found. It 
is an endogenous substance that accumulates in the cerebrospinal fluid 
during sleep deprivation [27].  
 Presence of phospholipids in saliva has also been previously 
reported [28]. Two groups of phospholipids, glycerophosphoethanolamines 
and glycerophosphocholines, have been detected in this study. In 
glycerophosphocholines (PC), phosphorylcholine moiety occupies a glycerol 
substitution site, while in phosphatidylethanolamine (PE) it is occupied by 
phosphorylethanolamine. Many different combinations are possible, with 
fatty acids of varying lengths and saturation attached at the C-1 and C-2 
positions of glycerol. Fatty acids containing 16, 18 and 20 carbons are the 
commonest. This wide variety lead to a great number of isomers with 
identical molecular weight that cannot be distinguished by single-stage mass 
spectrometry: some possible candidates are listed in Tables 1−4.  
 Other remarkable group of identified lipids is that formed by 
estrogens. Thus, 6-ketoestriol, estrone glucuronide, 16-oxoestrone, estrone 
3,4- (or 2,3-) quinine, estradiol, and 17-ethynylestradiol were detected. 
Saliva has proved to be an excellent biofluid for estrogens monitoring [7]. It 
 333 
Sent to Journal of Chromatography A Chapter 9 
is even preferred to blood due to the fact that most blood hormones 
(approximately 95%) are protein-bounded. By contrast, saliva contains a 
majority of free hormones that can be easily measured. As an example, saliva 
has been used for more than 30 years for monitoring estrogens changes 
throughout menstrual cycle to assess fertility. Actually, it has been 
demonstrated that human saliva shows cyclic variation in its composition 
during the menstrual cycle. Concretely, estradiol and its conjugated 
metabolites are found at high levels in women during their reproductive 
years [29,30]. Prediction of premature birth can also be detected through 
salivary estradiol measurement, a test approved by the FDA (Food and Drug 
Administration). Additionally, it is known that hormonal changes can lead to 
systemic disorders such as, diabetes mellitus, cancer or Cushing's syndrome 
[31].  
 Finally, cortisol and its derivatives 18-hydroxycorticosterone and 
derivative 18-hydroxycortisol was also detected. While this compound has 
not been previously found in urine, salivary cortisol has proved to be an 
excellent indicator of the plasma cortisol concentration, which is a 
biomarker for changes in adrenal function [32].  
 
3.4.3. Amino acids 
The free amino acids, arginine, carnitine, leucine and proline, were 
identified. It is well known that free amino acids are present in human saliva 
at relatively low concentrations (10− 6–10− 5 M ) [33]. The role and source of 
salivary free amino acids are only partially known. Some of them are known 
to be involved in the metabolism of microorganisms and protein 
decomposition processes. Their contribution to inflammatory periodontal 
disease has also been suggested [34].  
 Amino acid metabolism products, such as phenylpyruvic acid, enol-
phenylpyruvate, 3-dehydroxycarnitine, methylglutarylcarnitine, propyionyl 
carnitine and L-acetylcarnitine have also been identified. Phenylpyruvic acid 
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is a keto-acid produced by oral bacteria, mainly by B. gingivalis, B. 
endodontalis and B. loescheii. Thus, phenylpyruvic acid may be used as 
biomarker for amino acid metabolic activity of oral bacteria. On the other 
hand, propionylcarnitine, L-acetylcarnitine and dehydoroxycarnitnine are 
acylcarnitines, produced from fatty acids oxidation to produce energy. Thus, 
acylcarnitines may be used as markers of energy balance, exercise intensity 
and fat utilization. Acylcarnitines also provide valuable information for the 
study, diagnosis and understanding of metabolic disorders, myopathies, 
congestive heart failure and end stage of renal disease. Though no 
previously been reported in saliva, high levels of propionylcarnitine in urine 
are found in patients with methylmalonyl-CoA mutase (MUT) deficiency 
[35].  
 
3.4.4. Antioxidants 
 Other interesting group of compounds detected in saliva is that 
formed by antioxidants, which are likely to be obtained from diet. 
Antioxidants are believed to reduce the risk of certain diseases by reacting 
with free radicals, which are involved in the development of a wide variety 
of diseases, including cancer, stroke, chronic inflammation and rheumatism. 
Among them, alkaloids caffeine, theobromine, theophylline, paraxanthine, 3-
hydroxyphenylacetic acid, hydroxicinnamic acid, benzoic acid and uric acid 
were identified. Alkaloids are the most widely consumed psychostimulants 
in the world, mainly from tea and coffee. Furthermore, hydroxicynnamic 
acids can be found in a wide variety of edible plants such as peanuts, 
tomatoes, carrots, and garlic, and are also used in flavours, perfumes and 
pharmaceuticals. Benzoic acid occurs naturally free and bound as benzoic 
acid esters in many plant and animal species. Benzoic acid is a fungistatic 
compound widely used as a food preservative. 3-Hydroxyphenylacetic is a 
rutin metabolite that also exhibits antioxidant activity. In addition, it is an 
intermediate in the pathway of tyrosine metabolism. Vanillin is a catabolic 
product of ferulic acid degradation. Like many polyphenols found in plants, 
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vanillin has antioxidant and anti-tumor activities [24]. Uric acid is one of the 
most important antioxidants in saliva, and its levels in human saliva are 
related to those in blood. Interestingly, quantification of uric acid in saliva 
has been used as a biomarker of gout [36].  
 
3.4.5. Other compounds found in saliva  
 It is also worth noting the presence of aliphatic polyamines spermine 
(SP), spermidine (SPD), spermic acid and N-acetylcadaverine, traditionally 
associated with bad breath. These compounds also play an important role as 
cofactors in several biochemical processes associated with cellular activities 
and proliferation. Since the presence of polyamines in buccodental fluids has 
been well established, it is conceivable that their levels could increase in 
several pathological proliferative processes. Thus, their quantification have 
been reported as a tool for monitoring pathologies of oral cavity tissues 
associated with an intense metabolic activity, such as gingival hypertrophy 
or tumors of the maxillofacial area [37].  
 Niacinamide or vitamin B3 can be used as biomarker of pellagra. 
Ethyl phosphate was also found, which has been suggested as alcohol 
consumption biomarker in saliva, urine and serum [38]. Proline betaine is an 
osmoprotective compound and antibacterial compound found in urine. It is 
thought to serve as osmoprotective role for the kidney. Proline betaine is a 
glycine betaine analogue found in many citrus foods. Elevated levels of 
proline betaine in human urine are found after consumption of citrus fruits 
and juices [25]. Other potential biomarkers such as creatine, and nicotine 
glucuronide (an excretion product of nicotine) were also identified. 
 
4. Conclusions  
 Different sample preparation protocols have been compared for 
global metabolomics profiling analysis of saliva. Although saliva is scarcely 
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used in metabolomics studies, its potential for discriminating between 
metabolic profiles correlated with different pathologies and for monitoring 
changes induced by diet would makes this biofluid worth exploring. Among 
the protocols tested, hydrolysis (both basic and acidic) of saliva was found to 
be a suited strategy to maximize the number of detected features. In 
addition, ultrasound energy was used to enhance hydrolysis with an 
associated effect of increased metabolite coverage. Finally, a 
preconcentration step was carried out to attain an extra level of 
identification. Once the optimum sample preparation conditions were 
optimized, the resulting features were identified by querying against the 
HMDB. A total of 12 compounds in negative mode and 91 in positive mode 
with a mass tolerance window below 10 ppm were found from the acidic 
extract, whilst 13 in negative mode and 52 in positive were identified from 
the alkaline extract. Amino acids, sugars, lipids antioxidants and other 
potentially interesting biomarkers such as polyamines vitamin B3 and 
ethylphosphate were identified. This study covers the gap of knowledge 
about this biofluid and opens new possibilities to the use of saliva for 
biomarkers discovery and monitoring. The limited number of studies 
with saliva is reflected by the absence of databases and the limited 
bibliography, only target analyses have been addressed to date. By 
contrast, this global profiling approach aims to complete the current 
knowledge of the human metabolome. 
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Table 1. Identification of metabolites in saliva after acidic hydrolysis (negative ionization) 
 
 
 
HMDB ID Common Name 
Chemical 
Formula 
Theoretical 
adduct m/z 
Experimental error 
(mass units) 
Adduct 
Accuracy 
error (ppm) 
HMDB12942 Estrone-3,4-quinone C18H20O3 285.1484 0.001404 M+H [1+] 4.923 
HMDB12535 12S-HHT C17H27O3 280.2032 0.001587 M+H [1+] 5.663 
HMDB00372 16-Oxoestrone C18H20O3 285.1484 0.001404 M+H [1+] 4.923 
HMDB01926 17a-Ethynylestradiol C20H24O2 297.1788 0.00116 M+H [1+] 3.903 
HMDB00418 18-Hydroxycortisol C21H30O6 379.2115 0.002502 M+H [1+] 6.597 
HMDB13651 2-(14,15-Epoxyeicosatrienoyl) Glycerol C23H38O5 395.2791 0.001678 M+H [1+] 4.245 
HMDB02641 2-Hydroxycinnamic acid C9H8O3 165.0546 0.000122 M+H [1+] 0.739 
HMDB06831 3-Dehydroxycarnitine C7H15NO2 146.1175 0.000061 M+H [1+] 0.417 
HMDB ID Common Name 
Chemical 
Formula 
Theoretical 
adduct m/z 
Experimental 
error (mass units) 
Adduct 
Accuracy 
error (ppm) 
HMDB00300 Uracil C4H4N2O2 195.087646 0.000061 M+2ACN+H [1+] 0.312 
HMDB00718 Valeric acid C5H10O2 144.101898 0.000092 M+ACN+H [1+] 0.638 
HMDB13128 Valerylcarnitine C12H23NO4 144.101898 0.000092 M+ACN+2H [2+] 0.638 
HMDB00378 2-Methylbutyroylcarnitine C12H23NO4 144.101898 0.000092 M+ACN+2H [2+] 0.638 
HMDB02923 Isomaltose C12H22O11 170.050827 0.00148 M-2H [2-] 8.703 
HMDB00740 Lactulose C12H22O11 170.050827 0.00148 M-2H [2-] 8.703 
HMDB00258 Sucrose C12H22O11 170.050827 0.00148 M-2H [2-] 8.703 
HMDB11595 Lactosylceramide (d18:1/24:0) C54H103NO13 954.724548 0.001038 M-H20-H [1-] 1.087 
HMDB00319 18-Hydroxycorticosterone C21H30O5 383.183990 0.001221 M+Na-2H [1-] 3.186 
HMDB06758 17a,21-Dihydroxy-5b-pregnane-3,11,20-trione C21H30O5 383.183990 0.001221 M+Na-2H [1-] 3.186 
HMDB00063 Cortisol C21H30O5 383.183990 0.001221 M+Na-2H [1-] 3.186 
HMDB03441 Cinnamaldehyde C9H8O 167.026917 0.000687 M+Cl [1-] 4.113 
Table 2. Identification of metabolites in saliva after acidic hydrolysis (positive ionization) 
 
  
 
 
 
HMDB02035 4-Hydroxycinnamic acid C9H8O3 165.0546 0.000122 M+H [1+] 0.739 
HMDB00530 6-Ketoestriol C18H22O4 303.1521 0.000305 M+H [1+] 1.009 
HMDB01894 Aspartame C14H18N2O5 295.123 0.001404 M+H [1+] 4.773 
HMDB01870 Benzoic acid C7H6O2 123.0440 0.000061 M+H [1+] 0.417 
HMDB03449 Beta-D-Galactose C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB00516 Beta-D-Glucose C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB01847 Caffeine C8H10N4O2 195.0876 0.000137 M+H [1+] 0.702 
HMDB00660 D-Fructose C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB00143 D-Galactose C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB00122 D-Glucose C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB00169 D-Mannose C6H12O6 181.0706 0.001434 M+H [1+] 6.826 
HMDB12225 Enol-phenylpyruvate C9H8O3 165.0546 0.000122 M+H [1+] 0.739 
HMDB00068 Epinephrine C9H13NO3 184.0891 0.000443 M+H [1+] 2,419 
HMDB04483 Estrone glucuronide C24H30O8 447.1941 0.000031 M+H [1+] 0,069 
HMDB12228 Ethylphosphate C2H7O4P 127.0081 0.000092 M+H [1+] 0.730 
HMDB02497 Glycochenodeoxycholate-3-sulfate C26H43NO8S 530.2781 0.00061 M+H [1+] 1.150 
HMDB00201 L-Acetylcarnitine C9H17NO4 204.1230 0.000229 M+H [1+] 2.869 
HMDB03416 L-Arginine C6H14N4O2 175.1189 0.000153 M+H [1+] 0.873 
HMDB00062 L-Carnitine C7H15NO3 162.1124 0.001602 M+H [1+] 9.943 
HMDB00687 L-Leucine C6H13NO2 132.1019 0.000793 M+H [1+] 6.002 
HMDB00162 L-Proline C5H9NO2 116.0706 0.000893 M+H [1+] 7.693 
HMDB00158 L-Tyrosine C9H11NO3 182.0811 0.001404 M+H [1+] 7.753 
HMDB13133 Methylglutarylcarnitine C11H19NO6 262.1285 0.000793 M+H [1+] 3.025 
HMDB00211 Myoinositol C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB02496 
N-[(3a,5b,7a)-3-hydroxy-24-oxo-7-
(sulfooxy)cholan-24-yl]-Glycine 
C26H43NO8S 530.2781 0.00061 M+H [1+] 1.150 
HMDB02284 N-Acetylcadaverine C7H16N2O 145.1335 0,000854 M+H [1+] 5.884 
HMDB01406 Niacinamide C6H6N2O 123.0552 0.000008 M+H [1+] 0.065 
    
HMDB02117 Oleamide C18H35NO 282.2791 0.002472 M+H [1+] 8.757 
HMDB01860 Paraxanthine C7H8N4O2 181.0720 0.000214 M+H [1+] 0.564 
HMDB07885 PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)) C42H74NO8P 752.5224 0.005737 M+H [1+] 7.623 
HMDB08427 PC(x:a/y:b) C42H74NO8P 752.5224 0.005737 M+H [1+] 7.623 
HMDB11273 PC(P-18:1(11Z)/16:1(9Z)) C42H80NO7P 742.5745 0.003906 M+H [1+] 5.332 
HMDB00205 Phenylpyruvic acid C9H8O3 165.0546 0.000122 M+H [1+] 0.739 
HMDB00020 p-Hydroxyphenylacetic acid C8H8O3 153.0546 0.000031 M+H [1+] 0.202 
HMDB04827 Proline betaine C7H13NO2 144.1019 0.000015 M+H [1+] 0.104 
HMDB00824 Propionylcarnitine C10H19NO4 218.1386 0.001892 M+H [1+] 8.673 
HMDB06088 Scyllitol C6H12O6 181.0706 0.001236 M+H [1+] 6.826 
HMDB13075 Spermic acid C10H20N2O4 233.1495 0.001221 M+H [1+] 5.525 
HMDB01257 Spermidine C7H19N3 146.1651 0.001022 M+H [1+] 6.992 
HMDB01256 Spermine C10H26N4 203.2230 0.001175 M+H [1+] 5.781 
HMDB02825 Theobromine C7H8N4O2 181.0720 0.000107 M+H [1+] 0.590 
HMDB01889 Theophylline C7H8N4O2 181.0720 0.000107 M+H [1+] 0.590 
HMDB00289 Uric acid C5H4N4O3 169.0356 0.000107 M+H [1+] 0.633 
HMDB12308 Vanillin C8H8O3 153.0546 0.000153 M+H [1+] 0.202 
HMDB04883 Trihexosylceramide (d18:1/24:1(15Z)) C60H111NO18 576.4106 0.000061 M+H+NH4 [2+] 0.105 
HMDB10326 Thyroxine glucuronide C21H19I4NO10 488.3576 0.000244 M+H+Na [2+] 0.499 
HMDB13208 9-Hexadecenoylcholine C21H42NO2 363.3107 0.000305 M+Na [1+] 0.839 
HMDB13582 PGP(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)) C42H74O13P2 425.2374 0.000519 M+2H [2+] 1.220 
HMDB13567 PGP(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)) C42H74O13P2 425.2374 0.000519 M+2H [2+] 1.220 
HMDB13553 PGP(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) C42H74O13P2 425.2374 0.000519 M+2H [2+] 1.220 
HMDB13497 PGP(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) C42H74O13P2 425.2374 0.000519 M+2H [2+] 1.220 
HMDB00064 Creatine C4H9N3O2 195.0852 0.00116 M+ACN+Na [1+] 5.946 
HMDB13222 Beta-Guanidinopropionic acid C4H9N3O2 195.0852 0.00116 M+ACN+Na [1+] 5.946 
HMDB00300 Uracil C4H4N2O2 195.0876 0.001251 M+2ACN+H [1+] 6.410 
HMDB06027 Oxymesterone C20H30O3 664.4620 0.001282 2M+3H2O+2H [2+] 1.929 
  
 
 
 
HMDB08236 PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB08235 PC(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB08204 PC(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB08171 PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB08141 PC(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB08140 PC(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) C44H78NO8P 452.3203 0.001465 M+3ACN+2H [2+] 3.238 
HMDB12230 Gamma-glutamyl-L-putrescine C9H19N3O3 452.3190 0.002716 2M+NH4 [1+] 6.073 
HMDB06478 Iso-Valeraldehyde C5H10O 104.1069 0.000114 M+NH4 [1+] 1.095 
HMDB01272 Nicotine glucuronide C16H22N2O6 181.0721 0.000244 M+H+Na [2+] 1.347 
HMDB00826 Pentadecanoic acid C15H30O2 144.1015 0.000305 M+2Na [2+] 2.116 
HMDB01786 Ethenodeoxyadenosine C12H13N5O3 578.2268 0.000305 2M+3H2O+2H [2+] 5.274 
HMDB10326 Thyroxine glucuronide C21H19I4NO10 488.3576 0.000427 M+H+Na [2+] 0.874 
HMDB02212 Arachidic acid C20H40O2 330.3366 0.000549 M+NH4 [1+] 1.661 
HMDB10217 5-KETE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB10212 17,18-EpETE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB10210 15-KETE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB10209 15-HEPE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB10205 14,15-EpETE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB10202 12-HEPE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB05081 5-HEPE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB13633 12-KETE C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB01337 Leukotriene A4 C20H30O3 664.4620 0.00061 2M+3H2O+2H [2+] 0.918 
HMDB04029 11-Dehydrocorticosterone C21H28O4 195.0885 0.000885 M+2Na [2+] 4.536 
HMDB00700 Hydroxypropionic acid C3H6O3 181.0706 0.001236 2M+H [1+] 6.826 
HMDB00429 17a-Estradiol C18H24O2 295.1668 0.001678 M+Na [1+] 5.684 
 
 
 
 
    
Table 3. Identification of metabolites in saliva after basic hydrolysis (negative ionization) 
 
HMDB ID Common Name Chemical Formula 
Theoretical 
adduct m/z 
Adduct 
Experimental error 
(mass units)  
Accuracy 
error (ppm) 
HMDB12135 1-(3-Aminopropyl)-4-aminobutanal C7H16N2O 125.1079 M-H20-H [1-] 0.0004 3.357 
HMDB11768 Cer(d18:0/24:0) C42H85NO3 686.6224 M+Cl [1-] 0.0037 5.422 
HMDB11839 Ganglioside GD2 (d18:0/16:0) C77H137N3O34 548.2955 M-3H [3-] 0.0032 5.900 
HMDB12252 Linoleoyl ethanolamide C20H37NO2 358.2518 M+Cl [1-] 0.0027 7.430 
HMDB11514 LysoPE(20:3(11Z,14Z,17Z)/0:0) C25H46NO7P 548.2994 M+FA-H [1-] 0.0036 6.567 
HMDB11515 LysoPE(20:3(5Z,8Z,11Z)/0:0) C25H46NO7P 548.2994 M+FA-H [1-] 0.0036 6.567 
HMDB02284 N-Acetylcadaverine C7H16N2O 125.1079 M-H20-H [1-] 0.0004 3.357 
HMDB13561 PGP(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) C46H76O13P2 298.4848 M-3H [3-] 0.0021 7.179 
HMDB13574 PGP(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) C46H76O13P2 298.4848 M-3H [3-] 0.0028 9.524 
HMDB12342 PS(14:1(9Z)/14:1(9Z)) C34H62NO10P 710.3806 M+Cl [1-] 0.0029 4.124 
HMDB06403 Pseudoecgonyl-CoA C30H49N8O18P3S 971.1584 M+K-2H [1-] 0.0027 2.828 
HMDB10346 Triiodothyronine glucuronide C21H20I3NO10 807.8038 M-H20-H [1-] 0.0010 1.285 
HMDB12296 Trimethylaminoacetone C6H14NO 231.2078 2M-H [1-] 0.0019 8.183 
 
 
 
 
HMDB ID Common Name Chemical Formula 
Theoretical 
adduct m/z 
Adduct 
Experimental error 
(mass units)  
Accuracy 
error (ppm) 
HMDB03424 1-Hexadecanol C16H34O 122.1378 M+2H [2+] 0.0006 4.626 
HMDB02091 Isovalerylglucuronide C11H18O8 140.0574 M+2H [2+] 0.0012 8.825 
HMDB02916 4-Nitrocatechol C6H5NO4 140.0580 M+3ACN+2H [2+] 0.0006 4.141 
HMDB04827 Proline betaine C7H13NO2 161.1285 M+NH4 [1+] 0.0008 4.778 
HMDB06009 Isoputreanine C7H16N2O2 161.1285 M+H [1+] 0.0012 7.261 
HMDB13472 PGP(16:0/16:0) C38H76O13P2 1627.9415 2M+Na [1+] 0.0029 1.799 
HMDB11880 Ganglioside GM1 (d18:0/18:1(9Z)) C74H132N2O31 1627.9418 M+2ACN+H [1+] 0.0027 1.649 
Table 4. Identification of metabolites in saliva after basic hydrolysis (positive ionization) 
  
 
 
 
HMDB02345 Heneicosanoic acid C21H42O2 164.1665 M+2H [2+] 0.0001 0.091 
HMDB01352 Hydroxypyruvic acid C3H4O4 168.0267 M+ACN+Na [1+] 0.0016 9.444 
HMDB00691 Malonic acid C3H4O4 168.0267 M+ACN+Na [1+] 0.0016 9.444 
HMDB02780 Catechin C15H14O6 168.0287 M+2Na [2+] 0.0004 2.541 
HMDB00232 Quinolinic acid C7H5NO4 168.0291 M+H [1+] 0.0008 4.903 
HMDB11131 MG(18:0/0:0/0:0) C21H42O4 180.1614 M+2H [2+] 0.0009 5.167 
HMDB13076 Spermine dialdehyde C10H22N2O2 225.1573 M+Na [1+] 0.0021 9.149 
HMDB00392 2-Octenoic acid C8H14O2 225.1598 M+2ACN+H [1+] 0.0004 1.625 
HMDB05049 10-Nitrolinoleic acid C18H31NO4 225.1598 M+3ACN+2H [2+] 0.0004 1.625 
HMDB11626 Dodecanol C12H26O 225.1615 M+K [1+] 0.0021 9.486 
HMDB00560 5,8-Tetradecadienoic acid C14H24O2 225.1849 M+H [1+] 0.0017 7.522 
HMDB06954 
2-Methyl-3-hydroxy-5-formylpyridine-4-
carboxylate C8H7NO4 226.0087 M+2Na-H [1+] 0.0014 6.344 
HMDB01024 Phosphohydroxypyruvic acid C3H5O7P 226.0111 M+ACN+H [1+] 0.0010 4.455 
HMDB01358 Retinal C20H28O 326.2478 M+ACN+H [1+] 0.0007 2.056 
HMDB03112 (3R,3'R,13-cis)-b,b-Carotene-3,3'-diol C40H56O2 326.2478 M+2ACN+2H [2+] 0.0007 2.056 
HMDB03233 Lutein C40H56O2 326.2478 M+2ACN+2H [2+] 0.0007 2.056 
HMDB07080 DG(15:0/20:2(11Z,14Z)/0:0) C38H70O5 326.2504 M+2Na [2+] 0.0019 5.799 
HMDB07416 DG(20:2(11Z,14Z)/15:0/0:0) C38H70O5 326.2504 M+2Na [2+] 0.0019 5.799 
HMDB07090 DG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0) C40H68O5 326.2516 M+H+Na [2+] 0.0031 9.446 
HMDB07735 DG(22:5(7Z,10Z,13Z,16Z,19Z)/15:0/0:0) C40H68O5 326.2516 M+H+Na [2+] 0.0031 9.446 
HMDB11655 2-(3-Carboxy-3-aminopropyl)-L-histidine  C10H16N4O4 513.2416 2M+H [1+] 0.0033 6.421 
HMDB10359 17-hydroxyandrostane-3-glucuronide C25H40O8 513.2435 M+2Na-H [1+] 0.0014 2.735 
HMDB10321 3,17-Androstanediol glucuronide C25H40O8 513.2435 M+2Na-H [1+] 0.0014 2.735 
HMDB02057 Pristanoyl-CoA C40H70N7O18P3S 531.6928 M+2H [2+] 0.0028 5.281 
HMDB12913 CoA-20-COOH-LTE4 C44H64N8O22P3S2 607.6467 M+2H [2+] 0.0009 1.405 
HMDB11153 MG(P-18:0e/0:0/0:0) C21H42O3 685.6340 2M+H [1+] 0.0040 5.874 
HMDB04852 Ganglioside GM3 (d18:1/25:0) C66H122N2O21 701.9741 M+3ACN+2H [2+] 0.0030 4.260 
HMDB04913 Ganglioside GD3 (d18:1/16:0) C68H121N3O29 741.8895 M+H+K [2+] 0.0029 3.867 
HMDB00941 Cholest-5-ene C27H46 768.7430 2M+3H2O+2H [2+] 0.0004 0.476 
    
HMDB07413 DG(20:1(11Z)/24:1(15Z)/0:0) C47H88O5 774.6970 M+ACN+H [1+] 0.0038 4.884 
HMDB07441 DG(20:2(11Z,14Z)/24:0/0:0) C47H88O5 774.6970 M+ACN+H [1+] 0.0038 4.884 
HMDB07805 DG(24:0/20:2(11Z,14Z)/0:0) C47H88O5 774.6970 M+ACN+H [1+] 0.0038 4.884 
HMDB07814 DG(24:0/22:4(7Z,10Z,13Z,16Z)/0:0) C49H88O5 774.6970 M+NH4 [1+] 0.0038 4.884 
HMDB08972 PE(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) C41H70NO8P 818.5443 M+2ACN+H [1+] 0.0024 2.982 
HMDB09096 PE(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) C41H70NO8P 818.5443 M+2ACN+H [1+] 0.0024 2.982 
HMDB09452 PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)) C41H70NO8P 818.5443 M+2ACN+H [1+] 0.0024 2.982 
HMDB11391 PE(P-18:0/22:4(7Z,10Z,13Z,16Z)) C45H82NO7P 818.5460 M+K [1+] 0.0042 5.144 
HMDB11704 TG(15:0/18:0/18:3(9Z,12Z,15Z))[iso6] C54H98O6 887.7075 M+2Na-H [1+] 0.0025 2.818 
HMDB11708 TG(15:0/18:1(9Z)/18:2(9Z,12Z))[iso6] C54H98O6 887.7075 M+2Na-H [1+] 0.0025 2.818 
HMDB12561 13'-Hydroxy-gama-tocopherol C28H48O3 887.7099 2M+Na [1+] 0.0001 0.137 
HMDB08546 PC(22:0/22:1(13Z)) C52H102NO8P 944.7054 M+2Na-H [1+] 0.0046 4.910 
HMDB08768 PC(24:0/20:1(11Z)) C52H102NO8P 944.7054 M+2Na-H [1+] 0.0046 4.910 
HMDB08750 PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z)) C54H94NO8P 998.7321 M+2ACN+H [1+] 0.0013 1.344 
HMDB08814 PC(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) C54H94NO8P 998.7321 M+2ACN+H [1+] 0.0013 1.344 
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Comparison of sample preparation protocols for 
Metabolomics Profiling of human breast milk by high-
accuracy LC−TOF/MS and 1H-NMR 
 
B. Álvarez-Sánchez*, F. Priego-Capote, M.D. Luque de Castro 
 
Abstract 
 
 Breast milk is the main or unique source of feeding for children at 
early growing stages. Milk metabolomics could be of great interest to assess 
its nutritional value, to identify biomarkers of certain pathologies or to 
monitor its variability as a consequence of lactation state, food, 
supplementation, drugs intake or circadian variations. However, a complete 
characterization of maternal milk has so far not been reported, fact that 
could be ascribed to the lack of optimized standard operation protocols. In 
this study, a comparison between different analytical sample preparation 
protocols has been carried out, aiming at obtaining a representative 
metabolic profile of human breast milk. The influence of a centrifugation 
step for phases separation, pH adjustment and liquid–liquid extraction on 
the metabolomics coverage has been tested. The study revealed that 
acidification reported a negative effect on the coverage of polar metabolites, 
but it seems to positively affect the coverage of non-polar metabolites. On 
the other hand, centrifugation proved a significant influence on coverage as 
milk is composed by a fat-rich phase suspended in an aqueous serum. 
Finally, analysis by LC–TOF/MS and 1H-NMR platforms has been used for 
identification of 148 compounds, including sugars, glycerides, fatty acids and 
antioxidants, among others. 
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1. Introduction 
 
 Metabolomics is defined as the discipline responsible for the analysis 
of low molecular-weight compounds in biological samples under certain 
physiological conditions (Wishart et al. 2007). Therefore, metabolomics can 
be referred to biological fluids, tissues, cells or whole organisms. With 
regards to human metabolomics, biological fluids such as plasma, serum and 
urine have been commonly used, as they are easily and minimally or non-
invasively collected. Additionally, these biofluids directly reflect the global 
state of an individual and/or the response to drug treatment, and usually 
require the application of simple sample preparation protocols (Lindon et al. 
2007). In contrast to the vast literature devoted to urine and blood 
metabolomics, there is a gap in studies on the analysis of other biological 
fluids, such as saliva, maternal milk, semen or cerebral spinal fluid (Álvarez-
Sánchez et al. 2010; Gibney et al. 2005). Particularly, metabolomics of 
maternal milk could be of great interest to assess its nutritional value, to 
identify biomarkers of certain diseases or simply to monitor its variability as 
a consequence of lactation state, food, supplementation and drugs intake or 
circadian variations (Mitoulas et al. 2002).  
 Maternal milk is the primary or unique source of feeding for children 
during the early stages of growing, which are marked by a rapid 
development and continuous intake of nutrients (Shah 2000). Therefore, its 
high nutritional value should reflect a rich and varied composition, including 
proteins (caseins or immunoglobulins) (Mitoulas et al. 2002), calcium 
phosphate, citrate, minor ions, lipovitamins, antioxidants (Canfield et al. 
2003), and lipids (such as cholesterol and phospholipids) (Hamosha et al. 
1992), hydrosoluble vitamins (Picciano et al. 1995) and sugars (Coppa et al. 
2004). Whereas the immunoprotective function of certain proteins (i.e. 
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immunoglobulins) and peptides against virus and bacteria has been widely 
studied (Shah, N.P. 2000; Van de Perre P. 2003; Palmeira et al. 2009), scant 
attention has been paid to low-molecular weight metabolites which are also 
essential in the development of the individual. In this sense, lipids (Jensen 
R.G. 1999; Anderson et al. 1999; Blaas et al. 2011) and oligosaccharides 
(Kunz et al. 2000) are by far the best-characterized fractions. Target analysis 
of antioxidants (Canfield et al. 2003), lipovitamins (Tijerina-Sáenz et al. 
2009; Kamao et al. 2007), and hydrosoluble vitamins (Hoppu et al. 2005) 
have also recently been reported. However, since the best of our knowledge, 
characterization of maternal milk has not been developed so far, which 
could be attributed to the lack of optimized protocols. 
 If a complete elucidation of the metabolome or, more realistically, 
the widening of the metabolite coverage is intended, the ideal method of 
analysis should allow covering the largest range of metabolites regardless 
their chemical characteristics and differences in concentration. In this sense, 
the most feasible approach is to integrate the information obtained by 
different analytical methods, for instance, comparing the results provided by 
different sample preparation protocols, different analytical techniques, or 
applying different statistical treatments (Álvarez-Sánchez et al. 2010b). 
 In general terms, the final goal of metabolomics would be to obtain a 
complete, reproducible and reliable insight of the metabolic composition, 
which is usually accomplished by application of a suitable protocol based on 
the use of sensitive and accurate analytical equipment, usually mass 
spectrometry (MS) or nuclear magnetic resonance spectrometry (NMR) 
(Dieterle et al. 2011). The former can be considered as the preferred choice 
for metabolomics analysis. In fact, accurate mass spectrometry analyzers 
combined with complete mass spectra databases and high-resolution 
chromatography offer enormous capability for identification and provide 
extraordinary information about biological processes taking place in the 
sample. On the other hand, NMR-based metabolomics is also widely used 
due to its versatility, the possibility of direct analysis or with very low 
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sample preparation requirements and the recent introduction of high-field 
NMR analyzers with improved resolution capability (Viant et al. 2003; Lin et 
al. 2007). The main drawbacks of this technique are the complexity for 
interpretation and assignment of spectral information, the narrower 
dynamic range and the lower sensitivity as compared to mass spectrometry 
techniques.  
 Despite the rapid advances in analytical instrumentation, the major 
cause of errors in metabolomics analysis is still linked to sample preparation 
steps due to sample handling and analyst intervention. For this reason, 
different sample preparation protocols are usually tested to assess their 
influence on metabolomics coverage. The aim of the present study was to 
compare different analytical sample preparation protocols to obtain a 
complete metabolic profiling of human breast milk. Additionally, 
identification of the maximum number of extracted molecular features or 
potential metabolic peaks is also addressed. Therefore, LC–TOF/MS and 
unidimensional nuclear magnetic resonance (1H-NMR) are used to obtain a 
complementary profile of these samples. Information obtained from the 
present study would cover the existing gap in metabolomics experiments on 
breast milk, which could be of interest in the assessment of the nutritional 
state of breastfed neonates and infants or in the study of milk composition 
variability. 
 
2. Materials and methods 
 
2.1. Reagents and samples 
 
 LC–MS grade acetonitrile, MS-grade formic acid (Scharlab, Barcelona, 
Spain) and deionized water (18 MΩ·cm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) were used to prepare the 
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chromatographic phases. Chloroform and methanol from Scharlab were 
used for the characterization of the non-polar fraction. 
 Samples were kindly donated by five volunteers, in the first term of 
breastfeeding. No one referred any disease or health disorder. Each sample 
corresponded to a whole intake. After collection, all samples were pooled, 
aliquoted in 2-mL Eppendorf tubes, and stored at −80 ºC until processing.  
 
2.2. Instruments and apparatus 
 
 Centrifugation was carried out with a thermostated centrifuge 
Thermo Sorvall Legend Micro 21 R from Thermo (Thermo Fisher Scientific, 
Bremen, Germany). A Vacufuge centrifugal vacuum concentrator from 
Eppendorf (Eppendorf, Inc., Hamburg, Germany) was used to evaporate 
samples to dryness. 
 All samples were analyzed by an 1200 Series HPLC system (Agilent 
Technologies, Waldbronn, Germany) equipped with a binary pump, a 
degasser, a well plate autosampler and a thermostated column 
compartment, which was coupled to an Agilent 6530 TOF mass 
spectrometer equipped with a Jetstream® ESI source. MassHunter 
Workstation Data acquisition software (Agilent Technologies) was used to 
control the instrument. Data were processed using MassHunter Qualitative 
Analysis software (Agilent Technologies). Extraction of unknown features 
from raw data was carried out with the Molecular Feature Extraction (MFE) 
algorithm in Mass Hunter Qualitative analysis software. Analyses were 
processed using MassHunter Qualitative software and compound 
identification was performed using the METLIN Personal Metabolite 
Database, the Human Metabolome Database and the Molecular Formula 
Generation algorithm (Agilent Technologies). 1H-NMR spectroscopy was 
performed at 500.13 MHz using a Bruker AMX500 spectrometer 11.7 T 
(Bruker BioSpin GmbH, Rheinstetten, Germany). 
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2.3. Sample preparation protocols 
 
 The scheme followed for optimization of sample preparation is 
shown in Figure 1. Different experimental protocols were compared in order 
to obtain the maximum metabolite coverage. For each analysis, 100 µL of 
pooled milk were used. In a first study, the effect of centrifugation was 
tested, for which an aliquot was 1:1 mixed with methanol for protein 
precipitation and directly analyzed (1). This study was compared with other 
that included a final centrifugation step at 12000 g for 10 min, with constant 
temperature at 6 ºC (2).  
Characterization of the polar phase started with a preconcentration 
step, which was carried out by mixing an aliquot with pure methanol, then 
evaporating to dryness and reconstituting in mobile phase A (0.1% formic 
acid in water) (3). Afterwards, the effect of pH on the polar phase was 
evaluated. With this aim, acidification of samples was carried out by mixing 
1:1 an aliquot with methanol 10% (v/v) acidified with formic acid. The polar 
phase was then centrifuged and reconstituted in mobile phase A (4). Finally, 
the non-polar phase was also characterized, for which an aliquot was 1:2 
mixed with 50% methanol–chloroform. Then, the extract was centrifuged 
and the polar and non-polar phases were separated, evaporated and 
reconstituted in the chromatographic mobile phase A (0.1% formic acid in 
water) (5) and in 50% (v/v) acetonitrile–H2O solution 0.1% acidified with 
formic acid (6), respectively. The same experiment was repeated with a 
10:40:50 (v/v/v) formic acid–methanol–chloroform mixture (7 and 8). 
 
2.4. Liquid chromatography–mass spectrometry 
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 Chromatographic separation was carried out with a Zorbax Eclipse 
XDB-C18 column (4.6×150 mm, 5 µm particle size), in which 10 µL of sample 
was injected. Mobile phases, delivered at 1 mL/min, consisted of 0.1% 
formic acid in water (A) or in acetonitrile (B). The chromatographic gradient 
was as follows: 2% B for 5 min followed by a gradient to 100% B in 55 min 
and an isocratic step at 100% B for 10 min. The ESI Jetstream source 
operated in positive and negative ionization using the following conditions: 
needle voltage set at +/− 4 kV, nebulizer gas at 40 psi, drying and sheath gas 
flow rate and temperature at 8 and 11 L/min and 325 and 350 ºC, 
respectively.  
 Data were collected in both centroid and profile mode at a rate of 1 
spectrum per s in the extended dynamic range mode (2 GHz). Accurate mass 
spectra were adquired in the m/z range 60–1100. The instrument gave 
typical resolution 15000 FWHM (Full Width at Half Maximum) at m/z 121 
and 30000 FWHM at m/z 922. To assure the desired mass accuracy of 
recorded ions, continuous internal calibration was performed during 
analyses with the use of signals at m/z 121.0509 (protonated purine) and 
m/z 922.0098 [protonated hexakis(1H, 1H, 3H-tetrafluoro-propoxy)-
phosphazine or HP-921] in positive ion mode; in negative ion mode ions 
with m/z 119.0362 (proton abstracted purine) and m/z 966.000725 
(formate adduct of HP-921) were used. 
 
2.5. MS data processing 
 
Once samples were analyzed by LC−TOF/MS, data were extracted 
into features and the calculated neutral mass was queried against the 
METLIN and HMDB databases of known metabolites. Features extraction 
was based on the molecular feature extraction algorithm (MFE) that locates
  
 
Figure 1. Optimization of sample preparation steps for global metabolic profiling of milk by LC–TOF/MS. 
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and groups all ions related to the same neutral molecule. This relation is 
referred as to the covariance of peaks within the same chromatographic 
retention time, the charge-state envelope, isotopic distribution, and/or the 
presence of adducts and dimmers. The MFE took into account all ions 
exceeding 1000 counts, with charge state limited to a maximum of two and a 
peak spacing tolerance of 0.0025 m/z (plus 7 ppm). Each feature was given 
by a minimum of two ions. The extraction algorithm was based on a 
common organic model with chromatographic separation. The allowed 
positive ions were protonated species and sodium adducts, and the negative 
ions formed by formate adducts and proton losses. Dehydratation neutral 
losses were also allowed.  
 Molecular formulas were generated using the Molecular Formula 
Generator algorithm. Both mass accuracy and isotope information 
(abundance and spacing) were considered to limit the number of hits. Only 
the common elements C, H, N, O, P and S were considered in the generation 
of formulas. The calculated neutral mass of each feature was queried against 
the METLIN database for matching to compounds within a maximum mass 
tolerance window of 10 ppm. The METLIN database matched the neutral 
mass to the monoisotopic mass value calculated from the empirical formula 
of compounds in the database. Identified compounds were eventually 
contrasted against the Human Metabolome Database (HMDB) to confirm 
their occurrence in humans. 
  
2.6. 1H-NMR spectrometry analysis of milk samples: data acquisition and 
processing 
 
 Milk serum, obtained after centrifugation at 12000 g for 10 min at 4 ºC 
(400 µL) was mixed with with 150 µL of 0.1 mM solution of trimethylsilyl 
propionate (TSP), used as chemical shift reference, in deuterium water (D2O). 
The sample was examined at 4 ºC to minimize metabolic changes. No gross 
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degradation was noted in the signals of multiple spectra acquired under the 
same conditions   
 Standard solvent suppressed spectra were grouped into 16000 data 
points, averaged over 256 acquisitions. The data acquisition lasted in total 13 
min using a sequence based on the first increment of the Nuclear Overhauser 
Effect Spectroscopy (NOESY) pulse sequence to effect suppression of the 
water resonance and limit the effect of B0 and B1 inhomogeneities in the 
spectra (relaxation delay-90º-t1-90º-tm-90º-acquire Free Induction Decay 
(FID) signal), in which a secondary radio frequency irradiation field was 
applied at the water resonance frequency during the relaxation delay of 2 s 
and during the mixing period (tm = 150 ms), with t1 fixed at 3 s. The 
acquisitions were performed using a spectral width of 8333.33 Hz. Prior to 
Fourier transformation, the FID signals were multiplied by an exponential 
weight function corresponding to a line broadening of 0.3 Hz. Spectra were 
referenced to the TSP singlet at 0 ppm chemical shift.  
 
3. Results and discussion 
 
3.1. Characterization of milk serum by LC–TOF/MS 
 
3.1.1. Influence of centrifugation 
 Milk is constituted by an aqueous serum with colloidal particles 
formed by lipids and casein micelles. This heterogeneous composition 
makes difficult to obtain a complete profile of metabolites as a characteristic 
fingerprinting. Thus, the main drawback found in the analysis of untreated 
milk is attributed to sample instability since it is rapidly separated into two 
phases leading to irreproducible results. In addition, metabolic profiling 
analysis is conditioned by the partition of compounds between both phases 
according to their partition coefficient.  
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 An alternative to avoid this lack of precision is the inclusion of a 
centrifugation step for sample fractionation. The influence of milk 
centrifugation was evaluated in two aliquots that were subjected to a 
deproteinization step with methanol in an 1:1 (v/v) ratio. The high content 
of proteins makes mandatory a step for their removal since they are clear 
responsible for ionization suppression phenomena with loss of sensitivity. 
After that, one of the aliquots was centrifuged and the resultant serum was 
analyzed in both positive and negative ionization modes while the other 
aliquot was directly analysed. Non-centrifuged aliquot should give a larger 
number of molecular features as it contains both polar and non-polar 
metabolites. However, a similar number of molecular features were 
obtained. Thus, algorithm for extraction of molecular features allowed the 
isolation of 20 molecular features in the serum phase obtained after 
centrifugation in the negative ionization mode versus 26 molecular features 
detected after direct analysis of the non-centrifuged aliquot. This result can 
be justified by lower ionization efficiency in the non-polar phase, probably 
caused by ionization suppression of lipidic molecules. Owing to this, both 
phases should be analyzed separately and sample preparation optimized 
independently. Figure 2 shows a Venn diagram representing the molecular 
features obtained from both aliquots, in negative (2A) and positive (2B) 
ionization. As can be seen in Fig 2.A, 18 molecular features were commonly 
detected in both sample preparation tests, while 2 and 8 exclusive features 
were detected in negative mode for the centrifuged and non-centrifuged 
samples, respectively. On the other hand, 24 molecular features were 
commonly detected in positive mode, while 10 and 19 unique features were 
detected in the centrifuged and non-centrifuged samples, respectively. 
Therefore, a total of 53 molecular features were detected in positive 
ionization (49% of them in common for the two aliquots) while 28 
molecular features were detected in negative mode (64% in common for the 
two aliquots). 
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Figure 2. Venn diagram of molecular features obtained from the analysis of a 
centrifuged and a non-centrifuged aliquots, in negative (2A) and positive (2B) 
ionization modes. 
 
3.1.2. Characterization of the polar phase  
 The aforementioned protocol implies diluting aliquots in methanol, 
which might led to a decrease in the coverage. Therefore, a preconcentration 
step was carried out, for which an aliquot was 1:1 mixed with methanol and 
subsequently centrifuged. The polar phase was then evaporated to dryness 
and reconstituted in 100-µL mobile phase A (0.1% formic acid in water) to 
enhance ionization and improve chromatographic separation. Analysis of 
these aliquots in positive and negative ionization modes provided the base 
peak chromatograms (BPCs) illustrated in Figure 3. The conclusion of this 
test is that preconcentration increased the number of detected molecular 
features from 20 up to 60 by negative ionization. 
 One of the main drawbacks of milk metabolic profiling is the large 
dynamic range at which metabolites can be found and the presence of 
macromolecular units, mainly proteins, which might interfere not only in 
electrospray ionization but also in chromatographic resolution. As resulted 
in the previous section, these drawbacks can be minimized after protein 
removal by precipitation with an organic solvent such as methanol.  
(A)     (B) 
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Figure 3. Base peak chromatograms obtained without (grey line) and with 
preconcentration (black line) in positive (3A) and negative (3B) ionization. 
 
(A) 
(B) 
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 Protein precipitation can be aided by sample acidification since 
caseins and other proteins precipitate at pH below 5. Additionally, pH 
acidification could increase the solubility of metabolites with ionizable 
groups. With these premises, the following test involved the assessment of 
pH acidification on the deproteinization process using methanol with 10% 
(v/v) formic acid. This test was compared with that of the same process 
without acidification. The two aliquots were evaporated and reconstituted in 
100 µL mobile phase A. Figure 4 shows the Venn diagrams for negative (A) 
and positive (B) ionization modes with the molecular features extracted 
from the LC–TOF/MS analysis of the acidified sample (A), a non-acidified 
sample (NA). In negative mode, 48 molecular features were common to both 
the acidified and non-acidified aliquots, while the total number of detected 
features was 60 (NA) and 65 (A), respectively, for both analysis. Accordingly, 
the total number of detected features remained practically constant with the 
decrease of pH, thus demonstrating to be non-crucial for ionization. Results 
differ significantly in positive mode, as acidification leads to a decrease from 
49 to 22 unique features.  
 
 
Figure 4. Venn diagrams for negative (A) and positive (B) ionization modes 
with the molecular features extracted from the LC–TOF/MS analysis of the 
acidified sample (A), a non-acidified sample (NA). 
 
(A)      (B) 
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 This decrease can be due to the fact that acidification favors 
hydrolysis and metabolite co-precipitation, thus decreasing solubility.  
Globally, the total of molecular entities detected in positive mode was 118 
and 104 for A and NA, respectively. Base peak chromatograms from these 
experiments are illustrated in Figure 5 revealing the differences in the 
metabolic profile as a result of the acid medium. 
 
 
(A) 
(B) 
Figure 5. Base peak chromatograms obtained from the non-acidified 
(black line) and acidified (grey line) aliquots in positive (A) and negative 
(B) following the experimental protocols (3) and (4), respectively. 
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3.1.3. Characterization of the non-polar phase 
 The main limitation of the previous sample preparation strategies is 
that methanol is not able to solubilize the non-polar fraction completely and, 
for this reason, characterization of lipids is not suited. Aiming at 
characterizing the non-polar constituents, a methanol–chloroform mixture 
was added to a breast milk aliquot and the mixture was shaken for liquid–
liquid extraction. The two resulting phases were subsequently analyzed 
after centrifugation, evaporation and reconstitution as described in the 
experimental section. In negative mode, a total of 27 and 35 molecular 
features were extracted from the polar and non-polar phase, respectively, 
being only 5 of them common to both phases, which is a logical behavior 
taking into account differential solubility between phases. The same 
experiment was repeated by using 10:40:50 formic acid–methanol–
chloroform (7 and 8 in Figure 1), which led to a considerable increase in the 
number of unique features in the non-polar phase (chloroform). In fact, an 
increase from 35 to 94 unique features in the non-polar phase was obtained, 
against a decrease from 27 to 17 features in the polar phase. Therefore, the 
effect of pH was more acute on the non-polar phase than on the polar one, 
which could be linked to the release of metabolites by hydrolysis. In order to 
know which metabolites were affected by pH, this experiment was 
completed with a characterization of the non-polar phase by identification of 
the extracted features with METLIN and HMDB resources. Therefore, 94 
compounds were identified in the non-polar phase by measurement of 
accurate mass and a maximum mass difference of 10 ppm. These 
compounds are listed in supplementary Tables 1 and 2 for positive and 
negative ionization modes, respectively. 
 
3.2. Identification of metabolites in breast milk analysis 
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 Extracted molecular features from each experiment were searched 
against the METLIN and HMDB databases supported on measurement of 
accurate mass. The database search results are exposed in Tables 1 and 2 
that includes the HMDB code, common name, chemical formula, m/z ratio 
and detected adduct, accuracy error expressed as ppm and, finally, the 
analysis in which the metabolite was identified. Thus, polar fraction 
corresponded to the analysis of the sample after methanol deproteinization 
in 10% formic acid (1:1 v/v ratio), evaporation of the supernatant phase and 
reconstitution in mobile phase A. On the other hand, the non-polar fraction 
corresponded to the analysis of the sample after liquid–liquid extraction 
with methanol–chloroform in 10% formic acid, evaporation of the non-polar 
phase and reconstitution in acetonitrile–H2O (50:50 v/v) 0.1% acidified with 
formic acid. In total, 148 metabolites were identified, 105 of them in positive 
ionization and 48 in negative mode (5 of them were common to both 
ionization modes). Concerning the fraction where they were detected, 94 
metabolites were identified in the non-polar phase, while 85 were identified 
in the polar phase. These results mean that a 63% of total features were 
identified in the non-polar phase while 57% of them were found in the polar 
phase. Thus, it is worth mentioning the complementarities of both sample 
preparation strategies. As can be seen, the non-polar phase was marked by 
the presence of mono-, di- and triglycerides, glycerophospholipids such as 
glycerophosphoetanolamine, glycerophosphocholine, glycerophosphoserine 
and phosphatidylinositol metabolites. Special mention deserves the 
identification of carnitines for transport of fatty acids, gangliosides, steroid 
hormones such as aldosterone, inflammatory mediators such as leukotrine 
E4, and metabolites of phytyl diphosphate as an intermediate in the 
biosynthesis of steroids. Disaccharides and polysaccharides were also 
detected in this phase with interest of lactose derivatives that were present 
at high concentration. On the other hand, the polar phase was characterized 
by the presence of free fatty acids and derivatives such as HETEs 
(hydroxyeicosatetraenoic acids), other carboxylic acids such as citric acid 
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and pantothenic acid, monosaccharides such as glucose and fructose with 
their corresponding phosphate intermediates, among others.   
 
3.3. 1H-NMR spectrometry analysis of breast milk 
 
 Characterization of breast milk was completed by unidimensional 
1H-NMR analysis of breast milk and characteristic cross-peaks from 2D 
spectra to help in unequivocal assignation of the metabolites. In this case, an 
analytical strategy based on direct analysis of milk was employed. The NMR 
spectra were marked by the presence of major signals corresponding to 
lactose and lactose-based polysaccharides. Thus, Figure 6.A illustrates a 
characteristic spectrum for breast milk where, apart from the main 
disaccharides, other carbohydrates such as glucose and fucose, and 
carboxylic acids such as citric acid and glutamic acid were identified. Figure 
6.B shows a zoom in y-axis in which minor signals could be assigned. In this 
way, other monosaccharides such as xylose and arabinose, amino acids such 
as creatine and alanine and signals corresponding to fatty acids were 
identified. The resonances were identified with the Chenomx NMR software 
according to the Human Metabolome Database. Although it is evident that 
the identification capability of NMR cannot be compared with that reported 
by MS in the analysis of complex samples, the NMR spectra provided by 
breast milk constitute a characteristic fingerprinting that could be used as a 
fast snapshot view of its metabolic state.    
 
4.  Conclusions 
 
 The present study aims at testing different sample preparation 
strategies for analysis of the metabolic profile of human breast milk. A suited 
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optimization of the experimental protocol has been planned as a function of 
the metabolite coverage in order to maximize the number of identified 
metabolites. The variables taken into account were the dilution solvent, pH, 
centrifugation and liquid–liquid extraction. It can be concluded that the best. 
strategy should be the combination of a dual protocol: a deproteinization 
with methanol, evaporation and reconstitution in acidified water for 
analysis of the polar phase, and liquid–liquid extraction with methanol–
chloroform for analysis of the non-polar phaseOn the other hand, 
centrifugation leads to more repeatable analyses as sample stability is 
marked by the presence of two phases that progressively separate over time. 
Therefore, it is advisable to centrifuge the sample and independently 
analyze the resulting phases in an appropriate solvent. In addition, it is 
highly recommendable to carry out a solvent exchange to the initial 
chromatographic mobile phase to favor electrospray ionization as the 
coverage is increased up to three times.   
 
Figure 6A. Spectrum for breast milk obtained by 1H-NMR.  
 370 
Nuevas plataformas analíticas en metabolómica                                                                                    
Figure 6B. Spectrum zoomed in y-axis. 
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Table 1. Metabolites identified in the characterization of the non-polar and polar phases by LC–TOF/MS analysis in 
positive ionization mode. 
HMDB ID Common Name 
Chemical 
Formula 
Theoretic
al mass 
m/z 
Adduct 
Experimental 
error (mass 
units) 
Accurac
y error 
(ppm) 
Non-
polar 
phase 
Polar 
phase 
HMDB06478 Iso-Valeraldehyde C5H10O 104.1070 M+NH4 [1+] 0.0002 1.8347  X 
HMDB00076 Dihydrouracil C4H6N2O2 132.0768 M+NH4 [1+] 0.0005 3.4677  X 
HMDB00064 Creatine C4H9N3O2 132.0768 M+H [1+] 0.0005 3.4677 X  
HMDB10715 2-Phenylacetamide C8H9NO 136.0757 M+H [1+] 0.0003 2.2414 X  
HMDB03052 Lactaldehyde C3H6O2 138.0526 M+ACN+Na [1+] 0.0010 7.5696  X 
HMDB01392 p-Aminobenzoic acid C7H7NO2 138.0550 M+H [1+] 0.0003 1.8761 X X 
HMDB04827 Proline betaine C7H13NO2 144.1019 M+H [1+] 0.0003 0.0000  X 
HMDB00005 2-Ketobutyric acid C4H6O3 144.0655 M+ACN+H [1+] 0.0002 1.4854 X  
HMDB01259 Succinic acid semialdehyde C4H6O3 144.0655 M+ACN+H [1+] 0.0002 1.4854  X 
HMDB00826 Pentadecanoic acid C15H30O2 144.1015 M+2Na [2+] 0.0002 1.3740 X  
HMDB00148 L-Glutamic acid C5H9NO4 148.0604 M+H [1+] 0.0003 2.2693  X 
HMDB02931 N-Acetylserine C5H9NO4 148.0604 M+H [1+] 0.0003 2.2693 X  
HMDB02035 4-Hydroxycinnamic acid C9H8O3 165.0546 M+H [1+] 0.0006 3.7927  X 
HMDB00660 D-Fructose C6H12O6 181.0707 M+H [1+] 0.0009 0.0000  X 
HMDB00143 D-Galactose C6H12O6 181.0707 M+H [1+] 0.0009 5.1416  X 
HMDB00122 D-Glucose C6H12O6 181.0707 M+H [1+] 0.0009 5.1416  X 
HMDB02825 Theobromine C7H8N4O2 181.0720 M+H [1+] 0.0002 1.1819  X 
HMDB00469 5-Hydroxymethyluracil C5H6N2O3 184.0717 M+ACN+H [1+] 0.0009 5.1393 X  
HMDB06831 3-Dehydroxycarnitine C7H15NO2 184.0734 M+K [1+] 0.0005 2.8195  X 
HMDB00159 L-Phenylalanine C9H11NO2 188.0682 M+Na [1+] 0.0020 10.7089 X  
HMDB01565 Phosphorylcholine C5H15NO4P 202.1077 M+NH4 [1+] 0.0009 4.4531  X 
HMDB00355 3-Hydroxymethylglutaric acid C6H10O5 204.0866 M+ACN+H [1+] 0.0005 2.6165 X  
HMDB00201 L-Acetylcarnitine C9H17NO4 204.1230 M+H [1+] 0.0004 2.0919 X X 
HMDB13227 cis-5-Decenedioic acid C10H16O4 218.1387 M+NH4 [1+] 0.0004 1.7466 X X 
  
HMDB00824 Propionylcarnitine C10H19NO4 218.1387 M+H [1+] 0.0004 1.7466 X X 
HMDB12150 2-Keto-6-acetamidocaproate C8H13NO4 220.1180 M+CH3OH+H [1+] 0.0000 0.2090  X 
HMDB00210 Pantothenic acid C9H17NO5 220.1180 M+H [1+] 0.0000 0.2090 X X 
HMDB02013 Butyrylcarnitine C11H21NO4 232.1543 M+H [1+] 0.0001 0.5901  X 
HMDB09452 
PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(
9Z)) C41H70NO8P 246.1686 M+3H [3+] 0.0015 6.1990  X 
HMDB13128 Valerylcarnitine C12H23NO4 246.1700 M+H [1+] 0.0001 0.4956  X 
HMDB00982 5-Methylcytidine C10H15N3O5 258.1084 M+H [1+] 0.0013 4.9669  X 
HMDB00086 Glycerophosphocholine C8H20NO6P 258.1101 M+H [1+] 0.0005 1.8907 X X 
HMDB07975 PC(16:0/18:3(9Z,12Z,15Z)) C42H78NO8P 260.1834 M+2H+Na [3+] 0.0011 4.2239 X  
HMDB08006 PC(16:1(9Z)/18:2(9Z,12Z)) C42H78NO8P 260.1834 M+2H+Na [3+] 0.0011 4.2239 X  
HMDB08017 
PC(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,1
7Z)) C44H76NO8P 260.1842 M+3H [3+] 0.0003 1.0569 X X 
HMDB08142 
PC(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,1
5Z)) C44H76NO8P 260.1842 M+3H [3+] 0.0003 1.0569 X  
HMDB08206 
PC(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,
15Z)) C44H76NO8P 260.1842 M+3H [3+] 0.0008 2.9325  X 
HMDB00705 Hexanoylcarnitine C13H25NO4 260.1856 M+H [1+] 0.0009 3.5206 X X 
HMDB00455 Allocystathionine C7H14N2O4S 261.0306 M+K [1+] 0.0006 2.2220 X  
HMDB00124 Fructose 6-phosphate C6H13O9P 261.0370 M+H [1+] 0.0004 1.5209  X 
HMDB01401 Glucose 6-phosphate C6H13O9P 261.0370 M+H [1+] 0.0004 1.5209  X 
HMDB08051 PC(18:0/22:0) C48H96NO8P 282.9030 M+3H [3+] 0.0012 4.1003 X  
HMDB00573 Elaidic acid C18H34O2 283.2632 M+H [1+] 0.0006 2.2629  X 
HMDB00207 Oleic acid C18H34O2 283.2632 M+H [1+] 0.0006 2.2629  X 
HMDB01235 5-Aminoimidazole ribonucleotide C8H14N3O7P 296.0642 M+H [1+] 0.0011 3.7120 X  
HMDB06038 3'-O-Methylguanosine C11H15N5O5 298.1146 M+H [1+] 0.0000 0.0000  X 
HMDB09740 PE(24:0/24:1(15Z)) C53H104NO8P 312.9179 M+2H+Na [3+] 0.0014 4.4868 X  
HMDB03797 Bovinic acid C18H32O2 313.2737 M+CH3OH+H [1+] 0.0001 0.2937  X 
HMDB00673 Linoleic acid C18H32O2 313.2737 M+CH3OH+H [1+] 0.0001 0.2937  X 
HMDB00480 7,10-Hexadecadienoic acid C16H28O2 313.2743 M+IsoProp+H [1+] 0.0003 0.8778  X 
  
HMDB00186 Alpha-Lactose C12H22O11 343.1235 M+H [1+] 0.0009 2.5792 X X 
HMDB00163 D-Maltose C12H22O11 343.1235 M+H [1+] 0.0009 2.5792 X X 
HMDB00740 Lactulose C12H22O11 343.1235 M+H [1+] 0.0009 2.5792 X  
HMDB06603 3-b-Galactopyranosyl glucose C12H22O11 365.1054 M+Na [1+] 0.0005 1.5037  X 
HMDB03947 8Z,11Z,14Z-eicosatrienoyl-CoA 
C44H72N7O17P
3S 366.1379 M+3H [3+] 0.0003 0.9177 X  
HMDB01557 Riboflavin reduced C15H16N4O6 366.1408 M+NH4 [1+] 0.0026 7.0847 X  
HMDB06323 Tetracosapentaenoic acid (24:5n-3) C24H38O2 381.2764 M+Na [1+] 0.0038 9.9246 X  
HMDB12356 PS(16:0/18:0) C40H78NO10P 391.2887 M+H+NH4 [2+] 0.0036 9.2029 X  
HMDB08939 PE(16:0/20:5(5Z,8Z,11Z,14Z,17Z)) C41H72NO8P 391.7390 M+2Na [2+] 0.0037 9.5038 X  
HMDB09095 
PE(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)
) C41H72NO8P 391.7390 M+2Na [2+] 0.0037 9.5038 X  
HMDB09191 PE(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)) C41H72NO8P 391.7390 M+2Na [2+] 0.0039 9.9709  X 
HMDB09451 PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:0) C41H72NO8P 391.7390 M+2Na [2+] 0.0039 9.9709  X 
HMDB01397 Guanosine monophosphate C10H14N5O8P 427.0738 M+ACN+Na [1+] 0.0040 9.3614 X  
HMDB12380 PS(18:0/18:2(9Z,12Z)) C42H78NO10P 456.3152 M+3ACN+2H [2+] 0.0023 5.1499 X  
HMDB09765 PE(24:1(15Z)/22:0) C51H100NO8P 462.8445 M+H+K [2+] 0.0031 6.7906  X 
HMDB11593 Lactosylcermide (d18:1/20:0) C50H95NO13 478.8254 M+H+K [2+] 0.0001 0.2548  X 
HMDB12642 20-Oxo-leukotriene E4 C23H34NO6S 491.1739 M+K [1+] 0.0043 8.8217 X  
HMDB10034 PIP2(16:0/16:2(9Z,12Z)) C41H77O19P3 506.2028 M+2Na [2+] 0.0038 7.4753 X  
HMDB07852 LPA(0:0/18:2(9Z,12Z)) C21H39O7P 511.1624 M+2K+H [1+] 0.0004 0.7767 X  
HMDB02235 
O-6-deoxy-a-L-galactopyranosyl-
(1->2)-O-b-D-galactopyranosyl-(1-
>3)-2-(acetylamino)-1,5-anhydro-
2-deoxy-D-arabino-Hex-1-enitol C20H33NO14 512.1974 M+H [1+] 0.0010 1.9075 X X 
HMDB01064 Linoleoyl-CoA C39H66N7O17P3S 524.1930 M+H+NH4 [2+] 0.0034 6.5205  X 
HMDB00121 Folic acid C19H19N7O6 524.2001 M+2ACN+H [1+] 0.0038 7.2186 X  
HMDB06620 Fucosyllactose C18H32O15 527.1373 M+K [1+] 0.0013 2.5477 X X 
HMDB11913 Ganglioside GM3 (d18:0/12:0) C53H98N2O21 572.3223 M+2Na [2+] 0.0047 8.3187 X  
HMDB11484 LysoPE(0:0/20:3(11Z,14Z,17Z)) C25H46NO7P 587.3563 M+IsoProp+Na+H 0.0015 2.5981 X  
  
[1+] 
HMDB06569 6'-Sialyllactose C23H39NO19 634.2189 M+H [1+] 0.0019 3.0794 X  
HMDB11801 Ganglioside GD1a (d18:1/23:0) C90H159N3O39 636.3589 M+3H [3+] 0.0007 1.0544 X X 
HMDB11765 Cer(d18:0/22:0) C40H81NO3 646.6108 M+Na [1+] 0.0019 3.0204 X  
HMDB02430 
(3a,5b,7a)-23-Carboxy-7-hydroxy-
24-norcholan-3-yl-b-D-
Glucopyranosiduronic acid C30H48O10 647.3460 M+DMSO+H [1+] 0.0019 2.9227 X  
HMDB06834 D-Pantothenoyl-L-cysteine C12H22N2O6S 667.2289 2M+Na [1+] 0.0026 3.8413 X  
HMDB01373 Dephospho-CoA C21H35N7O13P2S 705.1827 M+NH4 [1+] 0.0003 0.4325 X  
HMDB06537 
(a-D-mannosyl)2-b-D-mannosyl-N-
acetylglucosamine C26H45NO21 730.2376 M+Na [1+] 0.0019 2.5909 X  
HMDB13647 Adenosine thiamine diphosphate C22H30N9O10P2S 738.1469 M+ACN+Na [1+] 0.0014 1.9021 X  
HMDB07324 
DG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,1
0Z,13Z,16Z,19Z)/0:0) C43H66O5 739.4100 M+2K+H [1+] 0.0010 1.4038  X 
HMDB07577 
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(
8Z,11Z,14Z,17Z)/0:0) C43H66O5 739.4100 M+2K+H [1+] 0.0010 1.4038  X 
HMDB07744 
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:
4(6Z,9Z,12Z,15Z)/0:0) C43H66O5 739.4100 M+2K+H [1+] 0.0010 1.4038  X 
HMDB06566 Lacto-N-tetraose C26H45NO21 746.2115 M+K [1+] 0.0018 2.3720 X X 
HMDB10580 PG(16:0/20:4(5Z,8Z,11Z,14Z)) C42H75O10P 803.5433 M+CH3OH+H [1+] 0.0002 0.2277 X  
HMDB10621 PG(18:1(11Z)/18:3(6Z,9Z,12Z)) C42H75O10P 803.5433 M+CH3OH+H [1+] 0.0002 0.2277 X  
HMDB07941 PC(15:0/18:3(6Z,9Z,12Z)) C41H76NO8P 818.4500 M+2K+H [1+] 0.0012 1.4918 X  
HMDB08935 PE(16:0/20:3(5Z,8Z,11Z)) C41H76NO8P 818.4500 M+2K+H [1+] 0.0012 1.4918 X  
HMDB11852 Ganglioside GD2 (d18:1/14:0) C75H131N3O34 818.4513 M+H+NH4 [2+] 0.0026 3.1315 X  
HMDB02211 Uroporphyrinogen I C40H44N4O16 854.3090 M+NH4 [1+] 0.0003 0.3570 X  
HMDB06705 Lacto-n-fucopentaose I C32H55NO25 854.3136 M+H [1+] 0.0020 2.0718 X X 
HMDB06576 Lacto-N-fucopentaose III C32H55NO25 854.3136 M+H [1+] 0.0020 2.0718 X X 
HMDB06706 Lacto-N-fucopentaose V C32H55NO25 854.3136 M+H [1+] 0.0020 2.0718 X X 
HMDB06577 Lacto-N-fucopentaose-2 C32H55NO25 854.3136 M+H [1+] 0.0020 2.0718 X X 
HMDB06805 Beta-Alanyl-CoA C24H41N8O17P3S 861.1415 M+Na [1+] 0.0023 2.6221 X  
  
HMDB10422 
TG(16:1(9Z)/14:0/18:2(9Z,12Z))[i
so6] C51H92O6 864.7051 M+ACN+Na [1+] 0.0008 0.9876 X X 
HMDB09493 PE(22:0/20:0) C47H94NO8P 864.7052 M+CH3OH+H [1+] 0.0001 0.1411  X 
HMDB06487 Pentaglutamyl folate C39H47N11O18 999.3439 M+ACN+H [1+] 0.0023 2.2595 X  
HMDB06589 Sialyllacto-N-tetraose a C37H62N2O29 999.3511 M+H [1+] 0.0049 4.9472 X  
HMDB10033 PIP2(16:0/16:1(9Z)) C41H79O19P3 1007.4059 M+K [1+] 0.0021 2.0597 X  
HMDB06602 Lacto-N-hexaose C40H68N2O31 1073.3879 M+H [1+] 0.0019 1.8195  X 
HMDB06532 Palmitoleyl CoA C37H64N7O17P3S 1080.2483 M+2K+H [1+] 0.0002 0.2259  X 
 
Table 2. Metabolites identified in the characterization of the non-polar and polar phases by LC–TOF/MS analysis in 
negative ionization mode. 
HMDB ID Common Name Chemical Formula 
Theoretical 
mass m/z 
Adduct 
Experimental 
error (mass 
units)  
Accurac
y error 
(ppm) 
Non-
polar 
phase 
Polar 
phase 
HMDB00444 3-Furoic acid C5H4O3 111.0088 M-H [1-] 0.0039 6.7177 X X 
HMDB01259 Succinic acid semialdehyde C4H6O3 161.0455 M+Hac-H [1-] 0.0042 7.9327  X 
HMDB02825 Theobromine C7H8N4O2 161.0463 M-H20-H [1-] 0.0027 9.5082 X X 
HMDB12883 Adrenochrome o-semiquinone C9H10NO3 161.0477 M-H20-H [1-] 0.0027 9.7266 X X 
HMDB03441 Cinnamaldehyde C9H8O 167.0269 M+Cl [1-] 0.0007 2.5677  X 
HMDB00641 L-Glutamine C5H10N2O3 181.0385 M+Cl [1-] 0.0028 9.8205  X 
HMDB00094 Citric acid C6H8O7 191.0197 M-H [1-] 0.0047 8.9247  X 
HMDB01014 4-Imidazolone-5-propionic acid C6H8N2O3 191.0229 M+Cl [1-] 0.0015 2.0308 X  
HMDB00210 Pantothenic acid C9H17NO5 218.1034 M-H [1-] 0.0049 6.3102 X X 
HMDB02396 Trimethyltridecanoic acid C16H32O2 255.2330 M-H [1-] 0.0019 8.5372 X  
HMDB00220 Palmitic acid C16H32O2 255.2330 M-H [1-] 0.0023 2.9002  X 
HMDB03797 Bovinic acid C18H32O2 279.2330 M-H [1-] 0.0021 9.5138  X 
HMDB06270 Linoelaidic acid C18H32O2 279.2330 M-H [1-] 0.0021 3.5406  X 
  
HMDB11711 
TG(15:0/18:2(9Z,12Z)/18:2(9Z,12Z))
[iso3] C54H96O6 279.2330 M-3H [3-] 0.0021 4.1397 X  
HMDB10737 (R)-3-Hydroxy-Octadecanoic acid C18H36O3 281.2480 M-H20-H [1-] 0.0016 9.3159  X 
HMDB00573 Elaidic acid C18H34O2 281.2486 M-H [1-] 0.0021 4.0829  X 
HMDB00207 Oleic acid C18H34O2 281.2486 M-H [1-] 0.0021 4.3844  X 
HMDB03529 Inositol 1,3,4,5,6-pentakisphosphate C6H17O21P5 288.9402 M-2H [2-] 0.0013 1.7249  X 
HMDB11563 MG(15:0/0:0/0:0) C18H36O4 297.2430 M-H20-H [1-] 0.0038 10.5686 X  
HMDB07578 
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(
5Z,8Z,11Z,14Z,17Z)/0:0) C43H64O5 329.2304 M-2H [2-] 0.0042 7.9326 X  
HMDB07353 
DG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7
Z,10Z,13Z,16Z,19Z)/0:0) C43H64O5 329.2304 M-2H [2-] 0.0042 8.2795 X  
HMDB04710 9,10,13-TriHOME C18H34O5 329.2334 M-H [1-] 0.0012 2.0834  X 
HMDB10222 9-HETE C20H32O3 355.2045 M+Cl [1-] 0.0009 2.2632  X 
HMDB03876 15(S)-HETE C20H32O3 355.2045 M+Cl [1-] 0.0009 3.1467  X 
HMDB00037 Aldosterone C21H28O5 381.1683 M+Na-2H [1-] 0.0012 2.5700 X  
HMDB03164 Chlorogenic acid C16H18O9 391.0437 M+K-2H [1-] 0.0015 3.6910 X  
HMDB06701 3-O-a-L-Fucopyranosyl-D-glucose C12H22O10 405.0402 M+Br [1-] 0.0019 1.9192  X 
HMDB02200 Leukotriene E4 C23H37NO5S 420.2209 M-H20-H [1-] 0.0042 4.3029 X  
HMDB00215 N-Acetyl-D-glucosamine C8H15NO6 487.1781 2M+FA-H [1-] 0.0009 0.8977  X 
HMDB11116 Phytyl diphosphate C20H42O7P2 501.2388 M+FA-H [1-] 0.0004 2.6514 X  
HMDB12501 
10,11-Dihydro-12R-hydroxy-
leukotriene E4 C23H38NO6S 501.2402 M+FA-H [1-] 0.0010 6.0665 X  
HMDB04270 D-Glucosaminide C18H35N3O13 522.1917 M+Na-2H [1-] 0.0027 5.2605   
HMDB11164 L-beta-aspartyl-L-glutamic acid  C9H14N2O7 523.1530 2M-H [1-] 0.0007 4.0433 X X 
HMDB00585 Glucosylgalactosyl hydroxylysine C18H34N2O13 523.1547 M+K-2H [1-] 0.0010 1.0512 X X 
HMDB03351 GDP-glucose C16H25N5O16P2 586.0588 M-H20-H [1-] 0.0013 8.3393  X 
HMDB01391 GDP-4-Dehydro-6-L-deoxygalactose C16H23N5O15P2 586.0593 M-H [1-] 0.0008 2.9052  X 
  
HMDB13617 Lipoyl-GMP C18H26N5O9PS2 586.0604 M+Cl [1-] 0.0002 0.8939 X  
HMDB01260 ADP-Ribosyl-L-arginine C21H35N9O15P2 736.1475 M+Na-2H [1-] 0.0021 2.7435  X 
HMDB09280 PE(20:1(11Z)/P-18:0) C43H84NO7P 778.5732 M+Na-2H [1-] 0.0044 5.6449 X X 
HMDB09249 PE(20:0/P-18:1(9Z)) C43H84NO7P 778.5732 M+Na-2H [1-] 0.0044 5.6449 X  
HMDB09491 PE(22:0/18:3(9Z,12Z,15Z)) C45H84NO8P 778.5751 M-H20-H [1-] 0.0039 5.0169 X X 
HMDB09232 PE(20:0/20:3(5Z,8Z,11Z)) C45H84NO8P 778.5751 M-H20-H [1-] 0.0039 5.0169 X  
HMDB09106 PE(18:2(9Z,12Z)/22:1(13Z)) C45H84NO8P 778.5751 M-H20-H [1-] 0.0039 5.0169 X  
HMDB11391 PE(P-18:0/22:4(7Z,10Z,13Z,16Z)) C45H82NO7P 778.5756 M-H [1-] 0.0020 5.1238 X  
HMDB03324 Biotripyrrin-b C25H27N3O6 929.3727 2M-H [1-] 0.0029 8.7143 X  
HMDB10466 TG(18:1(9Z)/18:1(9Z)/22:1(13Z)) C61H112O6 985.8441 M+FA-H [1-] 0.0024 7.2290 X  
HMDB05468 TG(18:2(9Z,12Z)/20:0/20:1(11Z)) C61H112O6 985.8441 M+FA-H [1-] 0.0024 5.6637 X  
HMDB05457 TG(18:1(9Z)/20:1(11Z)/20:1(11Z)) C61H112O6 985.8441 M+FA-H [1-] 0.0024 5.9069 X  
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Metabolomics fingerprinting 
 
 
 
 
 
 
   
  
 
 
 
 
   
 
 
 La Parte IV de la Memoria la constituye la investigación dedicada al 
estudio de huellas dactilares metabólicas mediante tres técnicas analíticas 
diferentes, pero complementarias. Además del denominador común que 
constituye la estrategia, la población en estudio estuvo constituida por 
individuos obesos no sometidos a medicación y sin ninguna patología que 
pudiese alterar el estudio. Se realizó un plan para la administración 
controlada de desayunos preparados con cuatro tipos de aceites de origen 
vegetal con diferente perfil de antioxidantes sometidos a un proceso de 
fritura simulado. La muestra utilizada en los tres capítulos que componen 
este bloque fue orina, con la que se obtuvo información del efecto de la 
ingesta de cada uno de los aceites en el metabolismo de cada individuo. El 
criterio considerado para la ordenación de los capítulos que componen este 
bloque ha sido el nivel de información proporcionada por los diferentes 
equipos analíticos utilizados para obtener los espectros correspondientes 
que, a su vez, condiciona el tipo de tratamiento quimiométrico a utilizar.  
 Con este criterio, el Capítulo 11 recoge la investigación realizada 
mediante NIRS con posterior análisis multivariante de tipo supervisado 
(PLS-CM) para predecir el efecto causado en el  metabolismo de los 
individuos por la ingesta de cada uno de los desayunos administrados. El 
Capítulo 12, dedicado a la utilización de NMR, junto al análisis no 
supervisado y supervisado (PCA y PLS-DA, respectivamente), para 
discriminar entre los dos muestreos realizados después de la ingesta frente 
al realizado en condiciones basales, así como la identificación de familias de 
metabolitos influenciados por la administración de cada desayuno. 
Finalmente, el Capítulo 13 recoge el estudio realizado mediante una técnica 
como LC–TOF/MS con el fin de no sólo igualar los niveles de discriminación 
conseguidos en los dos capítulos anteriores, sino también de identificar los 
metabolitos que han experimentado un mayor cambio asociado a la ingesta 
de cada desayuno. 
 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                               
                                                                                                                      
Part IV of the book is devoted to the research on metabolic 
fingerprintings by three different and complementary techniques. In 
addition to the common denominator of the given strategy, the population 
under study was constituted by obese individuals, non subjected to drugs 
intake and without pathologies that can influence the study. A plan was 
designed for controlled supply to the population of breakfasts prepared with 
four types of vegetal oils with different profile of antioxidants and subjected 
to a simulated frying process. The target sample used in all three chapters in 
this part of the book was urine, from which information about the effect on 
the metabolism of each individual of the intake of each of the breakfast was 
obtained. The criterium to order the chapters in this part was the level of 
information provided by the different instrumental plaftorms used to obtain 
the given spectra, which, in turn, determined the chemometric treatment to 
be applied. 
 With this criterium, Chapter 11 contains the research carried out by 
NIRS, with subsequent supervised multivariate analysis (PLS-CM) to predict 
the effect on the individuals metabolism of the intake of the different 
breakfasts. Chapter 12 describes the use of NMR, together with the non 
supervised and supervised analysis (PCA and PLS-DA, respectively) for 
discrimination between the two samplings developed after intake (taking as 
blank or control a sampling developed before breakfasts intake), and also 
identification of metabolites families affected by breakfast intake. Finally, 
Chapter 13 is devoted to the study based on LC–TOF/MS intending, not only 
to reach levels of discrimination similar to those in Chapters 11 and 12, but 
also to identify those metabolites that experienced a higher change 
associated to breakfast intake. 
  
 
 
 
CHAPTER 11: 
Near-infrared spectroscopy and 
partial least squares-class 
modelling (PLS-CM) for 
metabolomics fingerprinting 
discrimination of obese Individuals 
after intake of intervention breakfasts
  
Near-infrared spectroscopy and partial 
least squares-class modelling (PLS-CM) 
for metabolomics fingerprinting 
discrimination of obese individuals 
after intake of intervention breakfasts 
 
B. Álvarez-Sánchez1,,2 F. Priego-Capote, J. García-Olmo, M.C. Ortiz, L. Sarabia, 
M.D. Luque de Castro* 
 
1Department of Analytical Chemistry, Annex Marie Curie Building. Campus of 
Rabanales, University of Córdoba, E-14071, Córdoba, Spain 
2Institute of Biomedical Research Maimónides (IMIBIC), Reina Sofía Hospital, 
University of Córdoba, E-14071, Córdoba, Spain 
3S.C.A.I., NIR/MIR Spectroscopy Division, Ramón y Cajal Building, Campus of 
Rabanales, University of Córdoba, E-14071 Córdoba, Spain 
4Chemistry Department, Plaza Misael Bañuelos, s/n, University of Burgos, 
Burgos, Spain. 
5Mathematics and Computation Department. Plaza Misael Bañuelos, s/n, 
University of Burgos, Burgos, Spain 
 
Sent to Metabolomics for publication 
 
 
   
 
 
 
 
 
 
   
391 
Sent to Metabolomics Chapter 11 
Near-Infrared Spectroscopy and Partial Least Squares-
Class Modelling (PLS-CM) for Metabolomics 
Fingerprinting Discrimination of Obese Individuals 
after Intake of Intervention Breakfasts 
 
B. Álvarez-Sánchez, F. Priego-Capote, J. García-Olmo, M.C. Ortiz, L. Sarabias, 
M.D. Luque de Castro* 
Abstract 
 Near-infrared spectrometry (NIRS) has been used in nutritional 
metabolomics fingerprinting for the assessment of the intake of four 
intervention breakfasts prepared with four different vegetable oils that were 
previously subjected to a deep frying process for 20 cycles of 5 min at 180ºC. 
Target oils were an extra virgin olive oil and three varieties of refined 
sunflower oil. Of the three last, one of them was used as such, other was 
spiked with a synthetic oxidation inhibitor such as dimethylsiloxane and, 
finally, the last one was enriched with an extract of phenolic compounds 
from olive pomace, which are well-known because of their antioxidant 
properties. Urine sampled from individuals before intake and 2 and 4 h after 
intake, was directly analyzed by NIRS to obtain fingerprintings characteristic 
of the metabolome composition. Resulting urinary patterns were combined 
for statistical analysis by unsupervised and supervised approaches. Partial 
least squares-class modeling (PLS-CM) enabled to develop class-models for 
each intervention breakfast that enabled discrimination of urinary 
fingerprintings from individuals after breakfast intake. These models were 
statistically characterized by estimation of sensitivity and specificity 
parameters for the training and validation (prediction) steps, which 
reported quite acceptable values considering a nutritional study dealing 
with humans. The application of Variable Importance in Projection (VIP) 
algorithm enabled to detect those spectral regions with higher significance 
to explain the variability observed in the PLS class-models. Quantitative 
differences of VIP scores discriminated among the different classes under 
study. 
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1.  Introduction 
 
 Metabolomics is gaining popularity in the last decades in a wide 
range of research areas as it provides an insight of the metabolic state of 
biological systems. Thus, targeting metabolomics, which deals with analysis 
of a limited set of metabolites, is sensitively carried out by tandem mass 
spectrometry after chromatographic or electrophoretic separation although 
other less-sensitive detection systems can also be implemented depending 
on the required sensitivity [1]. Global metabolomics profiling, which aims at 
detecting a broad range of metabolites, is usually carried out by high-
resolution separation techniques [(high or ultra performance liquid 
chromatography (HPLC or UPLC), gas chromatography (GC) and capillary 
electrophoresis (CE)] coupled to a mass analyzer [Ion Trap (IT), 
Quadrupole-Time-of-Flight (Q-TOF) and Orbitrap] [2,3]. The last mode, 
known as metabolomics fingerprinting, is widely used to provide 
characteristic patterns or "fingerprints" of the biological system. Analytical 
methods for metabolomics fingerprinting are usually simple and require 
minimum or null sample preparation [4,5]. The main limitation of 
fingerprinting studies is that direct analysis is not always possible and 
sample dilution, extraction of metabolites or deproteinization are frequently 
mandatory steps.  
 Infrared spectrometry (IRS) is starting to gain wide acceptance 
within metabolomics for fingerprinting analysis [6] as it allows direct 
analysis of a wide range of biological samples, including tissues, cells and 
biofluids. The main limitation of IRS for its use in metabolomics is the 
relatively poor selectivity and sensitivity as compared to Nuclear Magnetic 
Resonance (NMR) and Mass Spectrometry (MS), which limits its suitability 
for global profiling and quantitative target analysis. However, rapidity and 
reproducibility of Fourier transform-IR (FT-IR), the nil sample treatment 
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required and the possibility of in-vivo studies even with solid samples are 
relevant benefits that have contributed to recognize IRS as a valuable tool 
for metabolic fingerprinting. Thus, IRS-fingerprinting has been used in 
microbiology for the identification of bacteria to the sub-species level [7], 
differentiation and identification of clinically relevant bacterial species [8,9]. 
Clinical applications of near-IR spectrometry (NIRS) include analysis of 
faeces for diagnosis [10], follicular fluids to provide a biomarker for VOOyte 
quality [11], and synovial fluid to aid in the diagnosis of arthritic disorders 
[12]. In terms of serum analysis, IR spectra have enabled to discriminate 
between diabetes type 1, diabetes type 2 and healthy donors [13]. Metabolic 
fingerprints of athletes to detect doping and overtraining has also been 
investigated using a variety of body fluids, demonstrating that FT-IR could 
be applied to routine clinical analysis [14]. Attempts at cancer research 
include the correct identification and early diagnosis of (pre)cancer stages, 
enabling prompt therapeutic intervention and leading to desirable 
prognosis. A significant number of studies have been undertaken using IRS 
techniques to detect several forms of cancers with varying degrees of 
success. However, it should be stated that these studies must be validated 
with hispathological data on the assayed biological sample.  
  The use of IRS for metabolic fingerprinting can only be addressed in 
combination with multivariate statistical techniques such as principal 
component analysis (PCA), partial least squares discriminant analysis (PLS-
DA) or partial least squares class modeling (PLS-CM) [25−27]. Against a 
discriminating technique, class-modelling techniques allow understanding 
the spectral properties of the sample and developing classification models, 
being possible to estimate sensitivity and specificity for each class-model. 
Sensitivity measures the capacity of the computed model to recognize its 
own objects whereas specificity measures the capacity of the model to reject 
foreign objects. Thus, both parameters jointly describe the performance of 
the computed models and allow evaluation of the possible confusion among 
categories or detection of outlier data. From the definitions it is clear that 
class-models with high sensitivity and high specificity are needed. However, 
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these parameters generally show opposite behaviour: when one increases 
the other decreases, so it is useful to evaluate the sensitivity and specificity 
of a family of classes both in fitting and in prediction [28,29].  
In this research NIR spectrometry has been used to obtain metabolic 
fingerprints of urine obtained from a nutritional study in humans. The 
nutritional study consisted of intake of four independent intervention 
breakfasts prepared with fried edible oils containing different 
concentrations of oxidation inhibitors naturally present or added to them. 
The analysis of the effects caused by the intake of the different breakfast was 
supported on a class-modelling (CM) statistical technique (PLS-CM). The aim 
of this study was to extend the applicability of IRS-based fingerprinting to 
human nutrition by exploring the effect of food intake on metabolism. In 
fact, IRS has been previously used to assess the nutritional characteristics of 
food and for quality control during food production [17,18], while there are 
not applications of IRS to evaluate the final effect of food intake on 
metabolism. This could be addressed in a similar way to studies proposed to 
evaluate the biological effect of toxins or drugs. One example is the analysis 
of urinary fingerprints, used to demonstrate the effect of chronic 
cysteamine (CS) supplementation [24] on the urinary metabolic profile, 
thus enabling identification of endogenous metabolites whose levels 
were disturbed by CS exposure. By extrapolation the purpose should be 
to analyze the change in the metabolic profile of biofluids after food 
consumption.  
Biological fluids such as plasma, serum or urine [22,23] have been 
commonly used for fingerprinting metabolomics, as they are easily and non-
invasively collected. Additionally, they directly reflect the global state of an 
individual and/or his response to drug treatment or diet intake, with the 
only requirement of simple sample preparation protocols. It is expected that 
metabolic changes due to the intake of breakfasts prepared with different 
oils would lead to changes in the urinary profile.  
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2.  Materials and methods 
 
2.1.  Oils and heating procedure 
 
The four edible oils used for this study were: 
(1) Extra virgin olive oil prepared by mixing different commercial extra-
virgin olive oils (VOO). The mixture was optimized for a final 
concentration of total phenols of 400 µg/mL, expressed as µg/mL of 
caffeic acid by the Folin−Ciocalteu test, and had the following fatty 
acids composition: 70.5% monounsaturated fatty acids (MUFAs), 
11.1% PUFAs, 18.4% saturated fatty acids (SFAs).  
(2) Commercial pure refined sunflower oil with nil content in phenolic 
compounds (S), and had the following fatty acids composition: 34.3% 
MUFAs, 58.3% PUFAs and 7.3% SFAs. 
(3) Refined high-oleic sunflower oil that was spiked at 400 µg/mL with a 
synthetic lipophilic oxidation inhibitor (dimethylsiloxane, DSO). This 
prepared oil had the following fatty acids composition: 71.8% 
MUFAs, 18.0% PUFAs and 10.2% SFAs. 
(4) Refined high-oleic sunflower oil that was enriched with an extract of 
hydrophilic phenols isolated from olive pomace by a protocol similar 
to that developed by Girón et al. [30]. The enrichment was carried 
out at 400 µg/mL of total phenols expressed as caffeic acid. The 
concentration of fatty acids was as follows: 76.7% MUFAs, 17.6% 
PUFAs and 5.8% SFAs. 
Each oil (2 L) was placed in a stainless-steel deep fryer, and was 
heated at 180 ºC ± 5 ºC for 5 min a total of 20 cycles. The purpose of the 
enrichment of refined edible oils with antioxidants was to enhance oils 
stability and improve healthy properties.  
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2.2. Subjects and samples 
 
 The experiment was planned following the guidelines dictated by the 
World Medical AsSiation Declaration of Helsinki (2004), which were 
supervised by the ethical review board of Reina Sofia Hospital (Córdoba, 
Spain) that approved the experiments. Eighteen obese individuals with a 
body mass index between 30–40 kg/m2 formed the cohort in this study. All 
of them gave their informed consent and underwent a comprehensive 
medical history, physical examination and clinical chemistry analysis before 
enrolment. Participants with evidence of kidney, pancreas, lung, liver or 
thyroid diseases were excluded. All subjects were non-diabetics, non-
smokers and did not manifested clinical evidences of cardiovascular disease. 
The target cohort was composed by 9 post-menopausal women, age 48–70 
years, and 9 men, age 39–70 years. None of the subjects was taking 
medication or supplementary vitamins with influential effect on urine 
metabolome.  
 All volunteers received four breakfasts in muffin format prepared 
with the four different oils (0.45 mL of oil per kilogram of body weight), 
previously subjected to the simulated frying process. The administration of 
each breakfast was randomized and crossed following a Latin square design, 
which increased the power of the study. The volunteers ate one of the 
breakfasts every two weeks (4 oils, 8 weeks). During the sampling period (4 
hours) subjects did not consume any food. 
 Sampling was performed following the Recommendations on 
Biobanking Procedures for urine processing and management recently 
published by the European Consensus Expert Group Report [31]. According 
to this document, biobanking procedures for urine should consider the 
following general consensus recommendations: (i) cells and particulate 
matter should be removed (e.g. by centrifugation); (ii) samples should be 
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stored at −80ºC or below; (iii) time limits for processing should have been 
defined experimentally and should be appropriate to the analytes to be 
measured; (iv) unless specified for a particular downstream analysis, urine 
samples should be stored without additives [32].  
 In order to obtain suitable control samples and carry out a time-
course study of urinary excretion after dietary intervention, samples were 
obtained at 0 (basal state) and 2 and 4 h after intake. Urine was collected in 
sterile containers, aliquoted in 2-mL Eppendorfs, centrifuged at 1500 g 4 ºC 
for 10 min and stored at –80 °C until analysis. This protocol ensures removal 
of particulates that may interfere with both analysis and quenching 
bacterial/enzymatic activity in urine during storage. 
 
2.3.  Instruments and apparatus 
 
 The instrument used for spectra collection was a Spectrum One NTS 
FT-NIR spectrophotometer (Perkin Elmer LLC, Shelton, USA) equipped with 
an integrating sphere module. Samples were analyzed by transflectance 
using a glass Petri dish and a hexagonal reflector with a total transflectance 
path length of approximately 0.5 mm. A diffuse reflecting stainless steel 
surface placed at the bottom of the cup reflected the radiation back through 
the sample to the reflectance detector. The spectra were collected using 
Spectrum Software 5.0.1 (Perkin Elmer LLC, Shelton, USA). Before analysis, 
aliquots were thawed and thermostated at 24 °C. The reflectance (log1/R) 
spectra were collected in duplicate and averaged for chemometric analysis.  
Centrifugation was carried out with a thermostated centrifuge 
Thermo Sorvall Legend Micro 21 R from Thermo (Thermo Fisher Scientific, 
Bremen, Germany). 
 
2.4.  Data acquisition and software 
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Two reflectance spectra were acquired for each sample at the 
wavelength range 800−2500 nm at 0.2 nm intervals. The two spectra per 
sample were averaged, resulting in 8501 reflectance measurements for each 
sample. Therefore, the preliminary data set was composed by 216 files 
(corresponding to the total spectra obtained for each urine sample taken 
before and 2 and 4 h after breakfast intake) × 8501 measurements.  
Unscrambler software (version 9.2, Process AS, Oslo, Norway) was 
used for data processing. To fit and validate the PLS models, the PLS Toolbox 
3.5 (Eigenvector Research, Inc) for MATLABTM was used. The MATLAB codes 
used for computing the RC and CVRC procedeures were developed by the 
authors. 
 
3. Results and discussion 
 
3.1. Data pretreatment 
 
Deep fat frying is one of the most common processes used 
worldwide for preparation of cooked food. However, frying lead to oxidation 
reactions resulting in loss of nutritional value as well as in changes of 
organoleptical properties [19,20]. It has been demonstrated that the 
presence of antioxidants, naturally existing in (or added to) oils, exerts 
beneficial effects by avoiding or delaying oxidation of compounds such as 
sterols, fatty alcohols, triterpenic dialcohols and unsaturated fatty acids. 
Phenolic compounds are naturally occurring antioxidants present in 
vegetable oils [21]. In the present study, we postulate that composition of 
vegetable oils and their antioxidant profile would have an impact on human 
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health and metabolism, which would be reflected in the metabolic profile 
and, concretely in the urinary fingerprint.  
Prior to multivariate analysis, the data set was normalized by 
application of the standard normal variate (SNV) and first Norris derivative. 
A common factor associated to metabolomics fingerprinting analysis in 
clinical and nutritional studies dealing with humans is the biological 
variability among individuals. This variability is frequently higher than 
variability associated to the effect caused by internal factors (diseases, 
metabolic disorders) or external factors (diet, lifestyle). For this reason, 
variability among individuals can be masked by their influence. In this 
research, data reduction was carried out in order to minimize the biological 
variability not ascribed to breakfasts intake. For this purpose, the spectrum 
acquired in basal state (t0) was subtracted from spectrum acquired 2 and 4 h 
after the consumption of the prepared meal. Therefore, the sample set was 
finally composed by 144 samples (18 individuals × 4 breakfasts × 2 
subtracted spectra) and 8501 measurements. By this data pretreatment  
minimization of inter-individuals variability sources should be expected, and 
thus, variability ascribed to the type of intervention breakfast be 
discriminated.   
Supplementary Figure 1 shows the accumulation of 144 spectra 
highlighting those corresponding to each breakfast. As can be seen, urine 
spectra behave as characteristic fingerprintings of the metabolic profile. 
Differences in the spectra associated to each breakfast can be clearly 
visualized revealing a variability source in specific zones of the spectrum. 
The only region that did not show variability among individuals was that in 
the wavelength range 800−1120 nm; therefore it was removed from the 
data set to avoid redundant information. A total of 1600 columns were 
eliminated from the data set leading to a final matrix composed by 144 
samples × 6901 measurements. 
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3.2. Statistical analysis by unsupervised and supervised analysis 
 
The comparison of metabolic fingerprintings obtained for each 
individual after intake of the four intervention breakfasts was supported on 
a dual strategy integrating two multivariate analysis techniques. The 
strategy was based on unsupervised analysis, to detect the presence of 
cluster of individuals that could be correlated with the intervention, and 
supervised analysis, incorporating information for the development of 
predictive models. Multivariate analysis started by unsupervised PCA 
analysis to reduce dimensionality of the data set. The purpose was to detect 
the presence of sample clusters that could be associated to the intake of 
certain fried oils. As previously explained, data were normalized and, in this 
case, the data set was autoscaled prior to the application of the algorithm. 
Figure 1 shows the scores plot corresponding to the PC1–PC2 space. As can 
be seen, no cluster or sample groupings associated to the intervention 
breakfast intake by individuals could be detected by combination of the two 
first PCs or by other combination. The explained variability in this case with 
the PC1 and PC2 was 34.89%. Influence of anthropometric factors such as 
age and gender was discarded since the individuals were neither classified 
according to these two variables.  
Attending to these results, the data set was analyzed by supervised 
analysis using PLS-CM. The proposed statistical methodology couples a PLS 
regression with a binary response and a hypothesis test to build a set of 
different models for each class. The PLS-CM technique has been previously 
applied to evaluate screening methods in chemical analysis [33]. PLS-CM 
seems to be specially suited for the study here reported since the 
correlations of absorbance values at different wavelengths or the possible 
collinearities do not limit PLS regression. Additionally, spectral regions with 
higher statistical relevance for the development of the model for each class 
can be identified.  
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Figure 1. Scores plot corresponding to the PC1–PC2 space obtained 
from the PXA analysis of the four classes. 
 
Supplementary Figure 1.A. Accumulation of 144 spectra; red: NSO, 
blue: PSO,DSO, VOO 
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Supplementary Figure 1.B. Accumulation of 144 spectra; red: VOO, 
blue: PSO,DSO, NSO. 
 
Supplementary Figure 1.C. Accumulation of 144 spectra; red: DSO, 
blue: PSO, VOO, NSO. 
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Supplementary Figure 1.D. Accumulation of 144 spectra; red: PSO, 
blue: VOO, DSO, NSO. 
 
Finally, and also importantly, the Q and T2 statistical parameters 
allow detecting outliers that can be eliminated from the data set to avoid 
erroneous application of the model. With these premises, the data set was 
associated to a vector y (response) with 144 lines to categorize the variable 
to be modeled. Thus, the value of this variable was "1" when the individual 
belonged to the modeled class, and "0" when the individual belonged to 
another class. This operation was performed for each intervention breakfast 
to develop an independent model for each one. Prior to analysis the raw data 
set was subjected to the following pretreatment: (i) first derivative of 
predictor variables by means of a Savitzky-Golay filter with a second order 
polynomial and a window of 15 points; (ii) standard normal variate (SNV); 
and, (iii) no pretreatment for the 1/0 binary response. Figure 2 illustrates 
the PLS plots provided for VOO intervention breakfast for the 1st and 2nd 
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and 3rd and 4th latent variables. As can be seen, individuals after intake of 
the modeled class were discriminated from the rest of individuals although 
partial overlapping can be visualized. Similar PLS-CM discriminations were 
observed for the resting intervention breakfasts. Therefore, the different 
effects resulting from the intake of the intervention breakfasts can be 
confirmed. 
 
3.3. Development of statistical models by PLS-CM for each intervention 
breakfast  
 
 Once discrimination between individuals after intake of each 
breakfast was accomplished, the next purpose was the characterization of 
the parameters that statistically define each class.  The main aspect 
distinctive of PLS-CM is that the class-models are built from estimations of 
the probability distribution of each category, which means that sensitivity 
and specificity can be computed. 
The graphical plot of both parameters is the risk curve (RC). In this 
sense, PLS-CM can be differentiated from PLS-DA [33−37], although they 
share some of their properties. Barker and Rayens [34] provided some 
insights and formal support to the PLS-DA method and suggested its use for 
dimension reduction aimed at discrimination. Also, González-Arjona et al. 
[37] established the relation between PLS-DA and procrustes discriminant 
analysis. However, the resulting methods were exclusively aimed at 
discrimination tasks. A discussion about the relation between PLS-CM and 
hypothesis test can be seen in ref. [38]. 
Usually, the class-models are computed to be used in prediction of 
future samples. In that sense, statistical validation about the expected 
behaviour in prediction should be given. When there are not many samples 
available, cross-validation is the preferred choice, i.e., to systematically split 
the available data set into different subsets of size t, which are used as an 
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evaluation set (validation or prediction set), while the remaining n−t 
samples become the training set. 
 
 
 
 
 
 
 
 
 
Figure 2.A. Scores of the first and second latent variables for the class model 
VOO vs. the rest. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.B. Scores of third and fourth latent variables for the class 
PSO, DSO, NSO 
VOO 
PSO, DSO, NSO 
VOO 
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 The procedure ends when all samples have been evaluated once. 
However, the usual cross-validation procedures are designed to evaluate the 
prediction capacity of a classification model. On the contrary, PLS-CM 
generates a set of class models, and thus, a procedure for this task needs to 
be defined. Ortiz et al. [38] proposed a segmented double cross-validation of 
the risk curve in the case of PLS-CM. In this research, the cross-validation for 
each PLS regression class-model has been carried out with three sets of 
evaluation, selecting samples according to the venetian blinds procedure. 
 
3.3.1. Class-models for VOO-intervention breakfast  
 The details of PLS regression with all the samples for training, X, and 
the three cross-validation sets are in Table 1. It is important to mention that 
in none of the four models exposed in Table 1, individuals with values of T2 
and Q parameters above the threshold value at 95% confidence were found; 
therefore, no outliers were detected. As Table 1 shows, with an explained 
variance in X between 42.3 and 44.4% (considering four latent variables), 
the four PLS class-models explains a variance between 73.7 and 81.6% of 
the individuals after intake of VOO-intervention breakfast. This means that 
less than a half of the variability of the spectra can be related to the intake of 
this intervention breakfast. 
 The means and standard deviations were 0.74 and 0.26 for VOO class 
and 0.001 and 0.18 for the non-VOO class (formed by individuals after intake 
of the resting breakfasts), respectively. Using two normal distributions with 
these parameters, the RC obtained is shown with a continuous line in Figure 
3.A. The cross-validation risk curve (CVRC) is depicted by open circles. As 
can be seen, models with 95.3% of sensitivity and 95.3% of specificity were 
obtained in the training step.  
Characterization was completed with cross-validation since a more balanced 
model (71.4% and 71.3% of sensitivity and specificity, respectively) was 
obtained. As previously emphasized, sensitivity and specificity present an
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Table 1. Statistical evaluation of PLS-CM model for VOO intervention breakfast 
versus the resting breakfasts. Root mean squared error in cross-validation 
(RMSECV) and in fitting (RMSEC) and cumulative variances of predictors (X) 
and response (y) explained by the PLS model as a function of the number of 
latent variables. The values selected for the model are indicated with italic 
characters. 
 
 
Nº of latent 
variables 
RMSECV RMSEC 
Explained variance 
in X (% 
accumulated) 
Explained variance 
in y (% 
accumulated) 
PLS  with all 108 samples (21 VOO and 87 non VOO) 
1 0.4430 0.4094 25.83 13.79 
2 0.4425 0.3231 34.12 46.31 
3 0.4184 0.2814 39.65 59.28 
4 0.4341 0.2261 42.29 73.70 
5 0.4388 0.1871 44.81 82.00 
PLS for the first training set 
1T
X , with 72 samples (14 VOO and 58 non VOO) 
1 0.4509 0.3943 25.26 20.02 
2 0.4402 0.2908 34.90 56.50 
3 0.4404 0.2523 40.43 67.26 
4 0.4553 0.2150 44.43 76.22 
5 0.5005 0.1779 47.27 83.73 
PLS for the second training set 
2T
X , with 72 samples (14 VOO and 58 nonVOO) 
1 0.5064 0.3386 7.65 41.05 
2 0.4973 0.3110 34.05 50.26 
3 0.5181 0.2525 38.99 67.21 
4 0.5242 0.1994 42.72 79.55 
5 0.5376 0.1526 45.08 88.03 
PLS for the third  training set 
3T
X , with 72 samples (14 VOO and 58 non VOO) 
1 0.4349 0.4102 27.64 13.46 
2 0.4402 0.3124 34.43 49.82 
3 0.4215 0.2461 40.01 68.86 
4 0.4185 0.1893 43.13 81.58 
5 0.4291 0.1533 45.98 87.91 
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opposite behavior. Thus, if a prediction model with 95% of sensitivity was 
required, specificity would decrease up to 25%, while a model with 95% of 
specificity would reduce sensitivity up to 29%. 
 
Figure 3.A. Risk curve (continuous line) and cross-validation risk curve (open 
circles) for VOO-class model. 
 
3.3.2. Class-models for NSO-intervention breakfast  
 The statistical parameters of PLS regression models for NSO-
intervention breakfasts is presented in Table 2. Similarly, four latent 
variables were used to define the class-model and no outliers at 95% of 
confidence were detected. The percentage of variance explained in X (or 
iT
X  
i= 1, 2, 3) block was similar to VOO class-model ranging from 42.6 to 
45.0%.The variance explained for the response variable ranged from 66.3 
and 78.7%, a little bit lower that the variance explained in the VOO-class 
model. As a result, the mean and standard deviation were 0.66 and 0.31 for S 
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class, while for the non-S were 0.06 and 0.31, respectively. Therefore, the 
means are closer and the RC is further from the 100%, as Figure 3.B shows. 
  
Figure 3.B. Risk curve (continuous line) and cross-validation risk curve (open 
circles) for NSO-class model.  
 
 In this case, an equilibrated model was obtained in the training step 
with 88.3 of sensitivity and 87.4% of specificity. On the other hand, the 
prediction model reported lower values for both parameters, with 71.4 and 
71.2% for sensitivity and specificity, respectively. Although both parameters 
were lower than in the VOO class-models, both parameters were similar in 
prediction for the two studies. The model can be forced to attain a 95% of 
specificity with a subsequent decrease of sensitivity up to 75.5% in the 
training step and up to 22.9% in prediction. Similarly, a model with 95% 
sensitivity could be forced with specificity values of 75.5 and 46.6% in the 
training and prediction steps, respectively. 
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Table 2. Statistical evaluation of PLS-CM developed model for S intervention 
breakfast versus the resting breakfasts. Root mean squared error in cross-
validation (RMSECV) and in fitting (RMSEC) and cumulative variances of 
predictors (X) and response (y) explained by the PLS model as function of the 
number of latent variables. The values selected for the model are indicated 
with italic characters. 
Nº of 
latent 
variables 
RMSECV RMSEC 
Explained variance 
in X (% 
accumulated) 
Explained 
variance in y (% 
accumulated) 
PLS  with all 108 samples (35 S and 73 non S) 
1 0.5460 0.5284 27.75 13.85 
2 0.5195 0.4425 35.78 39.57 
3 0.5078 0.3781 40.10 55.89 
4 0.5165 0.3304 43.18 66.32 
5 0.5197 0.2845 45.64 75.03 
PLS for the first training set 
1T
X , with 70 samples (23 S and 47 non S) 
1 0.5366 0.5043 27.24 10.09 
2 0.5194 0.3733 34.38 55.65 
3 0.5354 0.3183 39.59 67.76 
4 0.5460 0.2589 42.65 78.66 
5 0.5838 0.2280 46.68 83.45 
PLS for the second training set 
2T
X , with 72 samples (23 S and 49 non S) 
1 0.5412 0.5152 30.27 16.90 
2 0.5918 0.4116 34.77 46.96 
3 0.6140 0.3512 39.85 61.38 
4 0.6391 0.2858 43.09 74.43 
5 0.6585 0.2219 45.67 84.59 
PLS for the third  training set 
3T
X , with 73 samples (24 S and 49 non VOO) 
1 0.5241 0.4811 14.28 29.60 
2 0.5094 0.4360 37.13 42.17 
3 0.5035 0.3427 41.36 64.27 
4 0.4959 0.2979 45.04 73.00 
5 0.5304 0.2566 47.58 79.98 
 
 
 
 411 
Sent to Metabolomics                                                                                    Chapter 11                                                                                 
3.3.3. Class-models for DSO-intervention breakfast 
 The PLS model for intake of DSO-intervention breakfast was 
developed resulting in the parameters listed in Table 3. No anomalous data 
were found at 95% confidence level according to T2 and Q parameters. 
Except for PLS model for the second cross-validation set, the explained 
variance of predictor block ranged from 42.5 to 47.5% while the variance 
explained for the response y was from 82.0 to 85.3%. When the training set 
was
2T
X , the values of these variances were lower (particularly, 36.9 and 
47.5%, respectively). This behaviour could be ascribed to the presence of 
two subsets of individuals affected by a different trend. 
 
Figure 3.B. Risk curve (continuous line) and cross-validation risk curve (open 
circles) for NSO-class model.  
 412 
Nuevas plataformas analíticas en metabolómica                                                                                    
Table 3. Statistical evaluation of PLS-CM model for DSO intervention breakfast 
versus the resting breakfasts. Root mean squared error in cross-validation 
(RMSECV) and in fitting (RMSEC) and cumulative variances of predictors (X) 
and response (y) explained by the PLS model as a function of the number of 
latent variables. The values selected for the model are indicated with italic 
characters. 
Nº of 
latent 
variables 
RMSECV RMSEC 
Explained variance 
in X (% 
accumulated) 
Explained 
variance in y (% 
accumulated) 
PLS  with all 108 samples (28 DSO and 80 non DSO) 
1 0.4910 0.4707 28.08 14.56 
2 0.4746 0.3913 36.05 40.94 
3 0.4581 0.3053 39.76 64.06 
4 0.4410 0.2633 43.81 73.26 
5 0.4236 0.2159 45.64 82.01 
6 0.4344 0.1751 47.12 88.18 
PLS for the first training set 
1T
X , with 70 samples (18 DSO and 52 non DSO) 
1 0.4896 0.4660 31.10 15.56 
2 0.5019 0.3654 36.87 48.08 
3 0.4988 0.2614 39.87 73.43 
4 0.4864 0.2351 44.99 78.51 
5 0.4849 0.1943 47.48 85.32 
6 0.5221 0.1606 49.71 89.97 
PLS for the second training set 
2T
X , with 73 samples (19 DSO and 54 non DSO) 
1 0.5010 0.2563 25.37 19.67 
2 0.3899 0.1267 36.90 47.53 
3 0.4425 0.0634 41.21 66.11 
4 0.4425 0.0448 45.42 77.48 
5 0.3543 0.0093 48.41 85.78 
6 0.3991 0.0093 50.94 90.90 
PLS for the third  training set 
3T
X , with 73 samples (19 DSO and 54 non DSO) 
1 0.5039 0.4577 24.71 19.51 
2 0.5030 0.3725 35.16 46.70 
3 0.5042 0.2555 39.12 74.91 
4 0.4982 0.2043 42.53 83.96 
5 0.5048 0.1514 44.26 91.19 
6 0.5131 0.1220 46.35 94.28 
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 The mean and standard deviation of PLS values for DSO class models 
were from 0.24 to 0.82, respectively. Samples not belonging to the class 
formed by individuals after intake of DSO-intervention breakfast presented 
mean and standard deviation values of 0.01 and 0.18, respectively. In 
comparison with the VOO class-model, the mean values were more 
separated, while the standard deviations were similar, which explained the 
closer position to the axes of the RC. This can be checked in Figure 3.C. 
 The resulting model was more balanced in the training step, 97.6% 
of sensitivity and 97.7% of specificity, while in prediction these values were 
78.6 and 80.0%, respectively. Sensitivity could be improved up to a 95% of 
specificity with sensitivity of 98.8% in the training step and a reduction up 
to 28.6% in the prediction step. Analogously, a model with 95% sensitivity 
could be attained with specificity values of 99.2 and 38.8% for the training 
and prediction steps, respectively. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.C. Risk curve (continuous line) and cross-validation risk curve (open 
circles) for DSO-class model.  
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Table 4. Statistical evaluation of PLS-CM developed model for PSO intervention 
breakfast versus the resting breakfasts. Root mean squared error in cross-
validation (RMSECV) and in fitting (RMSEC) and cumulative variances of 
predictors (X) and response (y) explained by the PLS model as function of the 
number of latent variables. The values selected for the model are indicated 
with italic characters. 
Nº of 
latent 
variables 
RMSECV RMSEC 
Explained variance 
in X (% 
accumulated) 
Explained 
variance in y (% 
accumulated) 
PLS  with all 108 samples (28 PSO and 80 non PSO) 
1 0.4634 0.4441 28.96 11.23 
2 0.4463 0.3599 34.90 41.72 
3 0.4363 0.2876 39.04 62.77 
4 0.4142 0.2499 43.46 71.90 
5 0.4268 0.2147 45.92 79.25 
6 0.4320 0.1829 48.14 84.95 
PLS for the first training set 
1T
X , with 70 samples (14 PSO and 56  non PSO) 
1 0.4504 0.3752 20.41 29.61 
2 0.4291 0.2834 37.01 58.43 
3 0.4205 0.2138 40.81 77.15 
4 0.4036 0.1698 44.65 85.89 
5 0.3982 0.1399 48.23 90.21 
6 0.3999 0.1124 50.70 93.68 
PLS for the second training set 
2T
X , with 72 samples (16 PSO and 56  non PSO) 
1 0.4695 0.4357 26.02 14.56 
2 0.4650 0.3577 35.83 42.42 
3 0.4509 0.2750 40.05 65.96 
4 0.4366 0.2216 42.86 77.90 
5 0.4456 0.1872 46.10 84.24 
6 0.4574 0.1583 48.98 88.72 
PLS for the third  training set 
3T
X , with 71 samples (15 PSO and 56  non PSO) 
1 0.4427 0.4190 26.21 16.90 
2 0.4438 0.3191 31.57 51.80 
3 0.4358 0.2260 34.45 75.82 
4 0.4294 0.1959 40.19 81.83 
5 0.4301 0.1668 44.96 86.83 
6 0.4335 0.1414 48.38 9054 
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3.3.4. Class-models for PSO-intervention breakfast 
 The last PLS-CM was that for characterization of individuals after 
intake of PSO-intervention breakfasts (Table 4). As in all previous cases, not 
outliers at 95% of confidence level were found, which means that no 
anomalous cases were found in the complete experiment. The percentage of 
variance explained in X and y were between 40.2 and 48.2% and between 
71.9 and 85.9%, respectively. As compared to the three previous PLS-CM 
studies, similar values were found. The mean and standard deviation values 
for PSO class-models were 0.72 and 0.25, respectively, while these 
parameters were 0.03 and 0.2 for individuals that did not intake the referred 
intervention breakfast. As can be seen in Figure 4, the RC presented with 
these data, the RC curve is that of Fig. 3.D, that is equally positioned as the 
VOO RC. 
 The optimum model (more equilibrated) in the training step 
reported a 93.7% in sensitivity and 93.5% in specificity, while the prediction 
model provided that sensitivity and specificity values of 70.8 and 66.7%, 
respectively. The model could be forced up to a 95% of specificity with a 
decrease of sensitivity up to 97.3% in training and 33.3% in prediction. A 
model with 95% of specificity would involve a 97.45 of sensitivity in training 
and a relevant reduction up to 20.2% in prediction. 
 As a global summary, the PLS-CM study has verified that metabolic 
discrimination of individuals after intake of different intervention breakfasts 
can be attained by comparison of urine fingerprints by NIR spectrometry. 
The different classes (intervention breakfasts) could be ordered in terms of 
specificity and sensitivity as follows: DSO-intervention breakfast gave place 
to the class-model with the highest specificity and sensitivity parameters 
(RC closer to the axis), then S-class model, PSO-class model and, finally, the 
VOO-class model. Concerning prediction capability, this was quite acceptable 
for the four class-models studied. Among them, the DSO-model was the best 
in prediction capability, then VOO- and S-models were quite similar and, 
finally, the PSO-model. Although evaluated in the plots and tables, the 
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quantitative differences in the statistical parameters used to characterize 
the class models were below 10%. The differences observed in sensitivity 
and specificity for training and prediction steps could be ascribed to inter-
individual and intra-individual differences. With the data pretreatment 
employed in this research, inter-individual variability before the intake of 
breakfasts is minimized. However, each individual responds in a different 
way to each intake, and this type of variability is particularly relevant in 
clinical and nutritional studies dealing with humans. Apart from this inter-
individual variability, there is also contribution of intra-individual variability 
since each individual is influenced by a great variety of internal and external 
factors. In this study, some of these factors such as medication or diseases 
were controlled but, there are other factors that cannot be controlled. 
Taking into account that a nutritional study was carried out involving 
humans, the models are quite acceptable for the purpose of the research. 
 
Figure 3.C. Risk curve (continuous line) and cross-validation risk curve (open 
circles) for PSO-class model.  
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3.4. Identification of spectral regions responsible of intervention 
breakfast discrimination 
 
 The statistical characterization of the different class-models 
developed for each intervention breakfast enables the possibility to detect 
spectral regions responsible for the discrimination of each class. These 
spectral regions can be modified both in qualitative and quantitative terms. 
In this research, the identification of significant spectral regions contributing 
to explain the observed variability in each PLS-CM developed was carried 
out by the Variable Importance in Projection (VIP) algorithm. This algorithm 
provides a projection of the variables used to develop the PLS model with a 
score to quantify their statistical significance. A variable with a VIP score 
close to or greater than one can be considered important. Variables with VIP 
scores less than one are significantly less important and might be good 
candidates for exclusion from the model. It should be noted that the nature 
of the VIP calculation is such that when the model is rebuilt, new variables 
will always be below the threshold so an iterative variable exclusion is not 
recommended [40].  
  As can be seen, the same spectral regions are responsible to explain 
the variability of each PLS class-model. These spectral regions range from 
1800 to 2000 cm-1 and from 2350 to 2500 cm-1. Therefore, qualitatively, the 
intake of intervention breakfasts is similarly manifested attending to the 
urine NIR fingerprintings. Nevertheless, there are quantitative differences in 
the score values for these spectral regions. Thus, in the spectral region 
ranging from 1800 to 2000 cm-1, scores values are the highest for PSO-
intervention breakfast, then for DSO-intervention breakfast, VOO-
intervention breakfast and, finally for S-intervention breakfast. This region 
is frequently associated to hydroxyl functional groups, the first sobretone of 
carbonyl functional groups but also amino groups could be involved. 
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Therefore, families of compounds that could contribute to these signals 
range from oxidized compounds such as fatty acids, aldehydes or ketones 
and also amino compounds present in urine such as amino acids metabolites 
or carnitine derivatives (metabolites of fatty acids). Also, phenolic 
compounds could contribute to signals obtained in this region with special 
emphasis on VOO and PSO intervention breakfasts, although tocopherols are 
present in sunflower oils even at higher concentration than VOO. On the 
other hand, the spectral region from 2350 to 2500 cm-1 shows two different 
bands. In the area close to 2350, bands are more relevant for VOO class, 
being practically absent for PSO, DSO and S classes. However, the area closer 
to 2500 cm-1 presents a common profile for VOO and S classes while it is 
more attenuated for DSO and PSO classes. This region can be assigned to –
CH3, –CH2– and –CH=CH– groups present in chemical structures of 
metabolites proceeding from the metabolism of fried oils used to prepare 
the intervention breakfasts.  
 
4. Conclusions 
 
Metabolomics fingerprinting is practically dominated by the 
utilization of NMR and MS techniques due to their potential in qualitative 
analysis with identification purposes and the benefits in terms of 
selectivity/sensitivity. However, instrumentation based on these techniques 
is expensive and requires personnel with a high formation level. On the 
other hand, near-infrared spectrometry (NIRS) is a fast and reproducible 
technique specially suited for the development of classification methods to 
discriminate among classes. Thus, in this research NIRS has been employed 
to obtain urine fingerprintings for comparison of the metabolic effect caused 
by different intervention breakfasts. In this sense, the potential of NIRS as a 
tool for development of screening methods has been proved. Thus, after 
screening analysis, extensive research could be carried out with other more
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Figure 4.A. VIP scores for VOO PLS-class model. 
 
Figure 4. B. VIP scores for NSO PLS-class model. 
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Figure 4.C. VIP scores for DSO PLS-class model  
 
Figure 4.D. VIP scores for PSO-PLS class model.
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sophisticated techniques. The main benefits of PLS-CM have been taken for 
the development of this research. 
 
5.  Acknowledgements 
 
 The Spanish Ministerio de Ciencia e Innovación (MICINN) and FEDER 
program are thanked for financial support through project CTQ2009-07430. 
B.A.-S. and F.P.-C. are also grateful to the MICINN for an FPI scholarship 
(BES-2007-15043) and a Ramón y Cajal contract (RYC-2009-03921). 
 
6.  References 
 
[1] Dunn, W.U., Ellis D.I. (2008) Trends Anal. Chem. 24 (4) 285−294. 
[2] Theodoridis G., Gika H.G., Wilson I.D. (2008) Trends Anal. Chem. 27 (3) 
251−260. 
[3] Goodacre R., Vaidyanathan S., Dunn W., Harrigan G.G., Kell D.B., Trends 
Biotechnol. 22 (5) 245−252.   
[4] Ward J.L., Baker J.M., Beale M.H. (2008) FEBS Journal 274 (5): 1126–
1131. 
[5] Shulaev V., Cortes D., Miller G., Mittler R. (2008) Physiologia 
Plantarum 132 (2): 199–208. 
 [6]  R.G. Dambergs, A. Kambouris, I. L. Francis, M. Gishen, J. Agric. Food 
Chem. 50, 11 (2002) 3079–3084. 
 422 
Nuevas plataformas analíticas en metabolómica                                                                                    
[7] Ellis D., Broadhurst D., Kell D.B., Rowland J.J., Goodacre R. (2002) Appl. 
Environ. Microbiol. 68: 2822−2828. 
[8] Kaderbhai N.N., Broadhurst D.I., Ellis D.I., Goodacre R., Kell D.B. (2003) 
Comp. Funct. Genom. 4: 376−391.  
[9] Diem M., Boydston-White S., Chiriboga L. (1999) Appl. Spectrosc. 53: 
148A−161A.  
[10] Nakamura T., Takeuchi T., Terada A., Tando Y., Suda T. (1998) Int. J. 
Pancreatol. 23: 137−143. 
[11] Goodacre R., Timmins E.M., Gaudoin M., Fleming R. (2000) Hum. 
Reprod. 15: 1667−1671.  
[12] Eysel H.H., Jackson M., Nikulin A., Somorjai R.L., Thomson G.T.D., 
Mantsch H.H. (1997) Biospectroscopy 3: 161−167.  
[13] Petrich W., Dolenko B., Fruh J., Ganz M., Greger H., Jacob S., Keller F., 
Nikulin A.E., Otto M., Quarder O., Somorjai R.L, Staib A., Warner G., Wielinger 
H. (2000) Appl. Opt. 1: 3372−3379.  
[14] Petibois C., Cazorla G., Deleris G. (2002) Appl. Spectrosc. 56: 10−17. 
[15] Chiriboga L., Xie P., Yee H., Vigorita V., Zarou D., Zakim D., Diem M. 
(1998) Biospectroscopy 4: 47−53.  
[16] Lasch P., Haensch W., Lewis E.N., Kidder L.H. Naumann D. (2002) Appl. 
Spectrosc. 56: 1−9. 
[17] Cen H., He Y. (2007) Trends Food Sci. Technol. 18 (2): 72−83. 
[18] Infrared Spectroscopy for Food Quality Analysis and Control.  Ed. Da-
Wen Sun, 2009, Elsevier. 
[19] Tyagi V.K. Vasishtha A.K. (19996) J. Am. Oil Chem. S. 73: 499−506. 
   
423 
Sent to Metabolomics                                                                                    Chapter11                                                                                   
[20] Saguy I.S., Danaa D. (2003) J. Food Eng. 56: 143−152. 
[21] Japón-Luján R., Luque de Castro M.D. (2008) J. Agric. Food Chem. 56: 
(2008) 2505–2511. 
 [22] Llorach R., Urpi-Sarda M., Jauregui O., Monagas M., Andres-Lacueva C. 
(2009) J Proteome Res. 8 (11): 5060−5068. 
[23] Gibney M.J., Walsh M., Brennan L., Roche H.M., German B., van Ommen 
B. (2005) Am. J. Clin. Nutr. 82: 497–503. 
[24] Llorach R., Garrido I., Monagas M., Urpi-Sarda M., Tulipani S., Bartolome 
B., Andres-Lacueva C. (2010) J. Proteome Res. 9 (11): 5859−5867.   
[25] Cozzolino D., Flood L., Bellon J., Gishen M., De Barros Lopes M. (2006) 
Yeast 23 (14-15): 1089−96. 
[26] Westad F., Martens H. (2000) J. Near Infrared Spectrosc. 8: 117–124. 
[27] Cozzolino D., Holdstock M., Dambergs R.G., Cynkar W.U., Smith P.A. 
(2009) Food Chem. 116 (3): 761−765. 
[28] Ortiz M.C., Sarabia L.A., García-Rey R., M.D. Luque de Castro M.D. (2006) 
Anal. Chim. Acta 558: 125–13. 
[29] Díez R., Sarabia L.A., Ortiz M.C. (2007) Anal. Chim. Acta 585: 350–360. 
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Resonance Spectrometry (1H-NMR) 
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Abstract 
 In this study, comparison of urinary fingerprints obtained by 
unidimensional nuclear   magnetic resonance was carried out to 
discriminate between 144 samples obtained from 12 volunteers. Urine 
samples from obese individuals were taken after intake of meals prepared 
with four fried vegetable oils that differed in their antioxidant and fatty acids 
composition. The aim was to find possible statistical differences in the 
metabolic composition of urine related with the consumption of these oils, 
as a consequence of a different effect on individuals metabolism. The 
application of chemometric techniques (PCA and PLS-DA) to NMR spectra 
allowed the evaluation of changes in the levels of metabolites after intake of 
fried vegetable oils. Using PCA, discrimination of controls (basal state) and 
samples taken 4 h after intake was possible, letting to conclude that the 
intake of these oils had an effect on the urinary metabolic fingerprint. PLS-
DA was used to discriminate among different classes. This discrimination 
was possible by comparing classes in pairs, with prediction accuracies from 
84% to 100%. In a final step, chemical shifts responsible for discrimination 
were extracted. After a tentative identification of the main signals from NMR 
spectra, these chemical shifts were attributed to groups of endogenous or 
exogenous metabolites present in urine. The resulting approach is a 
competitive alternative to methodologies based on MS as it is rapid and 
requires minimum sample preparation.  
 
  
430 
Nuevas plataformas analíticas en metabolómica                                                                                    
 
1. Introduction 
 
 Metabolomics, defined as the study of all measurable metabolites in 
a given biological sample, provides a view to understand metabolic 
variations in complex biological organisms as a consequence of a given 
stimulus, such as a pathological condition, drug or diet administration or 
genetic variation [1,2]. Metabolomics analysis can be addressed by three 
different approaches depending on the aim of the study (i.e. targeting 
analysis, global profiling or metabolic fingerprinting). Thus, targeting 
analysis, the most sensitive and selective approach, aims at quantifying a 
relatively small group of metabolites. On the other hand, global profiling is 
focused on obtaining as much biological information of the sample as 
possible, using non-selective approaches with non-quantitative or 
semiquantitative purposes. Finally, metabolomics fingerprinting is widely 
used to provide characteristic patterns or "fingerprints" of the biological 
system [3]. The aim of metabolomics fingerprinting is to find statistical 
differences among groups subjected to a concrete stimulus and to relate 
these differences to the fingerprints (for example to spectral regions). 
Successful applications of this metabolomic approach in toxicity screening, 
biomarker discovery [4],  in vivo mapping [5,6], and functional genomics [7] 
have been well documented.  
 Metabolomics studies typically employ either Mass Spectrometry 
(MS) or Nuclear Magnetic Resonance (NMR) to interrogate biological 
samples, due to their great sensitivity/selectivity binomial and their 
versatility [8]. Although MS is clearly more sensitive than NMR, the latter 
offers great advantages for its use in high throughput fingerprinting, such 
as minimal requirements for sample preparation, and the non-
discriminating and non-destructive nature of the technique [9]. In fact, 
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1H-NMR spectra can be acquired rapidly in 3–15 min with minimum 
sample preparation, usually just entails buffering and internal standard 
addition [10]. Furthermore, 1H-NMR has been largely used to 
unequivocally determine metabolite structures, and perhaps due to its 
non-invasive nature, is more commonly used in mammalian systems than 
MS methodologies. Thus, NMR metabolomics has already demonstrated 
considerable potential as fingerprinting tool with extra capability to identify 
biomarkers in biological fluids [11], or in toxicological studies [12]. 
Nevertheless, its use in human nutrition is still limited [13] despite 
metabolomics is more sensitive than proteomics and genomics to subtle 
differences in biochemical profiles following dietary intervention. 
 Urine is an ideal biological fluid for NMR fingerprinting [13−16] in 
nutritional studies, as it directly reflects the global state of an individual 
after food intake, and requires minimum sample preparation. Nevertheless, 
urine NMR spectra are complex, making to visualize the effect of diet 
throughout the levels of metabolites difficult. On the other hand, it has been 
demonstrated that urine composition is affected by more sources of 
variability than other biofluids (e.g. plasma), including circadian variation, 
hydration state, and estrous cycle [17]. In addition, inter-individual variation 
in metabolism is generally the main source of variability due to their great 
diversity in genetic and environmental factors among individuals [18]. For 
these reasons, pattern recognition techniques, such as principal components 
analysis (PCA) and partial least squares discriminant analysis (PLS-DA) are 
frequently used to compare metabolite levels with classification purposes 
[19,20]. 
 Natural antioxidants are known to exert a protective effect against 
coronary heart disease [21,22]. Particularly, the health benefits of olive 
oil, the principal source of fat in the Mediterranean diet, are mainly 
attributed to its equilibrated fatty acid profile and rich composition in 
phenolic antioxidants [23,24]. Although benefits of olive oil and, 
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concretely, of its antioxidants, are gaining interest, the mechanisms 
involved in the protective effect are still unknown. 
 This study is focused on comparing the effect of the intake of fried 
vegetable oils with a natural or added content in oxidation inhibitors 
through the urine metabolome of obese individuals. For this purpose, 
urinary fingerprints were obtained by 1H-NMR to explore the effect of 
different breakfasts prepared with target oils on the selected cohort. 
Statistical analysis with PCA and PLS-DA would allow finding possible 
significant differences in the metabolic composition of urine related with the 
consumption of these oils, as a consequence of a different effect on 
metabolism. The oils used in this study had a different profile in 
antioxidants.  
  
2. Materials and methods  
 
2.1. Reagents and equipment 
 
 Centrifugation was carried out with a thermostated centrifuge 
Thermo Sorvall Legend Micro 21 R from Thermo (Thermo Fisher Scientific, 
Bremen, Germany); 1H-NMR spectroscopy was performed at 500.13 MHz 
using a Bruker AMX500 spectrometer 11.7 T (Bruker BioSpin GmbH, 
Rheinstetten, Germany), and trimethylsilyl propionate (TSP) was used as 
chemical shift reference. 
  A pH 7.2 buffer containing 200 mM sodium phosphate, 0.25 mM TSP, 
0.025% sodium azide, and 25% deuterium oxide, all from Sigma–Aldrich (St 
Louis, MO) was prepared. All reagents were stored at 4 ºC until use. 
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2.2. Preparation of oils 
 
The four edible oils used for this study were: 
(1) Extra virgin olive oil prepared by mixing different commercial extra-
virgin olive oils (VOO). The mixture was optimized for a final 
concentration of total phenols of 400 µg/mL, expressed as µg/mL of 
caffeic acid by the Folin−Ciocalteu test, and had the following fatty 
acids composition: 70.5% monounsaturated fatty acids (MUFAs), 
11.1% PUFAs, 18.4% saturated fatty acids (SFAs).  
(2) Commercial pure refined sunflower oil with nil content in phenolic 
compounds (NSO), and had the following fatty acids composition: 
34.3% MUFAs, 58.3% PUFAs and 7.3% SFAs. 
(3) Refined high-oleic sunflower oil that was spiked at 400 µg/mL with a 
synthetic lipophilic oxidation inhibitor (dimethylsiloxane, DSO). This 
prepared oil had the following fatty acids composition: 71.8% 
MUFAs, 18.0% PUFAs and 10.2% SFAs. 
(4) Refined high-oleic sunflower oil that was enriched with an extract of 
hydrophilic phenols isolated from olive pomace by a protocol similar 
to that developed by Girón et al. [30]. The enrichment was carried 
out at 400 µg/mL of total phenols, expressed as caffeic acid. The 
concentration of fatty acids was as follows: 76.7% MUFAs, 17.6% 
PUFAs and 5.8% SFAs. 
 Each oil (2 L) was placed in a stainless-steel deep fryer, and heated at 
180 ºC ± 5 ºC for 5 min a total of 20 cycles. The purpose of the enrichment of 
refined edible oils with antioxidants was to enhance oils stability and 
improve healthy properties. 
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2.3. Subjects and samples 
 
 Experiment was planned following the guidelines dictated by the 
World Medical Association Declaration of Helsinki (2004), which were 
supervised by the ethical review board of Reina Sofia Hospital (Córdoba, 
Spain) that approved the experiments. Seventeen obese individuals with a 
body mass index between 30–40 kg/m2 formed the cohort in this study. All 
of them gave their informed consent and underwent a comprehensive 
medical history, physical examination and clinical chemistry analysis before 
enrolment. Participants with evidence of kidney, pancreas, lung, liver or 
thyroid disease were excluded. All subjects were non-diabetics, non-
smokers and did not manifest clinical evidences of cardiovascular disease. 
The target cohort was composed by 17 post-menopausal women, age 48–70 
years, and 9 men, age 39–70 years. None of the subjects was taking 
medication or supplementary vitamins with influential effect on urine 
metabolome.  
 All volunteers received four breakfasts in muffin format prepared 
with the four different oils (0.45 mL of oil per kilogram of body weight), 
previously subjected to a simulated frying process. The administration of 
each breakfast was held at randomization and cross following a Latin square 
design, which increased the power of the study. The volunteers ate one of 
the breakfasts every two weeks (4 oils, 8 weeks). During the sampling 
period (4 h) the volunteers did not consume any food. 
 
2.3.1. Sampling 
 Sampling was performed following the Recommendations on 
Biobanking Procedures for urine processing and management recently 
published by the European Consensus Expert Group Report [25]. According 
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to this document, protocols for pretreatment urine should avoid additives 
for storing, include centrifugation for removal of particulates, and freezing at 
–80 ºC or below.  
 In order to obtain suitable control samples and carry out a time-
course study of urinary excretion after intake, samples were obtained at 0 
(just before intake, basal state) and 2 and 4 h from intake (post-basal states). 
Urine was collected in sterile containers, aliquoted in 2-mL Eppendorfs, 
centrifuged at 1500 g, 4 ºC for 10 min and stored at –80 °C until analysis. 
This protocol ensures eliminating particulates that may interfere analysis 
and quenching bacterial/enzymatic activity in urine during storage. 
 
2.4. Sample preparation 
 
 After thawing for analysis, aliquots of 400 µL were centrifuged at 
12000 g for 10 min at 4 ºC for spinning down non-soluble particles and 360 
µL of supernatant were mixed with 180 µL of buffer to minimize pH variation 
and with 60 µL of deuterium water (D2O) [8]; afterwards, urine samples 
were vortexed and placed into an 1-mL probe for analysis.  
 
2.5. Data acquisition 
 
 The samples weres analyzed at 4 ºC to minimize metabolic changes. 
Sample stability at 4ºC was proved by analyzing a urine sample in duplicate 
with a time interval of 15 h. No gross degradation was noted in the signals of 
multiple spectra acquired under the same conditions.  
 Standard solvent suppressed spectra were grouped into 16.000 data 
points, averaged over 256 acquisitions. The data acquisition lasted in total 13 
min using a sequence based on the first increment of the Nuclear Overhauser 
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Effect Spectroscopy (NOESY) pulse sequence to effect suppression of the 
water resonance and limit the effect of B0 and B1 inhomogeneity in the spectra 
(relaxation delay-90º-t1-90º-tm-90º-acquire Free Induction Decay —FID— 
signal), in which a secondary radio frequency irradiation field was applied at 
the water resonance frequency during the relaxation delay of 2 s and during 
the mixing period (tm = 150 ms), with t1 fixed at 3 s. The acquisitions were 
performed using a spectral width of 8333.33 Hz. Prior to Fourier 
transformation, the FID signals were multiplied by an exponential weight 
function corresponding to a line broadening of 0.3 Hz. Data processing was 
done with the MestRenova software. Chenomx. The "Metabonomic" GUI 
based on the R-Tcl/Tk interface [26], and the Agilent Mass Profiler 
Softwares were used for statistical analyses. Chenomx NMR Suite 5.0Profiler 
software was used for peak assignement.  
 
2.6. NMR spectral data processing 
 
 Firstly, spectra were referenced to the trimethylsilyl propionate (TSP) 
singlet at 0 ppm chemical shift. Afterwards, regions containing non-relevant 
information or spectral artifacts were removed. This step is necessary 
because the spectral width to acquire NMR data is usually wider than 
necessary to digitize all chemical shifts associated with endogenous 
metabolites [27]. Thus, downfield and upfield spectral areas without 
endogenous metabolites are initially excluded. On the other hand, spectral 
regions highly depending on the experimental parameters, such as water 
and reference regions are also deleted, as these regions are sensitive to 
spectral artifacts, such as inadequate phasing. Therefore, the spectrum 
outside the 0.2-10-ppm window was excluded. 
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2.6.1. Baseline and phase correction 
 Baseline correction is an essential step to obtain high quality NMR 
spectra. Rolling baselines can make difficult to identify peaks and can 
introduce significant errors into quantitative measurements [26]. On the 
other hand, the baseline of the spectrum should be flat and symmetrically 
disposed on either side of each of the peaks. If the baseline about the peaks 
is asymmetrical, then the spectrum requires phasing. All spectra were 
manually phase- and baseline-corrected using the MestRenova software. 
 
2.6.2. Binning 
The most common method for reducing the influence of shifting 
peaks is the so-called binning or bucketing method, which reduces spectrum 
resolution [28]. Thus, the spectra are integrated within small spectral 
regions, called "bins" or "buckets". Subsequent data analysis procedures 
applied to the binned spectra are not influenced by peak shifts, as long as 
these shifts remain within the borders of the corresponding bins. Therefore, 
NMR spectral data were automatically reduced into regions of equal width 
(0.02 ppm and 0.04 ppm) and the integral of each region was determined. 
The spectral region from 4.0–6.0 ppm was excluded from analysis to remove 
the effect of variations in the suppression of the water resonance and 
variations in the urea signal. 
 
2.6.3. Normalization 
A crucial step in pre-processing of spectrum data in metabonomic 
studies is the so-called normalization step [27]. This step tries to account for 
possible variations in sample concentrations. Normalization may also be 
necessary for technical reasons. If spectra are recorded using a different 
number of scans or different devices, the absolute values of the spectra vary, 
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and rendering a joint analysis of spectra without prior normalization is 
impossible. 
 
2.6.4. Statistical analysis 
 In this study, principal components analysis (PCA) and partial least 
squares discriminant analysis (PLS-DA) were used for sample classification 
and pattern recognition. The former is a non-supervised technique that 
allows exploring data groupings or patterns among samples. Thus, in PCA, 
data are transformed to a K-dimensional space (where K is equal to the 
number of variables), and are subsequently projected into a few principal 
components that describe the maximum variation within the data. The first 
PC is the linear combination of the original variables, which explains the 
maximum amount of variance in the data. The scores plots of the first two or 
three PCs provide bi- or tridimensional maps showing the relationship 
between data and displaying groupings [19,29]. The loadings plot shows the 
relationship between variables and in combination with the scores plot 
provide information concerning the importance of variables. PCA provides 
an easily understandable graphical approach to explore possible sample 
grouping and identify the spectral regions of difference between the classes. 
 On the other hand, PLS-DA is a linear regression method in which the 
multivariate variables corresponding to the observations (spectral 
descriptors) are associated with the class membership for each sample [29]. 
In contrast to PCA, the method is supervised (i.e. the class membership of 
the samples is included in the calculation). PLS-DA is used when clusters are 
not distinctly separated in the scores plot and groups overlap so that it is 
desirable to fine-tune the models to allow complete distinction between 
groups. As the method is based on the creation of a classification model, this 
allows predictions by assigning probabilities to new observations for class 
membership. Validation of the resulting PLS models was supported on 
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cross-validation tests due to the number of individuals composing the 
cohort under study. 
 
3. Results and discussion 
3.1. Principal components analysis  
 
The matrix containing the reduced spectral data was exported to the 
MPP software for statistical analysis. The preliminary data set was 
composed by 245 points per spectrum with a total of 144 spectra. In a first 
step, data were reduced by applying a fold change (FC) filter, which was 
employed to keep spectra regions with high abundance ratios between two 
classes of individuals. Afterwards, samples were subjected to PCA analysis to 
determine statistical differences between samples after oils intake and 
controls for each intervention breakfast. For this study, samples were 
classified as t0 (basal state, obtained before intake) for control individuals, 
t2 (post-basal state, obtained 2 h from intake) and t4 (post-basal state, 
obtained 4 h from intake). Figure 1 shows the PCA scores plots for each 
study. These analyses showed that t2 samples were not discriminated from 
controls for any of intervention breakfasts, except for VOO that shows a 
partial separation between control individuals and t2. On the other hand, t4 
samples were clearly grouped and separated from controls in all cases. This 
study led to conclude that intake has a metabolic effect on the urinary 
fingerprints for all types of consumed breakfasts but this effect could be only 
detected after 4 h from intake. Therefore, t4 samples were subsequently 
used to study statistical differences among diets by PCA and PLS-DA. Control 
samples were not included as independent group in further studies to 
reduce the number of classes considered in each analysis (namely, VOO, 
NSO, PSO and DSO). However, spectral regions responsible for differences 
(D) 
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among classes were evaluated by comparison of t4 and control groups in a 
final step. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In a second analysis, samples from the four intervention breakfasts 
were used in an initial PCA to explore possible groupings. The scores plot 
Figure 1. PCA scores plots obtained by comparison of t0, t2 and t4 samples for 
each intervention breakfast. 
(C) (D) 
(A) (B) 
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(Figure 2.A) demonstrated that differences exhibited among the four classes 
did not cause any separation and individuals forming the cohort were 
dispersed in the three-dimensional space, which explained only 40% of the 
overall variability. A slight clustering was observed for VOO intervention 
breakfast. With these premises,  PCA could not explain differences among 
breakfasts. A similar pattern has been found in the literature, where most of 
studies carried out with urine samples have required supervised analysis 
(mainly by PLS-DA) for development of classification and prediction models. 
This can be justified because metabolites are frequently found at low 
concentration and the large variability among individuals may mask 
variability from other sources or stimuli. 
 
3.2. Partial least squares discriminant analysis  
 
After non-supervised analysis, PLS-DA was needed to attain 
discrimination among groups and to create classification and prediction 
models. The PLS-DA scores plot obtained with the three first latent variables 
is shown in Figure 2.B. A certain clustering of individuals attending to the 
intervention breakfast can be visualized. However, only individuals after 
intake of breakfast prepared with VOO can be clearly separated. The 
predictive accuracy was used to evaluate the capability of the PLS model, 
which is defined as the percentage of correctly classified experiments in a 
given class. This accuracy is represented as a confusion matrix, with the true 
class in rows and the predicted class in columns. The diagonal contains the 
correctly classified samples. The accuracy matrix is different for training and 
cross-validation, and both jointly describe the prediction capability of the 
model.  
Table 1 shows the accuracy matrix for cross-validation (a) and 
training (b) for each class and the overall (mean) accuracy. PSO led the 
worst accuracy for training (20%), whereas NSO did for validation (54%). 
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The overall accuracy of the model was 49% and 87% for training and 
prediction; therefore, the model was inadequate for prediction. To the view 
of these results, the following scheme was to simplify the model to achieve 
total separation and finally, to find spectra regions that causes differences 
among classes. Accordingly, a second PLS study was carried out by 
comparing classes in groups of three. Table 2 shows the ranges and overall 
accuracies obtained for each study. As can be seen, the overall accuracies 
ranged from 40.5 to 70.5% for validation and from 92 to 100% for training. 
Interestingly, PSO, DSO and VOO, which are the groups based on oils with 
richer oxidation inhibitors content, gave the best results, indicating that 
their composition affect differently to the urinary fingerprint. By exploring 
the PLS scores graphics, DSO samples were randomly dispersed in the three 
analyses giving most of false positives by misclassification in the other three 
groups. 
  
 
 
 
 
 
 
 
Figure 2. Scores plot obtained with the PCA (A) and PLS (B) from the analysis of the 
four intervention breakfasts.  
 
As the PLS models using three classes did not lead to complete 
classification, groups were compared in pairs with the final aim of obtaining 
(A) 
(B) 
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Table 1. Characterization of the PLS model obtained with the analysis of the 
four classes for validation (a) and training (b). 
(a) 
 
Table 2. Ranges and overall accuracies obtained for validation and 
training for the PLS-DA models obtained from comparisons in groups of three 
classes 
 
 
 
[NSO] 
(Predicted) 
[PSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 6 1 3 3 46.15385 
[PSO] (True) 1 5 5 1 55.55556 
[DSO] (True) 3 5 2 0 20.00000 
[VOO] (True) 2 1 2 10 66.66666 
Overall accuracy 48.93617 
 
 
[NSO] 
(Predicted) 
[PSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 7 1 3 2 53.84615 
[PSO] (True) 0 9 0 0 100.000 
[DSO] (True) 0 0 10 0 100.000 
[VOO] (True) 0 0 0 15 100.000 
Overall accuracy 85.455 
 
     
  Accuracy (%) 
  
NSO, 
PSO,DSO 
NSO,PSO, 
DSO 
NSO,VOO, 
DSO 
PSO,NSO, 
VOO 
Validation 
Range 20-53.8 38.4-73.3 23-77 66.6-88.8 
Overall 40.625 60.5 43.2 73.5 
Training 
Range 92.3-100 76.9-100 93.3-100 100 
Overall 96.875 92.1 97.3 100 
(b) 
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Figure 3. PCA-DA scores plots of the comparative study of classes in pairs. 
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the spectra regions distinctive of each class. Thus, six PLS analyses 
were carried out, whose accuracy results are summarized in Table 3. 
Separation was excellent for all cases, with overall accuracies ranging from 
84% to 100%. Figure 3 contains the PLS scores plots for each study, showing 
a complete separation and grouping among classes. Loadings from these 
studies were used to extract the chemical shifts that explained variability 
associated to oils intake.  
 
3.3. Peaks assignment  
 
 After exploring the PLS models, the bins that caused separation 
among classes served to know the spectra regions that caused stronger 
variability associated with breakfast intake. The total number of bins was 
initially 151 and are listed in Table 3 for each PLS-DA study. Then, bins were 
filtered according to an algorithm based on fold change ratio, so the higher 
fold change, the larger differences between compared intervention 
breakfasts. After this filtration step, bins were reduced to 61, then used for 
development of PLS models. Table 4 lists the most significant bins, 
expressed as mean chemical shift values in ppm, contributing to 
discriminate among intervention breakfasts. The sign of the fold change 
ratio is also included for each bin. Figure 4 corresponds to the NMR spectra 
obtained with an urine sample. The spectrum has been zoomed and divided 
in three parts, corresponding to 0.5 to 2.5 ppm, 2 to 4.5 ppm and 6.5 to 9 
ppm (spectra regions excluded in the statistical analysis were not 
considered). The main signals were assigned with the Chenomx NMR 
Profiler software, by fitting the experimental spectrum with reference 
spectra from the database. The software profiled all peaks corresponding to 
the same compound considering their ratio as a function of concentration. 
Among the identified peaks, creatine, creatinine, hyppurate and citrate were 
the most abundant metabolites. Other minor compounds, such as amino 
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acids (alanine, tryptophan, glutamate) methylhistidine, phenilacetate, 
glucose, lactose, niaciamide and formate were also detected. Examining the 
chemical shift range (ppm) of the significant bins indicated that they were 
mainly located within 0.5–1.8 ppm, where glutamate and signals from lipids 
were assigned; 8–9 ppm, with contribution of formate and monosubstituted 
amino groups (1-methylnicotinamide, niacinamide and methylhistidine); 2–
3 ppm that accounted for citrate, creatine, creatinine, and other compounds 
containing amino groups (amino acids previously mentioned); and around 
6–7 ppm, that corresponded to aromatic metabolites.    
 
4. Conclusions  
 
A metabolomics fingerprinting approach based on NMR analysis of 
urine samples has been used to compare the metabolic effect caused by 
intake of intervention breakfasts prepared with different fried oils. Urine 
samples were taken in basal state and 2 and 4 h after intake of meals. 
Multivariate analysis of samples was carried out with PCA and PLS-DA to 
reveal: (i) Post-basal samples were only discriminated from basal samples at 
4 h after breakfasts intake; (ii) PLS-DA enabled to discriminate among 
intervention breakfasts if two classes were compared, with prediction 
accuracies from 84% to 100%. In a final step, chemical shifts responsible for 
discrimination were extracted. After a tentative identification of the main 
signals from NMR spectra, these chemical shifts were attributed to 
exogenous or endogenous groups of metabolites present in urine. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Peaks assignment in the NMR analysis of a urine sample 4 hours after intake of breakfast prepared 
with fried VOO. 
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Figure 4. Peaks assignement in the NMR analysis of a urine sample 4 hours after intake of breakfast prepared with 
fried VOO (continued). 
 Table 3. Ranges and overall accuracies obtained for validation and training for the PLS-DA models and total bins 
obtained used for the models from comparisons in pairs  
  Accuracy (%) 
  NSO vs PSO NSO vs DSO NSO vs VOO PSO vs VOO PSO vs DSO DSO vs VOO 
Validation 
Range 61.5−90 76.9−100 66−100 66−100 88.8−90 73.3−100 
Overall 73.9 86.3 85.7 80 89.4 83.3 
Training 
Range 100 100 100 100 88.8−100 100 
Overall 100 100 100 100 94.7 100 
Bins 41 60 38 54 42 60 
  
 
 
 
 
VOO vs PSO NSO vs PSO VOO vs DSO NSO vs DSO DSO vs PSO NSO vs VOO 
9.363 up 6.307 up 1.583 down 6.477 up 6.296 down 5.404 up 
1.617 down 9.735 up 9.227 down 6.443 up 6.169 down 4.421 down 
1.583 down 9.702 up 1.549 down 8.039 up 4.64 down 4.333 up 
1.549 down 9.43 up 0.701 down 9.193 up 4.529 down 3.506 up 
6.376 up 0.26 up 0.294 down 8.446 up 4.098 up 3.353 down 
0.531 down 1.821 up 9.193 down 9.363 up 3.994 down 3.048 up 
6.24 up 1.617 up 0.633 down 3.111 down 3.947 down 3.042 up 
6.41 up 1.685 up 6.376 up 8.344 up 3.917 down 3.040 down 
6.477 up 9.193 up 2.228 down 6.953 up 3.897 down 3.004 up 
9.057 up 8.616 down 0.361 down 6.715 up 3.815 up 2.919 down 
2.194 down 8.344 up 9.464 down 6.307 up 3.78 down 2.796 up 
0.735 up 0.599 up 9.532 down 8.616 down 3.742 down 2.783 up 
8.446 up 8.955 up 9.091 down 0.667 up 3.31 up 2.654 down 
0.769 up 0.667 up 8.955 down 6.647 up 3.281 down 2.534 up 
Table 4. More significant bins and the sign of regulation for each comparison obtained from comparisons in 
pairs 
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Global metabolomics profiling of human urine 
by LC–TOF/MS in accurate mode to evaluate the 
intake of breakfasts prepared with fried edible 
oils 
 
B. Álvarez-Sánchez, F. Priego-Capote, M.D. Luque de Castro* 
 
Abstract 
 
 Epidemiologic studies have demonstrated a direct relationship 
between coronary heart disease and diet as a consequence of fats 
consumption. The aim of this study was to obtain the metabolic profile of 
urine after a single intake of breakfasts prepared with fried edible oils from 
different sources. Thus, meals prepared with four different fried oils (olive 
oil, pure sunflower oil, sunflower oil enriched with olive phenols as natural 
antioxidants and sunflower oil enriched with the synthetic oxidation 
inhibitor dimethylsiloxane) were used in this study. A metabolomics global 
profiling approach has been used to reveal statistical differences in the 
metabolome of urine from individuals after intake of the different breakfasts 
and to identify compounds responsible for such variability. Urine samples 
obtained before (blank) and 2 and 4 hours after intake were analyzed by LC–
TOF/MS in accurate mode. Principal Component Analysis (PCA) and Partial 
Least Square Discriminant Analysis (PLS-DA) were carried out to establish 
differences among classes (intake of breakfast prepared with each oil) and 
to build a classification and prediction model. The PCA analysis showed a 
clear separation between urine from control individuals before breakfast 
consumption and urine from individuals 4 h after intake. On the other hand, 
the PLS-DA model allowed the development of classification models with 
acceptable accuracy parameters. The mass features obtained from this 
analysis were used to identify metabolites responsible for differences among 
classes and to infer the possible metabolic pathways.  
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1.  Introduction 
 
 Over the past century, nutritional studies were focused on 
alimentary ‘deficiencies’ by identifying compounds that were essential 
for human growth and health. However, the change in lifestyle has 
brought about a dramatic change in nutritional medicine, and current 
nutritional scientists are now challenged with finding new ways of 
treating or preventing diseases caused by nutritional ‘oversufficiencies’ 
such as obesity, diabetes, chronic inflammation and cardiovascular 
diseases. This new approach would intend to identify bioactive food 
components that potentially increase life expectancy, reduce weight, 
enhance physical or mental performance and prevent the above diseases 
characteristic of developed countries [1]. Among them, coronary heart 
disease (CHD) is the most prevalent cause of death in developed countries 
[2].  
Epidemiologic studies have proved a direct connection between diet 
and CHD, as is the case of fat consumption, which has  shown  to affect high- 
and low-density-lipoprotein cholesterol (HDL and LDL) concentrations. 
Despite consumption of fat-rich diets (35–40% of total energy) [3], 
Mediterranean populations have been characterized by a low prevalence of 
CHD, suggesting that diet in this area is healthier or, at least, more likely to 
protect against CHD throughout the effect of bioactive compounds [4]. In 
fact, olive oil, the principal source of fat in the Mediterranean diet, is known 
to exert a protective effect against heart diseases. The cause of these 
potential benefits has been ascribed to both an adequate fatty acid profile 
and the presence of nutraceuticals such as phenols, many of which are well-
known antioxidants [5]. Thus, olive oil is mainly constituted by glycerols and 
other minor components such as aliphatic and triterpenic alcohols, sterols, 
carotenoids and phenolic antioxidants, that can be both lipophilic and 
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hydrophilic [6]. Interestingly, whereas lipophilic phenols such as 
tocopherols can be found in other vegetable oils, most hydrophilic phenols 
[7,8] found in olive oil are absent in other oils [9]. Evidence demonstrates 
that these hydrophilic phenols are powerful antioxidants, both in vitro and 
in vivo [10]. Although further studies are required, these compounds might 
be good candidates as functional food components to protect against CHD.  
 Although benefits of olive oil and, concretely, of phenolic 
antioxidants are gaining interest, the mechanisms involved in this protective 
effect are still unknown. Therefore, it could be worth exploring how 
metabolism is affected by oils intake and, particularly, how olive oil 
contributes to CHD prevention. In this sense, metabolomics poses 
promising prospects, as demonstrated by the increasing number of 
applications on human nutrition, that has led to give the name of 
nutrimetabolomics to this area of metabolomics) [11−16]. The most 
promising and unexploited application of nutrimetabolomics is probably 
its use for monitoring diet intervention. This would allow determining 
metabolic changes related to administration of certain nutrients that 
have an impact on human health. Concretely, metabolomics 
fingerprinting and profiling have been used to determine the effects of 
food supplementation and diet intervention on metabolism. Thus, the 
scheme followed in these studies entails: (i) selecting an adequate food 
material for diet intervention as well as the appropriate population to 
participate in the study in order to obtain statistically representative 
results, (ii) analyzing biosamples taken after food intake under the same 
working conditions; (iii) using non-supervised or supervised statistical 
analysis to find diet-related differences between groups; (iv) determining 
analytical features responsible for these differences, which may be a 
region in the nuclear magnetic resonance (NMR) spectra or a molecular 
entity linked to an m/z value from a mass spectrum, (v) identifying 
related metabolites, which implies to query against available databases; 
and (vi) elucidating metabolic pathways in order to give as much 
biological information as possible [17]. These steps are possible if a 
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sensitive and accurate analytical platform is used since metabolic 
differences among fingerprints are usually small. In this sense, mass 
spectrometry (MS) or NMR are usually the preferred choices [18]. NMR 
allows direct analysis of most types of samples, including tissues; allows the 
recovery of samples for further analyses, and provides detailed information 
on molecular structure [19]. However, NMR is characterized by a poor 
sensitivity as compared to MS, and spectra from complex mixtures as 
biological samples can be very difficult to interpret due to overlapping 
among metabolite signals [20−22]. On the other hand, MS possesses high 
sensitivity and selectivity and provides accurate mass measurements thanks 
to recent improvements of mass analyzers. This technique, usually coupled 
with upstream separation techniques like gas chromatography (GC) [23] or 
liquid chromatography (LC), enables unequivocal identification of 
compounds and structure elucidation of a large number of metabolites, 
providing extra information about the biochemical relationships between 
them [24]. For this reason, MS is the preferred choice either to obtain 
metabolic profiles or to identify compounds responsible for metabolic 
changes. 
 Within the nutrimetabolomics context, biological fluids such as 
plasma, serum and urine [12,13,16] have been commonly used, as they are 
easily and non- (or scant) invasively collected, directly reflect the global 
state of an individual and/or the response to drug treatment or diet intake; 
usually requiring the application of simple sample preparation protocols. It 
is expected that metabolic changes due to diet lead to changes in the urinary 
profile.  
 The aim of this research was to determine short-term changes in the 
metabolic profile of urine after intake of a breakfast prepared with fried oils. 
With this aim, oils with different composition, particularly with different 
antioxidants profile, were used in order to detect differences in the 
metabolism reflected in the urinary profile. The cohort selected for this 
study was composed by obese individuals to find metabolic differences 
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correlated with fat consumption. A final identification of metabolites 
explaining the variability observed among groups was also intended to 
obtain information about the metabolic pathways affected by oils intake. 
  
2.  Experimental 
 
2.1.  Reagents 
 
 LC–MS grade acetonitrile, MS-grade formic acid (Scharlab, Barcelona, 
Spain) and deionized water (18MΩ·cm) from a Millipore Milli-Q water 
purification system (Millipore, Bedford, MA, USA) were used to prepare the 
chromatographic phases.  
 
2.2.  Instruments and apparatus 
 
 Centrifugation was carried out with a thermostated centrifuge 
Thermo Sorvall Legend Micro 21 R from Thermo (Thermo Fisher Scientific, 
Bremen, Germany). A Vacufuge centrifugal vacuum concentrator from 
Eppendorf (Eppendorf, Inc., Hamburg, Germany) was used to evaporate 
samples to dryness.  
 All samples were analyzed by an 1200 Series HPLC system (Agilent 
Technologies, Waldbronn, Germany) equipped with a binary pump, a 
degasser, a well plate autosampler and a thermostated column 
compartment, which was coupled to an Agilent 6530 TOF mass 
spectrometer equipped with a Jetstream® ESI source. MassHunter 
Workstation software (Agilent Technologies), including Data acquisition, 
Qualitative Analysis and Mass Profiler Professional, was used for processing 
raw MS data, including feature extraction, data filtering, statistical analysis 
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by ANOVA and PCA, followed by the construction of PLS prediction model, 
molecular formula and database searching. Compound identification was 
performed using the METLIN Personal Metabolite Database throughout the 
IDbrowser tool and the Molecular Formula Generation algorithm (Agilent 
Technologies). The Human Metabolome Database (HMDB) was used to 
confirm and extend identification. 
  
2.3.  Oils and heating procedure 
 
 Four edible oils were prepared for this study. Two of them were 
commercially obtained and the others were enriched with two types of 
oxidation inhibitors: a synthetic oxidation inhibitor (dimethylsiloxane, 
DMSO, at 400 µg mL–1) and a natural extract from olive pomace containing 
phenolic antioxidants obtained by a protocol similar to that developed by 
Girón et al. [25]. The purposes of the enrichment of refined edible oils with 
oxidation inhibitors were to enhance oils stability. The edible oils were:  
(1) VOO: Different extra-virgin olive oils mixed up to a total 
concentration of phenolic antioxidants of 400 µg mL–1, 
expressed as µg mL–1 of caffeic acid by the Folin−Ciocalteu 
(F–C) test. The oil was composed by 70.5% monounsaturated 
fatty acids (MUFAs), 11.1% PUFAs, 18.4% saturated fatty 
acids (SFAs);  
(2) NSO: non-enriched refined sunflower oil with 34.3% MUFAs, 
58.3% PUFAs and 7.3% SFAs. Due to the refining process, the 
concentration of hydrophilic antioxidants was null.   
(3) PSO: refined high-oleic sunflower oil enriched with phenols 
from olive-pomace extract up to 400 mg L–1, also expressed 
as caffeic acid, 76.7% MUFAs, 17.6% PUFAs and 5.8% SFAs. 
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(4) DSO: refined high-oleic sunflower oil enriched with 400 mg 
L–1 of dimethylsiloxane as an oxidation inhibitor, 71.8% 
MUFAs, 18.0% PUFAs and 10.2% SFAs. 
Two liters of the target oil was placed in a stainless-steel deep fryer. 
The oil was heated at 180 ºC ± 5 ºC for 5 min ten times every day for two 
days (total heating cycles: 20). The fried oils were used to prepare four types 
of baked muffins (one per fried oil) with conventional ingredients and 
classified for the experimental plan. 
 
2.4.  Subjects and samples 
 
 Experiment was planned following the guidelines dictated by the 
World Medical Association Declaration of Helsinki (2004), which were 
supervised by the ethical review board of Reina Sofia Hospital (Córdoba, 
Spain) that approved the experiments. Seventeen obese individuals with a 
body mass index between 30–40 kg m–2 formed the cohort in this study. All 
of them gave their informed consent and underwent a comprehensive 
medical history, physical examination and clinical chemistry analysis before 
enrolment. Participants with evidence of kidney, pancreas, lung, liver or 
thyroid disease were excluded. All subjects were non-diabetics, non-
smokers, without clinical manifestations of cardiovascular disease and off 
treatment. The target cohort was composed by 10 post-menopausal women, 
age 48–70 years, and 7 men, age 39–70 years. None of the subjects was 
taking medication or supplementary vitamins with influential effect on urine 
metabolome.  
 All volunteers received four breakfasts in muffin format prepared 
with the four different oils (0.45 mL of oil per kilogram of body weight), 
previously subjected to the simulated frying process. The administration of 
each breakfast was held at randomization and following a Latin crossed 
square design, which increased the power of the study. The volunteers ate 
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each breakfast every two weeks (4 oils, 8 weeks). During the sampling 
period (4 hours) the volunteers did not consume any food.  
Sampling was performed following the Recommendations on 
Biobanking Procedures for urine processing and management recently 
published by the European Consensus Expert Group [26]. According to this 
document, biobanking procedures for urine should consider the following 
general consensus recommendations: (i) cells and particulate matter should 
be removed (e.g. by centrifugation); (ii) samples should be stored at –80 ºC 
or below; (iii) time limits for the processing should have been defined 
experimentally and should be appropriate for the analytes to be measured; 
(iv) unless specified for a particular downstream analysis, urine samples 
should be stored without additives [27].  
 In order to obtain suitable control samples and carry out a time-
course study of urinary excretion after dietary intervention, samples were 
obtained at 0 (just before) and 2 and 4 h from intake. Urine was collected in 
sterile containers, aliquoted in 2-mL Eppendorfs, centrifuged at 1500 g, 4 ºC 
for 10 min and stored at –80 °C until analysis. This protocol ensures 
eliminating particulates, cells and bacteria that may interfere analysis and 
quenching enzymatic activity in urine during storage. 
 After thawing for analysis, samples were 1:4 diluted with deionized 
water, and their pH adjusted to 4.8 with ammonium acetate. Thus, the urine 
samples were ready to be injected in the analytical instrument 
 
2.5.  LC–TOF/MS analysis 
 
 The LC–TOF/MS  instrument used in this study was an Agilent Series 
1200 SL rapid resolution LC system (consisting of vacuum degasser, cooled 
autosampler, rapid resolution binary pump, and thermostatted column 
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compartment) hyphenated to an Agilent 6530 accurate-mass TOF MS with 
electrospray ionization (ESI) via Jet Stream Technology (Agilent 
Technologies, Santa Clara, CA, USA). Chromatographic separation was 
performed using a Teknokroma Mediterranean Sea C18 analytical column (5 
mm × 0.46 mm i.d., 3 µm particle size, from Agilent Technologies, Santa 
Clara, CA, USA) kept at a temperature of 25 ºC. Urine samples were eluted 
with a binary gradient of (A) 0.1 % formic acid in Milli Q water  and (B) 0.1% 
formic acid in ACN. The elution program was as follows: 0–1 min 2% B, 1–20 
min 100% B. A post-run of 5 min was included to equilibrate the column. 
The flow rate was maintained at 0.6 mmin–1. The volume of injected sample 
was 10 µL. The operating conditions were as follows: gas temperature, 325 
°C; drying gas, nitrogen at 8 L min–1; nebulizer pressure, 40 psi; sheath gas 
temperature, 350 °C; sheath gas flow, nitrogen at 11 L min–1; capillary 
voltage, 4000 V; skimmer, 65 V; octopole radiofrequency voltage, 750 V; 
focusing voltage, 90 V. Data acquisition (2.5 spectra s–1; mass range 60–1100 
m/z) was governed via the Agilent Mass Hunter Workstation software. The 
instrument gave typical resolution 15000 FWHM (Full Width at Half 
Maximum) at m/z 112.9856  and 30000 FWHM at m/z 1033.9881. To assure 
the desired mass accuracy of recorded ions, continuous internal calibration 
was performed during analyses with the use of signals at m/z 121.0509 
(protonated purine) and m/z 922.0098 [protonated hexakis (1H, 1H, 3H-
tetrafluoropropoxy) phosphazine or HP-921] in positive ion mode. In 
negative ion mode, ions with m/z 119.0362 (proton abstracted purine) and 
m/z 1033.988109 adduct of HP-921 were used. The instrument was 
calibrated and tuned according to procedures recommended by the 
manufacturer. 
 
2.6.  Data processing and statistical analysis 
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Once the samples were analyzed by LC/MS, data were extracted into 
molecular features. Features extraction was based on the extraction 
algorithm (MFE) that locates and groups all ions related to the same neutral 
molecule. This relation is referred as to the covariance of peaks within the 
same chromatographic retention time, the charge-state envelope, isotopic 
distribution, and/or the presence of adducts and dimmers. The MFE took 
into account all ions exceeding 1000 counts, with charge state limited to a 
maximum of two and a peak spacing tolerance of  0.0025 m/z (plus 7 ppm). 
Each feature was given by a minimum of two ions. The extraction algorithm 
was based on a common organic model with chromatographic separation. 
The allowed positive ions were protonated species and sodium adducts, and 
the negative ions formed by formate adducts and proton losses. 
Dehydratation neutral losses were also allowed. Figure 1 shows the base 
peak chromatograms obtained in negative ionization mode with a blank 
sample (black line) and a sample obtained 4 h after olive oil intake (grey 
line).  
 
Figure 1. Base peak chromatograms, negative ionization mode, 
provided by a control sample (black line) and obtained 4 h after 
breakfast prepared with fried VOO (grey line). 
 
 After extracting molecular features, files in compound exchange 
format (.cef files) were created for each sample and exported into the Mass 
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Profiler Professional (MPP) software for statistical analysis. Molecular 
formulas were generated using the Molecular Formula Generator algorithm. 
Both mass accuracy and isotope information (abundance and spacing) were 
considered to limit the number of hits. Only the common elements C, H, N, O, 
P and S were considered in the generation of formulas. The calculated 
neutral mass of each feature was queried against the METLIN database [28] 
for matching to compounds within a maximum mass tolerance window of 10 
ppm. The METLIN database matched the neutral mass to the monoisotopic 
mass value calculated from the empirical formula of compounds in the 
database. Identified compounds were eventually contrasted against the 
Human Metabolome Database (HMDB) [29] to confirm their occurrence in 
humans.  
 
3.  Results and discussion 
 
3.1.  Scheme for data processing 
 
3.1.1. Filtering 
 Multivariate statistical analysis was carried following a stepwise 
scheme described here. The process is initiated with a data set built from the 
exported raw .cef files. The data set includes all the molecular features 
extracted from each LC–TOF/MS analysis, leading to a huge number of data 
obtained from all samples (above 12000 molecular features). Therefore, it is 
important to eliminate redundant features to reduce the dimensionality of 
the data set prior to Principal Components Analysis (PCA) and Partial Least 
Square Discriminant Analysis (PLS-DA). For this purpose, the first step for 
data processing was to filter out all the non-influencing molecular features 
from the data matrix, remaining only those that could explain the variability 
associated to breakfasts intake and that would allow sample classification 
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and screening. Accordingly, three processing filters —namely, by frequency 
or occurrence in samples, by ANOVA according to a preset p-value, and by 
fold-change algorithm— were applied and are discussed here.  
Firstly, the frequency filter aims at keeping all the MFs defining of a 
class. Thus, all the MFs that were present in at least 50% of samples in at 
least one class (five classes encompassing individuals after intake of the four 
breakfasts and the controls formed by individuals prior breakfast intake). 
This means that MFs that were present in the majority of samples of one 
group were kept since they are supposedly defining the class. The cut-off of 
50% in the frequency filter was supported on the existing biological 
variability among individuals who could be influenced by numerous internal 
and external factors non-related with metabolism. The ANOVA-based filter 
aims at keeping MFs statistically significant to differentiate between two 
classes by estimation of p-values calculated for each MF by one-way ANOVA. 
The p-value cut-off of 0.05 was chosen to ensure that only MFs which differ 
among classes with statistical significance (95% in this particular case) are 
passed on and further processed (the lower the p-value, the more significant 
difference between the varieties). The final MFs filtration step was 
performed using fold change (FC) analysis, which was employed to find MFs 
with high abundance ratios between two classes of individuals (in this case 
diets and controls). 
 
 3.1.2. Chemometric analysis 
 PCA is frequently used as unsupervised pattern recognition 
technique enabling data dimensionality reduction, while retaining maximum 
variability of the data. This is performed via the transformation of measured 
variables into uncorrelated principal components, each being a linear 
combination of the original variables [21]. Following the above data 
pretreatment, PCA was employed in the first step of chemometric analysis 
for both positive and negative ionization to evaluate sample clustering 
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according to breakfasts intake and to find trends of MFs (after filtering) 
explaining the observed variability. 
 Afterwards, PLS-DA, a widely used supervised pattern recognition 
tool capable of sample class prediction, was used to build and validate a 
statistical model for class classification and prediction. The results of sample 
classification are presented in terms of accuracy in prediction abilities, 
expressed as the percentage of the samples correctly classified during model 
training and cross-validation, respectively.  
 
3.2.  Time-course study  
 
 It has been demonstrated that the effect of diet over metabolism 
persists a certain period of time, which may be different among metabolite 
classes. For example, metabolites of coffee are detected in urine collected 4–
5 h after coffee ingestion, whereas heterocyclic amines from grilled meat 
persist after 48–72 ho after intake [14]. Therefore, it is important to carry 
out a time course study to select the time after breakfasts intake that shows 
a higher incidence on the urinary profile. As oils are common components of 
meals, sampling was carried out during a fast period (4 h) after oils intake to 
avoid influence of other sources.  
 For the time-course study, samples were classified as t0 (blank 
samples, obtained before intake) as control individuals, t2 (samples 
obtained two h from intake) t4 (samples obtained 4 h from intake). Samples 
were analyzed by both positive and negative ionization modes, and the data 
from each analysis processed following the aforementioned scheme for 
extracting MFs. Entities were filtered by frequency (50% cut-off) and by fold 
change (2-fold cut-off). The number of molecular features remaining after 
application of these two algorithms ranged from 51 for DSO-based breakfast 
to 136 for PSO-based breakfast. After that, PCAs for each breakfast, where 
times 0, 2 and 4 correspond to the three classes in this study, were carried 
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out. The first conclusion of this study was that negative ionization led to 
more pronounced clustering and significantly better separation among 
sampling times, while positive ionization modes did not report a clear 
discrimination between urine samples collected at different periods. Figure 
3 shows the PCA model obtained in positive mode for the time course study, 
which led to worse separation as compared to those obtained in negative 
mode (Figure 3). With these premises, only the data set obtained from 
negative ionization mode was used further on. On the other hand Figure 3 
shows the scores graphs obtained from PCAs for each time-course study in 
negative ionization. As can be seen, separation between urine metabolites 
profiling at times 0 and 4 was clear for every diet, whereas there was 
overlapping of samples taken at 2 h with a different behavior.  
  
            
 Figure 3. Scores plots obtained from PCAs for each time-course study in negative 
ionization mode. (A) DSO; (B) PSO; (C) NSO; (D) VOO. 
 
(A)     (B) 
(C)     (D) 
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 Thus, PCAs over samples corresponding to DSO and PSO-based 
breakfasts (Fig. 2.A and 2.B) revealed an overlapping of samples taken after 
intake (t2 and t4) with a clear separation from samples before intake (t0). 
Therefore, the urinary metabolome changes after single intake of a breakfast 
prepared with fried PSO and DSO. In the case of the breakfast prepared with 
non-enriched sunflower oil, only samples taken at t4 showed a profile 
different from samples taken at t2 and before intake, which were grouped 
(Fig. 2.C). Finally, the only breakfast promoting the separation of the three 
sampling times was that prepared with fried VOO. In fact, it can be visualized 
a gradual change from urine samples taken before intake to those sampled 4 
h after the planned intake (Fig. 2.D). Attending to these results, differences 
among classes are likely to be obtained from samples 4 h after intake, as 
they are statistically different from the control individuals and, therefore, it 
is the optimum sampling time to evaluate the incidence of breakfasts 
prepared with the different fried oils. Additionally, PSO and DSO-based 
breakfasts showed clearer separations from intake as compared to NSO and 
VOO. This separation is acceptable for urine samples, as the effect of diet is 
diluted in urine secretion and non-supervised PCA expectedly gives a more 
realistic view of biological samples. The application of ANOVA filtering led to 
better separations by removal of molecular features that could produce a 
common pattern of non-informative signals. Thus, one-way ANOVA with a 
Bonferroni-Holm correction was tested in this study. A probability level of p 
< 0.05 was considered statistically significant. The PCA scores graph 
obtained after this filtering led to conclude that separation of the three 
classes (time) was complete for the four diets after applying the ANOVA 
filter, but this reduced the number of molecular features to less than 10%. 
This would hinder a final identification, so this filter was not further applied, 
considering that frequency and fold change filters were enough to obtain 
good separation.  
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3.3. Comparison of urinary metabolome profiles after breakfasts 
intake 
 
 Once independent discrimination of individuals after intake of the 
different breakfasts was attained, the next step was to establish statistical 
differences associated to breakfast consumption. For this study, t4 samples 
were used to create the raw data matrix, which was constituted by 12800 
molecular entities. In a first step, this matrix was treated to eliminate 
random variability, by applying frequency and fold change filters. Thus, after 
filtering by frequency, only MFs present in at least 50% of samples 
pertaining to one group were kept. This led to a reduction to 510 MFs 
proving the influence of redundant information and contribution to other 
internal and external factors. By the second filter, only MFs that differ 2-fold 
among classes were kept, leading to a total of 223 MFs. Figure 3 represents 
PCA scores plot carried out after filtering. As can be seen, the scores plot did 
not show clear clusters of samples according to the breakfast consumed 
finding a high dispersion.  
In a final study, PLS-DA was used to create a classification and 
prediction model. The scores plot obtained with the latent variables after 
application of this tool is shown in Figure 4. The robustness of the model can 
be evaluated through the predictive accuracy, defined as the percentage of 
correctly classified experiments in a given class. This accuracy is different 
for training and validation. Thus, the training set produces a confusion 
matrix, which is a matrix with the true class in rows and the predicted class 
in columns. The diagonal represents correctly classified samples. Table 1 
shows the accuracy for each class and the overall (mean) accuracy. These 
ranged from 58 to 100% for the different breakfasts in the training step and 
the overall accuracy was 85%.  
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The next step was to test the model for validation. The same set of 
samples was used for cross-validation of the trained model. Although 
redundant, this is considered a valid statistical procedure when the number 
of available samples is limited. The prediction matrix obtained from 
validation shows an overall accuracy of 65%. Both the training and 
validation steps pointed out that individuals after DSO and PSO-based meals 
intake were not properly predicted according to the urine metabolomics 
analysis. 
 
Table 1. Characterization of the PLS model obtained with the analysis of the 
four classes for cross-validation (a) and training (b). 
 (a) 
(b) 
 
[NSO] 
(Predicted) 
[PSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) 
Accuracy 
[NSO] (True) 10 1 0 1 83.33334 
[PSO] (True) 2 7 5 3 41.17647 
[DSO] (True) 2 3 9 0 64.28571 
[VOO] (True) 1 1 0 10 83.33334 
Overall accuracy 65.45454 
 
 After exploring these matrices, it can be observed that the lowest 
accuracy coefficients were obtained for DSO and PSO prepared breakfasts, 
with 41 and 64%, respectively, in the validation step estimated by cross-
validation. As the model was unlikely to predict the two previous groups of 
 
[NSO] 
(Predicted) 
[PSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) 
Accuracy 
[NSO] (True) 12 0 0 0 100.000 
[PSO] (True) 1 10 4 2 58.824 
[DSO] (True) 0 1 13 0 92.857 
[VOO] (True) 0 0 0 12 100.000 
Overall accuracy 85.455 
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individuals, the study was simplified by exploring the differences of VOO and 
NSO-prepared breakfasts independently with PSO and DSO-based meals by 
analysing differences in groups of three breakfasts. Data sets were 
constituted by 119 and 261 molecular features for PLS studies dealing with 
PSO and DSO-breakfasts. Therefore, a higher number of features was 
required to discriminate DSO-prepared breakfasts than to discriminate 
between PSO-based breakfasts. This strategy considerably improved the 
classification results, as shows Fig. 5 representing samples with the three 
first latent variables. Figure 5.A shows the scores plot that includes the 
variability for individuals after intake of VOO, NSO and PSO-prepared 
breakfasts. As can be seen, individuals after intake of VOO and NSO-based 
breakfasts are clearly separated. In between, it can be clearly visualized the 
group of invididuals after intake of PSO prepared breakfast, which seems to 
be logical. Additionally the model was able to predict with good accuracy 
levels. Thus, the training model achieved accuracy levels of 100% for the 
three groups of individuals, while cross-validation reported accuracy levels 
from 69% (for individuals after intake of NSO-based breakfast) to 92% (for 
individuals after intake of the breakfast prepared with fried VOO). In 
summary, this PLS-DA model was excellent to predict those individuals after 
intake of VOO-based breakfast but, at the same time, had a good prediction 
capability to discriminate those individuals after intake of NSO and PSO 
breakfasts. Qualitatively, individuals after intake of PSO-prepared meal 
provided a urinary metabolome close to individuals who ingested VOO-
based breakfast.   
 Complementarily, Fig. 5.B shows the scores plot that represents the 
variability for individuals after intake of VOO, NSO and DSO-prepared 
breakfasts. Similarly to the previous case, samples corresponding to VOO 
and NSO-based breakfasts are clearly separated. The difference here is that 
the group of samples associated to DSO are not located between the two 
non-enriched oils. Therefore, it can be considered as a completely different 
cluster or class in this model. This second model had again a good predictive 
capability with good accuracy levels, as can be seen in Table 3. Thus, the 
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training model similarly achieved accuracy levels of 100% for the three 
group of individuals, while cross-validation reported accuracy levels from 
50% for individuals after intake of DSO-based breakfast to 92% for 
individuals after intake of the breakfast prepared with fried VOO. In this 
case, this PLS-DA model was excellent to predict those individuals after 
intake of VOO-based breakfast and had a good prediction capability to 
discriminate NSO. However, cross-validation was not good enough to 
differentiate individuals after intake of sunflower oil with the synthetic 
oxidation inhibitor. In fact, 50% of individuals were misclassified since some 
of them were assigned to the intake of breakfast prepared with fried 
sunflower oil and others as individuals after the intake of the muffin 
prepared with VOO. In qualitative terms, individuals after intake of DSO-
prepared meal provided a urinary metabolome different from the two other 
groups of individuals, but prediction of them as an independent class was 
not good. 
Table 2. Characterization of the PLS model for the study involving VOO, NSO 
and PSO-prepared breakfasts; (a) validation and (b) training. 
 (a)  
 
(b) 
 
[NSO] 
(Predicted) [PSO] (Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 9 2 2 69.231 
[PSO] (True) 3 12 1 75 
[VOO] (True) 1 0 11 91.667 
Overall accuracy 78.049 
 
[NSO] 
(Predicted) [PSO] (Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 13 0 0 100 
[PSO] (True) 0 16 0 100 
[VOO] (True) 0 0 12 100 
Overall accuracy 100 
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3.4.  Identification of significant molecular features 
 
Table 3. Characterization of the PLS model for the study involving VOO, 
NSO and DSO-prepared breakfasts; (a) validation and (b) training. 
 (a)  
 
(b) 
 
[NSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 15 0 0 100 
[DSO] (True) 0 14 0 100 
[VOO] (True) 0 0 12 100 
Overall accuracy 100 
 
 A final identification step was carried out, for which the features 
obtained after the PLS analysis were queried against the METLIN database, 
which includes endogenous metabolites found in plasma and, in a lesser 
extent, exogenous human drugs and their metabolites. Finally, further 
identification of the resulting features was done by searching in the HMDB 
by comparing the experimental base peak mass against the [M–H]– peaks as 
well as other adducts such as those formed with formic acid or by 
dehydration. The database search results are summarized in Tables 3 and 4, 
which include the molecular formula, the detected adduct mass, matching 
tolerance, and the numeric reference in HMDB. A total of 50 compounds 
 
[NSO] 
(Predicted) 
[DSO] 
(Predicted) 
[VOO] 
(Predicted) Accuracy 
[NSO] (True) 11 1 3 73.333 
[DSO] (True) 5 7 2 50.000 
[VOO] (True) 0 1 11 91.667 
Overall accuracy 68.085 
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were identified from the entities list created after statistical analysis in the 
PLS-DA study involving VOO, NSO and PSO-prepared breakfasts with a mass 
tolerance window below 10 ppm (Table 4). Similarly, a total of 114 
compounds were identified in the case of the study including VOO, NSO and 
DSO-prepared breakfasts (Table 5). The 42 and 44% of metabolites 
identified in both PLS entities lists were in common revealing the similarity 
of both studies. These compounds are expected to be related with 
differences in metabolism produced by oils intake.  
  Among the identified metabolites, sugars, hormones, lipids, amino 
acids, and other minor components were identified. The occurrence of these 
compounds in urine as a consequence of oils intake is further discussed by 
comparison of fold change (FC) ratios of individuals after intake of different 
breakfasts (equivalent to concentration changes). 
 
Lipids 
 Lipids are the main constituents of oils. Thus, they are likely to 
appear in urine after oils intake. Among lipids, several mono- and 
diacylglycerides were identified, despite their non-polar character. The 
intake of NSO and VOO breakfasts led to similar urine levels of 
diacylglycerols (DG) linked to C20 or longer fatty acids, while individuals 
after DSO and PSO breakfasts reported FC ratios of –2 and 2.9, respectively. 
In the case of monoglycerols (MG), the intake of fried sunflower oils 
increased the concentration of detected MG as compared to the intake of 
VOO breakfast. This increase was maximum for individuals after intake of 
NSO breakfast, while it was minimum for PSO individuals. It has been 
demonstrated that a high percent of mono and diacylglycerols in oils aids to 
prevent and control obesity [30]. Concerning phospholipids, different 
metabolites such as phosphatidil glycerols (PG), phosphatidil glycerol 
phosphate derivatives (PGP) or phosphatidylinositol phosphate derivatives 
PIP  suffered concentration changes comparing NSO, DSO and VOO 
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breakfasts while only PIP metabolites contributed to explain the variability 
observed in the PLS-DA of NSO, PSO and VOO breakfasts.  
 Additionally, the acylglycines isobutirylgluycine and hexanoylglycine 
were also identified. These are minor metabolites of fatty acids conjugated 
with the amino acid glycine that are normally excreted in urine [31]. As a 
consequence of the breakfasts intake, urine from individuals who ingested 
NSO and DSO prepared breakfasts presented higher concentrations of both 
acylglycines than individuals after intake of VOO and PSO breakfasts. 
Therefore, these metabolites allowed discrimination as a result of the levels 
of phenolic antioxidants. Hydroxylated fatty acids such as hydroxybutyric 
acid or hydroxysebacic acid and dicarboxylic acids such as hexenedioic acid 
or hexadecadienoic acid were also significant metabolites to explain the 
variability in both PLS studies. These compounds were at lower 
concentration in urine from NSO and DSO individuals, while their 
concentration was higher in the urine from PSO individuals. 
Other minor lipids such as oxidation products of eicosanoids and 
prostanoids contributed to explain the variability in the study comparing 
DSO, NSO and VOO individuals. As should be expected, these oxidized 
metabolites involved in the inflammation cascade were found with FC ratios 
between 4 and 6 by comparison of individuals after intake of DSO and NSO 
breakfast versus VOO breakfast. This is a really interesting result since these 
metabolites were not crucial to discriminate PSO individuals. 
 
 Amino acids 
 The presence of amino acids and derivatives among the of 
metabolites detected in urine with contribution to differentiate among 
individuals after intake of breakfasts is supposedly due to protein 
breakdown. Therefore, dipeptides, L-gamma-glutamyl-L-isoleucine and L-
beta-aspartyl-L-leucine and the free aminoacid N(6)-methyllysine 
contributed to differentiate individuals after intake of PSO-based breakfast. 
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Oxidized forms of amino acids such as tryptophan, tyrosine or leucine were 
significant to distinguish individuals after intake of DSO and NSO breakfasts. 
However, the most abundant metabolites related to amino acid metabolism 
are catabolic products, which are normally found in urine. Among them, 
hydroquinone, serotonin, acetamidobutanoic acid, indol derivatives indoxyl 
sulphate and 3-indolebutyric acid and valeric acid derivatives alpha-
ketoisovaleric acid and 2-oxovaleric were identified.  
 
Other compounds  
 There are other minor constituents that were found to have a 
significant relationship with oils intake; for instance, nucleotide catabolic 
products and sugars were also detected. Thus, methylguanines are naturally 
occurring modified purines derived from tRNA. These are naturally found in 
biofluids and abnormally elevated in serum and urine of cancer patients and 
smokers [32]. 5-Hydroxymethyluracil is an oxidation product derived from 
thymine or 5-methylcytosine [33]. Among sugars, pentosides (xylose, ribose 
or arabinose) were also detected. Other normally occurring urinary 
metabolites such as 2-methylglutaric acid, sialic acid and riboflavin, were 
identified. 2-Methylglutaric acid is an organic acid usually found in human 
urine. 2-Methylglutaric acid is a metabolite of succinic acid, a citric acid cycle 
intermediate [34]. N-acetylneuraminic acid (NeuAc) or sialic acid is an acetyl 
derivative of the amino sugar neuraminic acid, which occurs in many 
glycoproteins, glycolipids, and polysaccharides in human tissues fluids, 
including serum, cerebrospinal fluid, saliva, urine, amniotic fluid, and breast 
milk [35]. Riboflavin or vitamin B2 is an easily absorbed, water-soluble 
micronutrient involved in energy production by aiding in the metabolism of 
fats, carbohydrates, and proteins [35]. Phenolic compounds and derivatives 
such as tyrosol, homovanillic acid, trimethoxycinnamic acid, 
phenylacetaldehyde or vanillylamine, among others, were detected in the 
urine from individuals after intake of breakfasts prepared with fried VOO 
and sunflower oil enriched with natural phenols. 
  
 
 
 
 
HMDB ID Common Name 
Chemical 
Formula 
Neutral 
Mass MW 
Adduct 
MW 
Charge Adduct, 
MW 
Difference 
(Da) 
MW 
Difference 
(ppm) 
1 HMDB02434 Hydroquinone C6H6O2 110.0368 109.0295 1- M-H  0.000328 3.00 
2 HMDB00620 Glutaconic acid C5H6O4 130.0266 111.0082 1- M-H20-H  0.000732 6.59 
 HMDB02092 Itaconic acid C5H6O4 130.0266 111.0082 1- M-H20-H  0.000732 6.59 
3 HMDB00808 N-Butyrylglycine C6H11NO3 145.0739 144.0666 1- M-H  0.000259 1.79 
 HMDB03681 4-Acetamidobutanoic acid C6H11NO3 145.0739 144.0666 1- M-H  0.000259 1.79 
4 HMDB00008 2-Hydroxybutyric acid C4H8O3 104.0473 149.0455 1- M+FA-H  0.000595 3.99 
5 HMDB00098 D-Xylose C5H10O5 150.0528 149.0455 1- M-H  0.00058 3.89 
 HMDB00646 L-Arabinose C5H10O5 150.0528 149.0455 1- M-H  0.00058 3.89 
6 HMDB00893 Suberic acid C8H14O4 174.0892 173.0819 1- M-H  0.000748 4.32 
7 HMDB00118 Homovanillic acid C9H10O4 182.0579 181.0506 1- M-H  0.000641 3.54 
 HMDB02643 
3-(3-hydroxyphenyl)-3-
hydroxypropanoic acid 
C9H10O4 
182.0579 181.0506 
1- M-H  0.000641 
3.54 
8 HMDB02142 Phosphoric acid H3O4P 97.976898 194.9465 1- 2M-H  0.000839 4.30 
9 HMDB00259 Serotonin C10H12N2O 176.0950 197.0696 1- M+Na-2H  0.0009 4.56 
 HMDB02038 N(6)-Methyllysine C7H16N2O2 160.1212 197.0698 1- M+K-2H  0.001068 5.41 
10 HMDB00682 Indoxyl sulfate C8H7NO4S 213.0096 212.0023 1- M-H  0.001282 6.05 
1º
1 
HMDB00701 Hexanoylglycine C8H15NO3 173.1052 218.1034 1- M+FA-H  0.000412 1.89 
12 HMDB01865 2-Oxovaleric acid C5H8O3 116.0473 231.0874 1- 2M-H 0.001389 6.01 
13 HMDB11170 L-gamma-glutamyl-L-isoleucine C11H20N2O5 260.1372 241.1188 1- M-H20-H  0.001434 5.95 
Table 4. Identification of molecular features related with oils intake after statistical analysis in the PLS-DA study 
involving VOO, NSO and PSO-prepared breakfasts. 
 
  
 HMDB11171 L-gamma-glutamyl-L-leucine C11H20N2O5 260.1372 241.1188 1- M-H20-H  0.001434 5.95 
14 HMDB03332 
3-Methoxy-4-Hydroxyphenylglycol 
sulfate 
C9H12O7S 
264.0304 245.0120 
1- M-H20-H  0.002426 
9.90 
15 HMDB11166 L-beta-aspartyl-L-leucine C10H18N2O5 246.1216 283.0702 1- M+K-2H  0.000183 0.65 
16 HMDB02511 3,4,5-Trimethoxycinnamic acid C12H14O5 238.0841 283.0823 1- M+FA-H  0.000916 3.24 
17 HMDB00393 3-Hexenedioic acid C6H8O4 144.0423 287.0772 1- 2M-H   0.001373 4.78 
18 HMDB00422 2-Methylglutaric acid C6H10O4 146.0579 291.1086 1- 2M-H  0.001556 5.35 
19 HMDB00230 N-Acetylneuraminic acid C11H19NO9 309.1060 308.0987 1- M-H  0.002258 7.33 
20 HMDB13240 Indoleacetyl glutamine C15H17N3O4 303.1219 340.0705 1- M+K-2H  0.00119 3.50 
21 HMDB12281 Portulacaxanthin II C18H18N2O7 374.1114 355.0930 1- M-H20-H  0.001556 4.38 
22 HMDB00244 Riboflavin C17H20N4O6 376.1383 357.1199 1- M-H20-H  0.000671 1.88 
23 HMDB00734 Indoleacrylic acid C11H9NO2 187.0633 373.1194 1- 2M-H  0.00351 9.41 
24 HMDB00897 7-Methylguanine C6H7N5O 165.0651 375.1283 1- 2M+FA-H  0.00293 7.81 
 HMDB01566 3-Methylguanine C6H7N5O 165.0651 375.1283 1- 2M+FA-H  0.00293 7.81 
 HMDB03282 1-Methylguanine C6H7N5O 165.0651 375.1283 1- 2M+FA-H  0.00293 7.81 
25 HMDB02302 3-Indolepropionic acid C11H11NO2 189.0790 377.1507 1- 2M-H  0.003693 9.79 
26 HMDB11554 MG(0:0/22:4(7Z,10Z,13Z,16Z)/0:0) C25H42O4 406.3083 387.2899 1- M-H20-H  0.001434 3.70 
 HMDB11584 MG(22:4(7Z,10Z,13Z,16Z)/0:0/0:0) C25H42O4 406.3083 387.2899 1- M-H20-H  0.001434 3.70 
27 HMDB11690 7-Aminomethyl-7-carbaguanine C7H9N5O 179.0807 403.1596 1- 2M+FA-H  0.002838 7.04 
28 HMDB02096 3-Indolebutyric acid C12H13NO2 203.0946 405.1820 1- 2M-H  0.002228 5.50 
29 HMDB01451 Lipoic acid C8H14O2S2 206.0435 411.0798 1- 2M-H  0.003387 8.24 
30 HMDB00350 3-Hydroxysebacic acid C10H18O5 218.1154 435.2236 1- 2M-H  0.001587 3.65 
31 HMDB06070 Pregnanetriol C21H36O3 336.2660 449.2516 1- M+TFA-H  0.004333 9.64 
32 HMDB10321 3,17-Androstanediol glucuronide C25H40O8 468.2723 449.2539 1- M-H20-H  0.002014 4.48 
 HMDB10339 3-alpha-androstanediol glucuronide C25H40O8 468.2723 449.2539 1- M-H20-H  0.002014 4.48 
  
 
 
 HMDB10359 17-hydroxyandrostane-3-glucuronide C25H40O8 468.2723 449.2539 1- M-H20-H  0.002014 4.48 
 HMDB00447 7a,12a-Dihydroxy-3-oxo-4-cholenoic 
acid 
C24H36O5 404.2563 449.2545 1- M+FA-H  0.001434 3.19 
33 HMDB11144 LPA(18:0e/0:0) C21H45O6P 424.2954 461.2440 1- M+K-2H  0.002563 5.56 
34 HMDB11539 MG(0:0/18:3(6Z,9Z,12Z)/0:0) C21H36O4 352.2614 465.2469 1- M+TFA-H  0.003723 8.00 
 HMDB11540 MG(0:0/18:3(9Z,12Z,15Z)/0:0) C21H36O4 352.2614 465.2469 1- M+TFA-H  0.003723 8.00 
 HMDB11569 MG(18:3(6Z,9Z,12Z)/0:0/0:0) C21H36O4 352.2614 465.2469 1- M+TFA-H  0.003723 8.00 
 HMDB11570 MG(18:3(9Z,12Z,15Z)/0:0/0:0) C21H36O4 352.2614 465.2469 1- M+TFA-H  0.003723 8.00 
35 HMDB02829 Androsterone glucuronide C25H38O8 466.2567 465.2494 1- M-H  0.001282 2.76 
36 HMDB00451 cis-4-Hydroxycyclohexylacetic acid C8H14O3 
158.0943 473.2756 
1- 3M-H  0.003662 
7.74 
37 HMDB03180 Cortol C21H36O5 368.2563 481.2419 1- M+TFA-H  0.004181 8.69 
38 HMDB10351 
11-beta-hydroxyandrosterone-3-
glucuronide 
C25H38O9 
482.2516 481.2443 
1- M-H  0.00174 
3.62 
39 HMDB09937 PIP(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) C47H82O16P2 964.5078 481.2466 2- M-2H 0.00058 1.21 
 HMDB09938 PIP(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09945 PIP(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09967 PIP(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09968 PIP(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09980 PIP(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09981 PIP(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09991 PIP(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB09992 PIP(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10009 PIP(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
  
 HMDB10014 PIP(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10017 PIP(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10018 PIP(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10021 PIP(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10022 PIP(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10024 PIP(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10029 PIP(22:5(4Z,7Z,10Z,13Z,16Z)/16:0) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
 HMDB10030 PIP(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) C47H82O16P2 964.5078 481.2466 2- M-2H  0.00058 1.21 
40 HMDB02004 5-Methoxydimethyltryptamine C13H18N2O 218.1419 481.2820 1- 2M+FA-H  0.000153 0.32 
41 HMDB00089 Cytidine C9H13N3O5 243.0855 485.1638 1- 2M-H  0.004089 8.43 
42 HMDB12167 4alpha-formyl-4beta-methyl-5alpha-
cholesta-8,24-dien-3beta-ol 
C29H46O2 426.3498 505.2687 1- M+Br  0.000488 0.97 
43 HMDB00030 Biotin C10H16N2O3S 244.0882 533.1746 1- 2M+FA-H  0.001282 2.40 
44 HMDB13043 Prostaglandin PGE2 1-glyceryl ester C23H38O7 426.2617 539.2473 1- M+TFA-H  0.004456 8.26 
45 HMDB10320 Cortolone-3-glucuronide C27H42O11 542.2727 541.2654 1- M-H  0.001526 2.82 
46 HMDB03529 Inositol 1,3,4,5,6-pentakisphosphate C6H17O21P5 579.8950 616.8436 1- M+K-2H  0.001831 2.97 
47 HMDB00296 Uridine C9H12N2O6 244.0695 731.2014 1- 3M-H  0.003418 4.67 
48 HMDB07411 
DG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,
19Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07438 
DG(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,
16Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07466 
DG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,1
6Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07495 
DG(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,
16Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07581 
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,
16Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07665 
DG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,
17Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
  
 
 
 
Table 5. Identification of molecular features related with oils intake after statistical analysis in the PLS-DA study 
involving VOO, NSO and DSO-prepared breakfasts 
 HMDB ID Common Name 
Chemical 
Formula 
Neutral 
Mass 
MW 
Adduct 
MW 
Charge Adduct, 
MW 
Difference 
(Da) 
MW 
Differenc
e (ppm) 
1 HMDB01169 4-Aminophenol C6H7NO 109.053 108.0454
9 
-1 M-H 0.000221 2.05 
2 HMDB02434 Hydroquinone C6H6O2 110.037 109.0295
0 
-1 M-H 0.000206 1.89 
3 HMDB00620 Glutaconic acid C5H6O4 130.027 111.0082 -1 M-H20-H 0.000832 7.49 
 HMDB02092 Itaconic acid C5H6O4 130.027 111.0082
2 
-1 M-H20-H 0.000832 7.49 
4 HMDB00562 Creatinine C4H7N3O 113.059 112.0516
4 
-1 M-H 0.000412 3.68 
 HMDB07690 
DG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,1
1Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07691 
DG(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,
14Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07718 
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,
14Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07747 
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z
,14Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
 HMDB07775 
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(
11Z)/0:0) 
C45H74O5 
694.5537 807.5392 
1- M+TFA-H  0.000305 
0.38 
49 HMDB02728 Thyroxine sulfate C15H11I4NO7S 856.6435 893.5921 1- M+K-2H  0.003113 3.48 
50 HMDB12562 13'-Hydroxy-gama-tocotrienol C28H42O3 426.3134 897.6250 1- 2M+FA-H  0.003174 3.54 
  
5 HMDB00535 Caproic acid C6H12O2 116.084 115.0764
5 
-1 M-H 0.000366 3.18 
6 HMDB00254 Succinic acid C4H6O4 118.027 117.0193
3 
-1 M-H 0.000328 2.80 
7 HMDB04284 Tyrosol C8H10O2 138.068 119.0497
0 
-1 M-H20-H 0.000687 5.77 
 HMDB06236 Phenylacetaldehyde C8H8O 120.058 119.0502
4 
-1 M-H 0.000145 1.22 
8 HMDB11724 4-Hydroxybenzyl alcohol C7H8O2 124.052 123.0451
5 
-1 M-H 0.000046 0.37 
9 HMDB03903 2-Hydroxyethanesulfonate C2H6O4S 125.999 124.9914
0 
-1 M-H 0.000488 3.90 
10 HMDB00393 3-Hexenedioic acid C6H8O4 144.042 125.0238
7 
-1 M-H20-H 0.000511 4.09 
11 HMDB00482 Caprylic acid C8H16O2 144.115 125.0966
5 
-1 M-H20-H 0.000717 5.73 
 HMDB00480 7,10-Hexadecadienoic acid C16H28O2 252.209 125.0971
8 
-2 M-2H 0.000183 1.46 
12 HMDB11655 2-(3-Carboxy-3-aminopropyl)-L-
histidine 
C10H16N4O4 256.117 127.0513
0 
-2 M-2H 0.00016 1.26 
13 HMDB00148 L-Glutamic acid C5H9NO4 147.053 128.0347
8 
-1 M-H20-H 0.000748 5.84 
14 HMDB04813 3-Methyluridine C10H14N2O6 258.085 128.0353
1 
-2 M-2H 0.000214 1.67 
15 HMDB12309 Vanillylamine C8H11NO2 153.079 134.0605
9 
-1 M-H20-H 0.0009 6.71 
16 HMDB02466 Hydroxybenzoic acid C7H6O3 138.032 137.0244
1 
-1 M-H 0.000458 3.34 
17 HMDB02730 Nicotinamide N-oxide C6H6N2O2 138.043 137.0356
5 
-1 M-H 0.000061 0.45 
18 HMDB01978 5-Hydroxypyrazinamide C5H5N3O2 139.038 138.0309
0 
-1 M-H 0.000046 0.33 
19 HMDB12153 3,4-Dihydroxybenzylamine C7H9NO2 139.063 138.0560
5 
-1 M-H 0.000275 1.99 
20 HMDB00730 Isobutyrylglycine C6H11NO3 145.074 144.0666
2 
-1 M-H 0.000015 0.10 
 HMDB03681 4-Acetamidobutanoic acid C6H11NO3 145.074 144.0666
2 
-1 M-H 0.000015 0.10 
 HMDB12151 2-Keto-6-aminocaproate C6H11NO3 145.074 144.0666
2 
-1 M-H 0.000015 0.10 
21 HMDB00641 L-Glutamine C5H10N2O3 146.069 145.0618
6 
-1 M-H 0.000015 0.10 
22 HMDB12815 5-Aminopentanal C5H11NO 101.084 146.0822
6 
-1 M+FA-H 0.000031 0.21 
23 HMDB01545 Pyridoxal C8H9NO3 167.058 148.0398
6 
-1 M-H20-H 0.00061 4.12 
24 HMDB00008 2-Hydroxybutyric acid C4H8O3 104.047 149.0455
3 
-1 M+FA-H 0.000626 4.20 
  
 
 
25 HMDB00283 D-Ribose C5H10O5 150.053 149.0455
5 
-1 M-H 0.00061 4.09 
 HMDB00646 L-Arabinose C5H10O5 150.053 149.0455
5 
-1 M-H 0.00061 4.09 
26 HMDB00239 Pyridoxine C8H11NO3 169.074 150.0555
1 
-1 M-H20-H 0.000626 4.17 
27 HMDB01182 6,8-Dihydroxypurine C5H4N4O2 152.033 151.0261
5 
-1 M-H 0.000137 0.91 
28 HMDB12209 Diethylphosphate C4H11O4P 154.039 153.0322
1 
-1 M-H 0.001007 6.58 
29 HMDB00177 L-Histidine C6H9N3O2 155.069 154.0622
0 
-1 M-H 0.000137 0.89 
30 HMDB00159 L-Phenylalanine C9H11NO2 165.079 164.0717
0 
-1 M-H 0.00029 1.77 
31 HMDB00337 (S)-3,4-Dihydroxybutyric acid C4H8O4 120.042 165.0404
7 
-1 M+FA-H 0.000793 4.80 
32 HMDB01366 Purine C5H4N4 120.044 165.0417
9 
-1 M+FA-H 0.000198 1.20 
33 HMDB00289 Uric acid C5H4N4O3 168.028 167.0210
6 
-1 M-H 0.000519 3.11 
34 HMDB02656 Prostaglandin A1 C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB02982 Prostaglandin B1 C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04243 12(S)-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04244 15(S)-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04692 12(R)-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04693 11H-14,15-EETA C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04696 11(R)-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB04699 8(S)-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB05050 15H-11,12-EETA C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB10204 14,15-DiHETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB10211 17,18-DiHETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB10216 5,15-DiHETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
  
 HMDB10219 8,15-DiHETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
 HMDB11135 5-HPETE C20H32O4 336.230 167.1077
6 
-2 M-2H 0.000504 3.02 
36 HMDB02243 Picolinic acid C6H5NO2 123.032 168.0302
3 
-1 M+FA-H 0.000443 2.64 
37 HMDB00893 Suberic acid C8H14O4 174.089 173.0819
2 
-1 M-H 0.000244 1.41 
38 HMDB01494 Acetylphosphate C2H5O5P 139.987 174.9568
6 
-1 M+Cl 0.000244 1.39 
39 HMDB00714 Hippuric acid C9H9NO3 179.058 178.0509
6 
-1 M-H 0.000122 0.69 
40 HMDB00122 D-Glucose C6H12O6 180.063 179.0561
1 
-1 M-H 0.000885 4.94 
 HMDB00143 D-Galactose C6H12O6 180.063 179.0561
1 
-1 M-H 0.000885 4.94 
 HMDB00169 D-Mannose C6H12O6 180.063 179.0561
1 
-1 M-H 0.000885 4.94 
 HMDB00660 D-Fructose C6H12O6 180.063 179.0561
1 
-1 M-H 0.000885 4.94 
41 HMDB00158 L-Tyrosine C9H11NO3 181.074 180.0666
2 
-1 M-H 0.000122 0.68 
42 HMDB01970 Methyluric acid C6H6N4O3 182.044 181.0367
1 
-1 M-H 0.000549 3.03 
43 HMDB00209 Phenylacetic acid C8H8O2 136.052 181.0506
3 
-1 M+FA-H 0.000305 1.68 
44 HMDB01392 p-Aminobenzoic acid C7H7NO2 137.048 182.0458
8 
-1 M+FA-H 0.000031 0.17 
45 HMDB01908 19-Hydroxy-PGE2 C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
 HMDB01979 6,15-Diketo,13,14-dihydro-PGF1a C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
 HMDB03247 20-Hydroxy-PGE2 C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
 HMDB04241 6-Ketoprostaglandin E1 C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
 HMDB04242 11-Dehydro-thromboxane B2 C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
 HMDB12110 5(6)-Epoxy Prostaglandin E1 C20H32O6 368.220 183.1026
6 
-2 M-2H 0.000717 3.92 
46 HMDB06029 N-Acetylglutamine C7H12N2O4 188.080 187.0724
3 
-1 M-H 0.001068 5.71 
47 HMDB00325 3-Hydroxysuberic acid C8H14O5 190.084 189.0768
4 
-1 M-H 0.00087 4.60 
48 HMDB00094 Citric acid C6H8O7 192.027 191.0197
3 
-1 M-H 0.000702 3.68 
49 HMDB02123 1,3,7-Trimethyluric acid C8H10N4O3 210.075 191.0569
0 
-1 M-H20-H 0.000336 1.76 
  
 
 
50 HMDB00127 D-Glucuronic acid C6H10O7 194.043 193.0353
7 
-1 M-H 0.000168 0.87 
 HMDB02545 Galacturonic acid C6H10O7 194.043 193.0353
7 
-1 M-H 0.000168 0.87 
51 HMDB02142 Phosphoric acid H3O4P 97.977 194.9465
2 
-1 2M-H 0.000931 4.78 
52 HMDB00565 Galactonic acid C6H12O7 196.058 195.0510
3 
-1 M-H 0.001007 5.16 
 HMDB00625 Gluconic acid C6H12O7 196.058 195.0510
3 
-1 M-H 0.001007 5.16 
53 HMDB01982 Dimethyluric acid C7H8N4O3 196.060 195.0523
7 
-1 M-H 0.000259 1.33 
54 HMDB00440 3-Hydroxyphenylacetic acid C8H8O3 152.047 197.0455
5 
-1 M+FA-H 0.000687 3.49 
55 HMDB00792 Sebacic acid C10H18O4 202.121 201.1132
4 
-1 M-H 0.000549 2.73 
56 HMDB00212 N-Acetylgalactosamine C8H15NO6 221.090 202.0715
5 
-1 M-H20-H 0.000809 4.00 
 HMDB00215 N-Acetyl-D-glucosamine C8H15NO6 221.090 202.0715
5 
-1 M-H20-H 0.000809 4.00 
57 HMDB00929 L-Tryptophan C11H12N2O2 204.090 203.0826
0 
-1 M-H 0.000473 2.33 
58 HMDB00350 3-Hydroxysebacic acid C10H18O5 218.115 217.1081
4 
-1 M-H 0.000473 2.18 
59 HMDB06695 Prolylhydroxyproline C10H16N2O4 228.111 227.1037
3 
-1 M-H 0.000565 2.49 
60 HMDB00019 Alpha-ketoisovaleric acid C5H8O3 116.047 231.0874
0 
-1 2M-H 0.001389 6.01 
 HMDB00310 Methylacetoacetic acid C5H8O3 116.047 231.0874
0 
-1 2M-H 0.001389 6.01 
 HMDB12233 Glutarate semialdehyde C5H8O3 116.047 231.0874
0 
-1 2M-H 0.001389 6.01 
61 HMDB00296 Uridine C9H12N2O6 244.070 243.0622
6 
-1 M-H 0.000412 1.70 
62 HMDB00497 5,6-Dihydrouridine C9H14N2O6 246.085 245.0779
1 
-1 M-H 0.000763 3.11 
63 HMDB10576 PG(16:0/18:3(6Z,9Z,12Z)) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
 HMDB10577 PG(16:0/18:3(9Z,12Z,15Z)) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
 HMDB10590 PG(16:1(9Z)/18:2(9Z,12Z)) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
 HMDB10646 PG(18:2(9Z,12Z)/16:1(9Z)) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
  
 HMDB10660 PG(18:3(6Z,9Z,12Z)/16:0) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
 HMDB10675 PG(18:3(9Z,12Z,15Z)/16:0) C40H73O10P 744.494 247.1574
4 
-3 M-3H 0.001633 6.61 
64 HMDB00005 2-Ketobutyric acid C4H6O3 102.032 249.0615
8 
-1 2M+FA-H 0.00177 7.11 
65 HMDB00695 Ketoleucine C6H10O3 130.063 259.1187
1 
-1 2M-H 0.001038 4.01 
66 HMDB03224 Deoxyribose C5H10O4 134.058 267.1085
5 
-1 2M-H 0.002625 9.83 
67 HMDB00153 Estriol C18H24O3 288.173 269.1541
4 
-1 M-H20-H 0.002441 9.07 
 HMDB00338 2-Hydroxyestradiol C18H24O3 288.173 269.1541
4 
-1 M-H20-H 0.002441 9.07 
68 HMDB00613 Erythronic acid C4H8O5 136.037 271.0670
8 
-1 2M-H 0.001282 4.73 
69 HMDB00393 3-Hexenedioic acid C6H8O4 144.042 287.0772
4 
-1 2M-H 0.000916 3.19 
70 HMDB00872 Tetradecanedioic acid C14H26O4 258.183 295.1317
1 
-1 M+K-2H 0.000092 0.31 
71 HMDB00101 Deoxyadenosine C10H13N5O3 251.102 296.1000
4 
-1 M+FA-H 0.000793 2.68 
 HMDB01563 1-Methylguanosine C11H15N5O5 297.107 296.1000
7 
-1 M-H 0.000763 2.58 
72 HMDB00814 N-Acetylglucosamine 6-sulfate C8H15NO9S 301.047 300.0394
9 
-1 M-H 0.001434 4.78 
73 HMDB00230 N-Acetylneuraminic acid C11H19NO9 309.106 308.0987
2 
-1 M-H 0.002045 6.64 
74 HMDB01961 1,7-Dimethylguanosine C12H17N5O5 311.123 310.1156
9 
-1 M-H 0.000183 0.59 
75 HMDB00398 3-Oxoadipic acid C6H8O5 160.037 319.0670
8 
-1 2M-H 0.000336 1.05 
76 HMDB01434 3-Methoxytyrosine C10H13NO4 211.084 324.0700
4 
-1 M+TFA-H 0.003082 9.51 
77 HMDB11658 2,8-Dihydroxyquinoline-beta-D-
glucuronide 
C15H15NO8 337.080 336.0725
1 
-1 M-H 0.001648 4.90 
78 HMDB10324 Benzoyl glucuronide C13H14O8 298.069 343.0670
8 
-1 M+FA-H 0.001251 3.65 
79 HMDB00150 Gluconolactone C6H10O6 178.048 355.0882
3 
-1 2M-H 0.002655 7.48 
 HMDB01353 2-Keto-3-deoxy-D-gluconic acid C6H10O6 178.048 355.0882
3 
-1 2M-H 0.002655 7.48 
80 HMDB00030 Biotin C10H16N2O3S 244.088 357.0737
6 
-1 M+TFA-H 0.003326 9.31 
81 HMDB03269 Nicotinuric acid C8H8N2O3 180.053 359.0997
3 
-1 2M-H 0.000122 0.34 
82 HMDB00244 Riboflavin C17H20N4O6 376.138 375.1310
1 
-1 M-H 0.000061 0.16 
83 HMDB00163 D-Maltose C12H22O11 342.116 377.0856
0 
-1 M+Cl 0.001678 4.45 
  
 
 
84 HMDB11554 MG(0:0/22:4(7Z,10Z,13Z,16Z)/0:0) C25H42O4 406.308 387.2899
2 
-1 M-H20-H 0.001892 4.89 
 HMDB11584 MG(22:4(7Z,10Z,13Z,16Z)/0:0/0:0) C25H42O4 406.308 387.2899
2 
-1 M-H20-H 0.001892 4.89 
85 HMDB04076 5-Hydroxykynurenamine C9H12N2O2 180.090 405.1779
5 
-1 2M+FA-H 0.000275 0.68 
86 HMDB01451 Lipoic acid C8H14O2S2 206.044 411.0797
7 
-1 2M-H 0.002625 6.39 
87 HMDB01903 Calcitriol C27H44O3 416.329 415.3217
8 
-1 M-H 0.002502 6.02 
88 HMDB13501 PGP(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,
19Z)) 
C44H74O13P 872.460 435.2229
6 
-2 M-2H 0.002106 4.84 
 HMDB13572 PGP(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,1
4Z)) 
C44H74O13P 872.460 435.2229
6 
-2 M-2H 0.002106 4.84 
 HMDB13587 PGP(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,
14Z)) 
C44H74O13P 872.460 435.2229
6 
-2 M-2H 0.002106 4.84 
89 HMDB13486 PGP(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13499 PGP(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)
) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13500 
PGP(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z
)) 
C44H76O13P 874.476 
436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13557 PGP(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)
) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13570 PGP(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13571 PGP(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)
) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13585 PGP(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)
) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
 HMDB13586 PGP(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z
)) 
C44H76O13P 874.476 436.2308
0 
-2 M-2H 0.002167 4.97 
90 HMDB00472 5-Hydroxy-L-tryptophan C11H12N2O3 220.085 439.1623
2 
-1 2M-H 0.000061 0.14 
  
91 HMDB00138 Glycocholic acid C26H43NO6 465.309 446.2906
5 
-1 M-H20-H 0.001526 3.42 
92 HMDB00631 Deoxycholic acid glycine conjugate C26H43NO5 449.314 448.3068
5 
-1 M-H 0.000824 1.84 
93 HMDB10339 3-alpha-androstanediol glucuronide C25H40O8 468.272 449.2539
1 
-1 M-H20-H 0.001526 3.40 
94 HMDB13609 D-Tryptophan C11H12N2O2 204.090 453.1779
5 
-1 2M+FA-H 0.001373 3.03 
95 HMDB01093 5a-Cholesta-8,24-dien-3-one C27H42O 382.324 461.2424
6 
-1 M+Br 0.000336 0.73 
 HMDB02394 Cholesta-4,6-dien-3-one C27H42O 382.324 461.2424
6 
-1 M+Br 0.000183 0.40 
96 HMDB11539 MG(0:0/18:3(6Z,9Z,12Z)/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003784 8.13 
 HMDB11539 MG(0:0/18:3(6Z,9Z,12Z)/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003845 8.26 
 HMDB11540 MG(0:0/18:3(9Z,12Z,15Z)/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003784 8.13 
 HMDB11540 MG(0:0/18:3(9Z,12Z,15Z)/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003845 8.26 
 HMDB11569 MG(18:3(6Z,9Z,12Z)/0:0/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003784 8.13 
 HMDB11569 MG(18:3(6Z,9Z,12Z)/0:0/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003845 8.26 
 HMDB11570 MG(18:3(9Z,12Z,15Z)/0:0/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003784 8.13 
 HMDB11570 MG(18:3(9Z,12Z,15Z)/0:0/0:0) C21H36O4 352.261 465.2469
5 
-1 M+TFA-H 0.003845 8.26 
97 HMDB02829 Androsterone glucuronide C25H38O8 466.257 465.2493
9 
-1 M-H 0.001343 2.89 
98 HMDB13043 Prostaglandin PGE2 1-glyceryl ester C23H38O7 426.262 471.2599
5 
-1 M+FA-H 0.00177 3.76 
 HMDB13045 Prostaglandin PGE2 glyceryl ester C23H38O7 426.262 471.2599
5 
-1 M+FA-H 0.00177 3.76 
 HMDB13653 Prostaglandin D2-1-glyceryl ester C23H38O7 426.262 471.2599
5 
-1 M+FA-H 0.00177 3.76 
99 HMDB09927 PIP(16:0/20:1(11Z)) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
 HMDB09949 PIP(18:0/18:1(11Z)) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
 HMDB09950 PIP(18:0/18:1(9Z)) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
 HMDB09960 PIP(18:1(11Z)/18:0) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
 HMDB09972 PIP(18:1(9Z)/18:0) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
 HMDB09998 PIP(20:1(11Z)/16:0) C45H86O16P2 944.539 471.2623
0 
-2 M-2H 0.00058 1.23 
  
 
 
100 HMDB09937 PIP(16:0/22:5(4Z,7Z,10Z,13Z,16Z) C47H82O16P 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09938 PIP(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09945 PIP(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09967 PIP(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09968 PIP(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09980 PIP(18:1(9Z)/20:4(5Z,8Z,11Z,14Z) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09981 PIP(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB09991 PIP(18:2(9Z,12Z)/20:3(5Z,8Z,11Z) C47H82O16P2 964.508 481.2466
4 
-2 M-2H 0.000427 0.89 
 HMDB09992 PIP(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10009 PIP(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10014 PIP(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10017 PIP(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10018 PIP(20:4(5Z,8Z,11Z,14Z)/18:1(9Z) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10021 PIP(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10022 PIP(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
  
 HMDB10024 PIP(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
 HMDB10029 PIP(22:5(4Z,7Z,10Z,13Z,16Z)/16:0) C47H82O16P2 964.508 481.2466
4 
-2 M-2H 0.000427 0.89 
 HMDB10030 PIP(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) C47H82O16P2 964.508 481.2466 -2 M-2H 0.000427 0.89 
101 HMDB03134 Biocytin C16H28N4O4S 372.183 485.1687
3 
-1 M+TFA-H 0.000092 0.19 
102 HMDB11544 MG(0:0/20:2(11Z,14Z)/0:0) C23H42O4 382.308 495.2939
2 
-1 M+TFA-H 0.00415 8.38 
 HMDB11574 MG(20:2(11Z,14Z)/0:0/0:0) C23H42O4 382.308 495.2939
2 
-1 M+TFA-H 0.00415 8.38 
103 HMDB06344 Alpha-N-Phenylacetyl-L-glutamine C13H16N2O4 264.111 527.2147
2 
-1 2M-H 0.001648 3.13 
104 HMDB00030 Biotin C10H16N2O3S 244.088 533.1745
6 
-1 2M+FA-H 0.000793 1.49 
105 HMDB10357 Tetrahydroaldosterone-3-glucuronide C27H40O11 540.257 539.2498
2 
-1 M-H 0.002502 4.64 
106 HMDB01526 S-Acetyldihydrolipoamide C10H19NO2S2 249.086 543.1696
8 
-1 2M+FA-H 0.001343 2.47 
107 HMDB02596 Deoxycholic acid 3-glucuronide C30H48O10 568.325 589.2994
4 
-1 M+Na-2H 0.000366 0.62 
108 HMDB00825 3'-Sialyllactose C23H39NO19 633.212 632.2043
5 
-1 M-H 0.001526 2.41 
109 HMDB06584 6-Sialyl-N-acetyllactosamine C25H42N2O19 674.238 673.2309
0 
-1 M-H 0.003967 5.89 
110 HMDB00115 Glycolic acid C2H4O3 76.016 75.00877 -1 M-H 0.000412 5.49 
111 HMDB01033 Hydrogen sulfite [HSO3]- 80.965 79.95736 -1 M-H 0.000053 0.66 
112 HMDB07411 DG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,
19Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
 HMDB07438 DG(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,
16Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
 HMDB07439 DG(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z
,19Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
 HMDB07466 DG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,1
6Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
 HMDB07495 DG(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,
16Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
 HMDB07581 DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,
16Z)/0:0) 
C45H74O5 694.554 807.5392
5 
-1 M+TFA-H 0.000671 0.83 
  
 
 
 HMDB07665 DG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,
17Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
 HMDB07690 DG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,1
1Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
 HMDB07691 DG(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,
14Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
 HMDB07718 DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,
14Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
 HMDB07747 DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z
,14Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
 HMDB07775 DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(
11Z)/0:0) 
C45H74O5 694.554 807.5392 -1 M+TFA-H 0.000671 0.83 
113 HMDB00357 3-Hydroxybutyric acid C4H8O3 104.047 85.02895 -1 M-H20-H 0.000671 7.89 
 HMDB00341 2-Octenedioic acid C8H12O4 172.074 85.02950 -2 M-2H 0.000114 1.34 
114 HMDB00139 Glyceric acid C3H6O4 106.027 87.00822 -1 M-H20-H 0.000824 9.47 
 HMDB00243 Pyruvic acid C3H4O3 88.016 87.00877 -1 M-H 0.000282 3.24 
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4.  Conclusions  
  
 In this study, the metabolic profile of urine after intake of four 
different oils was obtained. These oils were olive oil and sunflower oil, pure 
and enriched with natural antioxidants or a synthetic oxidation inhibitor 
such as dimethylsiloxane. Urine samples obtained before (blank) and 2 and 
4 h after intake were analyzed by LC–TOF/MS. PCA and PLS-DA were 
applied to establish differences among individuals after ingestion of 
prepared breakfasts and to build classification and prediction models. This 
study demonstrates the effect of oils composition on the urinary metabolic 
profile, showing statistical differences among samples obtained after intake 
of oils with different composition.  
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 La normativa vigente en la Universidad de Córdoba para la 
elaboración de una Memoria de Tesis Doctoral en la modalidad en la que se 
incluyen los artículos (publicados o próximos a su publicación) como tales 
requiere una discusión conjunta de los resultados, lo que puede ser más o 
menos factible dependiendo de la homogeneidad de la investigación 
realizada. La investigación recogida en esta Memoria tiene como 
denominador común la metabolómica y, en ella, el desarrollo de plataformas 
analíticas basadas en las diversas estrategias características de esta 
disciplina. Por tanto, se discutirán de forma separada las plataformas 
basadas en cada estrategia  Discusión independiente merecen las 
publicaciones sobre las revisiones bibliográficas dedicadas a las operaciones 
previas y a la preparación de muestra frecuentemente utilizadas en análisis 
metabolómico.  
 
Parte 1: Revisión sobre la preparación de la muestra 
 
 La investigación sobre la documentación bibliográfica realizada por 
la doctoranda durante los primeros años de desarrollo de su Tesis alertó 
sobre la situación de las etapas previas al análisis en metabolómica: Etapas 
que  han recibido una atención desigual, pobre en general. Este hecho se 
hizo patente en la reunión organizada en 2005 por la Sociedad de 
Metabolómica (www.metabolomicssociety.org) y que dio lugar a la conocida 
como “Metabolomics Standard Initiative” enfocada a la estandarización de 
las diferentes etapas y procesos necesarios para la obtención de información 
biológica en experimentos en metabolómica. El resultado de esta iniciativa 
es asegurar la transferibilidad de métodos de análisis y de estudios con el fin 
de posibilitar la reproducción exacta de éstos en cualquier laboratorio. La 
alerta condujo a la doctoranda al desarrollo de un estudio en profundidad de 
este aspecto que, a pesar de su enorme repercusión en los resultados finales 
de una investigación, no recibe la atención que merece. Una especie de 
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recopilación crítica para un uso más acertado de lo ya existente, junto con 
una llamada de atención de las deficiencias y carencias en esta parcela, es lo 
que se ha pretendido conseguir con la elaboración y publicación de la 
revisión realizada y que constituye la Parte I de esta Memoria de Tesis. La 
extensión de esta revisión condujo a su división en dos publicaciones en el 
mismo volumen de la revista TrAC (Trends in Analytical Chemistry), que 
lideraba en el momento de la publicación la clasificación de la Journal 
Citation Reports (ISI Web of Knowledge) en base al índice de impacto.  
En la primera de estas revisiones, con el título “Metabolomics 
analysis I. Selection of biological samples and practical aspects preceding 
sample preparation”, se describen las características de la metabolómica en 
comparación (y en relación) con otras ómicas menos recientes. Se pone 
también de manifiesto el escaso interés que se ha prestado a las primeras 
etapas del proceso analítico en metabolomica; lo que queda patente por el 
número de revisiones que se han publicado sobre la instrumentación 
utilizada en metabolómica y la ausencia de ellas sobre las etapas anteriores 
al uso de esta instrumentación, que son claves para que los instrumentos 
proporcionen una respuesta sin errores ni sesgos. Hablar de las diferentes 
estrategias en metabolómica resulta imprescindible en estos casos, ya que la 
preparación de la muestra es diferente para cada una de ellas; como 
imprescindible es también un esquema en el que el lector ubique cada una 
de las etapas a desarrollar. Ambos aspectos conducen a la discusión sobre la 
selección del material biológico más interesante para el muestreo 
(generalmente sangre u orina, pero también células o tejidos, además de 
otros fluidos como aliento, saliva, lágrimas, líquido cefalorraquídeo, leche 
materna, líquido sinovial o plasma seminal) y la forma más adecuada de 
detener la actividad enzimática en la muestra (quenching) para conseguir 
representatividad del estado del sistema en estudio en el momento del 
muestreo. La forma de conservación de la muestra dependiendo de sus 
características ha sido objeto de muy escasa investigación, a pesar de su 
papel clave en los cambios que se producen durante el almacenamiento y en 
los casos de descongelación/congelación repetida. Los errores a que da 
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lugar un mal desarrollo de esta etapa se enfatizan en la publicación, donde 
también se incluye la orientación sobre la forma más adecuada de realizarla 
en cada caso. 
La segunda parte de la revisión, publicada con el título 
“Metabolomics analysis II. Preparation of biological samples prior to 
detection” se dedica a la preparación de la muestra propiamente dicha. A 
pesar de que esta etapa engloba todas las sub-etapas durante las que los 
analitos se adecuan para la detección, el hecho de que los detectores 
utilizados en metabolómica generalmente estén conectados en línea con un 
equipo de separación (cromatógrafo o, menos comúnmente, equipo de 
electroforesis capilar), hace que se suela considerar terminada la etapa de 
preparación de la muestra cuando ésta (o lo que de ella queda tras su 
preparación, que recibe el nombre de “muestra analítica”) llega al sistema de 
separación. Se hace hincapié en la escasa innovación que se ha producido en 
esta etapa, que generalmente se desarrolla por métodos estrictamente 
convencionales, frente a los grandes logros en separación–detección, y se 
realiza una descripción más completa de cómo llevar a cabo la inactivación 
enzimática para el análisis rápido tras el muestreo.  
Todo ello precede a las etapas típicas de separación de los analitos 
de la matriz de la muestra: Extracción líquido–líquido o sólido–líquido, 
dependiendo del estado físico de la muestra, son sub-etapas que se 
requieren generalmente previas al análisis. Las formas más adecuadas para 
cada estrategia en metabolómica, función también del binomio matriz–
analito, se discuten críticamente. El caso especial de muestreo–preparación–
análisis en cultivos celulares es considerado de forma separada, dada su 
naturaleza y especiales características. Etapas adicionales, como 
derivatización, se discuten también en esta revisión considerando las 
diferentes alternativas existentes para su aceleración. Son de destacar los 
criterios analíticos de los autores de la revisión, junto con la experiencia en 
preparación de la muestra del grupo en el que se integra la doctoranda, que 
permiten tener una visión de estas operaciones que puede ser de utilidad 
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manifiesta para bioquímicos, clínicos u otros investigadores no 
familiarizados con su consideración crítica ni con el objetivo de su mejora.  
 
Parte 2: Análisis orientado (targeting analysis) 
 
 Este tipo de análisis, como cualquier estrategia en metabolómica, 
tiene sus ventajas e inconvenientes y proporciona una información limitada 
cuyo interés puede ser pobre (cuando se requiere obtener una información 
completa del metaboloma) o demasiado prolija (cuando sólo se persigue una 
huella dactilar, sin entrar en concentraciones o identificaciones 
individuales). Una vez definido el problema en cuestión y si éste se refiere a 
unos compuestos concretos, generalmente los precursores y los metabolitos 
de unas determinadas rutas metabólicas, el análisis orientado es la vía 
idónea para el estudio. Desarrollar un método basado en esta estrategia 
implica una óptima preparación de la muestra, obviamente tras las 
adecuadas etapas de muestreo y conservación de la muestra, seguida de una 
separación individual de los analitos (exhaustiva o no, dependiendo del 
analizador utilizado finalmente) y un sistema de detección tan sensible como 
requiera la concentración de los analitos. Una etapa de preconcentración 
puede resolver el problema de una detección poco sensible. Por tanto, se 
habla del desarrollo de métodos muy selectivos para obviar interferencias 
que pudiesen dificultar el análisis cualitativo/cuantitativo de los compuestos 
de interés, pero a su vez de elevada sensibilidad para su detección incluso a 
bajos niveles de concentración. Hasta 6 métodos se han desarrollado 
utilizando esta estrategia en los que, junto con una instrumentación variada 
que ha contribuido a la formación de la doctoranda, se ha pretendido en 
todo momento innovar en la etapa de preparación de la muestra con vistas a 
su aceleración y automatización y en la forma que mejor se ajustara a la 
subsiguiente etapa de análisis. El desarrollo de un método siempre ha de 
completarse con su validación y aplicación a muestras naturales que ponga 
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de manifiesto su utilidad. Los métodos desarrollados siempre se han 
aplicado a estos tipos de muestras; clínicas, cuando los analitos han sido los 
característicos de muestras de orina, sangre o incluso leche materna; o 
vegetales, cuando los analitos han sido típicos de esta área. 
 
Capítulos 3 y 4 
 Estrógenos y progestógenos constituyen un grupo de hormonas 
esteroideas con funciones  esenciales en el metabolismo femenino. De los 
primeros, los tres mayoritarios en mujeres son el estradiol, el estriol y la 
estrona, que pueden ser endógenos (formados a partir del colesterol 
mediante una ruta biosintética) o exógenos, administrados como parte de 
contraceptivos orales, en etapas postmenopáusicas y en el tratamiento de 
desórdenes en la menstruación. La progesterona es el más abundante de los 
progestógenos y un compuesto intermedio en la esteroidogénesis de 
estrógenos, andrógenos y corticosteroides; mientras que la pregnenolona es 
el precursor metabólico de la progesterona y pertenece al grupo de los 
neurosteroides. Estas hormonas, que han sido el objeto de 2 de los artículos 
publicados, se encuentran en la orina, el tipo de muestra para la que se ha 
desarrollado el método, casi exclusivamente como metabolitos conjugados, 
tales como glucurónidos, sulfatos, diglucurónidos, bisulfatos y sulfoglucu-
rónidos. Los dos problemas más importantes que plantea la determinación 
de estos metabolitos son el tiempo requerido para la hidrólisis enzimática 
de los conjugados (entre 12 y 18 h) y las bajas concentraciones a las que se 
encuentran en orina, además de la complejidad intrínseca de este tipo de 
muestra. 
 El problema abordado en primer lugar fue el de conseguir una 
adecuada sensibilidad para su determinación mediante una etapa de 
limpieza y preconcentración. Para ello se partió de un volumen de muestra 
relativamente grande en estudios clínicos (10 mL de muestra), pero no en el 
caso de muestras de orina que no presentan limitación. La preconcentración 
  
506 
Nuevas plataformas analíticas en metabolómica                                                                                    
se realizó en un volumen de muestra analítica de 150 μL tras la etapa de 
extracción en fase sólida, con factores de preconcentración entre 60 y 72. 
Para esta preparación de la muestra se utilizó un sistema automático de 
“laboratorio en una válvula (lab-on-valve o LOV)” con un tratamiento 
paralelo de muestras sometidas y no sometidas a hidrólisis enzimática para 
la determinación de los esteroides inicialmente libres y conjugados y la de 
sólo los libres, respectivamente. La optimización de la etapa de separación 
cromatográfica (cromatografía de líquidos, LC) y la del subsiguiente análisis 
mediante ionización por electroespray y espectrometría de masas de triple 
cuadrupolo, permitió alcanzar límites de detección de 1.8 pg en columna, ó 
0.06 ng/mL en la muestra, con desviaciones estándar relativas en el 
intervalo 1.93–10.99%. 
 El siguiente reto de este estudio fue la reducción del tiempo 
requerido para la hidrólisis enzimática mediante su aceleración por 
ultrasonidos, aspecto en el que el grupo en el que se integra la doctoranda 
tiene una reconocida experiencia. Una optimización multivariante de las 
variables implicadas en la hidrólisis (tanto las características de la sonda de 
ultrasonidos como las del sistema bioquímico) dio lugar a una disminución 
drástica del tiempo requerido para esta etapa, que se completó en 30 
minutos. La aplicabilidad del método, en cuyo desarrollo se utilizaron 
muestras de orina, se ratificó aplicándolo a una serie de muestras de este 
tipo. El tratamiento automático de la muestra con mínima intervención 
humana y la ausencia de contaminación por el desarrollo en línea son 
aspectos que soportan la reproducibilidad y utilidad del método para 
análisis sistemático de estos metabolitos. 
 
Capítulo 5 
 Los esfingolípidos son una familia de compuestos lipídicos que 
contienen una larga cadena amino-alcohol conocida como base esfingoide y 
son componentes de las membranas biológicas. Los esfingolípidos ejercen en 
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células funciones de transmisión y reconocimiento de señales y su 
metabolismo implica un gran número de rutas de sínTesis y de degradación, 
como es de esperar de la variedad de esfingolípidos presentes en las células. 
Existe un gran número de enfermedades asociadas a los esfingolípidos y su 
metabolismo, por lo que un método que permita determinarlos en un rango 
de concentraciones que abarque los valores extremadamente bajos a los que 
se encuentran en fluidos humanos es extremadamente útil. Su baja 
concentración y su naturaleza no polar constituyen los principales cuellos de 
botella para el análisis de estos compuestos. Los métodos existentes han 
estado basados mayoritariamente en extracción líquido–líquido, evapora-
ción del disolvente orgánico y reconstitución previa a su separación 
mediante LC. El uso de la extracción en fase sólida se ha circunscrito a 
métodos manuales, que han requerido una gran cantidad de muestra y de 
reactivos y la complejidad añadida de una etapa de derivatización. 
El método que se recoge como Capítulo 5 para el análisis orientado 
de precursores de esfingolípidos (a saber, D-esfingosina, D-eritro-
dihidroesfinganina, esfingosina 1-fosfato, D-eritro-dihidroesfingosina 1-
fosfato) se ha aplicado a su determinación en suero y en orina y está basado 
en una etapa de preparación de la muestra en un sistema LOV, que consiste 
en una etapa de extracción en fase sólida y elución con un eluyente en el que 
se ha disuelto el reactivo derivatizante (o-ftaladialdehído), previa a la 
introducción de los productos de la reacción en un μ-LC y a la detección de 
su fluorescencia inducida por láser. La excelente sensibilidad que 
proporciona este tipo de detección se pone de manifiesto en los bajos  
límites de detección que presenta el método en los dos fluidos biológicos (en 
los rangos 4.2–10.2 y 0.56–1.36 ng/mL para suero y orina, respectivamente) 
y la automatización de la preparación de la muestra lo hacen muy adecuado 
para análisis clínico. La validación del método se llevó a cabo por infusión 
directa de las muestras en un analizador de masas de triple cuadrupolo en el 
modo de seguimiento de reacciones múltiples (SRM), tanto para comparar 
los resultados con los del método propuesto, como para confirmar la 
identidad de los compuestos en estudio. Es de destacar que la sensibilidad y 
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precisión del método propuesto es mejor que —o similar a, dependiendo de 
los compuestos— las del método de validación. 
 
Capítulo 6 
 En contraposición a los metabolitos objeto de los anteriores métodos 
—todos ellos de naturaleza  lipídica—, los del método recogido como 
Capítulo 6 son compuestos hidrosolubles, ya que se trata de la vitamina B9 
(ácido fólico) y de sus metabolitos. Esta vitamina está implicada en una 
amplia variedad de procesos biológicos, ya que actúa como cofactor 
enzimático en las reacciones de transferencia del grupo metilo. El hecho de 
que la deficiencia de ácido fólico esté relacionada con numerosas 
enfermedades, así como con la síntesis de aminoácidos como la serina y la 
metionina, hace necesaria su determinación y la de sus metabolitos en 
diferentes fluidos biológicos en función del tipo de anomalía orgánica en la 
que puedan estar implicados.  
El desarrollo totalmente en línea de este método se realizó en tres 
matrices biológicas (orina, suero y leche materna) con el fin de demostrar su 
versatilidad e implicó las siguientes etapas: (i) Preparación de la muestra 
mediante un equipo comercial de extracción en fase sólida (Prospekt) que 
trabaja a alta presión. Una vez retenidos los analitos en el sorbente de 
relleno del cartucho, el eluyente, que es la fase móvil del sistema 
cromatográfico con el que está conectado en línea, se bombea y los 
compuestos eluidos se conducen a la cabeza de la columna cromatográfica. 
De esta forma, todo el eluido alcanza la columna —no sólo el que puede 
ocupar el bucle de la válvula de inyección del cromatógrafo, que en este caso 
no se utiliza. Se consigue de esta forma una máxima sensibilidad y un 
mínimo deterioro de los analitos, que no están en contacto en ningún 
momento con la atmósfera. (ii) La separación cromatográfica se realizó en 
régimen isocrático, utilizando una columna de interacción hidrofílica (HILIC) 
y una fase móvil con alto contenido orgánico, lo que favoreció la etapa 
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siguiente. (iii) La detección, basada en ionización mediante electroespray 
previa a un analizador de triple cuadrupolo, se vio positivamente 
influenciada por las condiciones de la etapa anterior. Basado en las 
anteriores etapas, el método permite la determinación de ácido fólico y sus 
metabolitos —ácido L-glutámico N-(p-aminobenzoilo) y su derivado de 
acetamida— con una excelente sensibilidad (del orden de las fracciones de 
picomol); lo que lo hace muy adecuado para análisis clínico en situaciones 
de deficiencia de estos compuestos.  
 
Capítulos 7 y 8 
 Los métodos que conforman estos dos capítulos de la Memoria 
tienen en común la naturaleza de las matrices en las que se han aplicado: 
Vegetales en ambos casos. 
 El método recogido en el Capítulo 7, si bien responde al 
denominador común de la Parte II de la Memoria (análisis orientado) no se 
engloba en el ámbito de la metabolómica, ya que los compuestos problema 
son, estrictamente hablando, productos de degradación, no pertenecientes a 
una ruta bioquímica. Los analitos corresponden al tipo denominado 
“subproductos de la desinfección”, ácidos haloacéticos de los que se 
seleccionaron los 9 más significativos (ácidos monocloro y monobromo 
acéticos, dicloro y dibromo acéticos, tricloro y tribromo acéticos, 
clorobromo acético, clorodibromo acético y bromodicloro acético). El 
objetivo fue la proposición de un método que mejorara significativamente el 
de referencia de la EPA para estos compuestos, pero basado en las mismas 
etapas y con el mismo sistema de separación individual y de detección 
(cromatografía de gases y detección por captura electrónica —GC–ECD). Por 
tanto, la aceleración y automatización de la etapa de preparación de la 
muestra, extremadamente larga en el método de la EPA, fue el objetivo 
primordial. La experiencia del grupo en el que se integra la doctoranda en el 
diseño de sistemas dinámicos y en el uso de energías auxiliares fue el 
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soporte para la construcción de un sistema dinámico en el que el lixiviante, 
conteniendo un reactivo derivatizante, se recirculaba a través de la muestra 
que estaba sometida a la acción de una sonda de ultrasonidos. La inversión a 
tiempo programado del sentido de circulación del lixiviante–derivatizante, 
eliminó el efecto de compacidad creciente de la muestra sólida creado 
cuando el lixiviante circula en un único sentido. La acción conjunta de los 
ultrasonidos y la transformación in situ de los analitos lixiviados en sus 
derivados metilados permitió reducir las más de 2 horas requeridas por el 
método EPA para ambas etapas (lixiviación y derivatización secuencial) a 
sólo 10 min. La eliminación justificada del estándar externo (utilizado en el 
método EPA) y una exhaustiva optimización de la etapa de extracción 
líquido–líquido previa a la separación cromatográfica y la detección 
completó un método que se aplicó con éxito a la determinación de los 
analitos en muestras vegetales como espinacas y acelgas, a las que los 
compuestos de interés podrían haber llegado a través de agua de riego.  
 El Capítulo 8 abarca un amplio análisis orientado, realizado en 
tomate, de numerosos metabolitos tales como carotenoides, provitaminas, 
vitaminas, fenoles y azúcares, que proporciona un perfil completo de estas 
familias de metabolitos. Estos compuestos, agrupados en función de su 
naturaleza en nutracéuticos (hidrofílicos y lipofílicos) y carbohidratos 
(mono y disacáridos), se separaron por LC y GC, respectivamente, y se 
determinaron por espectrometría de masas en ambos casos (triple 
cuadrupolo y masas en tándem, respectivamente). La etapa de lixiviación, 
acelerada por ultrasonidos, se llevó a cabo con una mezcla de 
tetrahidrofurano–metanol 3:1, que se evaporó a sequedad. El extracto seco 
se reconstituyó en el medio adecuado para cada etapa cromatográfica, que 
sólo en el caso de los azúcares requirió derivatización (sililación) antes de la 
inyección en el cromatógrafo. La optimización de la etapa cromatográfica y 
la de detección, exhaustiva para cada grupo de compuestos, junto con la 
rápida preparación de la muestra, proporcionan métodos sensibles, 
selectivos y precisos para la determinación de estos grupos de compuestos. 
Cada uno de los grupos, o su conjunto, pueden utilizarse como marcadores 
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para la selección de variedades de tomate o del tiempo para su recogida en 
programas de mejora de la calidad de este producto.  
 
Parte 3: Perfil metabolómico global 
 
 Esta estrategia, como cada una de las que se utilizan en 
metabolómica, tiene sus objetivos característicos y sus herramientas 
propias. Los objetivos se pueden resumir en la obtención de información lo 
más completa posible sobre la naturaleza de los metabolitos existentes en la 
muestra, que, según las características de ésta y del objetivo final, se puede 
reducir a metabolitos de carácter polar, apolar, etc. En los métodos de 
obtención del perfil metabolómico global se pretende maximizar el número 
de metabolitos detectados e identificados en una determinada muestra. Lo 
ideal sería conseguir el perfil completo de metabolitos presentes en la 
muestra, lo que es inviable en organismos considerados superiores, como 
caso de plantas (las estimaciones apuntan hasta 200.000 metabolitos) o 
humanos (7900 metabolitos según la HMDB —Human Metabolome Data 
Base) debido a los rangos de concentración a los que estos metabolitos están 
presentes, que pueden ser de varios órdenes de magnitud. Con el fin de 
maximizar el número de metabolitos identificados en una muestra se 
pueden combinar diferentes estrategias de preparación de muestra 
(extracción líquido–líquido con diferentes extractantes, extracción en fase 
sólida con diferentes fases estacionarias, reacciones de hidrólisis para la 
identificación de metabolitos conjugados, etc.) o de detección (LC–MS/MS 
con diferentes formas de ionización y con distintas modalidades 
cromatográficas, que a su vez pueden implicar diferentes fases 
estacionarias; GC–MS/MS con diferentes programas de temperatura, fases 
estacionarias o reacciones de derivatización; NMR, unidimensional o 
bidimensional, homonuclear o heteronuclear, etc.) de forma que se consigan 
resultados complementarios. Aún combinando diferentes métodos 
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analíticos, en la mayoría de las ocasiones sólo se consigue identificar una 
pequeña fracción de metabolitos. 
 Las herramientas quimiométricas y bioinformáticas utilizadas tienen 
una aplicación posterior a la de las plataformas analíticas. Las primeras de 
estas herramientas están constituidas por diferentes algoritmos de 
tratamiento de los datos para alinear cromatogramas y espectros de masas 
con los que realizar una adecuada comparación entre muestras, eliminar 
ruido de fondo o filtrar aquellas entidades moleculares no asociadas a la 
muestra. Las herramientas bioinformáticas están constituidas por las 
diferentes bases de datos con las que confrontar los resultados obtenidos  
para identificar metabolitos a partir de los espectros obtenidos en la 
aplicación de la correspondiente plataforma analítica. Bases de datos como 
METLIN (Scripps Center for Metabolomics and Mass Spectrometry) o HMDB 
son la clave para la obtención de esta información una vez deducidas las 
fórmulas moleculares en el caso de la espectrometría de masas, que ha sido 
la opción utilizada principalmente en esta investigación. 
Para la generación de estas fórmulas se requiere la aplicación de una 
serie de algoritmos que conduzcan a ellas, tales como: (i) La localización y 
agrupación de todos los iones relacionados con la misma molécula (e.g. 
covarianza de picos con el mismo tiempo de retención cromatográfico, la 
distribución isotópica y/o la presencia de aductos y dímeros) mediante el 
algoritmo MFE (molecular feature extraction); (ii) La generación de las 
fórmulas moleculares propiamente dichas utilizando el algoritmo 
correspondiente (Molecular Formula Generator), una vez realizadas las 
correcciones oportunas en cada caso (exactitud de masa e información 
isotópica —abundancia y distribución espacial en este último caso). 
Una vez obtenidas las fórmulas moleculares, la búsqueda mediante la 
base de datos METLIN o HMDB permite ajustar cada una de ellas con una 
determinada tolerancia en el valor de la masa (10 ppm como error máximo 
en la plataforma instrumental utilizada) y lleva a confirmar o no su 
existencia en los estudios clínicos o nutricionales realizados en humanos. 
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 La investigación realizada con esta estrategia se orientó al estudio de 
perfiles metabólicos en fluidos de muestreo no invasivo, como es el caso de 
dos fluidos humanos poco estudiados: La saliva y la leche materna. Todo ello 
se recoge en los Capítulos 9 y 10, cuyo conjunto constituye la Parte III de 
esta Memoria. 
 
Capítulos 9 y 10 
 Teniendo en cuenta los escasos estudios realizados sobre perfiles 
metabolómicos en saliva y en leche materna, la investigación se centró 
mayoritariamente en desarrollar protocolos de preparación de muestra 
óptimos para maximizar el número de metabolitos detectados e 
identificados mediante LC–TOF/MS en esos fluidos. Con este propósito, y 
teniendo en cuenta la muy diferente naturaleza de la saliva y la leche, la 
optimización implicó etapas distintas. 
La saliva es un fluido actualmente considerado como una interesante 
fuente de biomarcadores que pueden asociarse a diferentes patologías, y que 
implica un muestreo simple, no invasivo y sin requerimiento de personal 
sanitario para su obtención. Además, la composición de la saliva puede 
reflejar los niveles de ciertos metabolitos en sangre, por lo que es 
susceptible de uso como indicador del estado fisiológico del individuo.  
 La principal etapa y a la que se dedicó la parte más importante de la 
investigación recogida en el Capítulo 9 fue la optimización de la preparación 
de la muestra para la obtención de un perfil LC–TOF/MS lo más completo 
posible. La primera parte en el establecimiento del protocolo de preparación 
de la muestra más adecuado se dedicó a la optimización de la etapa de 
hidrólisis (ácida o básica) de los metabolitos potencialmente enlazados a 
otras moléculas. Los resultados de este estudio se compararon con los 
proporcionados por muestras no sujetas a hidrólisis (en todos los casos el 
seguimiento de esta etapa se realizó mediante LC–TOF/MS en los modos de 
ionización positivo y negativo). Los diagramas de Venn correspondientes 
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ponen de manifiesto de forma inequívoca la necesidad de la etapa de 
hidrólisis, la presencia de un mayor número de entidades moleculares al 
trabajar en modo de ionización negativo y un mayor número de metabolitos 
comunes al trabajar en modo positivo. La necesidad de la etapa de hidrólisis 
y su duración (30 min) indujo a su aceleración mediante ultrasonidos, con lo 
que se redujo a 10 min. Además, la hidrólisis asistida por ultrasonidos dio 
lugar a un número de entidades moleculares mayor que el modo 
convencional. Este hecho tuvo una especial influencia en el modo de 
ionización positivo en ambos tipos de hidrólisis, ácida y básica (de nuevo 
comparadas con las proporcionadas por la hidrólisis convencional mediante 
diagramas de Venn). 
La baja concentración de metabolitos en saliva hizo necesaria una 
etapa de preconcentración, con la que se consiguió un incremento de 
entidades moleculares (174 en el modo de ionización positivo y 84 en el 
negativo para la hidrólisis ácida y 150 y 70, respectivamente, para la 
hidrólisis básica), y por tanto la capacidad de detección. A la etapa de 
comparación de protocolos de preparación de muestra siguió la de 
identificación de las entidades moleculares con las bases de datos METLIN y 
HMDB, que no incluyen información acerca de la composición de la saliva. 
Este hecho dificultó la interpretación de los resultados, ya de por si 
complicada por la presencia de compuestos procedentes de la ingestión de 
alimentos y por los resultantes de la reacción con compuestos endógenos de 
la saliva. 
Un total de 12 compuestos en el modo de ionización negativo y 91 en 
el positivo (tolerancia en exactitud de masa por debajo de 10 ppm) fueron 
encontrados en la muestra sometida a hidrólisis ácida, mientras que en la 
sometida a hidrólisis básica se encontraron 13 y 52 en los modos de 
ionización negativa y positiva, respectivamente. La presencia de los 
metabolitos identificados (azúcares, lípidos, aminoácidos, antioxidantes y 
otros componentes minoritarios) se ha justificado de forma exhaustiva.  
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 En el estudio sobre leche materna (Capítulo 10), una primera etapa 
de desproteinización, con o sin subsiguiente etapa de centrifugación, puso 
de manifiesto las diferencias en el número y naturaleza de los metabolitos 
existentes dependiendo de que se aplique o no esta última etapa. Los 
diagramas de Venn permiten tanto visualizar claramente este comporta-
miento como poner más claramente de manifiesto el diferente comporta-
miento cuando la etapa de desproteinización se realiza en un medio ácido 
(metanol conteniendo un 10% de ácido fórmico). Por otra parte, la 
existencia de compuestos polares y no polares hizo necesaria la extracción 
de la muestras con mezclas metanol–cloroformo para la separación de las 
fracciones polar–apolar, respectivamente. El escaso número de metabolitos 
comunes en ambas fracciones ratifica la necesidad de esta etapa de 
separación. La combinación de estas estrategias de preparación de muestra 
permitió incrementar el número de metabolitos identificados. 
 La obtención de los espectros de masas en los modos de ionización 
positivo y negativo para cada fracción condujo a la aplicación de los 
algoritmos correspondientes para conocer las entidades moleculares y, 
finalmente, a la búsqueda en las bases de datos METLIN y HMBD para la 
adjudicación a un determinado compuesto y la confirmación o no de su 
existencia en humanos, respectivamente. Todo este tratamiento dio como 
resultado total la identificación de 29 metabolitos en las fracciones polar y 
apolar estudiadas en modo de ionización positivo, y a la de 33 en el modo de 
ionización negativo.  
 El perfil realizado mediante 1H-RMN unidimensional permitió 
obtener una huella digital que corroboró parcialmente los resultados 
obtenidos mediante LC–TOF/MS con una mínima preparación de la muestra. 
 Este estudio ha puesto de manifiesto por primera vez la importancia 
del pH, la centrifugación y la extracción líquido–líquido en la preparación de 
este tipo de muestra. Finalmente, un cambio del medio en el que se 
encuentra la muestra analítica tras la preparación a la fase móvil 
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cromatográfica permite conseguir un incremento de la sensibilidad en la 
etapa de ionización por electroespray de hasta 3 veces.  
 Características destacables de estas muestras son la necesidad de 
una etapa de desproteinización, el amplio rango de concentración de los 
analitos y el variable número de compuestos susceptibles de solubilización 
en medio ácido por la presencia de grupos ionizables. Por tanto, con este 
estudio global se ha propuesto una estrategia con la que acometer el análisis 
metabolómico global de un fluido biológico de gran interés, y que puede ser 
de utilidad con fines de evaluación nutricional. 
 
 
Parte 4: Huella dactilar metabolómica 
 
 La última de las estrategias utilizadas en metabolómica tuvo como 
objetivo obtener perfiles representativos de un grupo de muestras (huella 
dactilar metabolómica) que permitieran su discriminación frente a otros 
grupos de muestras, definidos o no. Las técnicas analíticas utilizadas con 
mayor frecuencia en esta disciplina son las espectrométricas, que generan 
un espectro representativo de la composición de la muestra. En concreto, 
NMR, MS mediante inyección directa o previa separación cromatográfica o 
electroforética y, en menor medida, FT-IR son las técnicas preferentemente 
utilizadas en metodologías destinadas a comparar huellas dactilares 
metabolómicas. En la investigación recogida en este bloque de la Tesis se 
han utilizado las tres técnicas mencionadas: FT-IR en la región del infrarrojo 
cercano (NIRS), NMR en régimen unidimensional y LC–TOF/MS a partir de 
una matriz de datos compuesta por un perfil de metabolitos.  
 Normalmente, los métodos de análisis de la huella dactilar 
metabolómica suelen utilizar, siempre que es posible, protocolos directos 
con el fin de simplificar el análisis de un gran número de muestras y 
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minimizar la alteración de su composición. Este aspecto suele ser, en la 
mayoría de los casos, perfectamente viable en FT-IR y NMR. Sin embargo, el 
análisis directo mediante espectrometría de masas es poco frecuente, 
excepto en muestras líquidas de naturaleza principalmente acuosa y con una 
moderada concentración salina. En este bloque de la Tesis, la muestra 
seleccionada fue orina humana, que se analizó de forma directa en el caso de 
NIR y se diluyó como etapa previa en el caso de NMR y LC–TOF/MS debido a 
la pequeña concentración de proteínas (muestras con concentración 
significativa de proteínas requieren una etapa de desproteinización).  
 La estrategia de huella dactilar metabolómica carece de sentido sin la 
implementación de técnicas de análisis multivariante que permitan reducir 
la dimensionalidad de las matrices de datos que usualmente se manejan (n 
muestras × m variables). Estas técnicas tienen como objetivo detectar la 
presencia de grupos o clases en la población en estudio en base a algún 
criterio que no se aporta para el desarrollo del modelo (análisis no 
supervisado) o se aporta con el objetivo de desarrollar modelos con 
capacidad de predicción (análisis supervisado). En este bloque de la Tesis se 
ha aplicado como estrategia general la combinación de técnicas de análisis 
no supervisado y de análisis supervisado con los siguientes objetivos: (i) 
Detectar la presencia de agrupamientos de muestras de acuerdo con el 
objetivo del estudio o por causas externas al mismo (características 
antropológicas de la población) mediante análisis por componentes 
principales (PCA); (ii) Desarrollar modelos con capacidad de predicción de 
una o varias variables respuesta (información aportada al modelo) mediante 
análisis por mínimos cuadrados parciales utilizando diferentes algoritmos. 
Una vez terminado el análisis, el objetivo fue en todos los estudios la 
búsqueda y posterior identificación de los metabolitos o familias de 
metabolitos que permiten explicar la variabilidad observada en cada uno de 
los estudios. Así, diferentes algoritmos estadísticos como ANOVA o de 
estimación de cambio relativo (en inglés fold change analysis) han permitido 
la identificación de las variables (metabolitos) que contribuyen en mayor 
medida a explicar la variabilidad observada.  
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 El esquema de trabajo descrito se ha aplicado en nutrimetabolómica  
para evaluar el efecto de la ingesta por individuos obesos de desayunos 
preparados con diferentes aceites vegetales sometidos a fritura controlada. 
Para ello, se tomaron muestras de orina en condiciones basales y 2 y 4 h 
después de la ingesta de cada uno de los desayunos. Con el objetivo de 
aumentar el interés estadístico de este estudio, los pacientes ingirieron cada 
desayuno después de un período de 2 semanas con el fin de normalizar las 
condiciones basales. Los aceites utilizados fueron: (i) Oliva virgen extra con 
un contenido natural de antioxidantes fenólicos de 400 µg/mL, expresado en 
contenido de ácido gálico según el método de Folin-Ciocalteu (VOO); (ii) 
aceite de girasol comercial con un contenido nulo de antioxidantes fenólicos 
debido al proceso de obtención —aceite refinado— (NSO); (iii) Aceite de 
girasol alto oleico refinado enriquecido con un inhibidor de la oxidación 
sintético como es el dimetilsiloxano a una concentración de 400 µg/mL 
(DSO); y, finalmente, (iv) aceite de girasol alto oleico refinado enriquecido 
con un extracto rico en fenoles procedente de alperujo hasta una 
concentración fenólica de 400 µg/ml, de acuerdo con el método de Folin-
Ciocalteu (PSO). 
 Tres estudios utilizando las tres técnicas de detección previamente 
indicadas componen los Capítulos 11–13. El orden en el que se exponen es el 
de nivel de información creciente que proporcionan. 
  
Capítulo 11 
 Este primer capítulo describe la utilización de la técnica NIRS que es, 
de las tres utilizadas, la que menos se ha aplicado en estudios de huella 
dactilar metabolómica. De hecho, se ha utilizado únicamente con propósitos 
de clasificación y predicción puesto que su capacidad de identificación de 
metabolitos es escasa. Entre sus ventajas destaca la rapidez de medida, la 
posibilidad de análisis directo, incluso en el caso de muestras sólidas 
(tejidos), facilidad de uso del instrumento y reducido coste de adquisición y 
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mantenimiento del equipo. Esta primera investigación en huella dactilar 
metabolómica se basó en la utilización de una técnica de modelado de clases 
en análisis supervisado como es la PLS-CM (del inglés Partial Least Squares-
Class Modeling) con el que se desarrollaron cuatro modelos, uno por cada 
desayuno ingerido, con el fin de predecir su ingesta frente al resto. Frente a 
las técnicas PLS basadas en análisis discriminante (PLS-DA), la técnica de 
PLS-CM permite interpretar las propiedades espectrales de las muestras que 
componen cada clase y estimar los parámetros de sensibilidad (capacidad de 
un modelo para predecir individuos pertenecientes a la clase modelada) y 
especificidad (capacidad de un modelo para predecir la no pertenencia de un 
individuo a la clase modelada) para las etapas de desarrollo y validación 
cruzada. Ambos parámetros son de enorme utilidad puesto que dan idea de 
la robustez de cada uno de los modelos. Otra novedad de esta investigación 
es el pretratamiento de datos realizado. Así, los espectros NIR no se 
utilizaron tal cual, sino que los obtenidos en condiciones basales para cada 
individuo fueron substraídos de los obtenidos en condiciones post-basales. 
El objetivo de este tratamiento fue minimizar la variabilidad entre 
individuos para evitar el efecto de enmascaramiento de la variabilidad 
asociada a la ingesta de los desayunos. La aplicación del algoritmo VIPs 
(Variables Important in Projection) permitió identificar aquellas regiones 
espectrales de mayor peso estadístico para explicar la variabilidad 
observada en cada modelado de clases. Estas regiones espectrales 
coincidieron para todos los desayunos administrados, pero se detectaron 
diferencias en el nivel de significado de cada una de ellas. 
 
Capítulo 12 
 La investigación que compone el segundo capítulo de esta partetuvo 
como objetivo evaluar la utilización de la NMR en el estudio anteriormente 
descrito. En este caso las muestras se diluyeron con un tampón para ajustar 
el pH y con agua deuterada para la estabilización del campo magnético. El 
estudio se inició con la aplicación de una técnica de análisis no supervisado, 
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PCA, que permitió discriminar las muestras tomadas 4 h después de la 
ingesta de cada desayuno frente a las muestras control. Una vez detectado el 
mayor cambio metabólico ocasionado por la ingesta de cada desayuno, la 
siguiente etapa fue el desarrollo de modelos de discriminación entre pares 
de clases (muestras tomadas a las 4 h después de la ingesta de cada 
desayuno) basados en PLS-DA. Con este análisis se consiguieron capacidades 
de predicción entre 84 y 100% para los diferentes estudios comparando 
clases dos a dos.  
 Una ventaja frente al estudio anterior fue que las variables con 
mayor significado estadístico para explicar la variabilidad observada en cada 
estudio se correspondían con señales de desplazamiento químico, que 
pueden permitir la identificación de metabolitos mediante bases de datos 
adecuadas (en este caso Chenomx). Con estas consideraciones fue posible la 
identificación de metabolitos tales como ácidos glutámico y cítrico, lípidos y 
compuestos con grupos amino, tales como niacinamida, metilhistidina, 
creatina o creatinina como los principales responsables de las discriminacio-
nes estudiadas. 
 
Capítulo 13 
 El último de los capítulos de este bloque contiene la información 
sobre el estudio realizado utilizando LC–TOF/MS de alta resolución. En este 
caso también se ha utilizado una estrategia combinada de análisis no 
supervisado mediante PCA y supervisado mediante PLS-DA. Previamente, la 
matriz de datos se simplificó mediante la aplicación de un filtro por 
frecuencia al 50% (eliminación de aquellas entidades moleculares no 
presentes en al menos el 50% de las muestras pertenecientes a cada clase) y 
un análisis de cambio relativo (fold change analysis). El análisis mediante 
PCA permitió discriminar de forma clara los perfiles metabólicos 
pertenecientes a individuos 4 h después de la ingesta de forma 
independiente de cada desayuno preparado con los 4 aceites utilizados. Por 
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otro lado, el análisis mediante PLS-DA permitió discriminar entre los perfiles 
de metabolitos detectados en el suero extraído 4 h después de la ingesta de 
los desayunos preparados con los aceites fritos. Para ello, se compararon las 
clases de tres en tres. Así, en el primer estudio se compararon los perfiles 
metabólicos proporcionados por la ingesta de VOO, NSO y PSO 
consiguiéndose una capacidad de predicción por encima del 69% en 
validación cruzada, mientras que en el desarrollo del modelo fue del 100% 
para todos los aceites. En el segundo estudio, diseñado para la comparación 
de los perfiles metabólicos obtenidos tras la ingesta de VOO, NSO y DSO, se 
consiguieron capacidades de predicción mediante validación cruzada del 92, 
73 y 50%, respectivamente, mientras que la predicción en el desarrollo del 
modelo fue del 100%. Por tanto, se puede concluir que la capacidad de 
predicción para cada uno de los desayunos fue buena (a excepción del 
desayuno preparado con DSO, que presentó una baja capacidad de 
predicción en validación cruzada) teniendo en cuenta que se trata de un 
estudio biológico sobre nutrición. 
La alta resolución que se consigue con la técnica LC–TOF/MS 
incrementa la capacidad de identificación de los metabolitos de mayor 
influencia en la variabilidad observada en cada uno de los estudios mediante 
PLS-DA. Así, entre los metabolitos identificados se pueden citar azúcares, 
hormonas, lípidos, aminoácidos y otros compuestos minoritarios.  El 
potencial de identificación de los metabolitos con mayor peso estadístico es 
pues la principal ventaja de la plataforma utilizada en esta investigación. 
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 The present regulation of the University of Córdoba that deals with 
the writing of the Book of a Doctoral Thesis, in the modality in which the 
articles (published or close to publication) are included themselves, 
indicates that the report must include a section of discussion of the results. 
This regulation can be accomplished in a different extent, depending on the 
homogeneity of the developed research. Thus, as research in this Thesis has 
metabolomics as a common denominator, sections in this book are devoted 
to the development of analytical platforms based on the different strategies 
characteristic of this discipline. Therefore, the discussion of the results 
encompasses, a separated discussion of the developed platforms based on 
each strategy. An independent consideration deserves the publications on 
reviews devoted to operations previous to metabolomics analysis.  
 
PART 1: Sample preparation in metabolomics 
 
 During the first years of the Thesis the PhD student carried out an 
exhaustive bibliographic research in metabolomics, which led to alert about 
the poor attention paid to the analytical steps prior to detection. This fact 
was clearly highlighted in the meeting organized in 2005 by the 
Metabolomics Society (www.metabolomicssociety.org) that created the 
“Metabolomics Standard Initiative”, focused on standardization of the 
different steps and processes necessary to obtain information from 
metabolomics experiments. This initiative should allow transferability of 
analytical methods, thus making possible to exactly reproduce analytical 
conditions in any laboratory. This led to an in-depth study on these steps 
that, despite of being of enormous importance in the final results of the 
metabolomics experiment, have not received the deserved attention. 
Therefore, the purposes of Part 1 of this book was to develop a critical 
compilation of the reported methods in metabolomics, aimed at making a 
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better use of the existing information, together with a call for attention on 
the deficiencies and lags in this area. The extent of the overall review led to 
two publications in the same volume of TrAC (Trends in Analytical 
Chemistry) journal, which, with the highest impact index in Analytical 
Chemistry, leaded the Journal Citation Report (from the ISI Web of 
Knowledge). 
 In the first part of the review, entitled “Metabolomics analysis I. 
Selection of biological samples and practical aspects preceding sample 
preparation”, the characteristics of metabolomics analysis as compared to 
(and in relation with) other less recent omics are described. This also 
highlights the scant interest paid to the first steps of the analytical process in 
metabolomics, as demonstrated by the large number of publications on 
analytical instrumentation as compared to the few publications on sample 
preparation, despite of being a key aspect to obtain minimum errors or bias 
from the instruments. It is also worth describing the different strategies 
used in metabolomics, as sample preparation differs for each strategy; the 
review also includes a scheme where the reader can localize every step to be 
developed. These aspects led to a discussion on the selection of the most 
interesting biological material for sampling (mainly blood or urine, but also 
cells and tissues, in addition to other fluids such as breath, synovial fluid, 
bile, amniotic fluid, saliva, tears, breast milk or seminal plasma) and the way 
to quench the enzymatic activity in the sample to achieve representativeness 
in sampling. In addition, the most suitable sample storage protocol for each 
biological material depending on its characteristics have also been 
discussed, as it is the key to preserve sample integrity and avoid metabolites 
degradation, which mainly occurs because of repeated freezing/thaw steps. 
Consequences of inadequate storage protocols, as well as some advice about 
this step are emphasized in the review. 
The second part of the review, published under the title 
“Metabolomics analysis II. Preparation of biological samples prior to 
detection”, is devoted to sample preparation itself. Despite this step involves 
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all sub-steps to prepare analytes for detection, the fact that most of the 
detectors used in metabolomics are on-line connected to separation 
equipment (viz. a chromatograph or, less commonly, capillary electro-
phoresis equipment) leads to consider the end of sample preparation when 
the sample (or, more exactly, that remaining after preparation, with is called 
as “analytical sample”) reaches the separation system. The scarce innovation 
introduced in sample preparation so far is emphasized, as this step is usually 
developed by conventional approaches. This fact makes more noticeable the 
great achievements on separation–detection equipment. Enzymatic 
quenching for a fast analysis after sampling is described in detail.  
All this aspects precede the typical steps for analytes extraction from 
the sample matrix, usually carried out by liquid–liquid extraction or solid–
liquid extraction, depending on the physical state of the sample. The  most 
appropriate treatment for each metabolomics strategy, as a function of the 
matrix–analyte binomial, are critically discussed. The special case of 
sampling–sample preparation–analysis on cell cultures is separately 
considered, as required by its nature and special characteristics. Additional 
steps, such as derivatization, are also discussed in this review. It is worth 
noting the analytical criteria of the authors of this review, together with the 
experience on sample preparation of the team in which the PhD student is 
integrated. Both aspects allow a vision of these operations that can be of 
clear utility for biochemists, clinicians or other researchers who are not 
familiar with the critical study or the improvement of sample preparation in 
metabolomics. 
 
Part 2: Targeting analysis 
 
 This type of analysis, similarly to other strategies in metabolomics, 
has advantages and disadvanges, as it provides information limited to a 
group of compounds, which can be poor (when the complete information on 
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the metabolome is required) or too prolix (when a fingerprinting is the aim, 
with no interest in neither individual identification or quantitation). After 
defining the concrete analytical problem, targeting analysis is the best 
approach if quantification of a limited set of compounds (usually the 
precursors and metabolites of some pathways) is the aim. Development of a 
method based on this strategy involves an appropriate sample preparation 
(which necessarily consider optimization of sampling and storage), followed 
by an individual separation of the analytes (which can be exhaustive or not, 
depending on the analyzer finally used) and a detection system as sensitive 
as required by the concentration of the analytes. However, a 
preconcentration step can solve the problem caused by low-sensitive 
detection. Therefore, targeted analysis refers to methods enough selective to 
circumvet the potential interferents that can difficult qualitative–
quantitative analysis of the target compounds, but also to endow the 
methods with high sensitivity to detect very low concentrations. A total of 6 
methods have been developed based on this strategy using an assorted 
instrumentation, which has contributed to the formation of the PhD student. 
The aim in all cases has been to innovate in acceleration and automatization 
of sample preparation in order to improve the resulting characteristics of 
the overall method. After optimizing the main variables, a final application of 
the resulting method to natural samples is mandatory to demonstrate its 
usefulness. The methods developed in this Thesis have always been applied 
to either vegetables or clinical samples (in the latter case when the analytes 
have been those characteristic of urine, blood or even breast milk). 
 
Chapters 3 and 4 
 Estrogens and progestogens are a group of steroid sex hormones 
with essential functions in female metabolism. Among estrogens, the most 
abundant in women are estradiol, estriol and estrone, which can be 
endogenous (formed from colesterol through a biosynthetic pathway) or 
exogenous, frequently administrated as a part of oral contraceptives, in 
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estrogen replacement therapy of post-menopausal women, and in the 
treatment of menstrual disorders. Progesterone is the most abundant 
progestogen and also an intermediate compound in the steroidogenesis of 
estrogens, androgens and corticosteroids; while pregnenolone, the 
metabolic precursor  of progesterone, belongs to the group of neurosteroids. 
These hormones are the object of two of the published articles, which are 
present in urine (the type of sample for which the method has been 
developed) almost exclusively as conjugated metabolites such as 
glucuronides, sulfates, diglucuronides, bisulfates and sulfoglucoronides. The 
two more significant problems in the determination of these metabolites are 
the time required for enzymatic hydrolysis of the conjugates (between 12 
and 18 h) and the low concentrations at which they are in urine, in addition 
to the intrinsic complexity of this type of sample.  
The problem to be firstly overcome was to achieve the required 
sensitivity for their determination by using a cleanup/preconcentration 
system. Thus, solid-phase extraction allowed reducing sample volume from 
10 mL (a relatively high sample volume in clinical studies) to 150 μL of the 
analytical sample, with preconcentration factors ranging from 60 to 72. A 
“laboratory on a valve (lab-on-valve or LOV)” automated system was used 
for in parallel treatment of samples, which could be previously subjected to 
enzymatic hydrolysis, for determination of total steroids present in the 
sample (free and conjugated), or directly injected into the LOV system, to 
determine the free fraction. Optimization of the chromatographic step 
(liquid chromatography, LC) and subsequent analysis by electrospray 
ionization and triple-quad mass spectrometry, allowed reaching detection 
limits of 1.8 pg on column (0.06 ng/mL in sample), with relative standard 
deviations within 1.93–10.99%. 
The next challenge in this study was to shorten the required time for 
enzymatic hydrolysis by using ultrasound energy, taking advantage of the 
experience of the research group. Multivariate optimization of the variables 
involved in each step (both those characteristic of the ultrasound probe and 
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those of the biochemical system), led to a dramatic decrease of the time for 
this step, which was complete after 30 min. Automation of all steps for 
sample preparation support the reproducibility of the method and its 
usefulness for routine analysis of these metabolites.  
 
Chapter 5 
 Sphingolipids, a family of lipids endowed with a long amino-alcohol 
chain, known as sphingoid base, are components of biological membranes. 
Sphingolipids exert different functions in signal transmission and cell 
recognition, and their metabolism involves a number of synThesis and 
degradation pathways, as expected from the variety of sphingolipids present 
in cells. There are several diseases associated to sphingolipids and their 
metabolism; therefore, it would be of great interest to develop a sensitive 
method that allows their determination in human biofluids, as they are 
present at extremely low concentrations. Together with these low 
concentrations, their non-polar nature are the main bottlenecks for their 
analysis. The existing methods have been based mainly on liquid–liquid 
extraction, evaporation of the organic solvent and reconstitution prior to 
separation by LC. The use of phase-solid extraction has been restricted so far 
to manual methods that have required a high amount of both sample and 
reagents, and the added complexity of a derivatization step.  
 The method in Chapter 5 for the targeted analysis of spingolipid 
precursors (namely, D-sphingosine, D-erytro-diydosphingosine, sphingosine 
1-phosphate, and D-erytro-dihydrosphingosine 1-phosphate) has been 
applied to their determination in serum and urine. It is based on a sample 
preparation step, using an LOV system, which consists of solid-phase 
extraction and elution with the derivatizing reagent (o-phthaldialdehyde) 
dissolved in the eluent, prior to the chromatographic separation of the μ-LC 
and detection by laser-induced fluorescence. This type of detection provides 
excellent sensitivity, as demonstrated by the low limits of detection achieved 
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in the two biological fluids (within the ranges 4.2–10.2 and 0.56–1.36 ng/mL 
for serum and urine, respectively); the sample preparation was fully 
automated, which makes the method very appropriate for clinical analysis. 
Validation of the method was carried out by direct infusion of samples into a 
triple-quad mass-detector in mode of multiple reaction monitoring (MRM), 
aiming at comparing the results with those provided by the proposed 
method and confirming the identity of the target compounds. It is worth 
emphasizing that both sensitivity and precision of the proposed method is 
better than —or similar to, depending on the compounds— those of the 
validation method. 
 
Chapter 6 
 By contrast to the previously discussed metabolites —all them of 
lipidic nature— Chapter 6 deals with the analysis of a family of hydrophilic 
compounds: vitamin B9 (folic acid) and its metabolites. This vitamin is 
involved in a wide variety of biological processes, as long as it acts as 
enzymatic cofactor in the transference of methyl-group reactions. Due to the 
fact that a deficiency of folic acid is related with a number of diseases, and 
that it is involved in the synThesis of amino acids such as serine and 
methionine, quantification of this vitamin and its related catabolites in 
different biological fluids may allow to determine anomalies in their levels 
as a consequence of a disease or abnormal function. 
 With this aim, a method for quantification of these target metabolites 
in three different biological matrices (urine, serum and breast milk) was 
proposed, demonstratintg its versatility. It involved three steps: (i) Sample 
preparation by a commercial solid-phase extraction (SPE) system 
(Prospekt) working at high pressure. Once the analytes are retained in the 
sorbent cartridge, the eluent, which is the mobile phase of the 
chromatograph on-line connected to the Prospekt system, is pumped and 
the eluted compounds are led to the chromatographic column. Maximum 
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sensitivity is thus obtained and minimum analytes degradation, which are 
never in contact with the atmosphere. (ii) The chromatographic separation 
is carried out by an isocratic regime with high content of organic phase, 
thanks to the use a hydrophilic interaction column (HILIC); this favoured the 
following step. (iii) Detection, based on electrospray ionization prior to a 
triple-quad mass analyzer, was positively influenced by the conditions in 
step ii. Thus, the resulting method allows the determination of folic acid and 
its metabolites —N(p-aminobenzoyl)-L-glutamic acid and its acetamide 
derivative— with an excellent sensitivity (in the order of picomol fractions); 
thus making this method very appropriate for clinical analysis in cases of 
deficiency of these compounds. 
 
Chapters 7 and 8 
 The methods that constitute these chapters of the book have been 
applied to vegetable matrices. By contrary to the previous studies, these are 
solid matrices, making necessary to lixiviate analytes in a quantitative and 
reproducible manner.  
 Despite it is under the common denominator of Part II of the book 
(targeted analysis), method developed in Chapter 7 is not properly within 
the field of metabolomics, as the target compounds are not metabolites but 
degradation products formed from disinfection processes, so they do not 
belong to an endogenous biochemical pathway, but to the category of 
“disinfection by-products”. Among these compounds, 9 of the most 
significant haloacetic acids were selected (monochloro- and monobromo 
acetic acids, dichloro- and dibromo acetic acids, trichloro- and tribromo 
acetic acids; chrorobromo acetic- chlorodibromo acetic- and bromodichloro 
acetic acids). The objective was to develop a method adapted from the EPA 
reference method for drinking water to vegetable matrices that can be 
contamined by the effect of watering The method is based on the same steps 
and with the same individual separation and detection systems (gas 
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chromatography and electron capture detection, GC–ECD) but with 
acceleration and automation of the sample preparation step —very long in 
the EPA method— as the basic objective. The experience of the research 
group in which the PhD student is integrated in the design of dynamic 
systems and in the use of auxiliary energies was the support to construct a 
dynamic system in which the lixiviant, containing the derivatizing reagent, 
was recirculated through the sample, which was subjected to the action of 
an ultrasound probe. The change of direction at preset intervals of the 
lixiviating–derivatizing mixture avoided increased compactness of the solid 
sample, which occurs when the lixiviant circulates in a single direction. The 
joint effect of ultrasound and in situ derivatization of the lixiviated analytes 
into their methylated derivatives allowed to shorten the step from more 
than 2 h (required in the EPA method for extraction and subsequent 
derivatization) to only 10 min. An exhaustive optimization of the liquid–
liquid step prior to chromatographic separation and detection completed 
the method, which was successfully applied to the determination of the 
target analytes in vegetables such as spinach and chard. 
 Chapter 8 is devoted to a wide targeted analysis in tomato 
encompassing a number of metabolites such as carotenoids, provitamins, 
vitamins, phenols and sugars providing a complete profile of the target 
families. The compounds, grouped as a function of their nature into 
nutraceuticals (both hydrophilic and lipophilic) and carbohydrates (mono 
and disaccharides), were separated by LC and GC, respectively, and 
determined by mass spectrometry (triple-quad and ion-trap tandem-mass, 
respectively). The lixiviation step, accelerated by ultrasound energy, was 
carried out with a 3:1 tetrahydrofuran–methanol mixture, then evaporated 
to dryness. The dry extract was reconstituted in the appropriate medium for 
each chromatographic steps, which required derivatization (silylation) only 
in the case of sugars prior to injection into the gas chromatograph. 
Optimization of the chromatographic and detection steps, exhaustive for 
each group of compounds, together with the fast sample preparation, 
provide sensitive, selective, and precise methods for determination of these 
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groups of compounds, which can be used as markers to select either tomat 
varieties or collection time in cultivar improvements. 
 
Part 3: Global metabolic profiling 
 
 This strategy differs from others in metabolomics in its scope and 
analytical tools used. Thus, the scope of global metabolic profiling is to 
obtain the maximum information about metabolites existing in the biological 
system under study, which may require different approaches depending on 
their characteristics, i.e., if they are polar or non-polar and their 
concentration ranges. Global profiling methods seek to maximize the 
metabolite coverage, which is the number of detected metabolites in a given 
sample. Ideally, a complete metabolic profile should be obtained, which is 
unviable in the case of complex organisms such as plants (with 200000 
estimated metabolites) or humans (with 7900 metabolites indexed in the 
HMDB) due to the wide concentration ranges at which metabolites are 
present, usually within several orders of magnitude. With the aim of 
maximizing the number of identified metabolites in a given sample, it is 
possible to combine several sample preparation strategies (e.g. liquid–liquid 
extraction with different solvents, solid-phase extraction with different 
stationary phases, hydrolysis reactions for identification of conjugated 
metabolites) and/or detection techniques (liquid chromatography−mass 
spectrometry in simple (MS) or multiple (MS/MS) mode, by different 
ionization modes or different chromatographic separations; for instance, by 
using different stationary phases;  gas chromatography−mass spectrometry 
(GC MS or GC−MS/MS) with different temperature gradients, stationary 
phases or derivatization protocols; nuclear magnetic resonance (NMR) 
mono- or bidimensional, homo- or heteronuclear, etc., so as to achieve 
complementary results. Even after combining different analytical methods, it 
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is only possible identify a small fraction of the overall components in most 
cases. 
 In this research, chemometrics and bioinformatics have eventually 
been used to extract information after the application of the analytical 
platforms. In the former, different algorithms for data pretreatment are used 
to align chromatograms and MS or NMR spectra for an adequate comparison 
between samples, eliminate background noise or filter molecular entities 
non-associated with sample composition. With respect to the bioinformatic 
tools used in this research, these are constituted by a variety of metabolite 
databases to query results for a final identification. Therefore, the use of 
databases such as METLIN (Scripts Center for Metabolomics and Mass 
Spectrometry) or HMDB (Human Metabolome Database) are essential to 
obtain accurate identification. In the case of MS, which is the main analytical 
platform used in this part of the research, a first step in identification 
involves elucidation of molecular formulas from composite spectra. Thus, 
different algorithm are applied for generating these formulas, entailing: (i) 
location and grouping of all the ions related to a given molecule (e.g. peak 
covariance for all ions with the same retention time, the charge envelope 
and/or the presence of dimmers and adducts ions) by means of the 
molecular features extraction algorithm (MFE), and (ii) generation of 
molecular formulas themselves by the Molecular Formula Generator 
algorithm (MFG) after correcting mass accuracy, isotopic distribution and 
abundance. Afterwards, database search allows adjusting every feature with 
a mass abundance window (in this research, below 10 ppm of difference 
between experimental and theoretical masses) and confirming biological 
occurrence of compounds in the examined biofluids, for nutritional or 
clinical applications. Following this scheme, research carried out by this 
strategy was focused on obtaining metabolic profiles of biofluids with non-
invasive sampling, such as saliva and milk, which are fluids still unexploited 
in metabolomics. All these aspects are described in Chapters 9 and 10, 
constituting part 3 of this book. 
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Chapters 9 and 10 
 Bearing in mind the scarce reports dealing with metabolic profiling 
of saliva and human breast milk, research was focused on the development 
of optimum protocols for sample preparation to maximize the number of 
metabolites detected and identified by LC−TOF/MS. With this aim, and 
considering the very different nature of saliva and milk, optimization 
involved different steps. 
 Saliva is a biofluid that is gaining importance as an interesting source 
of biomarkers without needing healthcare personnel for sampling. 
Moreover, saliva composition may reflect values of several metabolites in 
blood, which makes this biofluid suitable for indicating the physiological 
state of an individual. The main contribution of the research enclosed in 
Chapter 9 was the optimization of sample preparation to obtain a complete 
LC−TOF/MS metabolic profile. Thus, the protocol started with a hydrolysis 
(acidic or basic) step to release metabolites that may be conjugate to other 
molecules (such as proteins). The results were compared to other protocols 
without enzymatic hydrolysis, in every case followed by LC−TOF/MS 
detection in both positive and negative modes. Venn diagrams shows 
unequivocally the need of a hydrolysis step, which was accelerated (as it 
lasted 30 min) by ultrasound, and reduced to 10 min. Furthermore, US-
assisted hydrolysis led to an increase of the molecular features with respect 
to the non-hydrolyzed sample, especially for positive ionization mode. 
Afterwards, a preconcentration step was carried out to increase the number 
of molecular features (174 in positive mode and 84 in negative mode for 
acidic hydrolysis and 150 and 70, respectively, for basic hydrolysis). Once 
sample preparation protocols were optimized, identification of the extracted 
molecular features was carried out by comparing with the METLIN and 
HMDB, being worth noting the absence of metabolites indexed for saliva. 
This fact, as well as the presence of exogenous compounds from foods 
intake, complicated identification. 
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 Conclusively, a total of 12 compounds in negative ionization and 91 
in positive (with a mass tolerance below 10 ppm) were identified from 
acidic hydrolysis, while 13 and 52 were found from basic hydrolysis, 
respectively. The detected metabolites, including sugars, lipids, amino acids, 
antioxidants and other minor components, were exhaustively justified and 
contrasted. 
 On the other hand, Chapter 10 focuses on global profiling of maternal 
milk. In this case, sample preparation started with a deproteinization, with 
or without subsequent centrifugation, with considerable differences 
between them. Venn diagrams clearly show these differences in the number 
and nature of detected metabolites depending on the inclusion of a 
centrifugation step, although showing a different pattern when 
deproteinization was carried out in acidic medium (10% formic acid in 
methanol). On the other hand, the presence of both polar and non-polar 
fractions involved liquid–liquid extraction of samples with methanol–
chloroform, for polar and non-polar extraction, respectively. The presence of 
common metabolites in both phases justified the use of liquid–liquid 
extraction, and combination of these strategies allowed increasing the 
number of detected metabolites. Finally, preconcentration by evaporation 
and reconstitution in an organic solvent increased three times the number of 
detected metabolites.  
 After applying the extraction algorithm, mass spectra from both 
positive and negative ionization modes provided molecular features. Finally, 
to search in the METLIN and HMDB for identification and confirmation of 
the presence in humans was carried out. This led to a total of 29 metabolites 
in polar and non-polar fraction in positive and 33 in negative modes. The 
metabolic profile obtained from monodimensional 1H-NMR allowed to 
obtain a fingerprint that complemented results from LC−TOF/MS, in this 
case with minimum sample preparation. 
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 This study highlights for the first time the importance of pH, 
centrifugation and liquid–liquid extraction in sample preparation of this  
type of samples. Significant characteristics of this research was the need for 
deproteinizing samples, the wide range of concentration of metabolites and 
the variable number of compounds likely to be solved in acidic medium by 
the presence of ionisable groups. Therefore, the global profiling approach 
offers the possibility to analyze a global profile of a biological fluid that can 
be interesting from a clinical or nutritional point of view. 
 
 Part 4: Metabolomics fingerprinting 
 
 The last strategy used in metabolomics aims at obtaining 
representative profiles or fingerprints from a group of samples that allow 
discriminating against other defined or non-defined classes. Analytical 
platforms frequently used in this discipline are mainly spectrometrics, as 
they generate a spectrum representative of sample composition. Concretely, 
NMR, MS by direct infusion or with short chromatographic or 
electrophoretic separation, and, less frequently, FT-IR are the leading 
techniques for fingerprinting. The research developed in this part of the 
Thesis was based on these three analytical platforms; FT-IR in near-infrared 
region (NIRS), mono-dimensional NMR and LC−TOF/MS. 
 Metabolomics fingerprinting methods usually entail direct analysis 
methods, as far as it is possible, to simplify the analysis of a great number of 
samples for representative results and minimize alterations in sample 
composition. This is quite usual in NMR and NIRS, whereas direct analysis 
by MS is not frequent, except for aqueous samples with moderate salts 
content. Therefore, in this last part of the book, sample selected for 
fingerprinting analysis was urine, involving direct analysis for NIRS, and 
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dilution for NMR and LC−TOF/MS. Thus, deproteinization was not necessary 
due to the very low proteins content in urine. 
 Metabolomics fingerprinting cannot be carried out without 
employing multivariate analysis techniques that allow reducing 
dimensionality of the raw data usually obtained, which forms matrices of n 
samples x m variables. These techniques have in common the detection of 
classes or groups within the population following a certain criterium, which 
may be included (supervised) or not (non-supervised) during the model 
development. In this part of the Thesis both supervised and non-supervised 
strategies have been combined with the following aims: (i) to detect the 
presence of clustering according to the aim of the study or by extrinsic 
causes (for instance, anthropologic characteristics) by principal component 
analysis(PCA); (ii) to build prediction models with one or more response 
variables (information that has to be included in the model) by partial least 
squares (PLS) by different algorithms. Afterwards, the aim was to find 
metabolites or families of metabolites that enabled to explain the observed 
variability in each model. Thus, different tools such as ANOVA or Fold 
Change analysis allowed the identification discriminating metabolites with 
higher influence in the explained variability. 
 This scheme has been applied to nutrimetabolomics to evaluate the 
effect of the intake by obese individuals of breakfasts prepared with 
different vegetable oils after deep-frying. Urine samples from these subjects 
were obtained before and 2 and 4 h after the intake. With the aim of 
increasing the statistical relevance of the study, breakfast intake was carried 
out after a period of 2 weeks to recovering basal conditions. The oils used in 
this study were: (i) extra virgin olive oil (VOO) with a final concentration of 
total phenols of 400 µg/mL expressed as µg/mL of caffeic acid by the 
Folin−Ciocalteu test; (ii) pure refined sunflower oil with nil content in 
phenolic compounds (NSO); (iii) refined high-oleic sunflower oil that was 
spiked at 400 µg/mL with a synthetic lipophilic oxidation inhibitor 
(dimethylsiloxane, DSO); and (iv) refined high-oleic sunflower oil (PSO) that 
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was enriched with an extract of hydrophilic phenols isolated from olive 
pomace at 400 µg/mL of total phenols expressed as caffeic acid.  
 Therefore, three different analytical strategies were used, as 
explained in Chapters 11 to 13. The order followed was based on the 
increasing level of information obtained from each instrumental platform. 
 
Chapter 11 
 This chapter is devoted to the use of NIRS to obtain urinary 
fingerprints. This technique is the less applied to fingerprinting. In fact, it 
has been only used with classification and prediction purposes, as it has 
scarce capacity to unequivocally identify metabolites. Among its strengths, it 
is worth noting its rapidity, the possibility to directly analyze samples (even 
solid samples such as tissues), the easiness to use and the low acquisition 
and maintenance costs of the equipment.  
 The research was based on the use of a modelling technique by 
supervised PLS-CM (Partial-Least Squares- Class Modelling), which served to 
develop four models, one for each breakfast intake. In comparison to other 
PLS techniques based on discriminant analysis (PLS-DA), PLS-CM gives 
information about spectral characteristics of each class and estimates 
sensitivity (capacity of the model to predict samples from the modelled 
class) and specificity (capacity of the model to discriminate from samples 
belonging to other classes) for the model development and class validation.  
Both parameters are very useful as they describe the robustness of each 
model. Other novelty of this research is the data pretreatment. Thus, 
spectral data were not used themselves, but blank spectra were subtracted 
from the spectra obtained after intake. The aim was to minimize variability 
among individuals to avoid the effect of hindering variability associated to 
breakfast intake. The use of VIP algorithm (Variables Important in 
Projection) led to identify spectral regions with the highest statistical 
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relevance to explain variability observed in each model. These regions were 
the same for all classes, but differences in the significance levels were found. 
 
Chapter 12 
 This chapter was focused on the use of NMR for the aforementioned 
nutritional study. In this case, samples were diluted for pH adjustment with 
buffer and deuterated water to lock the magnetic field strength. The study 
started with  the application of a non-supervised analysis technique (PCA) to 
discriminate samples taken 4 h after intake against control samples. Once 
identified the biggest metabolic change associated to breakfast intake for 
each breakfast, the next step was the development of discrimination models 
between pairs of classes (with samples taken 4 h after intake) based on PLS-
DA. By this analysis, accuracy levels of prediction between 84 and 100% 
were achieved. 
One advantage of this study as compared with the previous one is 
that signals associated to a larger variability between classes corresponded 
to chemical shifts in the NMR spectra, which were used to identify 
metabolites by peak assignement with Chenomx and HMDB database. With 
these premises, it was possible to identify glutamic acid, citric acid, lipids 
and compounds with amino groups, such as niacinamide, methylhistidine 
creatine and creatinine, as responsible for variability among classes. 
 
Chapter 13 
 The last chapter of this book was devoted to the analysis by high 
resolution LC−TOF/MS. In this case, a combined strategy based on 
supervised and non-supervised analysis by PLS-DA and PCA, respectively, 
was also used. In a previous step, the raw data matrix obtained from the 
analysis of all samples was simplified by applying a filter by frequency, thus 
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eliminating all molecular features that were not present in at least 50% of 
samples in each class, and a Fold Change filter. The PCA analysis allowed 
discriminating metabolic profiles detected in urine taken 4 h after intake. On 
the other hand, PLS-DA was used to discriminate metabolites from classes 
comparing breakfastss in groups of three, using samples after 4 h from 
intake. Thus, the first study provided discrimination between NSO, PSO and 
VOO with more than 69% of prediction accuracy in cross validation. In the 
second study, VOO, NSO and DSO classes were compared, giving prediction 
capabilities above 92, 73 and 50% by cross validation, with accuracy levels 
for model development of 100%. Therefore, it can be concluded that 
prediction capability for each class was good taking into account the use of 
biological samples, which implies a high degree of variability. The less 
favorable prediction for cross validation was obtained for DSO. 
 Finally, the high resolution achieved by this technique increases the 
identification capability; thus, metabolites with a higher significance in 
explained variability were identified. It is worth noting the presence of 
sugars, hormones, lipids, amino acids and other minor compounds, the 
metabolism of which is affected by intake of these oils. The potential for 
unequivocally identifying these compounds was the greatest advantage of 
this application. 
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 Un estudio en profundidad de la bibliografía en metabolómica ha 
permitido evaluar críticamente el estado actual de las etapas que preceden 
al análisis (selección de la muestra, muestreo, conservación y preparación), 
mostrando sus deficiencias o carencias y proporcionando así pautas para la 
investigación en esta parcela de la metabolómica,  que, hasta la fecha, no 
había recibido una adecuada atención. 
 Se ha planteado el uso de las tres estrategias características de la 
metabolómica con objetivos típicos de cada una de ellas. 
 
 Así, el análisis orientado se ha usado en el área clínica 
(principalmente en lipidómica, pero también en otras sub-disciplinas de la 
metabolómica) y en metabolómica vegetal para realizar los siguientes 
estudios: 
(i)         El desarrollo de un método para la determinación de hormonas 
esteroideas femeninas en orina cuyas características analíticas 
están basadas en la reducción drástica del tiempo requerido para 
la hidrólisis enzimática gracias a la acción de una sonda de 
ultrasonidos, el desarrollo miniaturizado y automatizado de la 
etapa de limpieza y concentración de los analitos mediante un 
sistema lab-on-valve previa a la adecuada separación por 
cromatografía de líquidos y a la cuantificación sensible y 
selectiva mediante espectrometría de masas de triple cuadrupolo 
tras la ionización por electroespray. 
(ii)          El diseño de una configuración instrumental para la 
determinación de precursores de esfingolípidos basada en un 
sistema lab-on-valve para la preparación de la muestra —sangre 
u orina— mediante extracción en fase sólida, y posterior 
derivatización de los analitos de forma simultánea con la elución 
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(inclusión del agente derivatizante —o-ftaldialdehído— en el 
eluyente). Esta configuración aceleró de forma drástica la etapa 
de preparación de la muestra. Se llevó a cabo la separación 
individual de los productos de derivatización de los analitos 
mediante el uso de un micro-cromatógrafo de líquidos con 
detección por fluorescencia asistida por láser. La aplicación de 
esta configuración dio lugar a un método que resultó ser tanto o 
más sensible que el basado en el uso de un detector de masas de 
triple cuadrupolo utilizado para la validación.  
(iii) También en el área clínica, pero para analitos hidrosolubles, se 
ha puesto a punto un método de determinación de ácido fólico 
(vitamina B9) y sus metabolitos en suero, orina y leche materna 
en el que se han alcanzado límites de detección muy bajos con los 
que poder diagnosticar estados de deficiencia de esta vitamina. 
Para ello se ha utilizado un sistema de extracción en fase sólida 
automático que trabaja a alta presión y está conectado en línea 
con el cromatógrafo, lo que permite que alcance la cabeza de la 
columna de interacción hidrofílica todo el eluido del cartucho 
utilizando fase móvil cromatográfica como eluyente. Un detector 
de masas de triple cuadrupolo completa el equipo analítico para 
el desarrollo de este método. 
 Se han desarrollado dos métodos basados en análisis orientado para 
compuestos en muestras vegetales.  
(iv)        El primero para la determinación en plantas de los subproductos 
de desinfección constituidos por los ácidos haloacéticos, en el 
que la etapa de preparación de la muestra se acortó 
enormemente con respecto al de referencia de la EPA gracias a la 
lixiviación asistida por ultrasonidos y a la integración de esta 
etapa con la de derivatización, para la posterior separación–
determinación mediante cromatografía de gases y detección por 
captura electrónica. 
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(v)         El desarrollo de tres métodos  basados en la utilización de 
cromatografía de gases y de líquidos con detección por 
espectrometría de masas ha permitido obtener perfiles de 
compuestos de interés nutracéutico tales como carotenoides, 
provitaminas, vitaminas, fenoles e hidratos de carbono 
(mayoritariamente azúcares). El interés de estas metodologías 
radica en su uso potencial como marcadores en programas de 
mejora de la calidad del tomate mediante la selección de 
variedades y el establecimiento del tiempo óptimo de 
recolección. 
 
 La obtención del perfil metabólico se ha orientado a fluidos 
biológicos poco estudiados con lo que: 
 
(vi)        Se han puesto a punto protocolos de preparación de muestra 
complementarios para la obtención de perfiles metabólicos 
mediante LC–TOF/MS de fluidos biológicos de muestreo no 
invasivo y poco o nada utilizados hasta la fecha en este tipo de 
estrategia: Saliva y leche materna. El estudio exhaustivo de las 
etapas implicadas en la preparación de la muestra y la aplicación 
de la plataforma analítica utilizada (complementada en el caso de 
leche con NMR) han permitido obtener resultados excelentes en 
términos de número de metabolitos identificados en estos 
fluidos. La composición de metabolitos presentes en ambos 
biofluidos, no considerados en las actuales bases de datos de 
metabolómica, incrementa el interés de los estudios realizados 
poniendo de manifiesto las buenas características de los 
protocolos desarrollados. 
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 La estrategia de la huella dactilar metabolómica ha sido utilizada en 
un estudio de nutrimetabolómica destinado a la comparación de los efectos 
metabólicos causados por la ingesta independiente de cuatro desayunos 
preparados con aceites vegetales sometidos a fritura. Este bloque ha sido 
abordado con la utilización de tres plataformas analíticas que han permitido 
obtener las siguientes conclusiones: 
  
(vii) La espectrometría de NIR junto a la técnica multivariante 
adecuada, en este caso PLS-CM, es de especial utilidad para el 
desarrollo de modelos predictivos en estudios de 
nutrimetabolómica. En este caso se ha demostrado la utilidad de 
un pretratamiento de datos dirigido a la substracción de los 
espectros obtenidos para cada individuo en estado basal de los 
obtenidos tras la ingesta de los desayunos preparados con cada 
uno de los aceites. La utilización de la técnica de PLS-CM ha 
demostrado un gran potencial para el modelado de cada una de 
las clases estudiadas.  
 
(viii) La espectrometría de NMR combinada con un técnica 
multivariante, en este caso PLS-DA, ha permitido avanzar un 
nivel respecto al estudio anterior en términos de información 
biológica. En concreto, se ha podido detectar la mayor 
variabilidad frente al estado basal en las huellas dactilares 
correspondientes al tiempo de muestreo de 4 h después de la 
ingesta. Además, el mayor poder de resolución de la NMR ha 
quedado patente con la identificación de aquellos metabolitos 
con mayor significado estadístico para explicar la variabilidad 
observada.   
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(ix)        El uso de LC–TOF/MS ha hecho posible la obtención del máximo 
nivel de información biológica mediante el desarrollo de 
modelos discriminantes que permiten predecir el desayuno 
ingerido comparando dietas tres a tres. Además, la alta 
resolución, soportada en el análisis cromatográfico y en la 
espectrometría de masas en modo exactitud de masa, ha 
permitido alcanzar el mayor número de metabolitos 
identificados, además de poder diferenciar aquellos compuestos 
con mayor significado estadístico para cada una de las ingestas. 
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 An in-depth study of the literature in metabolomics has allowed a 
critical assessment of the present situation of the steps previous to analysis 
(sample selection, sampling, storage and preparation), showing its 
deficiencies or lacks; thus providing patterns for research in this step which 
had not received appropriate attention so far. 
 The three characteristic strategies of metabolomics have been used 
with the typical objectives of each. 
 
Targeting analysis has been used in the clinical area (mainly in lipidomics, 
but also in other metabolomics sub-disciplines) and in plant metabolomics 
to develop the following studies: 
(i)        The development of a method for the determination of female 
esteroid hormones in urine, with analytical characteristics based 
on the drastic reduction of the time required for enzymatic 
hydrolysis thanks to the action of an ultrasound probe, the 
miniaturized and automatized development of cleanup and 
concentration of the analytes by a lab-on-valve system prior to 
the appropriate individual separation of the analytes by liquid 
chromatography, sensitive and selective quantitation by 
electrospray ionization and triple-quad mass detection. 
(ii)        The use of an instrumental configuration for the individual 
determination of sphingoid precursors, based on a lab-on-valve 
system for sample preparation of serum and urine —by solid-
phase extraction and derivatization of the target analytes, 
carried out simultaneously to elution (by solving the derivatizing 
agent, o-phthaldialdehyde, in the eluant)— and final quantitation 
by laser-induced fluorescence. This configuration drastically 
accelerated sample preparation. By means of a micro-LC, the 
analytes were individually separated and finally identified and 
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quantified by laser induced fluorescence. The resulting method 
was equal to, or more sensitive than, that based on a triple-quad 
mass detector, used for confirmatory analysis.  
(iii) Also in the clinical area, but for hydrosoluble analytes, a method 
for the determination of folic acid (vitamin B9) and its 
metabolites in serum, urine and breast milk has been developed. 
The very low limits of detection achieved allow determination of 
deficiency states of this vitamin. For this achievement, an 
automated system for solid phase extraction working at high 
pressure has been coupled on-line to a liquid chromatograph, 
thus allowing that all the eluate reached the chromatographic 
column of hydrophilic interaction by using the chromatographic 
mobile phase as eluent. A triple-quad mass spectrometer 
completed the analytical equipment for development of this 
method. 
 Two methods have been developed for targeting analysis of 
compounds in vegetable samples. 
(iv)       The first method for the determination in plants of disinfection 
byproducts, constituted by haloacetic acids, in which the sample 
preparation step was drastically shortened as compared with the 
reference EPA method. The shortening of this step was achieved 
by assisting leaching with ultrasound and integrating this step 
with derivatization as overall step prior to individual 
separation–determination by gas chromatography and electron-
capture detection. 
(v)         The development of three anaylytical methods based on the use 
of gas and liquid chromatography with mass spectrometry led to 
obtain profiles of compounds with great interest as 
nutraceuticals, such as carotenoids, provitamins, vitamins, 
polyphenols, and carbohydrates (mainly sugars). The interest of 
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these methods relies on their potential use as biomarkers in 
programs of tomato improvements, to enhance product quality 
by cultivar selection and know the optimum time for harvesting. 
 
 Metabolomic profiling approaches have been devoted to the analysis 
of samples scarcely studied; thus: 
(vi) Sample preparation protocols have been developed to obtain 
complementary metabolomic profiles by LC–TOF/MS of 
biological fluids of non-invasive sampling that have been 
scarcely or never used so far for this type of metabolomic 
strategy: saliva and breast milk. The exhaustive study of the 
steps involved in sample preparation and the application of the 
analytical platform LC–TOF/MS (complemented with NMR in 
the case of milk samples) have made possible to obtain excellent 
metabolomics profiles. The presence of metabolites that had not 
been identified previously demonstrated the great potential of 
the developed protocols. 
 
 Metabolomics fingerprinting approaches have been used in a 
nutrimetabolomics study aimed at comparing the metabolic effects of the 
intake of four different meals, prepared with fried vegetable oils. This part 
has bee carried out by using three different analytical platforms, which led 
to the following conclusions:  
(vii) Near-infrared spectrometry, together with a multivariant 
technique (PLS-CM) was used to build predictive models. In this 
nutritional, the effectiveness of sample pretreatment based on 
substraction of spectra obtained in basal conditions to those 
obtained after meals intake. The use of PLS-CM has 
demonstrated to provide great results for modelling every class. 
  
556 
Nuevas plataformas analíticas en metabolómica                                                                                    
(viii) NMR spectrometry, combined with a multivariant technique 
(PLS-DA), allowed to obtain a step forward in the information 
obtained for this study. Thus, the metabolic fingerprints obtained 
4 h after intake were significatively more different from blank 
samples than in the previous study. Moreover, the higher 
resolution capability of NMR was evident for identification of 
several compounds related to oils intake. 
(ix)        LC-TOF/MS allowed to obtain the maximum level of biological 
information by the development of discriminant models by PLS-
DA, which allowed predicting meals intake by comparing 
breakfasts in groups of three. Furthermore, the higher resolution 
of this technique and the use of high-accuracy mass 
spectrometry led to identify a great number of compounds that 
where statistically related to the intake of each breakfast.  
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An approach to the phytochemical profile of rocket 
(Eruca sativa (Mill.) Thell) 
Myriam Villatoro-Pulido, Feliciano Priego-Capote, Beatriz Álvarez-Sánchez, 
Shikha Saha, Mark Philo, Sara Obregón-Cano, Antonio De Haro-Bailón5, Rafael 
Font, Mercedes Del Río-Celestino 
 
Abstract 
 
The purpose of this study was to determine the profile of different 
families of compounds with nutraceutical and organoleptical properties in 
leaves or four rocket accessions (Eruca vesicaria subsp. sativa). The target 
families were glucosinolates, isothiocyanates, phenolic compounds, 
carotenoids and carbohydrates. The four accessions were named according 
to the total content of glucosinolates that ranged from 14.02 to 28.24 μmol/ 
g of dry weight. Glucoraphanin represented up to 52% of the total 
glucosinolate content in leaves (high glucosinolate content 1 accession). 
Accessions showed differences in the hydrolysis of glucoraphanin and 
formation of the isothiocyanate, sulforaphane. Data showed no correlation 
between both compounds in leaves, which suggested differences in the 
myrosinase activity within accessions. In addition leaves of rocket had 
variable phenolic profiles represented by quercetin-3-glucoside, rutin, 
traces of myricetin, quercetin and phenolic acids such as ferulic and p-
coumaric acids. The total carotenoid content ranged from 16.2 to 275 μg/g 
of dry weight revealing a high variability. Lutein was the main carotenoid 
ranging from 8.3 to 124.3 μg/g dw. The low glucosinolate content 2 
accession is a good candidate for future breeding programs because of its 
pattern of healthy beneficial related compounds. However, further research 
is essential to evaluate the biological activity of these four accessions, 
assessing the possible non-desirable effects before planning strategies to 
design functional food and improving consumer’s health. 
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Abstract 
 The present importance of metabolomics to go inside the unsolved 
secrets of living organisms, as a single discipline or together with other 
omics, has open the interest in the analytical platforms to obtain proper 
metabolomic information. The steps involved in developing these platforms 
(viz. sampling, sample storage, sample preparation, individual metabolites 
separation, if required, and detection) are critically discussed as a function 
of the type of organism under study, the type of sample and the families of 
metabolites to be analyzed. An overview of the fundamentals of key 
equipment in metabolomics, such as that based on nuclear magnetic 
resonance or mass spectrometry is also given for better understanding of its 
usefulness in this discipline.  
Key words 
Metabolomics; analytical platforms; mass spectrometry; nuclear magnetic 
resonance; biological samples; sample preparation; gas chromatography; 
liquid chromatography. 
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  ACE unidad de extracción en fase sólida  
ANOVA análisis de varianza 
a-pABGA derivado acetamida de ácido L-glutámico N-(p-aminobenzoilo) 
BDCAA ácido  bromodicloro acético 
CBAA ácido clorobromo acético 
CDBAA  ácido clorodibromo acético 
CE electroforesis capilar 
DAD detector de diodos en fila 
DBAA ácid dibromo acético 
DCAA ácido dicloro acético  
DSO aceite de girasol enriquecido con dimetilsiloxano 
ECD detección por captura electrónica 
ESI ionización por electrospray 
FA ácido fólico 
FC estimación de cambio relativo 
FIA Análisis por inyección en flujo 
FT-IR espectrometría de reflectancia en el infrarrojo por transformadas de 
Fourier 
GC cromatografía de gases 
HILIC cromatografía líquida con fase estacionaria de interacción hidrófila 
HPD bomba de alta presión dispensadora de disolventes 
LC cromatografía líquida 
LIF  fluorescencia inducida por láser 
LLE extracción líquido–líquido 
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LOV laboratorio en válvula 
MBAA ácido monobromo acético 
MCAA ácido monocloro acético 
MS espectrometría de masas 
MS/MS espectrometría de masas en tándem 
NIRS espectrometría de reflectancia en el infrarrojo cercano 
NSO aceite de girasol natural 
OPA o-ftaladialdehído 
pABGA ácido L-glutámico N-(p-aminobenzoilo) 
PCA análisis por componentes principales 
PLS-CM 
análisis discriminante de componentes principales por modelado de 
clases 
PLS-DA análisis discriminante de componentes principales  
PSO aceite de girasol enriquecido con polifenoles  
qQq espectrómetro de masas de triple cuadrupolo 
RMN resonancia magnética nuclear 
RP-C18 cromatografía líquida con fase estacionaria reversa C-18 
Sa D-eritro-dihidroesfinganina 
Sa1-P  D-eritro-dihidroesfingosina 1-fosfato 
So D-esfingosina 
So-1P esfingosina 1-fosfato 
SPE  extracción en fase sólida 
SRM seguimiento de reacciones múltiples  
TBA ácido tribromo acético 
TCAA ácid tricloro acético 
TOF espectrómetro de masas de tiempo de vuelo 
VOO aceite de oliva virgen 
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µLC micro-liquid chromatograpy 
1D-NMR monodimensional Nuclear Magnetic Resonance 
2D-NMR bidimensional Nuclear Magnetic Resonance 
ACE automatic cartridge exchange 
a-pABGA para-aminobenzoglutamic acid acetamide-derivative 
AU absorbance units 
BDCAA bromidichloroacetic acid 
BPC base peak chromatogram 
BSTFA N,O-Bis(trimethylsilyl)trifluoroacetamide  
CDBAA chlorodibromoacetic acid 
CE capillary electrophoresis 
CHD coronary heart disease 
CI chemical ionization 
COSI correlation spectroscopy 
CV coefficient of variation 
D2O deuterated water 
DAD diode array detector 
DBPs disinfection by products 
DSO sunflower oil enriched with dimethylsiloxane 
ECD electron capture detection 
EI electron impact 
EMV electron multiplier voltage 
EPA environmental protection agency 
ESI electrospray ionization 
FA folic acid 
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FC fold change 
FDA food and drug administration 
FIA flow-injection analysis 
FMASE focused microwave-assisted Soxhlet extraction 
FTIRS Fourier transform-infrared spectroscopy 
GC gas chromatography 
GMs genetic modifications 
HAA haloacetic acids 
HILIC hydrophilic interaction chromatography 
HMBC heteronuclear multiple-bond correlation spectroscopy 
HMDB human metabolome database 
HPD high-pressure delivery unit 
HSQC heteronuclear single-quantum correlation spectroscopy 
HUSERMET human serum metabolites database 
IS internal standard 
IT ion trap 
KEGG Kyoto encyclopedia of genes and genomes 
LC liquid chromatography 
LIF laser-induced detection 
LOD limit of detection 
LOQ limit of quantification 
LOV lab-on-valve 
MALDI matrix-assisted laser desorption/ionization 
MAS magic angle spin 
MCA metabolic control analysis 
MCAA monochloroacetic acid 
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MFE molecular features extraction 
MIAMET minimum Information about a metabolomics experiment 
MRM multiple reaction monitoring 
MS mass spectrometry 
MSI metabolomics standard initiative 
MS/MS tandem mass spectrometry 
MUFAs mono-unsaturated fatty acids 
NIRS near-infrared spectrometry 
NMR nuclear magnetic resonance 
NOESY nuclear overhauser effect spectroscopy 
NSO non-treated sunflower oil 
OPLS-DA orthogonal projections to latent structures discriminant 
analysis 
pABGA para-aminobenzoglutamic acid 
PCA principal components analysis 
PLS-CM partial least squares-class 
PLS-DA Modelling 
PP peristaltic pump 
PSO poliphenols-enriched sunflower oil 
PUFA poliunsaturated fatty acid 
Q1 first Quadrupole 
Q3 third Quadrupole 
QqQ triple quadrupole mass detector 
RBC red blood cells 
RFU relative fluorescence units 
RP-LC reverse-phase-liquid chromatography 
RSD relative standard deviation 
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S/N signal-to-noise ratio 
Sa sphinganine 
Sa1P sphinganine-1-phosphate 
SIM single-ion-monitoring 
SLs sphingolipids 
So sphingosine 
So1P sphingosine 1-phosphate 
SPE solid phase extraction 
SRM single reaction monitoring 
SV switching valve 
TBAA tribromoacetic acid 
TCAA trichloroacetic acid 
TIC total ion chromatogram 
TMCS trimethylchlorosilane 
TOCSY total correlation spectroscopy 
TOF time-of-flight mass spectrometer 
TSP trimethylsilyl-propionate 
U enzimatic activity 
UPLC ultra-high performance liquid chromatography 
US ultrasound 
USAEH ultrasound-assisted enzymatic hydrolysis 
VOO virgin olive oil 
 
 
